{"nbformat":4,"nbformat_minor":0,"metadata":{"colab":{"provenance":[],"authorship_tag":"ABX9TyP75NZiGz+7TdDMOnSpbVR9"},"kernelspec":{"name":"python3","display_name":"Python 3"},"language_info":{"name":"python"}},"cells":[{"cell_type":"code","source":["import spacy\n","import pandas as pd\n","\n","# Pastikan Anda sudah menginstal model en_ner_bc5cdr_md:\n","!pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.5.3/en_ner_bc5cdr_md-0.5.3.tar.gz\n","nlp = spacy.load(\"en_ner_bc5cdr_md\")\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"tCvJYfxs-suX","executionInfo":{"status":"ok","timestamp":1736739019396,"user_tz":-420,"elapsed":73664,"user":{"displayName":"Nurul Mutiah","userId":"18371090533349483196"}},"outputId":"390e67fe-674d-4d59-92d9-1c3e9a3df505"},"execution_count":1,"outputs":[{"output_type":"stream","name":"stdout","text":["Collecting https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.5.3/en_ner_bc5cdr_md-0.5.3.tar.gz\n","  Downloading https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.5.3/en_ner_bc5cdr_md-0.5.3.tar.gz (119.8 MB)\n","\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m119.8/119.8 MB\u001b[0m \u001b[31m6.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n","\u001b[?25h  Preparing metadata (setup.py) ... \u001b[?25l\u001b[?25hdone\n","Collecting spacy<3.7.0,>=3.6.1 (from en_ner_bc5cdr_md==0.5.3)\n","  Downloading spacy-3.6.1-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (25 kB)\n","Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.11 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (3.0.12)\n","Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (1.0.5)\n","Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (1.0.11)\n","Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (2.0.10)\n","Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (3.0.9)\n","Collecting thinc<8.2.0,>=8.1.8 (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3)\n","  Downloading thinc-8.1.12-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (15 kB)\n","Requirement already satisfied: wasabi<1.2.0,>=0.9.1 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (1.1.3)\n","Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (2.5.0)\n","Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (2.0.10)\n","Collecting typer<0.10.0,>=0.3.0 (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3)\n","  Downloading typer-0.9.4-py3-none-any.whl.metadata (14 kB)\n","Collecting pathy>=0.10.0 (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3)\n","  Downloading pathy-0.11.0-py3-none-any.whl.metadata (16 kB)\n","Collecting smart-open<7.0.0,>=5.2.1 (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3)\n","  Downloading smart_open-6.4.0-py3-none-any.whl.metadata (21 kB)\n","Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (4.67.1)\n","Requirement already satisfied: numpy>=1.15.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (1.26.4)\n","Requirement already satisfied: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (2.32.3)\n","Requirement already satisfied: pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (2.10.4)\n","Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (3.1.5)\n","Requirement already satisfied: setuptools in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (75.1.0)\n","Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (24.2)\n","Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (3.5.0)\n","Requirement already satisfied: language-data>=1.2 in /usr/local/lib/python3.10/dist-packages (from langcodes<4.0.0,>=3.2.0->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (1.3.0)\n","Collecting pathlib-abc==0.1.1 (from pathy>=0.10.0->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3)\n","  Downloading pathlib_abc-0.1.1-py3-none-any.whl.metadata (18 kB)\n","Requirement already satisfied: annotated-types>=0.6.0 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (0.7.0)\n","Requirement already satisfied: pydantic-core==2.27.2 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (2.27.2)\n","Requirement already satisfied: typing-extensions>=4.12.2 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (4.12.2)\n","Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (3.4.1)\n","Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (3.10)\n","Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (2.3.0)\n","Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (2024.12.14)\n","Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.10/dist-packages (from thinc<8.2.0,>=8.1.8->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (0.7.11)\n","Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.10/dist-packages (from thinc<8.2.0,>=8.1.8->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (0.1.5)\n","Requirement already satisfied: click<9.0.0,>=7.1.1 in /usr/local/lib/python3.10/dist-packages (from typer<0.10.0,>=0.3.0->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (8.1.8)\n","Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (3.0.2)\n","Requirement already satisfied: marisa-trie>=1.1.0 in /usr/local/lib/python3.10/dist-packages (from language-data>=1.2->langcodes<4.0.0,>=3.2.0->spacy<3.7.0,>=3.6.1->en_ner_bc5cdr_md==0.5.3) (1.2.1)\n","Downloading spacy-3.6.1-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (6.6 MB)\n","\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m6.6/6.6 MB\u001b[0m \u001b[31m38.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n","\u001b[?25hDownloading pathy-0.11.0-py3-none-any.whl (47 kB)\n","\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m47.3/47.3 kB\u001b[0m \u001b[31m3.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n","\u001b[?25hDownloading pathlib_abc-0.1.1-py3-none-any.whl (23 kB)\n","Downloading smart_open-6.4.0-py3-none-any.whl (57 kB)\n","\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m57.0/57.0 kB\u001b[0m \u001b[31m3.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n","\u001b[?25hDownloading thinc-8.1.12-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (919 kB)\n","\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m919.6/919.6 kB\u001b[0m \u001b[31m29.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n","\u001b[?25hDownloading typer-0.9.4-py3-none-any.whl (45 kB)\n","\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m46.0/46.0 kB\u001b[0m \u001b[31m3.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n","\u001b[?25hBuilding wheels for collected packages: en_ner_bc5cdr_md\n","  Building wheel for en_ner_bc5cdr_md (setup.py) ... \u001b[?25l\u001b[?25hdone\n","  Created wheel for en_ner_bc5cdr_md: filename=en_ner_bc5cdr_md-0.5.3-py3-none-any.whl size=119790307 sha256=b3ad8c1f68c9f86b09dc0017ea17bb0f3f3c076ba612b88f9d1984c8b5079211\n","  Stored in directory: /root/.cache/pip/wheels/14/f5/28/d5bb4d966a84523c9135ec2113fb756fcc3098929f841334c1\n","Successfully built en_ner_bc5cdr_md\n","Installing collected packages: typer, smart-open, pathlib-abc, pathy, thinc, spacy, en_ner_bc5cdr_md\n","  Attempting uninstall: typer\n","    Found existing installation: typer 0.15.1\n","    Uninstalling typer-0.15.1:\n","      Successfully uninstalled typer-0.15.1\n","  Attempting uninstall: smart-open\n","    Found existing installation: smart-open 7.1.0\n","    Uninstalling smart-open-7.1.0:\n","      Successfully uninstalled smart-open-7.1.0\n","  Attempting uninstall: thinc\n","    Found existing installation: thinc 8.2.5\n","    Uninstalling thinc-8.2.5:\n","      Successfully uninstalled thinc-8.2.5\n","  Attempting uninstall: spacy\n","    Found existing installation: spacy 3.7.5\n","    Uninstalling spacy-3.7.5:\n","      Successfully uninstalled spacy-3.7.5\n","\u001b[31mERROR: pip's dependency resolver does not currently take into account all the packages that are installed. This behaviour is the source of the following dependency conflicts.\n","en-core-web-sm 3.7.1 requires spacy<3.8.0,>=3.7.2, but you have spacy 3.6.1 which is incompatible.\u001b[0m\u001b[31m\n","\u001b[0mSuccessfully installed en_ner_bc5cdr_md-0.5.3 pathlib-abc-0.1.1 pathy-0.11.0 smart-open-6.4.0 spacy-3.6.1 thinc-8.1.12 typer-0.9.4\n"]},{"output_type":"display_data","data":{"application/vnd.colab-display-data+json":{"pip_warning":{"packages":["spacy","thinc"]},"id":"a1db366a115040e9be9c11d8269ba0fb"}},"metadata":{}},{"output_type":"stream","name":"stderr","text":["/usr/local/lib/python3.10/dist-packages/spacy/util.py:910: UserWarning: [W095] Model 'en_ner_bc5cdr_md' (0.5.3) was trained with spaCy v3.6.1 and may not be 100% compatible with the current version (3.7.5). If you see errors or degraded performance, download a newer compatible model or retrain your custom model with the current spaCy version. For more details and available updates, run: python -m spacy validate\n","  warnings.warn(warn_msg)\n","/usr/local/lib/python3.10/dist-packages/spacy/language.py:2195: FutureWarning: Possible set union at position 6328\n","  self.meta.update(data)\n"]}]},{"cell_type":"code","source":["from google.colab import drive\n","drive.mount('/content/drive')"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"cjZgpY_QBNKt","executionInfo":{"status":"ok","timestamp":1736408663592,"user_tz":-420,"elapsed":30204,"user":{"displayName":"Nurul Mutiah","userId":"18371090533349483196"}},"outputId":"5bd92e98-1248-4f73-a25d-38f02d8e583c"},"execution_count":6,"outputs":[{"output_type":"stream","name":"stdout","text":["Mounted at /content/drive\n"]}]},{"cell_type":"code","source":["import pandas as pd\n","df = pd.read_csv(\"/content/drive/Shareddrives/Riset 2023/DataKratomGraph.csv\")\n","df.head()"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":206},"id":"PZG-6GApBZXa","executionInfo":{"status":"ok","timestamp":1736408681087,"user_tz":-420,"elapsed":1758,"user":{"displayName":"Nurul Mutiah","userId":"18371090533349483196"}},"outputId":"524ec73e-8086-4140-f2b1-a95e52986744"},"execution_count":7,"outputs":[{"output_type":"execute_result","data":{"text/plain":["                                            abstract\n","0  Mitragyna speciosa Korth also known as kratom,...\n","1  Mitragynine, an analgesic alkaloid from the pl...\n","2  Kratom (Mitragyna speciosa) is a Southeast Asi...\n","3  BACKGROUND: Consumption of kratom (Mitragyna s...\n","4  Introduction: Chronic neuropathic pain is as a..."],"text/html":["\n","  <div id=\"df-bd7ef5e4-d88c-4ec6-a616-dcef21442dbc\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>abstract</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>Mitragyna speciosa Korth also known as kratom,...</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>Mitragynine, an analgesic alkaloid from the pl...</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>Kratom (Mitragyna speciosa) is a Southeast Asi...</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>BACKGROUND: Consumption of kratom (Mitragyna s...</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>Introduction: Chronic neuropathic pain is as a...</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-bd7ef5e4-d88c-4ec6-a616-dcef21442dbc')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-bd7ef5e4-d88c-4ec6-a616-dcef21442dbc button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-bd7ef5e4-d88c-4ec6-a616-dcef21442dbc');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","<div id=\"df-e53c05de-11fe-415e-b425-e6b9cd748d93\">\n","  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-e53c05de-11fe-415e-b425-e6b9cd748d93')\"\n","            title=\"Suggest charts\"\n","            style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","  </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","  <script>\n","    async function quickchart(key) {\n","      const quickchartButtonEl =\n","        document.querySelector('#' + key + ' button');\n","      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","      quickchartButtonEl.classList.add('colab-df-spinner');\n","      try {\n","        const charts = await google.colab.kernel.invokeFunction(\n","            'suggestCharts', [key], {});\n","      } catch (error) {\n","        console.error('Error during call to suggestCharts:', error);\n","      }\n","      quickchartButtonEl.classList.remove('colab-df-spinner');\n","      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","    }\n","    (() => {\n","      let quickchartButtonEl =\n","        document.querySelector('#df-e53c05de-11fe-415e-b425-e6b9cd748d93 button');\n","      quickchartButtonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","    })();\n","  </script>\n","</div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"df","summary":"{\n  \"name\": \"df\",\n  \"rows\": 395,\n  \"fields\": [\n    {\n      \"column\": \"abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 395,\n        \"samples\": [\n          \"Mitragyna speciosa, a species of plant that is native to Thailand, Malaysia and \\nSoutheast Asia, contains two major psychoactive alkaloids: mitragynine and \\n7-hydroxymitragynine. Pharmacologically, the alkaloids exhibit biphasic \\neffects-at low doses, stimulant effects are realized, while high doses exhibit \\nsedative effects. For years, the plant has been used recreationally and \\nmedicinally for these effects, but its use has been implicated in and associated \\nwith intoxications and deaths. In this case report, we describe two cases \\nwhereby decedents presented with single-substance fatal intoxications by \\nmitragynine in the absence of other postmortem toxicological findings. The cases \\nentail young male decedents in outdoor settings (e.g., driving a vehicle and \\nbicycle). Postmortem blood concentrations were 2,325 and 3,809\\u2009ng/mL. The \\nmedical examiner certified the cause of death as acute mitragynine intoxication \\nin both cases. The toxicology results presented become useful when considering \\nmitragynine to be the offending agent in lethal single-drug intoxications; \\nfurther, the information included is pertinent to medical examiners, forensic \\npathologists, forensic toxicologists and emergency department personnel in \\nevaluating possible poisoning and lethality by mitragynine.\",\n          \"Mitragyna speciosa (Kratom in Thai), native in Southeast Asia, is increasingly \\nmisused as a herbal drug of abuse. During metabolism studies on the Kratom \\nalkaloids mitragynine, its diastereomers speciogynine and speciociliatine as \\nwell as paynantheine in rats and humans, further isomeric compounds were \\ndetected in Kratom users' urine. The question arose whether these compounds were \\nformed from the low abundant, isomeric alkaloids mitraciliatine (MC) and \\nisopaynantheine (ISO-PAY). Therefore, the aim of the presented study was to \\nidentify using liquid chromatography-linear ion trap-mass spectrometry their \\nphase I and II metabolites in rat urine after administration of pure MC or \\nISO-PAY, to confirm their formation in humans, and finally to confirm whether \\nthe above-mentioned isomeric compounds in human urine represent MC and ISO-PAY \\nand/or their metabolites. The metabolic pathways of both alkaloids in rats were \\nfound to be comparable to those of their corresponding diastereomers. In the \\nhuman urines tested, not all metabolites found in rats could be detected because \\nof the much lower amounts of MC and ISO-PAY in Kratom. However, all the \\nabove-mentioned so far unknown isomeric compounds could be identified in the \\nhuman urine samples as MC, ISO-PAY and/or their metabolites. The used LC \\nseparation was also suitable for the differentiation of all other Kratom \\nalkaloids and their metabolites in human urine.\",\n          \"BACKGROUND AND OBJECTIVE: Kratom (Mitragyna speciosa) is a tropical tree found \\nin southern Thailand and northern states of the Malay Peninsula. Kratom is \\ncommercially available and used as an alternative to treat opioid withdrawal. \\nMitragynine is the major indole alkaloid found in kratom leaves. This review \\naimed to summarize available pharmacokinetic information about mitragynine.\\nMETHODS: PubMed, Scopus, and Web of Science were systematically searched from \\ntheir inceptions to June 2018. All types of pharmacokinetic studies of \\nmitragynine were included for further systematic review.\\nRESULTS: Seventeen articles were reviewed. Mitragynine is a lipophilic weak base \\npassively transported across the intestinal wall and blood brain barrier. 85-95% \\nis bound to plasma protein and extensively metabolized by phase I and \\nparticularly phase II enzymes. Actions on CYP enzymes are unlikely to impact \\ndrug metabolism at concentrations likely to exist in kratom-consuming humans. In \\nrats and humans, mitragynine is rapidly absorbed after orally administration \\n(Tmax\\u02dc1.5\\u2009h, Cmax\\u02dc0.3-1.8 \\u03bcM). Vd was 37-90\\u2009L/kg; t1/2 was 3-9 hr; mostly \\nexcreted as metabolites in urine. Bioavailability was estimated as 21%. It also \\nrapidly penetrated and redistributed in brain. A quality assessment tool \\ntailored for pharmacokinetic studies was also created which rated some studies \\nof lower value.\\nCONCLUSION: Rudimentary pharmacokinetics of mitragynine was described in this \\nsystematic review. However, the discovered studies provided scant information on \\nthe role of metabolism and redistribution into tissues nor the rate of \\nexcretion.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"}},"metadata":{},"execution_count":7}]},{"cell_type":"code","source":["number_of_samples = 395\n","sample_transcription = df['abstract'].iloc[:number_of_samples]\n","print(sample_transcription[:1000]) # prints just the first 1000 characters"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"znLFJZQ6Be85","executionInfo":{"status":"ok","timestamp":1736408708095,"user_tz":-420,"elapsed":339,"user":{"displayName":"Nurul Mutiah","userId":"18371090533349483196"}},"outputId":"b004561c-e132-404b-aaf2-3f9c1146e96e"},"execution_count":8,"outputs":[{"output_type":"stream","name":"stdout","text":["0      Mitragyna speciosa Korth also known as kratom,...\n","1      Mitragynine, an analgesic alkaloid from the pl...\n","2      Kratom (Mitragyna speciosa) is a Southeast Asi...\n","3      BACKGROUND: Consumption of kratom (Mitragyna s...\n","4      Introduction: Chronic neuropathic pain is as a...\n","                             ...                        \n","390    We examined the use of Kratom (Mitragyna sp.),...\n","391    In Thailand, there are four Mitragyna species;...\n","392    Administration of the aqueous extract of Mitra...\n","393    Kratom (Mitragyna speciosa) is a tropical plan...\n","394    The kratom story in Malaysia is a bit intricat...\n","Name: abstract, Length: 395, dtype: object\n"]}]},{"cell_type":"code","execution_count":9,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"u_3aB1Mt-m0s","executionInfo":{"status":"ok","timestamp":1736408784609,"user_tz":-420,"elapsed":40448,"user":{"displayName":"Nurul Mutiah","userId":"18371090533349483196"}},"outputId":"aa984472-c592-482e-aaf8-af593ffb14ef"},"outputs":[{"output_type":"stream","name":"stdout","text":["\u001b[1;30;43mStreaming output truncated to the last 5000 lines.\u001b[0m\n","Detected entities in text: 'Kratom (Mitragyna speciosa) is a popular plant-based extract that \n","has dose-dependent stimulatory and sedative effects. It has been used for \n","self-treatment of opioid withdrawal and can result in seizures, hepatotoxicity, \n","and infectious complications from bacterial contamination. Reports of morbidity \n","and mortality associated with Kratom may be confounded by coingestants. We \n","report a case of severe rhabdomyolysis and pressure necrosis leading to \n","fasciotomy in a patient who was using Kratom.\n","CASE REPORT: A 31-year-old male with substance use presented to the emergency \n","department after loss of consciousness for 6 hours after smoking Kratom. He was \n","found to have rhabdomyolysis, acute renal and hepatic injury, and electrolyte \n","disturbances. No ethanol was detected, and urine drug screen was negative. Over \n","the next 3 hours, the patient developed signs of compartment syndrome and he was \n","transferred to the operating room for fasciotomy. He required continuous renal \n","replacement therapy for 48 hours and his labs and clinical status improved. He \n","was discharged 18 days later. A serum and urine sample from the first day of \n","presentation were analyzed for mitragynine and 7-hydroxymitragynine using an \n","Ultra Performance Liquid Chromatography-Tandem Mass Spectrometer (UPLC-MSMS) \n","method. The serum mitragynine was 5 ng/mL and the urine mitragynine 6 ng/mL.\n","CONCLUSIONS: Although there are numerous reports of opioids resulting in \n","prolonged periods of immobilization and rhabdomyolysis, this is not commonly \n","reported in Kratom overdoses.This case report highlights the profound sedative \n","effect of Kratom and the potential of pressure necrosis injury resulting in \n","rhabdomyolysis and compartment syndrome requiring fasciotomy.': [('seizures', 'DISEASE'), ('hepatotoxicity', 'DISEASE'), ('rhabdomyolysis', 'DISEASE'), ('loss of consciousness', 'DISEASE'), ('rhabdomyolysis', 'DISEASE'), ('ethanol', 'CHEMICAL'), ('compartment syndrome', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('rhabdomyolysis', 'DISEASE'), ('necrosis', 'DISEASE'), ('rhabdomyolysis', 'DISEASE'), ('compartment syndrome', 'DISEASE')]\n","Detected entities in text: 'To understand and highlight the current issues, emerging trends, and \n","regulations of kratom in the United States.\n","DATA SOURCES: PubMed and PubMed Central of the National Library of Medicine, \n","MEDLINE, PsycINFO, and ClinicalTrials.gov databases were utilized.\n","STUDY SELECTION: Studies published between January 1, 2000, and June 30, 2020, \n","were accessed by using the MeSH term mitragyna in the context of toxicity, \n","safety, and legislation and jurisprudence.\n","DATA EXTRACTION: The final qualitative synthesis included 11 studies by \n","following Preferred Reporting Items for Systematic Reviews and Meta-Analyses \n","Statement guidelines.\n","RESULTS: The US Drug Enforcement Administration (DEA) initially proposed to \n","place kratom under Schedule I of the Controlled Substances Act, but the DEA \n","later withdrew the intent, and kratom is still a legal substance in most of the \n","United States. A low to moderate kratom dose produces mild stimulant properties, \n","whereas large doses produce sedative effects that are identical to opiates. Its \n","regular use at a higher dose is associated with dependence. Management of \n","overdose is similar to that of patients presenting with opioid abuse, although \n","kratom may potentially pose a higher risk for drug toxicity and organ injury \n","compared to opioids due to intrinsic properties and adulteration. There is no \n","clinical evidence for its safety and efficacy. The US Food and DEA do not \n","recognize any legitimate medical use of kratom.\n","CONCLUSIONS: Kratom is an emerging public health concern and is abused as an \n","alternative to opioids. Stringent policies and public awareness campaigns are \n","required to curb the perception of its safe use, which needs to be substantiated \n","with well-designed clinical trials.': [('toxicity', 'DISEASE'), ('DEA', 'CHEMICAL'), ('overdose', 'DISEASE'), ('opioid abuse', 'DISEASE'), ('toxicity', 'DISEASE'), ('organ injury', 'DISEASE'), ('DEA', 'CHEMICAL')]\n","Detected entities in text: 'The present study aims to examine the association between Kratom use \n","and serum lipid level.\n","METHOD: This study compared the serum lipid profile of Kratom users and \n","non-users living in Nam Phu Subdistrict, a special area that allows the \n","traditional use of Kratom. The study subjects consisted of 581 individuals aged \n","18 and above. Binary logistic regression was used to determine an association \n","between Kratom use and serum lipid level.\n","RESULTS: The findings revealed an association between Kratom use and an elevated \n","HDL level (≥60 mg/dL) with an adjusted OR of 1.82 (95% CI, 1.17-2.8), and an \n","association between Kratom use and a triglyceride level <90 mg/dL with an \n","adjusted OR of 1.75 (95% CI; 1.17-2.63). There were no associations between \n","Kratom use and LDL as well as total cholesterol level.\n","DISCUSSION AND CONCLUSIONS: This study provided additional evidence of Kratom \n","use and a favorable lipid profile. Prevention of coronary heart disease or \n","cerebrovascular disease via an improvement in the lipid profile may be a future \n","pharmaceutical application of Kratom.': [('cholesterol', 'CHEMICAL'), ('coronary heart disease', 'DISEASE'), ('cerebrovascular disease', 'DISEASE')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa Korth.) is an indigenous plant of Southeast Asia, \n","which has been used in traditional medicine for centuries. Despite local \n","communities in Southern Thailand viewing Kratom as a traditional remedy and not \n","as an illicit drug, Thailand criminalized Kratom in 1943 which has led to \n","tensions between government authorities and local communities. This study \n","employed a mixed-method design to explore alternative ways to decriminalize \n","Kratom, using a Participatory Action Research framework to develop a community \n","charter to better manage Kratom in Tambon Namphu, a rural sub-district in \n","Southern Thailand. Quantitative data consisted of face-to-face surveys with 457 \n","Tambon Namphu residents, 104 students and teachers and on-line self-complete \n","surveys conducted with 1,058 people outside Tambon Namphu. Qualitative data were \n","collected using focus groups, in-depth interviews and through public forums \n","conducted with Tambon Namphu residents. Survey results indicate that most \n","participants agreed with decriminalization of both Kratom cultivation and \n","consumption and typically reported positive attitudes towards people who use \n","Kratom. The most common reasons for supporting Kratom decriminalization were \n","Kratom's perceived benefits for work productivity and health. People had more \n","positive attitudes towards the consumption of fresh Kratom leaves than Kratom \n","decoctions which were deemed more harmful. Participatory action research methods \n","were used to pilot the development of a community consensus framework for Kratom \n","control in Donsai, a village of 127 households. Following successful piloting, \n","the community consensus framework on Kratom control was adopted in Donsai, \n","adapted across Tambon Namphu and then extended to cover 135 villages across \n","Thailand.': []\n","Detected entities in text: 'An increasing number of Americans are turning to kratom for \n","self-management of various pain, anxiety, and mood states and as an opioid \n","substitute. Addiction to this unique botanical develops and carries a high \n","relapse risk and, to date, there are no guidelines on how to maintain long-term \n","abstinence. The aim of this article is to compile all available information on \n","management of \"kratom use disorder\" (KUD)-as coined here-from the literature, \n","with evidence from the clinical practice of expert addictionologists in an \n","attempt to develop a standard of care consensus.\n","METHODS: A systematic literature search was conducted to capture all relevant \n","cases pertaining to maintenance treatment for KUD. Results were supplemented \n","with case reports and scientific posters gleaned from reliable online sources \n","and conference proceedings. Additionally, a survey of members of the American \n","Society of Addiction Medicine (ASAM) was administered to assess the practice \n","patterns of experts who treat patients with KUD in isolation of a comorbid \n","opioid use disorder (OUD).\n","RESULTS: Based on a literature review, 14 reports exist of long-term management \n","of KUD, half of which do not involve a comorbid OUD. Pharmacological modalities \n","utilized include mostly buprenorphine but also a few cases of naltrexone and \n","methadone, all with favorable outcomes. This is supported by the results of the \n","expert survey, which demonstrated that those who have managed KUD in isolation \n","of a comorbid OUD reported having utilized buprenorphine (89.5%), as well as the \n","other medications for opioid use disorder (MOUD).\n","CONCLUSIONS: This is the first comprehensive review to examine the existing \n","literature referring to management of KUD in combination with a survey of \n","current experts' clinical consensus regarding pharmacological management. Based \n","on this information, it seems reasonable that the indication for MOUD should be \n","extended to cases of moderate to severe KUD.': [('pain', 'DISEASE'), ('anxiety', 'DISEASE'), ('OUD', 'DISEASE'), ('comorbid OUD', 'DISEASE'), ('buprenorphine', 'CHEMICAL'), ('naltrexone', 'CHEMICAL'), ('methadone', 'CHEMICAL'), ('comorbid OUD', 'DISEASE'), ('buprenorphine', 'CHEMICAL')]\n","Detected entities in text: 'The development of a method for the rapid screening of food and drug products \n","for constituents such as mitragynine, the most abundant alkaloid found in \n","Mitragyna speciosa (kratom) plant leaves, has become increasingly important. The \n","use of kratom is said to produce stimulant or narcotic effects and poses risks \n","of addiction, abuse, and dependence, much like other opioids. Direct Analysis in \n","Real Time with thermal desorption mass spectrometry (DART-TD-MS), hand-held mass \n","spectrometry, portable ion mobility spectrometry (IMS), and portable \n","Fourier-transform infrared spectroscopy (FT-IR) were each evaluated as \n","field-deployable screening techniques for the detection of mitragynine in food \n","and drug products. These devices offer the potential for rapid, early detection \n","of mitragynine in suspect products entering the United States through \n","international mail facilities and other ports of entry. Ninety-six kratom \n","products, including capsules, bulk powder, and bulk plant material, were \n","analyzed by either direct sampling of the solid material or by solvent \n","extraction. True and false positive and negative results are reported, based on \n","comparison to results from qualitative screening using gas chromatography with \n","mass spectral detection (GC-MS), liquid chromatography with mass spectral \n","detection (LC-MS), and/or quantitative screening using high-performance liquid \n","chromatography with ultraviolet detection (HPLC-UV), with a discussion of the \n","assessment of each technique for use in the field. Each device demonstrated \n","attributes that would be favorable for use in screening of suspected \n","mitragynine-containing products at places like ports of entry, and simultaneous \n","deployment of two or more of these devices as part of a workflow would be the \n","most effective for rapid screening of these products. This combination of rapid \n","screening orthogonal techniques suited to a non-laboratory environment will \n","allow onsite destruction of products found to contain mitragynine.': [('mitragynine', 'CHEMICAL'), ('IMS', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('HPLC-UV', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa (Korth.) Havil. or locally known as ketum/daun \n","sebiak/biak-biak belongs to Rubiaceae family and generally occurs in secondary \n","forest or disturbed areas in tropical and subtropical region. This research \n","enumerated the characterisation of Mitragyna speciosa leaf anatomy and \n","micromorphology features which is still not well documented. This medium to \n","large sized tree species characterised with opposite arrangement, \n","ovate-acuminate leaf and with 12-17 pairs of veins. Transverse sections of \n","petioles showed that this species has petiole outlines with slightly convex at \n","the middle of the adaxial part and 'U'-shaped on abaxial side. Results also \n","showed that this species has paracytic and hypostomatic stomata, combination of \n","non-glandular (majority) and glandular trichomes (minority), with observation on \n","the secretory cells present in petiole and midrib parenchyma cells. Cuticle on \n","the abaxial and adaxial epidermal surfaces showed the presence granule and wax \n","films with periclinal and anticlinal walls can be differentiated clearly. The \n","results obtained in this study can be used to providing additional systematics \n","information of Mitragyna speciosa with the documentation of the leaf anatomy and \n","micromorphology characters.': []\n","Detected entities in text: 'Mitragyna speciosa, also known as kratom, has been used for mitigating the \n","severity of opioid withdrawal in humans. Its main indole alkaloid, mitragynine, \n","has been considered as a pharmacotherapy for pain conditions and opioid \n","replacement therapy. However, at high doses, chronic mitragynine may also have \n","an addiction potential. The effects of chronic action of mitragynine in the \n","brain are still unknown. The present study developed a mitragynine withdrawal \n","model in rats and used it for a proteomic analysis of mitragynine withdrawal \n","effects. Mitragynine (30 mg/kg, i.p.) was administered daily over a period of 14 \n","days and then withdrawn. A proteomic analysis revealed that from a total of 1524 \n","proteins identified, 31 proteins were upregulated, and 3 proteins were \n","downregulated in the mitragynine withdrawal model. The Rab35 protein expression \n","increased most profoundly in the mitragynine withdrawal group as compared to \n","vehicle group. Therefore, it is proposed that Rab35 in the brain might be \n","considered as a potential biomarker during mitragynine withdrawal and might be \n","valuable target protein in developing new pharmacotherapies in the future.': [('indole', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom or Mitragyna speciosa (Korth.) is an evergreen tree of the coffee family \n","native to South-East Asia and Australasia. It is used by locals recreationally \n","to induce stimulant and sedative effects and medically to soothe pain and opiate \n","withdrawal. Its leaves are smoked, chewed, or infused, or ground to yield \n","powders or extracts for use as liquids. It contains more than 40 alkaloids; \n","among these, mitragynine and 7-hydroxymitragynine are endowed with variable mu, \n","delta, and kappa opioid stimulating properties (with 7-hydroxymitragynine having \n","a more balanced affinity), rhynchophylline, which is a non-competitive NMDA \n","glutamate receptor antagonist, but is present in negligible quantities, and \n","raubasine, which inhibits α1-adrenceptors preferentially over α2-adrenceptors, \n","while the latter are bound by 7-hydroxymitragynine, while mitragynine counters \n","5-HT2A receptors. This complexity of neurochemical mechanisms may account for \n","kratom's sedative-analgesic and stimulant effects. It is commonly held that \n","kratom at low doses is stimulant and at higher doses sedative, but no cut-off \n","has been possible to define. Long-term use of kratom may produce physical and \n","psychological effects that are very similar to its withdrawal syndrome, that is, \n","anxiety, irritability, mood, eating, and sleep disorders, other than physical \n","symptoms resembling opiate withdrawal. Kratom's regulatory status varies across \n","countries; in Italy, both mitragynine and the entire tree and its parts are \n","included among regulated substances. We describe the case of a patient who \n","developed anxiety and dysphoric mood and insomnia while using kratom, with these \n","symptoms persisting after withdrawal. He did not respond to a variety of \n","antidepressant combinations and tramadol for various months, and responded after \n","1 month of clomipramine. Well-being persisted after discontinuing tramadol.': [('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('rhynchophylline', 'CHEMICAL'), ('NMDA', 'CHEMICAL'), ('glutamate', 'CHEMICAL'), ('raubasine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('withdrawal syndrome', 'DISEASE'), ('anxiety', 'DISEASE'), ('irritability', 'DISEASE'), ('sleep disorders', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('anxiety', 'DISEASE'), ('dysphoric mood', 'DISEASE'), ('insomnia', 'DISEASE'), ('antidepressant', 'CHEMICAL'), ('tramadol', 'CHEMICAL'), ('clomipramine', 'CHEMICAL'), ('tramadol', 'CHEMICAL')]\n","Detected entities in text: 'Kratom ingestion for its psychotropic effect or to self-treat opioid withdrawal \n","symptoms has increased over the last 10 years in the United States. Although \n","mild adverse effects have been observed in users, reports of respiratory failure \n","and shock after kratom consumption remain rare. In this case, a 35-year-old man \n","initially presented to the emergency department with profound circulatory shock, \n","metabolic acidosis, hypoxia, and symptoms of autonomic nervous system \n","dysfunction. The patient required vasopressor support, multiregimen sedation and \n","rapid sequence intubation, mechanical ventilation, and emergent hemodialysis. \n","Within 72 hours, the patient's condition stabilized, and he was extubated. The \n","patient reported regular consumption of large quantities of kratom as well as \n","injection of heroin and cocaine. In this report, a rare clinical presentation \n","after kratom ingestion is described.': [('respiratory failure', 'DISEASE'), ('shock', 'DISEASE'), ('shock', 'DISEASE'), ('metabolic acidosis', 'DISEASE'), ('hypoxia', 'DISEASE'), ('heroin', 'CHEMICAL'), ('cocaine', 'CHEMICAL')]\n","Detected entities in text: '7-Hydroxymitragynine (7-HMG) is an oxidative \n","metabolite of mitragynine, the most abundant alkaloid in the leaves of Mitragyna \n","speciosa (otherwise known as kratom). While mitragynine is a weak partial \n","µ-opioid receptor (MOR) agonist, 7-HMG is a potent and full MOR agonist. It is \n","produced from mitragynine by cytochrome P450 (CYP) 3A, a drug-metabolizing CYP \n","isoform predominate in the liver that is also highly expressed in the intestine. \n","Given the opioidergic potency of 7-HMG, a single oral dose pharmacokinetic and \n","safety study of 7-HMG was performed in beagle dogs.\n","METHODS: Following a single oral dose (1 mg/kg) of 7-HMG, plasma samples were \n","obtained from healthy female beagle dogs. Concentrations of 7-HMG were \n","determined using ultra-performance liquid chromatography coupled with a tandem \n","mass spectrometer (UPLC-MS/MS). Pharmacokinetic parameters were calculated using \n","a model-independent non-compartmental analysis of plasma concentration-time \n","data.\n","RESULTS: Absorption of 7-HMG was rapid, with a peak plasma concentration (Cmax, \n","56.4 ± 1.6 ng/ml) observed within 15 min post-dose. In contrast, 7-HMG \n","elimination was slow, exhibiting a mono-exponential distribution and mean \n","elimination half-life of 3.6 ± 0.5 h. Oral dosing of 1 mg/kg 7-HMG was well \n","tolerated with no observed adverse events or significant changes to clinical \n","laboratory tests.\n","CONCLUSIONS: These results provide the first pharmacokinetic and safety data for \n","7-HMG in the dog and therefore contribute to the understanding of the putative \n","pharmacologic role of 7-HMG resulting from an oral delivery of mitragynine from \n","kratom.': [('7-Hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom is a psychoactive ethnomedicine indigenous to Southeast Asia that over the last 20 years has emerged in the West due to internet marketing and lack of federal regulations [1, 2]. Sold online as a “legal high” or a “legal opioid,” many users are led to believe that Kratom is a safe herbal supplement [3]. At low doses, it blocks the reuptake of norepinephrine, serotonin, and dopamine, producing a motivational and stimulating effect. At high doses, it is an opioid and alpha-2 agonist, creating an analgesic and calming effect [4].\n","\n","As the government scrutinizes opioid prescribing, physicians are changing their opioid prescribing practices and are now inclined to taper, sometimes abruptly, their patients off opioids. Unfortunately, due to physiological opioid dependence, many of these opioid-tapered patients resort to alternative means to obtain their desired effects. Additionally, many patients with Opiate Use Disorders do not have timely and/or affordable access to addiction treatment services. Many such individuals have turned to Kratom as an alternative to alleviate their pain, opioid withdrawals, and opioid addiction. Others are using Kratom recreationally as a stimulant, a mood enhancer, or as a sedative [5]. The efficacy of Kratom for all these purposes is still inconclusive [6]. Research, however, has shown that Kratom can cause severe adverse effects, withdrawal symptoms, and addiction [7].\n","\n","This article aims to acquaint clinicians with Kratom and describe approaches to manage patients using Kratom according to the existing literature. We discuss a case of Kratom addiction in a 29-year-old Veteran who stated he used Kratom for pain relief and mood enhancement and deliberately used Kratom to avoid detection by the Treatment Court.': [('norepinephrine', 'CHEMICAL'), ('serotonin', 'CHEMICAL'), ('dopamine', 'CHEMICAL'), ('pain', 'DISEASE'), ('pain', 'DISEASE')]\n","Detected entities in text: 'Kratom is a plant homogenous to Southeast Asia with a long history of \n","traditional use as medicinal herbs. However, recent years have witnessed its \n","pervasive infiltration into international audience with growing public health \n","concern. This cross-sectional study was conducted from 1 August 2017 till 31 \n","August 2018 aiming to explore the practice and perspectives of kratom use and \n","misuse among adolescents in northwest Malaysia. The study involved a \n","self-administered questionnaire that was designed for the purpose of the study. \n","The instrument had undergone prior validation process with a good overall \n","internal reliability for the knowledge domain (Cronbach's alpha = 0.728) and \n","attitude domain (Cronbach's alpha = 0.700). The questionnaire was distributed to \n","135 respondents involving adolescents aged 13 to 19 years old via convenience \n","(non-kratom user) and snowball sampling (kratom users). There were 65 (47.8%) \n","kratom users, while 70 (51.5%) were kratom-naïve. Among the kratom users, peer \n","influence was the most common reason for them to be first involved with kratom, \n","26 (41.3%) whereas the reasons for kratom use quoted were to improve physical \n","stamina, 10 (16.4%), as painkiller, 9 (14.8%), and to be accepted by peers, 7 \n","(11.5%). Multiple logistic regression found that older age (95% CI: 0.13, 0.58; \n","p = 0.001) and being active smokers (95% CI: 39.33, 980.63; p < 0.001) \n","significantly predict kratom use among adolescents. The emerging trend of kratom \n","abuse and misuse especially among the younger generation in Malaysia is raising \n","concern and warrants social and governmental vigilance.': []\n","Detected entities in text: 'Kratom mainly grows in Southeast Asia. It is widely used for pain management and \n","opioid withdrawal, which is available online for cheaper prices. Alkaloids \n","extracted from kratom such as mitragynine and 7-hydroxy mitragynine exhibit \n","analgesic properties by acting through µ receptors. Commonly reported side \n","effects of kratom include hypertension, tachycardia, agitation, dry mouth, \n","hallucinations, cognitive and behavioral impairment, cardiotoxicity, renal \n","failure, cholestasis, seizures, respiratory depression, coma, and sudden cardiac \n","death from cardiac arrest. Rhabdomyolysis is a less commonly reported lethal \n","effect of kratom. Limited information is available in the literature. In this \n","article, we present a case of a 45-year-old female who is overdosed with kratom \n","and presented with lethargy, confusion, transient hearing loss, and right lower \n","extremity swelling and pain associated with weakness who was found to have \n","elevated creatinine phosphokinase. She was diagnosed with rhabdomyolysis, \n","compartment syndrome, multiorgan dysfunction including acute kidney injury, \n","liver dysfunction, and cardiomyopathy. She underwent emergent fasciotomy and \n","required hemodialysis. Her renal and liver function subsequently improved. We \n","described the case and discussed pharmacology and adverse effects of kratom \n","toxicity with a proposed mechanism and management. We conclude that it is \n","essential for emergency physicians, internists, intensivists, cardiologists, and \n","nephrologists to be aware of these rare manifestations of kratom and consider a \n","multidisciplinary approach.': [('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('hypertension', 'DISEASE'), ('tachycardia', 'DISEASE'), ('agitation', 'DISEASE'), ('dry mouth', 'DISEASE'), ('hallucinations', 'DISEASE'), ('cognitive and behavioral impairment', 'DISEASE'), ('cardiotoxicity', 'DISEASE'), ('cholestasis', 'DISEASE'), ('seizures', 'DISEASE'), ('respiratory depression', 'DISEASE'), ('coma', 'DISEASE'), ('death', 'DISEASE'), ('cardiac arrest', 'DISEASE'), ('Rhabdomyolysis', 'DISEASE'), ('lethargy', 'DISEASE'), ('confusion', 'DISEASE'), ('hearing loss', 'DISEASE'), ('swelling', 'DISEASE'), ('pain', 'DISEASE'), ('weakness', 'DISEASE'), ('creatinine', 'CHEMICAL'), ('rhabdomyolysis', 'DISEASE'), ('compartment syndrome', 'DISEASE'), ('multiorgan dysfunction', 'DISEASE'), ('liver dysfunction', 'DISEASE'), ('cardiomyopathy', 'DISEASE'), ('toxicity', 'DISEASE')]\n","Detected entities in text: 'Mitragyna speciosa (Korth.) Havil. [MS], or \"kratom\" in Thai, is the only \n","narcotic species among the four species of Mitragyna in Thailand, which also \n","include Mitragyna diversifolia (Wall. ex G. Don) Havil. [MD], Mitragyna hirsuta \n","Havil. [MH], and Mitragyna rotundifolia (Roxb.) O. Kuntze [MR]. M. speciosa is a \n","tropical tree belonging to the Rubiaceae family and has been prohibited by law \n","in Thailand. However, it has been extensively covered in national and \n","international news, as its abuse has become more popular. M. speciosa is a \n","narcotic plant and has been used as an opium substitute and traditionally used \n","for the treatment of chronic pain and various illnesses. Due to morphological \n","disparities in the genus, the identification of plants in various forms, \n","including fresh leaves, dried leaf powder, and finished products, is difficult. \n","In this study, DNA barcoding combined with high-resolution melting (Bar-HRM) \n","analysis was performed to differentiate M. speciosa from allied Mitragyna and to \n","assess the capability of Bar-HRM assays to identify M. speciosa in suspected \n","kratom or M. speciosa-containing samples. Bar-HRM analysis of PCR amplicons was \n","based on the ITS2, rbcL, trnH-psbA, and matK DNA barcode regions. The melting \n","profiles of ITS2 amplicons were clearly distinct, which enabled the \n","authentication and differentiation of Mitragyna species from allied species. \n","This study reveals that DNA barcoding coupled with HRM is an efficient tool with \n","which to identify M. speciosa and M. speciosa-containing samples and ensure the \n","safety and quality of traditional Thai herbal medicines.': [('opium', 'CHEMICAL'), ('pain', 'DISEASE')]\n","Detected entities in text: 'Kratom is an unregulated kappa-opioid receptor agonist available for order on \n","the internet that is used as a remedy for chronic pain. We present a case of a \n","middle-aged man who suffered a cardiac arrest in the setting of kratom \n","ingestion.': [('chronic pain', 'DISEASE'), ('cardiac arrest', 'DISEASE')]\n","Detected entities in text: ' Amid a Canadian opioid crisis, many have turned to natural health \n","products, such as kratom (Mitragyna speciosa), to manage their opioid \n","withdrawal. Kratom has also been reported to relieve anxiety, improve stamina, \n","and heighten physical performance. Given that kratom is not authorized for sale \n","by Health Canada, many have turned to online retailers to purchase kratom due to \n","its easy accessibility online. This study investigated the quality of consumer \n","health information provided on the websites of online vendors selling kratom to \n","consumers in Canada.\n","METHODS: Following searches on Google.ca using search terms designed to simulate \n","the information-seeking behaviour of a typical patient-user online, eligible \n","websites were assessed using the 16-question DISCERN instrument, a tool designed \n","to assess the quality of consumer health information. Searches were conducted on \n","March 27, 2020 and only websites presenting information in English were \n","included.\n","RESULTS: A total of 200 webpages were identified; after screening based on \n","eligibility criteria and combining different webpages that belonged to the same \n","website, 51 websites were found to be eligible. The mean summed DISCERN score \n","across all 51 websites was 36.95 (SD = 2.44) out of 75, which reflects poor \n","quality consumer health information across the subset of websites. The overall \n","quality of websites was poor, as 78% (n = 40) of vendors received a score of 2 \n","or less out of 5.\n","CONCLUSIONS: Individuals who seek information about kratom online are frequently \n","exposed to poor quality consumer health information. Those looking to purchase \n","kratom online are not provided with the critical information necessary to make \n","an informed decision regarding its use, such as the complete details about the \n","risks and side effects or a description of how kratom affects the body. Given \n","the growing interest in kratom, knowledge of the quality of information \n","available can lead to improved dialogue between healthcare providers and \n","patients.': [('anxiety', 'DISEASE')]\n","Detected entities in text: 'Mitragyna speciosa, a tropical tree also known as kratom, is an emerging \n","substance of abuse with dose-dependent stimulant and opioid-like effects. Kratom \n","may be purchased legally in the United States and is marketed online as a safe \n","alternative to opioids and a cheap alternative to opioid replacement therapy. \n","However, adverse reactions to ingestion are largely unknown and may pose a \n","significant public health risk. This article describes a man with an \n","intracerebral hemorrhage possibly secondary to kratom ingestion.': [('intracerebral hemorrhage', 'DISEASE')]\n","Detected entities in text: 'Illicit drugs are used to produce a sense of euphoria in the user. Like \n","marijuana, kratom is a plant-based substance. The leaves of the Mitragyna \n","speciosa tree were used to treat mild medical conditions in Thailand and \n","Malaysia as a stimulant in low doses, and sedative and analgesic at high doses. \n","Over recent years, kratom gained popularity as a recreational drug among younger \n","individuals in Southeast Asia due to its availability as a cheap and easily \n","assessable substance with euphoric effects. This trend has rapidly made its way \n","to the West. Unlike marijuana, in the United States kratom's use as an \n","inexpensive herbal recreational \"supplement\" is poorly popularized. However, \n","emerging reports garnished from use as a recreational drug reveals a potential \n","health hazard. Seizures and neurological consequences have been reported from \n","kratom abuse. Complex pharmacokinetics place patients at further risk of side \n","effects and drug interactions. Still, individuals can legally purchase kratom at \n","stores and through online distributers in capsule form or as teas, powders, and \n","extracts under the veil of a harmless herbal remedy. Without United States Food \n","and Drug Administration oversight, kratom has a high potential for abuse and \n","without regulatory control threatens public safety.': [('Seizures', 'DISEASE')]\n","Detected entities in text: 'Mitragyna speciosa (kratom) produces numerous compounds with pharmaceutical \n","properties including the production of bioactive monoterpene indole and oxindole \n","alkaloids. Using a linked-read approach, a 1,122,519,462 bp draft assembly of M. \n","speciosa \"Rifat\" was generated with an N50 scaffold size of 1,020,971 bp and an \n","N50 contig size of 70,448 bp that encodes 55,746 genes. Chromosome counting \n","revealed that \"Rifat\" is a tetraploid with a base chromosome number of 11, which \n","was further corroborated by orthology and syntenic analysis of the genome. \n","Analysis of genes and clusters involved in specialized metabolism revealed genes \n","putatively involved in alkaloid biosynthesis. Access to the genome of M. \n","speciosa will facilitate an improved understanding of alkaloid biosynthesis and \n","accelerate the production of bioactive alkaloids in heterologous hosts.': [('indole', 'CHEMICAL'), ('oxindole', 'CHEMICAL')]\n","Detected entities in text: 'Ten indole and oxindole alkaloids (1-10) were isolated from the freshly \n","collected leaves of Malaysian Mitragyna speciosa (Kratom). The chemical \n","structures of these compounds were established on the basis of extensive 1D and \n","2D NMR and HRMS data analysis. The spectroscopic data of mitragynine oxindole B \n","(4) are reported herein for the first time. The spatial configuration of \n","mitragynine oxindole B (4) was confirmed by single-crystal X-ray diffraction. \n","Simultaneous quantification of the isolated alkaloids in the M. speciosa leaf \n","specimens collected from different locations in the northern region of \n","Peninsular Malaysia was also performed using UPLC-MS/MS. The oxindole alkaloids \n","(1-4) and the indole alkaloid (10) were assessed for binding affinity at opioid \n","receptors. Corynoxine (1) showed high binding affinity to μ-opioid receptors \n","with a Ki value of 16.4 nM. Further, corynoxine (1) was 1.8-fold more potent \n","than morphine in rats subjected to a nociceptive hot plate assay. These findings \n","have important implications for evaluating the combined effects of the minor \n","oxindole alkaloids in the overall therapeutic activity of M. speciosa.': [('indole', 'CHEMICAL'), ('mitragynine oxindole B', 'CHEMICAL'), ('mitragynine oxindole B', 'CHEMICAL'), ('indole', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('oxindole alkaloids', 'CHEMICAL')]\n","Detected entities in text: 'Kratom, Mitragyna speciosa Korth., is being widely consumed in the United States \n","for pain management and the reduction of opioid withdrawal symptoms. The central \n","nervous system (CNS) active alkaloids of kratom, including mitragynine, \n","7-hydroxymitragynine, and numerous additional compounds, are believed to derive \n","their effects through opioid receptor activity. There is no literature \n","describing the systemic exposure of many of these alkaloids after the \n","consumption of kratom. Therefore, we have developed and validated a \n","bioanalytical method for the simultaneous quantitation of 11 kratom alkaloids \n","(mitragynine, 7-hydroxymitragynine, corynantheidine, speciogynine, \n","speciociliatine, paynantheine, corynoxine, corynoxine-B, mitraphylline, \n","ajmalicine, and isospeciofoline) in rat plasma. The validated method was used to \n","analyze oral pharmacokinetic study samples of lyophilized kratom tea (LKT) and a \n","marketed product, OPMS liquid shot, in rats. Among the 11 alkaloids, only \n","mitragynine, 7-hydroxymitragynine, speciociliatine, and corynantheidine showed \n","systemic exposure 8 h postdose, and the dose-normalized systemic exposure of \n","these four alkaloids was higher (1.6-2.4-fold) following the administration of \n","the commercial OPMS liquid. Paynantheine and speciogynine levels were \n","quantifiable up to 1 h postdose, whereas none of the other alkaloids were \n","detected. In summary, the method was successfully applied to quantify the \n","exposure of individual kratom alkaloids after an oral dose of traditional or \n","commercial products. This information will contribute to understanding the role \n","of each alkaloid in the overall pharmacology of kratom and elucidating the \n","pharmacokinetic differences between traditional and commercial kratom products.': [('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('corynantheidine', 'CHEMICAL'), ('speciogynine', 'CHEMICAL'), ('speciociliatine', 'CHEMICAL'), ('paynantheine', 'CHEMICAL'), ('corynoxine', 'CHEMICAL'), ('corynoxine-B', 'CHEMICAL'), ('isospeciofoline', 'CHEMICAL'), ('kratom tea', 'CHEMICAL'), ('OPMS', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('speciociliatine', 'CHEMICAL'), ('OPMS', 'CHEMICAL'), ('Paynantheine', 'CHEMICAL'), ('speciogynine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom is a substance that when ingested produces an opioid-like \n","effect. As kratom continues to gain popularity, increasing numbers of cases of \n","addiction, dependence, and adverse events have been reported, as well as an \n","increase in mortality associated with its use. George E. Wahlen Department of \n","Veterans Affairs Medical Center has been using buprenorphine/naloxone for the \n","treatment of kratom withdrawal and dependence in both primary care and specialty \n","addiction treatment settings in the Veteran population. Cases: We present three \n","cases that describe the use of buprenorphine/naloxone for kratom dependence. For \n","each case, we describe the withdrawal symptoms from kratom, induction and \n","long-term maintenance on buprenorphine/naloxone in kratom dependence, the impact \n","of polysubstance use disorders in management of kratom dependence, and the use \n","of urine drug screens for kratom alkaloids during treatment. Discussion: This \n","case series demonstrates that patients with kratom dependence can effectively be \n","treated with buprenorphine/naloxone. It appears that it is safe to induce \n","buprenorphine/naloxone as early as eight hours after last kratom use and \n","maintenance dosing for kratom use was similar to maintenance doses used in \n","opioid use disorder. Prolonged and continued withdrawal symptoms were reported \n","despite treatment with buprenorphine/naloxone and multiple daily doses of up to \n","24mg per day may be beneficial for prolonged withdrawal symptoms and for \n","cooccurring pain. Polysubstance use with kratom dependence may require higher \n","levels of care and higher doses of buprenorphine/naloxone. Urine drug screens \n","may be best practice for monitoring kratom alkaloids concentrations and \n","facilities that utilize buprenorphine/naloxone to treat kratom dependence should \n","have testing available. Further research is needed on the impact and the \n","treatment of kratom dependence.': [('buprenorphine/naloxone', 'CHEMICAL'), ('buprenorphine/naloxone', 'CHEMICAL'), ('kratom dependence', 'DISEASE'), ('buprenorphine/naloxone', 'CHEMICAL'), ('polysubstance', 'CHEMICAL'), ('kratom dependence', 'DISEASE'), ('alkaloids', 'CHEMICAL'), ('kratom dependence', 'DISEASE'), ('buprenorphine/naloxone', 'CHEMICAL'), ('buprenorphine/naloxone', 'CHEMICAL'), ('buprenorphine/naloxone', 'CHEMICAL'), ('cooccurring pain', 'DISEASE'), ('Polysubstance', 'CHEMICAL'), ('kratom dependence', 'DISEASE'), ('buprenorphine/naloxone', 'CHEMICAL'), ('alkaloids', 'CHEMICAL'), ('buprenorphine/naloxone', 'CHEMICAL'), ('kratom dependence', 'DISEASE'), ('kratom dependence', 'DISEASE')]\n","Detected entities in text: ' Kratom (Mitragyna speciosa Korth.) is a traditional folk remedy used \n","in Southeast Asia and is known to have a significant opioid-like effect. \n","However, it is unknown whether kratom consumption can impair quality of life \n","(QoL). This study aimed to examine the QoL of people who use kratom by comparing \n","it with that of healthy non-kratom using controls and to determine the \n","association between patterns of kratom use and QoL among people who use kratom. \n","Methods: 200 respondents (100 subjects who use kratom and 100 healthy controls) \n","were recruited for this cross-sectional study. The World Health Organization \n","Quality of Life-BREF was administered to all the respondents to assess QoL, \n","while the Kratom Dependence Scale (KDS) was used to assess the severity of \n","kratom dependence among the subjects who use kratom. Results: The physical \n","health, psychological, and environment QoL scores of the subjects who use kratom \n","were significantly lower than those of the healthy controls. Multiple linear \n","regression analysis revealed greater KDS score and longer duration of kratom use \n","were significant predictors of physical health QoL, while only greater KDS score \n","significantly predicted psychological and environment QoL scores. Conclusion: \n","Prolonged kratom use and kratom dependence may negatively impact the QoL of \n","people who use kratom, hence kratom addiction has to be treated adequately.': [('KDS', 'CHEMICAL'), ('kratom dependence', 'DISEASE'), ('KDS', 'DISEASE'), ('KDS', 'DISEASE')]\n","Detected entities in text: 'Kratom is a legal, widely available substance that contains opioid agonist \n","alkaloids. Due to the marketing of kratom as an opioid alternative for treatment \n","of pain, anxiety, depression, or to reduce opioid withdrawal symptoms, the use \n","of kratom has increased among persons in the USA including pregnant women. This \n","systematic review of the peer-reviewed literature regarding kratom in relation \n","to maternal and infant outcomes resulted in analysis of six case reports of \n","prenatal kratom exposure. Maternal and infant withdrawal from kratom exposure \n","was described in each case, resulting in pharmacologic treatment for both \n","mothers and infants.': [('pain', 'DISEASE'), ('anxiety', 'DISEASE'), ('depression', 'DISEASE')]\n","Detected entities in text: 'Mitragynine is the main alkaloid isolated from the leaves of Mitragyna speciosa \n","Korth (Kratom). Kratom has been widely used to relieve pain and opioid \n","withdrawal symptoms in humans but may also cause memory deficits. Here we \n","investigated the changes in brain electroencephalogram (EEG) activity after \n","acute and chronic exposure to mitragynine in freely moving rats. Vehicle, \n","morphine (5 mg/kg) or mitragynine (1, 5 and 10 mg/kg) were administered for 28 \n","days, and EEG activity was repeatedly recorded from the frontal cortex, \n","neocortex and hippocampus. Repeated exposure to mitragynine increased delta, but \n","decreased alpha powers in both cortical regions. It further decreased delta \n","power in the hippocampus. These findings suggest that acute and chronic \n","mitragynine can have profound effects on EEG activity, which may underlie \n","effects on behavioral activity and cognition, particularly learning and memory \n","function.': [('Mitragynine', 'CHEMICAL'), ('pain', 'DISEASE'), ('memory deficits', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('1, 5 and 10\\u2009mg/kg', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Chronic administration of opioids produces physical dependence and \n","opioid-induced hyperalgesia. Users claim the Thai traditional tea \"kratom\" and \n","component alkaloid mitragynine ameliorate opioid withdrawal without increased \n","sensitivity to pain. Testing these claims, we assessed the combined kratom \n","alkaloid extract (KAE) and two individual alkaloids, mitragynine (MG) and the \n","analog mitragynine pseudoindoxyl (MP), evaluating their ability to produce \n","physical dependence and induce hyperalgesia after chronic administration, and as \n","treatments for withdrawal in morphine-dependent subjects. C57BL/6J mice \n","(n = 10/drug) were administered repeated saline, or graded, escalating doses of \n","morphine (intraperitoneal; i.p.), kratom alkaloid extract (orally, p.o.), \n","mitragynine (p.o.), or MP (subcutaneously, s.c.) for 5 days. Mice treated \n","chronically with morphine, KAE, or mitragynine demonstrated significant \n","drug-induced hyperalgesia by day 5 in a 48 °C warm-water tail-withdrawal test. \n","Mice were then administered naloxone (10 mg/kg, s.c.) and tested for opioid \n","withdrawal signs. Kratom alkaloid extract and the two individual alkaloids \n","demonstrated significantly fewer naloxone-precipitated withdrawal signs than \n","morphine-treated mice. Additional C57BL/6J mice made physically dependent on \n","morphine were then used to test the therapeutic potential of combined KAE, \n","mitragynine, or MP given twice daily over the next 3 days at either a fixed dose \n","or in graded, tapering descending doses. When administered naloxone, mice \n","treated with KAE, mitragynine, or MP under either regimen demonstrated \n","significantly fewer signs of precipitated withdrawal than control mice that \n","continued to receive morphine. In conclusion, while retaining some liabilities, \n","kratom, mitragynine, and mitragynine pseudoindoxyl produced significantly less \n","physical dependence and ameliorated precipitated withdrawal in \n","morphine-dependent animals, suggesting some clinical value.': [('hyperalgesia', 'DISEASE'), ('tea', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('pain', 'DISEASE'), ('KAE', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('mitragynine pseudoindoxyl', 'CHEMICAL'), ('MP', 'DISEASE'), ('hyperalgesia', 'DISEASE'), ('morphine', 'CHEMICAL'), ('kratom alkaloid extract', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('MP', 'DISEASE'), ('morphine', 'CHEMICAL'), ('KAE', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('hyperalgesia', 'DISEASE'), ('naloxone', 'CHEMICAL'), ('Kratom alkaloid extract', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('KAE', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('MP', 'DISEASE'), ('naloxone', 'CHEMICAL'), ('KAE', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('MP', 'DISEASE'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine pseudoindoxyl', 'CHEMICAL')]\n","Detected entities in text: 'Leaves harvested from the Southeast Asian tree Mitragyna speciosa (kratom) have \n","a history of use as a traditional ethnobotanical source of medicine to combat \n","fatigue, improve work productivity, and to reduce opioid-related withdrawal \n","symptoms. Kratom leaves contain an array of alkaloids thought to be responsible \n","for the bioactivity reported by users. Interest in the consumptive effects of \n","kratom has led to its recent popularity and use in North America, Western \n","Europe, and Australia. Although the chemistry and pharmacology of select kratom \n","alkaloids are understood, studies have not examined the influence of production \n","environment on growth and alkaloidal content. To directly address this need, 68 \n","kratom trees were vegetatively propagated from a single mother stock to reduce \n","genetic variability and subjected to four varying fertilizer application rates. \n","Leaves were analyzed for chlorophyll concentration, biomass, and alkaloidal \n","content to understand the physiological response of the plant. While increasing \n","rates of fertilizer promoted greater plant growth, relationships with alkaloidal \n","content within leaves were highly variable. Fertility rate had little influence \n","on the concentration of mitragynine, paynantheine, speciociliatine, \n","mitraphylline, and corynoxine per leaf dry mass. 7-Hydroxymitragynine was below \n","the lower limit of quantification in all the analyzed leaf samples. Low to \n","medium rates of fertilizer, however, maximized concentrations of speciogynine, \n","corynantheidine, and isocorynantheidine per leaf dry mass, suggesting a \n","promotion of nitrogen allocation for secondary metabolism occurred for these \n","select alkaloids. Strong correlations (r 2 = 0.86) between extracted leaf \n","chlorophyll and rapid, non-destructive chlorophyll evaluation (SPAD) response \n","allowed for development of a reliable linear model that can be used to diagnose \n","nutrient deficiencies and allow for timely adjustment of fertilization programs \n","to more accurately manage kratom cultivation efforts. Results from this study \n","provide a greater understanding of the concentration and synthesis of nine \n","bioactive alkaloids in fresh kratom leaves and provide foundational information \n","for kratom cultivation and production.': [('fatigue', 'DISEASE'), ('consumptive', 'DISEASE'), ('chlorophyll', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('paynantheine', 'CHEMICAL'), ('speciociliatine', 'CHEMICAL'), ('7-Hydroxymitragynine', 'CHEMICAL'), ('speciogynine', 'CHEMICAL'), ('nitrogen', 'CHEMICAL'), ('chlorophyll', 'CHEMICAL'), ('chlorophyll', 'CHEMICAL'), ('SPAD', 'CHEMICAL')]\n","Detected entities in text: 'Among the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, \n","fatigue, and headache can affect the quality of life of patients, even after the \n","end of the acute phase of the infection and can be long lasting. The current \n","treatment of these symptoms, also because COVID-19 patients have been asked not \n","to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen \n","are often unsatisfactory. Among the above mentioned symptoms malaise and fatigue \n","seem the most difficult to treat. In this case report we describe the use of \n","kratom (Mitragyna speciosa) by a patient with confirmed COVID-19 infection. What \n","we observed was a fast and sustained relieve of the above mentioned symptoms.': [('COVID-19 fever', 'DISEASE'), ('pain', 'DISEASE'), ('aches', 'DISEASE'), ('myalgia', 'DISEASE'), ('fatigue', 'DISEASE'), ('headache', 'DISEASE'), ('infection', 'DISEASE'), ('ibuprofen', 'CHEMICAL'), ('fatigue', 'DISEASE'), ('COVID-19 infection', 'DISEASE')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa Korth., Rubiaceae) is native to and has traditional \n","use in Southeast Asia. The number of kratom users outside of Southeast Asia has \n","increased significantly in recent decades with use spreading to the Unites \n","States (US) and Europe. Because of its reputed opioid-like psychoactive effects \n","at higher doses, kratom has been regulated in several countries and is subject \n","to an import ban by the US Food and Drug Administration. Nonetheless, in the US \n","it is estimated that 10-15 million people consume kratom primarily for the \n","self-treatment of pain, psychiatric disorders, to mitigate withdrawal from or \n","dependence on opioids, and to self-treat opioid use disorder or other substance \n","use disorders (SUDs). Due to the global COVID-19 pandemic, a shortage in the \n","supply of kratom products may place unexpected burdens on kratom users, \n","potentially influencing some who use kratom for SUD self-treatment to regress to \n","harmful drug use, hence increasing the likelihood of adverse outcomes, including \n","overdose. Inadequate treatment, treatment barriers, and increases in the sales \n","of adulterated kratom products on the internet or in convenience stores could \n","exacerbate circumstances further. Although there are currently no verified \n","indications of kratom scarcity, researchers and clinicians should be aware of \n","and remain vigilant to this unanticipated possibility.': [('pain', 'DISEASE'), ('psychiatric disorders', 'DISEASE'), ('SUDs', 'CHEMICAL'), ('SUD', 'CHEMICAL'), ('overdose', 'DISEASE'), ('adulterated kratom', 'CHEMICAL')]\n","Detected entities in text: 'Speciociliatine is a minor indole alkaloid found in kratom, a southeast Asian \n","medicinal plant, used for centuries to increase energy, enhance mood, and \n","mitigate pain and opioid dependence. An ultra-performance liquid chromatography \n","tandem mass spectrometry method was developed and validated to quantify \n","speciociliatine in rat plasma. The quantitation range was 3-600 ng/mL. The \n","validated method was applied to a preclinical pharmacokinetic study in male \n","Sprague-Dawley rats after 2.5 mg/kg intravenous (I.V.) and 20 mg/kg oral (P.O.) \n","dosing. The plasma was analyzed to obtain concentration-time profiles and \n","results were subjected to non-compartmental analysis to determine \n","pharmacokinetic parameters including volume of distribution (6.2 ± 2.3 L/kg \n","I.V.), clearance (0.7 ± 0.2 L/hr/kg), and absolute oral bioavailability (20.7 \n","%). Speciociliatine had higher systemic exposure and lower clearance compared to \n","the other kratom alkaloids mitragynine and corynantheidine. The speciociliatine \n","pharmacokinetic parameters described here will help to better understand the \n","overall effects reported with kratom product use.': [('indole alkaloid', 'CHEMICAL'), ('pain', 'DISEASE'), ('±', 'CHEMICAL'), ('kratom alkaloids mitragynine', 'CHEMICAL'), ('corynantheidine', 'CHEMICAL')]\n","Detected entities in text: 'Pain management devoid of serious opioid adverse effects is still far from reach \n","despite vigorous research and development efforts. Alternatives to classical \n","opioids have been sought for years, and mounting reports of individuals finding \n","pain relief with kratom have recently intensified research on this natural \n","product. Although the composition of kratom is complex, the pharmacological \n","characterization of its most abundant alkaloids has drawn attention to three \n","molecules in particular, owing to their demonstrated antinociceptive activity \n","and limited side effects in vivo. These three molecules are mitragynine (MG), \n","its oxidized active metabolite, 7-hydroxymitragynine (7OH), and the \n","indole-to-spiropseudoindoxy rearrangement product of MG known as mitragynine \n","pseudoindoxyl (MP). Although these three alkaloids have been shown to \n","preferentially activate the G protein signaling pathway by binding and \n","allosterically modulating the μ-opioid receptor (MOP), a molecular level \n","understanding of this process is lacking and yet important for the design of \n","improved therapeutics. The molecular dynamics study and experimental validation \n","reported here provide an atomic level description of how MG, 7OH, and MP bind \n","and allosterically modulate the MOP, which can eventually guide structure-based \n","drug design of improved therapeutics.': [('Pain', 'DISEASE'), ('pain', 'DISEASE'), ('alkaloids', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7OH', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('pseudoindoxyl', 'CHEMICAL'), ('MP', 'DISEASE'), ('alkaloids', 'CHEMICAL'), ('7OH', 'CHEMICAL'), ('MP', 'DISEASE')]\n","Detected entities in text: 'In Japan, mitragynine, 7-hydroxymitragynine and Mitragyna speciosa Korth. (M. \n","speciosa, \"Kratom\") were controlled as Designated Substances under the \n","Pharmaceutical and Medical Device Act from March 2016. In this study, the \n","origins of 16 Kratom products obtained from the illegal drug market in Japan \n","were investigated by DNA analyses and LC-MS analyses. When the PCR-restriction \n","fragment length polymorphism (RFLP) was performed using the restriction enzyme \n","XmaI (as reported by Sukrong et al. to be able to distinguish M. speciosa), the \n","same DNA fragment patterns were obtained from all 16 products. On the other \n","hand, as a result of the identification of the plant species of each product by \n","nucleotide sequence analyses, the sequences of M. speciosa were detected in only \n","14 products. Despite the facts that mitragynine and 7-hydroxymitragynine were \n","detected also in the other two products by the LC-MS analyses, M. speciosa DNAs \n","were not amplified from these products by the PCR. Moreover, the DNA amplicons \n","of the other psychotropic plant (Mesembryanthemum sp., e.g. \"Kanna\") were \n","detected. This plant PCR amplicon has the restriction site for the XmaI at the \n","same position of the M. speciosa PCR amplicon and it is difficult to distinguish \n","\"Kratom\" and \"Kanna\" by the conventional PCR-RFLP. When the restriction enzyme \n","XhoI was used simultaneously with the Xmal, the specific DNA fragment was only \n","observed from the M. speciosa amplicon and it was possible to distinguish both \n","species using this improved PCR-RFLP method. This method is useful to identify \n","the origin of Kratom products distributed in the illegal drug market.': [('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('nucleotide', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom is a botanical product used as an opium substitute with abuse \n","potential.\n","METHODS: Assessment of suspected cases of kratom-induced liver injury in a \n","prospective US cohort.\n","RESULTS: Eleven cases of liver injury attributed to kratom were identified with \n","a recent increase. The majority were male with median age 40 years. All were \n","symptomatic and developed jaundice with a median latency of 14 days. The liver \n","injury pattern was variable, most required hospitalization and all eventually \n","recovered. Biochemical analysis revealed active kratom ingredients.\n","CONCLUSION: Kratom can cause severe liver injury with jaundice.': [('opium', 'CHEMICAL'), ('liver injury', 'DISEASE'), ('liver injury', 'DISEASE'), ('jaundice', 'DISEASE'), ('liver injury', 'DISEASE'), ('jaundice', 'DISEASE')]\n","Detected entities in text: 'Interest in the Southeast Asian natural remedy kratom has increased \n","in Western countries recently, along with increasing concern over its potential \n","toxic effects.Objective: To describe and compare demographics, common \n","co-exposure substances, clinical effects, treatments, and medical outcomes of \n","kratom \"abuse\" exposures in the United States (US) and Thailand.Methods: This is \n","a retrospective analysis of kratom \"abuse\" exposures, defined as use when \n","attempting to gain a psychotropic effect, reported to the National Poison Data \n","System (NPDS) in the US and the Ramathibodi Poison Center (RPC) in Thailand from \n","2010 to 2017. Multivariate analysis identified risk factors for severe medical \n","outcomes, defined as both ICU admissions and death.Results: \n","Nine-hundred-twenty-eight cases were included (760 from NPDS and 168 from RPC). \n","A greater proportion of cases involved co-exposures in Thailand (64.8% versus \n","37.4%; odds ratio [OR] = 3.10, 95% confidence interval [CI] = 2.15-4.47, p \n","< .01). Both countries had a similar prevalence of opioid and benzodiazepine \n","co-ingestions, but the US had more co-ingestions with other sedatives (4.6% \n","versus 0%, OR = 0, 95% CI = 0-0.47, p < .01). Common clinical effects included \n","tachycardia (30.4%), agitation/irritability (26.2%), and drowsiness/lethargy \n","(21.1%). Six deaths occurred, including one single-substance exposure in the US, \n","three multiple-substance exposures in the US, and two multiple-substance \n","exposures in Thailand. Severe medical outcomes were reported more frequently in \n","the US (OR = 18.82, 95% CI = 5.85-60.56, p < .01).Conclusions: Despite lower \n","frequencies of co-ingestants overall, US kratom abuse exposures yielded greater \n","clinical severity. This disparity may be attributable to differences in the \n","products labeled \"kratom,\" greater sedative co-exposures in the US, and/or \n","differences in population genetics or use patterns.': [('death', 'DISEASE'), ('benzodiazepine', 'CHEMICAL'), ('tachycardia', 'DISEASE'), ('deaths', 'DISEASE'), ('single-substance', 'CHEMICAL'), ('multiple-substance', 'CHEMICAL'), ('multiple-substance', 'CHEMICAL'), ('kratom abuse', 'DISEASE')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa) is a plant extract that exhibits opioid agonistic \n","activity at the µ-opioid receptor. The use of this substance has increased \n","recently due to widespread local availability across the United States, \n","primarily at gas stations. Repeated kratom use has been shown to have major \n","adverse effects leading to physiological dependence and addiction similar to \n","other opioids. We used a novel contingency management (CM) program utilizing \n","nonmonetary reinforcers along with medication-assisted treatment (MAT) using \n","buprenorphine in an office-based setting to treat kratom use disorder in two \n","cases. MAT with buprenorphine in a CM-based setting was found to be an effective \n","strategy for treating kratom use disorder.': [('CM', 'DISEASE'), ('buprenorphine', 'CHEMICAL'), ('buprenorphine', 'CHEMICAL')]\n","Detected entities in text: '7-Hydroxymitragynine is a potent opioid analgesic alkaloid isolated from the \n","Thai medicinal herb Mitragyna speciosa. In the present study, we investigated \n","the opioid receptor subtype responsible for the analgesic effect of this \n","compound. In addition, we tested whether development of tolerance, \n","cross-tolerance to morphine and naloxone-induced withdrawal signs were observed \n","in chronically 7-hydroxymitragynine-treated mice. Subcutaneous (s.c.) \n","administration of 7-hydroxymitragynine produced a potent antinociceptive effect \n","mainly through activation of mu-opioid receptors. Tolerance to the \n","antinociceptive effect of 7-hydroxymitragynine developed as occurs to morphine. \n","Cross-tolerance to morphine was evident in mice rendered tolerant to \n","7-hydroxymitragynine and vice versa. Naloxone-induced withdrawal signs were \n","elicited equally in mice chronically treated with 7-hydroxymitragynine or \n","morphine. 7-Hydroxymitragynine exhibited a potent antinociceptive effect based \n","on activation of mu-opioid receptors and its morphine-like pharmacological \n","character, but 7-hydroxymitragynine is structurally different from morphine. \n","These interesting characters of 7-hydroxymitragynine promote further \n","investigation of it as a novel lead compound for opioid studies.': [('7-Hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('7-Hydroxymitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom is a psychoactive substance that is isolated from the plant \n","Mitragyna speciosa. The leaves can be chewed fresh or dried, smoked, or infused \n","similar to herbal teas. The plant leaves have been used by natives of Southeast \n","Asia for centuries. The substance has been used for its stimulant activity at \n","low doses, and as an opium substitute at higher doses due to a morphine like \n","effect.\n","CASE SUMMARY: A 37-year-old female with a history of depression and obesity \n","(body mass index: 32) presented to emergency room with a week-long history of \n","nausea, decreased appetite, fatigue, and two days of jaundice. On admission \n","bilirubin was markedly elevated. Her condition was thought to be due to \n","consumption of Kratom 2 wk before onset of symptoms. Liver biopsy showed changes \n","mimicking primary biliary cholangitis. Patient's symptoms and jaundice improved \n","quickly.\n","CONCLUSION: The use of Kratom has been on the rise in recent years across the \n","United States and Europe. Several case reports have associated adverse health \n","impact of Kratom-containing products including death due to its ability to alter \n","levels of consciousness. Only a few case reports have highlighted the \n","hepatotoxic effects of Kratom. Even fewer reports exist describing the detailed \n","histopathological changes.': [('opium', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('depression', 'DISEASE'), ('obesity', 'DISEASE'), ('nausea', 'DISEASE'), ('decreased appetite', 'DISEASE'), ('fatigue', 'DISEASE'), ('jaundice', 'DISEASE'), ('bilirubin', 'CHEMICAL'), ('primary biliary cholangitis', 'DISEASE'), ('jaundice', 'DISEASE'), ('death', 'DISEASE'), ('hepatotoxic', 'DISEASE')]\n","Detected entities in text: 'Out-of-treatment HIV positive opiate users often engage in risky injecting and \n","sexual behaviors. We sought the self-reported experiences on whether or not \n","kratom (Mitragyna speciosa Korth.) use was associated with a reduction in HIV \n","risk behaviors among them. A convenience sample consisting of thirty-two HIV \n","positive opiate users participated in the study. Of this, three-fifths \n","(n = 20/32) used kratom to suppress opiate withdrawal, increase energy, as a \n","heroin substitute, to reduce heroin dependence and self-treat psychological \n","problems. More than one-third (38%) in the sample claimed that kratom use \n","reduced their risky injecting and sexual behaviors. Given the small sample size, \n","the perceived association between kratom use and the reduction in HIV risk \n","behaviors could not be established more convincingly. However, the findings \n","provide the basis for a broader-based study to evaluate the potential of kratom \n","in curtailing HIV risk behaviors among HIV positive opiate users.': [('heroin dependence', 'DISEASE'), ('HIV risk behaviors among HIV positive opiate users', 'DISEASE')]\n","Detected entities in text: 'The safety and efficacy of kratom (Mitragyna speciosa) for treatment of pain is \n","highly controversial. Kratom produces more than 40 structurally related \n","alkaloids, but most studies have focused on just two of these, mitragynine and \n","7-hydroxymitragynine. Here, we profiled 53 commercial kratom products using \n","untargeted LC-MS metabolomics, revealing two distinct chemotypes that contain \n","different levels of the alkaloid speciofoline. Both chemotypes were confirmed \n","with DNA barcoding to be M. speciosa. To evaluate the biological relevance of \n","variable speciofoline levels in kratom, we compared the opioid receptor binding \n","activity of speciofoline, mitragynine, and 7-hydroxymitragynine. Mitragynine and \n","7-hydroxymitragynine function as partial agonists of the human µ-opioid \n","receptor, while speciofoline does not exhibit measurable binding affinity at the \n","µ-, δ- or ƙ-opioid receptors. Importantly, mitragynine and 7-hydroxymitragynine \n","demonstrate functional selectivity for G-protein signaling, with no measurable \n","recruitment of β-arrestin. Overall, the study demonstrates the unique binding \n","and functional profiles of the kratom alkaloids, suggesting potential utility \n","for managing pain, but further studies are needed to follow up on these in vitro \n","findings. All three kratom alkaloids tested inhibited select cytochrome P450 \n","enzymes, suggesting a potential risk for adverse interactions when kratom is \n","co-consumed with drugs metabolized by these enzymes.': [('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('speciofoline', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('speciofoline', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('pain', 'DISEASE')]\n","Detected entities in text: 'Preparations from the leaves of the kratom plant (Mitragyna speciosa) are \n","consumed for their opioid-like effects. Several deaths have been associated with \n","kratom used concomitantly with some drugs. Pharmacokinetic interactions are \n","potential underlying mechanisms of these fatalities. Accumulating in vitro \n","evidence has demonstrated select kratom alkaloids, including the abundant indole \n","alkaloid mitragynine, as reversible inhibitors of several cytochromes P450 \n","(CYPs). The objective of this work was to refine the mechanistic understanding \n","of potential kratom-drug interactions by considering both reversible and \n","time-dependent inhibition (TDI) of CYPs in the liver and intestine. Mitragynine \n","was tested against CYP2C9 (diclofenac 4'-hydroxylation), CYP2D6 \n","(dextromethorphan O-demethylation), and CYP3A (midazolam 1'-hydroxylation) \n","activities in human liver microsomes (HLMs) and CYP3A activity in human \n","intestinal microsomes (HIMs). Comparing the absence to presence of NADPH during \n","preincubation of mitragynine with HLMs or HIMs, an ∼7-fold leftward shift in \n","IC50 (∼20 to 3 μM) toward CYP3A resulted, prompting determination of TDI \n","parameters (HLMs: K I , 4.1 ± 0.9 μM; k inact , 0.068 ± 0.01 min-1; HIMs: K I , \n","4.2 ± 2.5 μM; k inact , 0.079 ± 0.02 min-1). Mitragynine caused no leftward \n","shift in IC50 toward CYP2C9 (∼40 μM) and CYP2D6 (∼1 μM) but was a strong \n","competitive inhibitor of CYP2D6 (K i , 1.17 ± 0.07 μM). Using a recommended \n","mechanistic static model, mitragynine (2-g kratom dose) was predicted to \n","increase dextromethorphan and midazolam area under the plasma concentration-time \n","curve by 1.06- and 5.69-fold, respectively. The predicted midazolam area under \n","the plasma concentration-time curve ratio exceeded the recommended cutoff \n","(1.25), which would have been missed if TDI was not considered. SIGNIFICANCE \n","STATEMENT: Kratom, a botanical natural product increasingly consumed for its \n","opioid-like effects, may precipitate potentially serious pharmacokinetic \n","interactions with drugs. The abundant kratom indole alkaloid mitragynine was \n","shown to be a time-dependent inhibitor of hepatic and intestinal cytochrome P450 \n","3A activity. A mechanistic static model predicted mitragynine to increase \n","systemic exposure to the probe drug substrate midazolam by 5.7-fold, \n","necessitating further evaluation via dynamic models and clinical assessment to \n","advance the understanding of consumer safety associated with kratom use.': [('deaths', 'DISEASE'), ('indole', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('diclofenac', 'CHEMICAL'), ('dextromethorphan', 'CHEMICAL'), ('midazolam', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('dextromethorphan', 'CHEMICAL'), ('midazolam', 'CHEMICAL'), ('midazolam', 'CHEMICAL'), ('indole', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('midazolam', 'CHEMICAL')]\n","Detected entities in text: 'Sexual enhancers increase sexual potency, sexual pleasure, or libido. Substances \n","increasing libido alter the concentrations of specific neurotransmitters or sex \n","hormones in the central nervous system. Interestingly, the same pathways are \n","involved in the mechanisms underlying many psychiatric and neurological \n","disorders, and adverse reactions associated with the use of aphrodisiacs are \n","strongly expected. However, sexual enhancers of plant origin have gained \n","popularity over recent years, as natural substances are often regarded as a \n","safer alternative to modern medications and are easily acquired without \n","prescription. We reviewed the psychiatric and neurological adverse effects \n","associated with the consumption of herbal aphrodisiacs Areca catechu L., \n","Argemone Mexicana L., Citrus aurantium L., Eurycoma longifolia Jack., Lepidium \n","meyenii Walp., Mitragyna speciosa Korth., Panax ginseng C. A. Mey, Panax \n","quinquefolius L., Pausinystalia johimbe (K. Schum.) Pierre ex Beille, Piper \n","methysticum G. Forst., Ptychopetalum olacoides Benth., Sceletium tortuosum (L.) \n","N. E. Brown, Turnera diffusa Willd. ex. Schult., Voacanga africana Stapf ex \n","Scott-Elliot, and Withania somnifera (L.) Dunal. A literature search was \n","conducted on the PubMed, Scopus, and Web of Science databases with the aim of \n","identifying all the relevant articles published on the issue up to June 2020. \n","Most of the selected sexual enhancers appeared to be safe at therapeutic doses, \n","although mild to severe adverse effects may occur in cases of overdosing or \n","self-medication with unstandardized products. Drug interactions are more \n","concerning, considering that herbal aphrodisiacs are likely used together with \n","other plant extracts and/or pharmaceuticals. However, few data are available on \n","the side effects of several plants included in this review, and more clinical \n","studies with controlled administrations should be conducted to address this \n","issue.': [('psychiatric', 'DISEASE'), ('psychiatric', 'DISEASE'), ('aurantium', 'CHEMICAL'), ('Ptychopetalum olacoides Benth', 'DISEASE'), ('Sceletium', 'CHEMICAL')]\n","Detected entities in text: 'The effect of an indole-alkaloid mitragynine isolated from the Thai medicinal \n","herb kratom (Mitragyna speciosa) on neurogenic contraction of smooth muscle was \n","studied in guinea-pig vas deferens. Mitragynine inhibited the contraction of the \n","vas deferens produced by electrical transmural stimulation. On the other hand, \n","mitragynine failed to affect the responses to norepinephrine and ATP. \n","Mitragynine did not reduce KCl-induced contraction in the presence of \n","tetrodotoxin, prazosin and alpha,beta-methylene ATP. Mitragynine inhibited \n","nicotine- or tyramine-induced contraction. By using the patch-clamp technique, \n","mitragynine was found to block T- and L-type Ca2+ channel currents in N1E-115 \n","neuroblastoma cells. In the Ca2+ measurement by a fluorescent dye method, \n","mitragynine reduced KCl-induced Ca2+ influx in neuroblastoma cells. The present \n","results suggest that mitragynine inhibits the vas deferens contraction elicited \n","by nerve stimulation, probably through its blockade of neuronal Ca2+ channels.': [('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('norepinephrine', 'CHEMICAL'), ('ATP', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('tetrodotoxin', 'CHEMICAL'), ('prazosin', 'CHEMICAL'), ('alpha', 'CHEMICAL'), ('beta-methylene ATP', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('neuroblastoma', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('neuroblastoma', 'DISEASE'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Made as a tea, the Thai traditional drug \"kratom\" reportedly \n","possesses pharmacological actions that include both a coca-like stimulant effect \n","and opium-like depressant effect. Kratom has been used as a substitute for opium \n","in physically-dependent subjects. The objective of this study was to evaluate \n","the antinociception, somatic and physical dependence produced by kratom tea, and \n","then assess if the tea ameliorated withdrawal in opioid physically-dependent \n","subjects.\n","METHODS: Lyophilized kratom tea (LKT) was evaluated in C57BL/6J and opioid \n","receptor knockout mice after oral administration. Antinociceptive activity was \n","measured in the 55 °C warm-water tail-withdrawal assay. Potential locomotor \n","impairment, respiratory depression and locomotor hyperlocomotion, and place \n","preference induced by oral LKT were assessed in the rotarod, Comprehensive Lab \n","Animal Monitoring System, and conditioned place preference assays, respectively. \n","Naloxone-precipitated withdrawal was used to determine potential physical \n","dependence in mice repeatedly treated with saline or escalating doses of \n","morphine or LKT, and LKT amelioration of morphine withdrawal. Data were analyzed \n","using one- and two-way ANOVA.\n","RESULTS: Oral administration of LKT resulted in dose-dependent antinociception \n","(≥1 g/kg, p.o.) absent in mice lacking the mu-opioid receptor (MOR) and reduced \n","in mice lacking the kappa-opioid receptor. These doses of LKT did not alter \n","coordinated locomotion or induce conditioned place preference, and only briefly \n","reduced respiration. Repeated administration of LKT did not produce physical \n","dependence, but significantly decreased naloxone-precipitated withdrawal in \n","morphine dependent mice.\n","CONCLUSIONS: The present study confirms the MOR agonist activity and therapeutic \n","effect of LKT for the treatment of pain and opioid physical dependence.': [('tea', 'CHEMICAL'), ('opium', 'CHEMICAL'), ('kratom tea', 'CHEMICAL'), ('tea', 'CHEMICAL'), ('kratom tea', 'CHEMICAL'), ('respiratory depression', 'DISEASE'), ('Naloxone-precipitated', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('pain', 'DISEASE')]\n","Detected entities in text: 'Commercially available Kratom (Mitragyna speciosa) is a dietary supplement that \n","has gained popularity in the United States for its psychoactive effects and \n","potential medicative properties as an opioid receptor agonist. Likewise, sudden \n","discontinuation may be accompanied by an opioid-like withdrawal. We present the \n","first case in the literature of the withdrawal manifesting in disturbing \n","obsessive thoughts after the substance was used as an opioid replacement \n","treatment by our patient, as well as the first case where lorazepam is utilized \n","for mitigation of these thoughts.': [('lorazepam', 'CHEMICAL')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa Korth.) has been used in Southeast Asia \n","for hundreds of years to increase energy, for relaxation, and to diminish opioid \n","withdrawal. Kratom use has recently spread to Western countries. Kratom could \n","potentially be used for the treatment of opioid withdrawal and pain, but more \n","insight is needed into its abuse potential. Therefore, we investigated the \n","rewarding properties of the primary kratom alkaloid mitragynine and its active \n","metabolite 7-hydroxymitragynine, and morphine as a reference drug in male and \n","female rats. These compounds have agonist activity at mu-opioid receptors.\n","METHODS: The compounds were tested in an intracranial self-stimulation (ICSS) \n","procedure, which allows for the evaluation of the rewarding/aversive and \n","sedative effects of drugs. Rewarding doses of drugs decrease the brain reward \n","thresholds, and aversive drug doses have the opposite effect.\n","RESULTS: Mitragynine, 7-hydroxymitragynine, and morphine affected the brain \n","reward thresholds. A high dose of 7-hydroxymitragynine (3.2 mg/kg) increased the \n","brain reward thresholds, whereas an intermediate dose of morphine (10 mg/kg) \n","decreased the reward thresholds. 7-Hydroxymitragynine and morphine affected the \n","response latencies. Five mg/kg of morphine increased response latencies. \n","7-Hydroxymitragynine tended to increase the response latencies, but the post hoc \n","analyses did not reveal a significant effect. There were no sex differences in \n","the effects of mitragynine, 7-hydroxymitragynine, and morphine on the reward \n","thresholds and the response latencies.\n","CONCLUSIONS: These initial findings indicate that mitragynine and \n","7-hydroxymitragynine are not rewarding in the ICSS procedure. The present \n","results suggest that these kratom alkaloids do not have abuse potential.': [('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('7-Hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('7-Hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Little is known about the cardiotoxic effects of kratom (Mitragyna \n","speciosa Korth.), a medicinal plant. This analytical cross-sectional study \n","investigated the prevalence of electrocardiogram (ECG) abnormalities and QTc \n","intervals in regular kratom users compared with non-kratom-using control \n","subjects.\n","METHODS: We enrolled regular kratom users and non-kratom-using control subjects \n","from three communities. Demographic data, clinical data, kratom use \n","characteristics, and ECG findings were recorded. The mitragynine content of \n","kratom juice was quantified using a validated gas chromatography-mass \n","spectrometry (GC-MS) method.\n","RESULTS: A total of 200 participants (100 kratom users and 100 control subjects) \n","participated in this study. The prevalence of ECG abnormalities in kratom users \n","(28%) did not differ from that of control subjects (32%). Kratom use was not \n","associated with ECG abnormalities, except for significantly higher odds of sinus \n","tachycardia (OR = 8.61, 95% CI = 1.06-70.17, p = 0.035) among kratom users \n","compared with control subjects. The odds of observing borderline QTc intervals \n","were significantly higher for kratom users compared with control subjects, \n","regardless of the age of first use, the duration of use, the daily quantity \n","consumed, and the length of time that had elapsed between last kratom use and \n","ECG assessment. Nevertheless, there were no differences in the odds of having \n","prolonged QTc intervals between kratom users and controls. The estimated average \n","daily intake of mitragynine consumed by kratom users was 434.28 mg.\n","CONCLUSION: We found no link between regular kratom use and electrocardiographic \n","abnormalities with an estimated average daily intake of 434.28 mg of \n","mitragynine.': [('cardiotoxic', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('ECG abnormalities', 'DISEASE'), ('tachycardia', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Some opioid use disorder (OUD) patients attempt to self-treat \n","using herbal remedies such as kratom. However, kratom use itself can \n","paradoxically cause physical dependence and OUD. Currently, there are no \n","guidelines for treating patients with OUD stemming from kratom use. Our \n","empirically-based hypothesis was that there would be a correlation between the \n","amount of kratom used and the amount of buprenorphine-naloxone required for \n","opioid agonist therapy.\n","METHODS: This study includes a systematic review assessing treatment of \n","kratom-dependent patients with buprenorphine-naloxone; a case series of our \n","kratom-dependent patients; calculation of the correlation between the kratom \n","dose and the buprenorphine-naloxone dose required to treat kratom-associated \n","OUD; and our proposed starting doses for using buprenorphine-naloxone to treat \n","kratom OUD.\n","RESULTS: The OVID MEDLINE (1946-2020) database was searched using the terms \n","\"kratom,\" \"buprenorphine,\" and \"case report.\" This search yielded 3 relevant \n","cases of patients having kratom OUD who were treated with buprenorphine-naloxone \n","with the amounts of all substances reported. Review of the bibliographies, \n","citing articles, and Google Scholar turned up three additional cases, yielding 6 \n","literature cases that were analyzed. We also analyzed 2 patients from our \n","clinic, giving a total of 8 patients included in the Pearson correlation \n","coefficient calculation. We found a strong correlation of 0.84 between these \n","variables, consistent with our hypothesis.\n","CONCLUSIONS: Based on our analysis, patients using <20 g of kratom/d could be \n","initiated on opioid agonist therapy with 4/1 mg-8/2 mg buprenorphine-naloxone/d, \n","while patients using kratom doses >40 g/d could be initiated with 12/3 \n","mg-16/4 mg of buprenorphine-naloxone/day.': [('OUD', 'DISEASE'), ('OUD', 'DISEASE'), ('OUD', 'DISEASE'), ('buprenorphine-naloxone', 'CHEMICAL'), ('buprenorphine-naloxone', 'CHEMICAL'), ('buprenorphine-naloxone', 'CHEMICAL'), ('OUD', 'DISEASE'), ('buprenorphine-naloxone', 'CHEMICAL'), ('buprenorphine', 'CHEMICAL'), ('OUD', 'DISEASE'), ('buprenorphine-naloxone', 'CHEMICAL'), ('g/d', 'CHEMICAL')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa, Korth) is a tree-like plant that is indigenous to \n","Southeast Asia. Kratom leaf products have been used in traditional folk medicine \n","for their unique combination of stimulant and opioid-like effects. Kratom is \n","being increasingly used in the West for its reputed benefits in the treatment of \n","pain, depression and opioid use disorder. Recently, the United States Food and \n","Drug Administration and Centers for Disease Control have raised concerns \n","regarding the contamination of some kratom products with toxic metals (Pb and \n","Ni) and microbes such as Salmonella. To further explore this issue, eight \n","different kratom products were legally purchased from various \"head\"/\"smoke\" \n","shops in the Western Suburbs of Chicago and then tested for microbial burden, a \n","panel of metals (Ni, Pb, Cr, As, Hg, Cd), and levels of the main psychoactive \n","alkaloid mitragynine. All of the samples contained significant, but variable, \n","levels of mitragynine (3.9-62.1 mg/g), indicating that the products were, in \n","fact, derived from kratom. All but two of the samples tested positive for the \n","presence of various microbes including bacteria and fungi. However, none of the \n","samples tested positive for Salmonella. Seven products showed significant levels \n","of Ni (0.73-7.4 µg/g), Pb (0.16-1.6 µg/g) and Cr (0.21-5.7 µg/g) while the other \n","product was negative for metals. These data indicate that many kratom products \n","contain variable levels of mitragynine and can contain significant levels of \n","toxic metals and microbes. These findings highlight the need for more stringent \n","standards for the production and sale of kratom products.': [('pain', 'DISEASE'), ('depression', 'DISEASE'), ('Pb', 'CHEMICAL'), ('Ni', 'CHEMICAL'), ('Ni', 'CHEMICAL'), ('Pb', 'CHEMICAL'), ('Cr', 'CHEMICAL'), ('Cd', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Ni', 'CHEMICAL'), ('Pb', 'CHEMICAL'), ('Cr', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Use of kratom is increasing in the United States due to its \n","perceived safety as a botanical product. This review provides salient \n","information about kratom for the practicing clinician.\n","METHODS: We conducted a literature search of MedLine, UpToDate, and Google using \n","the terms \"kratom\" and \"Mitragyna speciosa\" for articles published within the \n","last 10 years.\n","RESULTS: We reviewed > 500 articles. Kratom is derived from the Mitragyna \n","speciosa plant of Southeast Asia. It has grown in popularity within the United \n","States due to its dual effects of acting as a stimulant at low doses and acting \n","as an opioid-like substance at higher dosages. The 2 major active ingredients in \n","kratom, mitragynine and 7-OH mitragynine, act as partial agonists at the \n","mu-opioid receptor. While adverse consequences are normally mild, there are \n","several potentially serious adverse effects, including respiratory depression, \n","especially with chronic, high-dose usage. Furthermore, in case reports, \n","concomitant use of kratom with other substances has been linked to seizures. \n","Unfortunately, an increasing number of deaths have been linked to kratom usage. \n","Six states have made it illegal to possess or sell kratom.\n","CONCLUSIONS: Kratom is an emerging drug of abuse in the United States. Its use \n","is increasing in individuals who may seek to experience an opioidlike \"high\" as \n","well as to help reduce withdrawal effects from other opioids.': [('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('respiratory depression', 'DISEASE'), ('high-dose', 'CHEMICAL'), ('seizures', 'DISEASE'), ('deaths', 'DISEASE')]\n","Detected entities in text: 'Mitragynine is the most abundant psychoactive alkaloid derived from the leaves \n","of Mitragyna speciosa (kratom), a tropical plant indigenous to regions of \n","Southeast Asia. Mitragynine displays a moderate affinity to opioid receptors, \n","and kratom is often self-prescribed to treat pain and/or opioid addiction. The \n","purpose of this study was to investigate the safety and pharmacokinetic \n","properties of mitragynine in the dog. Single dose oral (5 mg/kg) and intravenous \n","(0.1 mg/kg) pharmacokinetic studies of mitragynine were performed in female \n","beagle dogs. The plasma concentrations of mitragynine were measured using \n","ultra-performance liquid chromatography coupled with a tandem mass spectrometer, \n","and the pharmacokinetic properties were analyzed using non-compartmental \n","analysis. Following intravenous administration, mitragynine showed a large \n","volume of distribution (Vd, 6.3 ± 0.6 L/kg) and high clearance (Cl, \n","1.8 ± 0.4 L/h/kg). Following oral mitragynine dosing, first peak plasma (Cmax, \n","278.0 ± 47.4 ng/mL) concentrations were observed within 0.5 h. A potent \n","mu-opioid receptor agonist and active metabolite of mitragynine, \n","7-hydroxymitragynine, was also observed with a Cmax of 31.5 ± 3.3 ng/mL and a \n","Tmax of 1.7 ± 0.6 h in orally dosed dogs while its plasma concentrations were \n","below the lower limit of quantification (1 ng/mL) for the intravenous study. The \n","absolute oral bioavailability of mitragynine was 69.6%. Administration of \n","mitragynine was well tolerated, although mild sedation and anxiolytic effects \n","were observed. These results provide the first detailed pharmacokinetic \n","information for mitragynine in a non-rodent species (the dog) and therefore also \n","provide significant information for allometric scaling and dose predictions when \n","designing clinical studies.': [('Mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom, or Mitragyna speciosa Korth., is a tropical plant prevalent in Southeast \n","Asia, and it is utilized as a traditional remedy for symptomatic relief of \n","various illnesses. It has been labeled as an atypical opioid with significant \n","narcotic-like properties, capable of inducing kratom dependence among those who \n","misuse or abuse it. The prevalence of kratom use has drastically increased \n","worldwide, raising concerns among healthcare providers, particularly regarding \n","the availability of efficacious treatment options for kratom dependence. This \n","manuscript provides a comprehensive narrative review of literature focusing on \n","the psychoactive alkaloids of kratom, the possible neurobiological and \n","pathophysiological models underlying the occurrence of kratom dependence, and \n","the clinical presentations and effective treatment options available for kratom \n","dependence. The psychoactive alkaloids of kratom, such as mitragynine (MG) and \n","7-hydroxymitragynine (7-HMG), act as partial mu opioid agonists and induce \n","kratom dependence. As a result, regular kratom use leads to withdrawal symptoms \n","on abstinence, along with craving, tolerance, and cross-tolerance to morphine. \n","The psychological withdrawal symptoms reported include depressed mood, anxiety, \n","restlessness, irritability, and feeling tense, while the physical withdrawal \n","symptoms are myalgia and body ache, joint pain, lacrimation, running nose, \n","yawning, insomnia, diarrhea, feverish sensation, loss of appetite, tremors, \n","itching over the body, loss of concentration, and chills. Neonatal withdrawal \n","symptoms, such as oral intolerance, restlessness, irritability, and vomiting, \n","are also reported in newborns of women who are on regular kratom use. Sublingual \n","buprenorphine-naloxone (Suboxone) is reported as a promising treatment for \n","detoxification and maintenance replacement therapy for kratom-dependent users. \n","Alternative treatments for in-patient detoxification include intravenous \n","clonidine and a combination of oral dihydrocodeine and lofexidine. We conclude \n","by adding a note on the research gap concerning kratom dependence, which future \n","studies should focus on.': [('kratom dependence', 'DISEASE'), ('kratom dependence', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('depressed mood', 'DISEASE'), ('anxiety', 'DISEASE'), ('irritability', 'DISEASE'), ('myalgia', 'DISEASE'), ('ache', 'DISEASE'), ('pain', 'DISEASE'), ('insomnia', 'DISEASE'), ('diarrhea', 'DISEASE'), ('loss of appetite', 'DISEASE'), ('tremors', 'DISEASE'), ('chills', 'DISEASE'), ('irritability', 'DISEASE'), ('vomiting', 'DISEASE'), ('buprenorphine-naloxone', 'CHEMICAL'), ('Suboxone', 'CHEMICAL'), ('clonidine', 'CHEMICAL'), ('dihydrocodeine', 'CHEMICAL'), ('lofexidine', 'CHEMICAL')]\n","Detected entities in text: 'Reports of kratom (Mitragyna speciosa) use, a medicinal plant widely \n","found in Southeast Asia, are on the rise in the US. However, the prevalence and \n","characteristics of individuals who use kratom in the US is unknown.\n","OBJECTIVE: To estimate lifetime prevalence of, and descriptive characteristics \n","associated with, kratom use in a sample of the US general population.\n","METHODS: A cross-sectional survey was administered online by Qualtrics® research \n","panel aggregator. Utilizing quota-based sampling, data was collected from a US \n","sample aged 18-59 years, representative to age, geographic region, ethnicity, \n","income, and education level. Data was collected regarding respondent \n","demographic/clinical characteristics, as well as frequency/patterns of kratom \n","and other drug use.\n","RESULTS: Among 1,842 respondents, 112 (6.1%) reported use of kratom within their \n","lifetime. Respondents who used kratom were largely between 25-44 years old, \n","male, employed, and at higher educational levels. A total of 24.1% to 47.3% of \n","respondents indicated self-reported diagnoses for addiction, and 42.9% reported \n","having previously received treatment for addiction. A total of 71.4% to 92% of \n","respondents who used kratom also reported use of other drugs, including \n","nicotine, cannabis, cocaine, ecstasy, methamphetamine, and heroin.\n","CONCLUSIONS: To our knowledge, this analysis provides the first estimate of \n","kratom use in the general US population, providing insight on \n","demographic/clinical characteristics of individuals reporting use.': [('nicotine', 'CHEMICAL'), ('cannabis', 'CHEMICAL'), ('cocaine', 'CHEMICAL'), ('ecstasy', 'CHEMICAL'), ('methamphetamine', 'CHEMICAL')]\n","Detected entities in text: 'Despite the relative reduction in opioid and other illicit \n","substance overdoses in the past few years, clinicians must remain vigilant in \n","keeping up to date on emerging trends with regard to potential substances of \n","abuse. As overdoses of traditional drugs of abuse decrease in light of \n","legislative and de-prescribing initiatives, it stands to reason that alternative \n","agents, including natural products, have increased. Toxicities associated with \n","these agents have been contributing to emergency department visits across the \n","globe.\n","AREAS COVERED: This evaluation covers salvia, kratom, and psilocybin mushrooms, \n","and was accomplished through a comprehensive review of PubMed, SCOPUS, ProQuest \n","Central, ProQuest Dissertations, and CINAHL. Thirty-one pieces of literature are \n","included in this evaluation. The objective of this review is to provide \n","clinicians with the information necessary to provide bedside care for overdoses \n","of salvia, kratom, and psilocybin mushrooms.\n","EXPERT OPINION: Salvia, kratom, and psilocybin mushrooms may not be an initial \n","consideration when healthcare practitioners are triaging an overdose scenario; \n","however, data from around the world demonstrate an increased use of these \n","agents. While not typically fatal, clinicians must be prepared to assess these \n","as a potential etiology of overdoses and provide appropriate supportive care.': [('Toxicities', 'DISEASE'), ('psilocybin', 'CHEMICAL'), ('psilocybin', 'CHEMICAL'), ('psilocybin', 'CHEMICAL'), ('overdose', 'DISEASE'), ('overdoses', 'DISEASE')]\n","Detected entities in text: 'Mitragyna speciosa, otherwise known as kratom, is a plant in the coffee family \n","(Rubiaceae) native to Southeast Asia and Thailand whose leaves have been shown \n","to cause opioid-like and stimulant responses upon ingestion. The major \n","pharmacologically active compounds present in kratom, mitragynine and \n","7-hydroxymitragynine (7-HMG), are both indole alkaloids and are responsible for \n","its opioid-like activity. While kratom is most commonly known for its affinity \n","for mu-opioid receptors, research has shown one of its active components has \n","effects on the same receptors to which some antipsychotics bind, such as D2 \n","dopamine, serotonin (5-HT2C and 5-HT7), and alpha-2 adrenergic receptors \n","displaying possible indications of kratom to be used as both antipsychotics and \n","antidepressants. Although studies to evaluate this effect are still lacking, \n","several online and in-person surveys note relief of depression and anxiety \n","symptoms among those who consume kratom products, and in fact identify it as a \n","common reason for consumption. This then highlights the dire need for further \n","research to be conducted on kratom, its mechanism of action and the constituents \n","that elicit these antidepressant, anxiolytic, and antipsychotic properties.': [('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('indole alkaloids', 'CHEMICAL'), ('dopamine', 'CHEMICAL'), ('serotonin', 'CHEMICAL'), ('antidepressants', 'CHEMICAL'), ('depression', 'DISEASE'), ('anxiety', 'DISEASE'), ('antidepressant', 'CHEMICAL')]\n","Detected entities in text: 'Kratom has a long history of traditional medicine use in Southeast \n","Asia. Consumption of kratom products has also been reported in the US and other \n","regions of the world. Pain relief is among many self-reported kratom effects but \n","have not been evaluated in controlled human subject research. Methods: Kratom \n","effects on pain tolerance were assessed in a randomized, placebo-controlled, \n","double-blind study. During a 1-day inpatient stay, participants received a \n","randomized sequence of kratom and placebo decoctions matched for taste and \n","appearance. Pain tolerance was measured objectively in a cold pressor task (CPT) \n","as time (seconds) between the pain onset and the hand withdrawal from the ice \n","bath. Health status, vital signs, objective, and subjective indicators of \n","withdrawal symptoms, self-reported data on lifetime kratom use patterns, and \n","assessments of blinding procedures were also evaluated. Results: Twenty-six \n","males with the mean (SD) age 24.3 (3.4) years were enrolled. They reported the \n","mean (SD) 6.1 (3.2) years of daily kratom consumption. Pain tolerance increased \n","significantly 1 hour after kratom ingestion from the mean (SD) 11.2 (6.7) \n","seconds immediately before to 24.9 (39.4) seconds 1 hour after kratom \n","consumption (F(2,53.7)=4.33, p=0.02). Pain tolerance was unchanged after \n","consuming placebo drinks: 15.0 (19.0) seconds immediately before and 12.0 (8.1) \n","seconds 1 hour after consumption of placebo (F(2,52.8)=0.93, p=0.40). No \n","discomfort or signs of withdrawal were reported or observed during 10-20 hours \n","of kratom discontinuation. Conclusions: Kratom decoction demonstrated a \n","substantial and statistically significant increase in pain tolerance. Further \n","rigorous research on kratom pain-relieving properties and a safety profile is \n","needed.': [('Pain', 'DISEASE'), ('pain', 'DISEASE'), ('Pain', 'DISEASE'), ('pain', 'DISEASE'), ('Pain', 'DISEASE'), ('Pain', 'DISEASE'), ('pain', 'DISEASE')]\n","Detected entities in text: 'Recently, we found that mitragynine, a major constituent of Mitragyna speciosa, \n","has an opioid agonistic activity, but its weak potency could not explain the \n","opium-like effect of this plant. In the present study, bioassay-guided \n","fractionation of the crude extract of the leaves of M. speciosa was carried out \n","to search for potent opioid agonists other than mitragynine. Opioid agonistic \n","activities were evaluated using twitch contraction induced by electrical \n","stimulation in guinea-pig ileum. The crude extract of M. speciosa inhibited the \n","twitch contraction in a concentration-dependent manner. The inhibition was \n","reversed by naloxone. The opioid effect was detected only in the crude base \n","fraction, which was followed by the isolation of five indole alkaloids. Among \n","these alkaloids, 7-hydroxymitragynine showed the most potent opioid effect on \n","the electrically-stimulated contraction (pD (2) = 8.38 +/- 0.12). The potency, \n","calculated using pD (2) values, was 30- and 17-fold higher than that of \n","mitragynine and morphine, respectively. Antagonism of naloxone on \n","concentration-response curves for 7-hydroxymitragynine confirmed its opioid \n","effect. These results suggest that the opioid effect of M. speciosa is mostly \n","based on the activity of 7-hydroxymitragynine.': [('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('twitch', 'DISEASE'), ('twitch', 'DISEASE'), ('naloxone', 'CHEMICAL'), ('indole', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('naloxone', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Two separate commercial products of kratom [Mitragyna speciosa (Korth.) Havil. \n","Rubiaceae] were used to generate reference standards of its indole and oxindole \n","alkaloids. While kratom has been studied for over a century, the \n","characterization data in the literature for many of the alkaloids are either \n","incomplete or inconsistent with modern standards. As such, full 1H and 13C NMR \n","spectra, along with HRESIMS and ECD data, are reported for alkaloids 1-19. Of \n","these, four new alkaloids (7, 11, 17, and 18) were characterized using 2D NMR \n","data, and the absolute configurations of 7, 17, and 18 were established by \n","comparison of experimental and calculated ECD spectra. The absolute \n","configuration for the N(4)-oxide (11) was established by comparison of NMR and \n","ECD spectra of its reduced product with those for compound 7. In total, 19 \n","alkaloids were characterized, including the indole alkaloid mitragynine (1) and \n","its diastereoisomers speciociliatine (2), speciogynine (3), and mitraciliatine \n","(4); the indole alkaloid paynantheine (5) and its diastereoisomers \n","isopaynantheine (6) and epiallo-isopaynantheine (7); the N(4)-oxides \n","mitragynine-N(4)-oxide (8), speciociliatine-N(4)-oxide (9), \n","isopaynantheine-N(4)-oxide (10), and epiallo-isopaynantheine-N(4)-oxide (11); \n","the 9-hydroxylated oxindole alkaloids speciofoline (12), isorotundifoleine (13), \n","and isospeciofoleine (14); and the 9-unsubstituted oxindoles corynoxine A (15), \n","corynoxine B (16), 3-epirhynchophylline (17), 3-epicorynoxine B (18), and \n","corynoxeine (19). With the ability to analyze the spectroscopic data of all of \n","these compounds concomitantly, a decision tree was developed to differentiate \n","these kratom alkaloids based on a few key chemical shifts in the 1H and/or 13C \n","NMR spectra.': [('indole', 'CHEMICAL'), ('oxindole', 'CHEMICAL'), ('N(4)-oxide', 'CHEMICAL'), ('indole', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('speciogynine', 'CHEMICAL'), ('mitraciliatine', 'CHEMICAL'), ('indole alkaloid', 'CHEMICAL'), ('paynantheine', 'CHEMICAL'), ('isopaynantheine', 'CHEMICAL'), ('epiallo-isopaynantheine', 'CHEMICAL'), ('9-hydroxylated oxindole alkaloids speciofoline', 'CHEMICAL'), ('isorotundifoleine', 'CHEMICAL'), ('isospeciofoleine', 'CHEMICAL'), ('oxindoles corynoxine A', 'CHEMICAL'), ('corynoxine B', 'CHEMICAL'), ('3-epirhynchophylline', 'CHEMICAL'), ('3-epicorynoxine B', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa (Kratom) is a psychotropic tropical tree that is indigenous \n","to Southeast Asia, Africa and New Guinea. Kratom has gained popularity in the \n","United States in more recent years as an opioid agonist. Although Kratom is \n","considered an opioid agonist with abuse potential, its use is not federally \n","regulated. We report on a 47 year-old male presenting to our clinic for \n","treatment of an opioid use disorder. This began with the use of prescription \n","opioids from a doctor, and when this was no longer available this patient \n","started using Kratom. He had used Kratom for one year to treat opioid withdrawal \n","symptoms and chronic pain, resulting in worsening depression, anxiety and pain. \n","He experienced tolerance and withdrawal symptoms related to Kratom. He was \n","initiated on buprenorphine-naloxone at home with improved pain management. Four \n","months after initiation, the patient's depression and anxiety symptoms resolved, \n","and he was able to discontinue his antidepressant and anxiolytic medications. \n","Kratom dependence and withdrawal appear similar to that of opioids, and may also \n","lead to worsening depression and anxiety. Buprenorphine-naloxone may be a viable \n","option to consider for treating opioid use disorder complicated by Kratom use, \n","chronic pain, and depression.': [('pain', 'DISEASE'), ('depression', 'DISEASE'), ('anxiety', 'DISEASE'), ('pain', 'DISEASE'), ('buprenorphine-naloxone', 'CHEMICAL'), ('pain', 'DISEASE'), ('depression', 'DISEASE'), ('anxiety', 'DISEASE'), ('antidepressant', 'CHEMICAL'), ('depression', 'DISEASE'), ('anxiety', 'DISEASE'), ('Buprenorphine-naloxone', 'CHEMICAL'), ('chronic pain', 'DISEASE'), ('depression', 'DISEASE')]\n","Detected entities in text: 'Kratom, or Mitragyna speciosa Korth., is a tropical plant \n","that has been reported to exhibit opioid-like effects. Although opioids have \n","been demonstrated to alter the lipid profile of regular users, data on the \n","lipid-altering effects of kratom are scarce. This study aimed to compare the \n","fasting lipid profile of regular kratom users to that of healthy subjects who do \n","not use kratom. It also determined the association between various \n","characteristics of kratom users and the serum triglycerides, total cholesterol, \n","low-density lipoprotein (LDL), and high-density lipoprotein (HDL) levels of \n","regular kratom users.\n","METHODS: A total of 200 participants (n = 100 kratom users and n = 100 healthy \n","subjects who do not use kratom) were recruited for this analytical \n","cross-sectional study. Data on sociodemographic status, kratom use \n","characteristics, cigarette smoking, physical activity, body mass index (BMI), \n","fasting serum lipid profile, and liver function were collected from all \n","participants.\n","RESULTS: The liver parameters of the study participants were within normal \n","range. The serum total cholesterol and LDL of kratom users were significantly \n","lower than those of healthy subjects who do not use kratom. There were no \n","significant differences in the serum triglyceride and HDL levels. However, \n","higher average daily frequency of kratom use and increasing age were associated \n","with increased serum total cholesterol among kratom users. Other kratom use \n","characteristics such as age of first kratom intake, duration of kratom use, and \n","quantity of daily kratom intake were not associated with increased serum \n","triglyceride, total cholesterol, LDL, and HDL levels.\n","CONCLUSIONS: Our findings suggest regular kratom consumption was not linked to \n","elevated serum lipids, except when there is a higher frequency of daily kratom \n","intake. However, the study was limited by the small sample size, and hence a \n","more comprehensive study with larger sample size is warranted to confirm the \n","findings.': [('cholesterol', 'CHEMICAL'), ('low-density', 'CHEMICAL'), ('cholesterol', 'CHEMICAL'), ('triglyceride', 'CHEMICAL'), ('cholesterol', 'CHEMICAL'), ('triglyceride', 'CHEMICAL'), ('cholesterol', 'CHEMICAL'), ('lipids', 'CHEMICAL')]\n","Detected entities in text: 'Opiate addiction is a major health problem in many countries. A \n","crucial component of the medical treatment is the management of highly aversive \n","opiate withdrawal signs, which may otherwise lead to resumption of drug taking. \n","In a medication-assisted treatment (MAT), methadone and buprenorphine have been \n","implemented as substitution drugs. Despite MAT effectiveness, there are still \n","limitations and side effects of using methadone and buprenorphine. Thus, other \n","alternative therapies with less side effects, overdosing, and co-morbidities are \n","desired. One of the potential pharmacotherapies may involve kratom's major \n","indole alkaloid, mitragynine, since kratom (Mitragyna speciosa Korth.) \n","preparations have been reported to alleviate opiate withdrawal signs in \n","self-treatment in Malaysian opiate addicts.\n","METHODS: Based on the morphine withdrawal model, rats were morphine treated with \n","increasing doses from 10 to 50 mg/kg twice daily over a period of 6 days. The \n","treatment was discontinued on day 7 in order to induce a spontaneous morphine \n","abstinence. The withdrawal signs were measured daily after 24 h of the last \n","morphine administration over a period of 28 abstinence days. In rats that \n","developed withdrawal signs, a drug replacement treatment was given using \n","mitragynine, methadone, or buprenorphine and the global withdrawal score was \n","evaluated.\n","RESULTS: The morphine withdrawal model induced profound withdrawal signs for 16 \n","days. Mitragynine (5-30 mg/kg; i.p.) was able to attenuate acute withdrawal \n","signs in morphine dependent rats. On the other hand, smaller doses of methadone \n","(0.5-2 mg/kg; i.p.) and buprenorphine (0.4-1.6 mg/kg; i.p.) were necessary to \n","mitigate these effects.\n","CONCLUSIONS: These data suggest that mitragynine may be a potential drug \n","candidate for opiate withdrawal treatment.': [('methadone', 'CHEMICAL'), ('buprenorphine', 'CHEMICAL'), ('methadone', 'CHEMICAL'), ('buprenorphine', 'CHEMICAL'), ('co-morbidities', 'DISEASE'), ('indole', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('methadone', 'CHEMICAL'), ('buprenorphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('i.p', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('methadone', 'CHEMICAL'), ('i.p', 'CHEMICAL'), ('buprenorphine', 'CHEMICAL'), ('i.p', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'A simple, quick, selective, sensitive, and effective field-friendly method \n","capable of being used by nonexperts has been developed for detecting mitragynine \n","in Mitragyna speciosa (kratom) using surface-enhanced Raman spectroscopy (SERS). \n","Over 100 samples and blanks (known to be either positive or negative for the \n","presence of mitragynine) were examined in duplicate using five identical \n","handheld Raman spectrometers, which provided a data set of over 1,000 \n","examinations. Based on the results of these analyses, the method yielded a \n","true-positive rate of 99.3%, a true-negative rate of 97.9%, a false-positive \n","rate of 2.1%, and a false-negative rate of 0.7%. The average minimum detectable \n","concentration (Cm ) of mitragynine that reproducibly yielded a match for one of \n","the library spectra on all five instruments was determined to be 342 ng/mL \n","(ppb). This Cm value is a conservative estimate considering that the extraction \n","process was not fully optimized by this study, which was not necessary since the \n","Cm value achieved was well below typical mitragynine concentrations in kratom \n","(1.3-2.3%). The method is ideal (i) for prioritizing samples for additional \n","testing using other more time-consuming laboratory-based techniques needed to \n","detect and quantify mitragynine and (ii) for field use at international mail \n","facility (IMF) satellite laboratories to help interdict kratom and prevent this \n","dangerous product from reaching the U.S. supply chain.': [('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'To inform readers about the increasingly popular Western \n","dietary supplement, kratom (Mitragyna speciosa) and how the products are \n","available in the Western world compared with traditional Southeast Asian use. \n","Kratom has been traditionally used for increasing stamina of outdoor laborers \n","(farmers), mood enhancement, pain, and opium addiction. Interestingly, kratom \n","has been reported to have a paradoxical effect in that stimulant feelings, and \n","sedative feelings can be obtained depending on the amount utilized. There are \n","several biologically active alkaloids present in kratom.\n","RECENT FINDINGS: Recent studies have been focused on the interactions of \n","mitragynine, the most abundant alkaloid, and opioid-like effects. This has been \n","driven by the harm that kratom products have produced in the Western world, in \n","stark contrast to the lack of harm in Southeast Asian traditional use over \n","centuries. Many users in the Western world ingest kratom for mood enhancement \n","and/or to ween themselves from prescription or illicit opioids. Highly \n","concentrated products and recreational use and misuse have resulted in \n","individuals pushing doses to levels that have not been imagined or ever studied \n","in animal, let alone humans.\n","SUMMARY: Kratom, as a preparation and how it is utilized is different around the \n","world.': [('pain', 'DISEASE'), ('opium', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Tryptophan decarboxylase (TDC, EC 4.1.1.28) catalyzes tryptophan decarboxylation \n","to form tryptamine through the cofactor pyridoxal-5'-phosphate (PLP), a crucial \n","stage in the production of the terpenoid indole alkaloids like camptothecin \n","(CPT). A new gene encoding TDC was identified from the CPT-producing plant \n","Ophiorrhiza pumila by transcriptome analysis, termed OpTDC2. It contained a \n","1,536 bp open reading frame that encodes a 511 amino acid protein with a \n","molecular mass of 57.01 kDa and an isoelectric point of 6.39. Multiple sequence \n","alignment and phylogenetic tree analysis showed the closest similarity (85%) \n","with the TDC from Mitragyna speciosa. Moreover, the highest expression of OpTDC2 \n","was observed in the O. pumila root. To achieve high-efficiency expression of \n","OpTDC2 in Escherichia coli, we fused the TF tag onto the N-terminal of the \n","OpTDC2. Optimum enzymatic activity was observed at 45 °C, pH 8 and cofactor \n","concentration of 0.1 mM. The catalytic reaction was strongly inhibited by metal \n","ions of Cu2+ , Zn2+ , and Fe2+ . The l-tryptophan was particularly catalyzed \n","compared with d-tryptophan. Besides, the Km and kcat of the OpTDC2 were 1.08 mM \n","and 0.78 Sec-1 , respectively. The results provided information on new \n","functional OpTDC2 that might be used in synthetic biology for the enhanced \n","biosynthesis of CPT in O. pumila.': [('Tryptophan', 'CHEMICAL'), ('tryptophan', 'CHEMICAL'), ('tryptamine', 'CHEMICAL'), (\"pyridoxal-5'-phosphate\", 'CHEMICAL'), ('PLP', 'CHEMICAL'), ('indole alkaloids', 'CHEMICAL'), ('camptothecin', 'CHEMICAL'), ('amino acid', 'CHEMICAL'), ('mM.', 'CHEMICAL'), ('Cu2', 'CHEMICAL'), ('l-tryptophan', 'CHEMICAL'), ('d-tryptophan', 'CHEMICAL'), ('kcat', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa ('kratom') contains mu opioid partial \n","agonists. It is widely available, and occasionally used as a home remedy for \n","opioid use disorder. The Drug Enforcement Agency considers kratom a drug of \n","concern; however, prevalence of use and role in drug misuse are unknown. This \n","study aimed to characterize kratom use in the United States.\n","DESIGN: Cross-sectional Survey of Non-Medical Use of Prescription Drugs (NMURx) \n","Program, 2018 third quarter and 2019 first quarter.\n","SETTING: A validated non-probability online survey in the United States.\n","PARTICIPANTS: A total of 59 714 respondents aged 18 years or older, weighted to \n","represent the adult US population (n = 252 063 800).\n","MEASUREMENTS: In addition to prevalence of past-year kratom and other drug use, \n","behavior proportions were estimated. The Drug Abuse Screening Test (DAST-10) \n","estimated consequences of drug abuse.\n","FINDINGS: The estimated prevalence of past-year kratom use in the adult US \n","population was 0.8% [95% confidence interval (CI) = 0.7-0.9], representing \n","2 031 803 adults. Life-time prevalence was 1.3% (95% CI = 1.2-1.4), representing \n","3 353 624 adults. Kratom users were younger (mean 35 years, P < 0.001), with \n","higher proportions of males (61.0 versus 48.6%, P < 0.001), students (14.1 \n","versus 7.5%, P < 0.001) and health-care professionals (9.7 versus 4.5%, \n","P < 0.001) and fewer bachelor's/advanced degree graduates (33.4 versus 42.6%, \n","P < 0.001) compared with non-users. Results were inconclusive on whether there \n","was a difference in kratom use by race, household income or employment status. \n","Among those with past-year kratom use, 36.7% (95% CI = 32.1-41.3) non-medically \n","used prescription opioids, 21.7% (95% CI = 18.0-25.5) used illicit opioids, \n","54.4% (95% CI = 49.5-59.3) used another illicit drug and 67.1% (95% \n","CI = 62.5-71.8) used cannabis. The DAST-10 profile was more often \n","substantial/severe in kratom users (21 versus 1%, P < 0.001) compared with \n","non-users.\n","CONCLUSIONS: Estimated United States past-year prevalence of kratom use is 0.8%, \n","and kratom users tend to have more serious substance abuse profiles than \n","non-users or users of cannabis, alcohol or cigarettes. To our knowledge, this is \n","the first description of kratom use at the national level.': [('drug abuse', 'DISEASE'), ('cannabis', 'CHEMICAL'), ('substance abuse', 'DISEASE'), ('cannabis', 'CHEMICAL'), ('alcohol', 'CHEMICAL')]\n","Detected entities in text: 'Mitragynine is the major alkaloid of Mitragyna speciosa (kratom) \n","with potential as a therapeutic in pain management and in depression. There has \n","been debate over the potential side effects of the drug including addiction risk \n","and cognitive decline.\n","AIMS: To evaluate the effects of mitragynine on neurophysiological systems \n","function in the prefrontal cortex (PFC), cingulate cortex (Cg), orbitofrontal \n","cortex, nucleus accumbens (NAc), hippocampus (HIP), thalamus (THAL), basolateral \n","amygdala (BLA) and ventral tegmental area of rats.\n","METHODS: Local field potential recordings were taken from animals at baseline \n","and for 45 min following mitragynine administration (10 mg/kg, \n","intraperitoneally). Drug-induced changes in spectral power and coherence between \n","regions at specific frequencies were evaluated. Mitragynine-induced changes in \n","c-fos expression were also analyzed.\n","RESULTS: Mitragynine increased delta power and reduced theta power in all three \n","cortical regions that were accompanied by increased c-fos expression. A \n","transient suppression of gamma power in PFC and Cg was also evident. There were \n","no effects of mitragynine on spectral power in any of the other regions. \n","Mitragynine induced a widespread reduction in theta coherence (7-9 Hz) that \n","involved disruptions in cortical and NAc connectivity with the BLA, HIP and \n","THAL.\n","CONCLUSIONS: These findings show that mitragynine induces frequency-specific \n","changes in cortical neural oscillatory activity that could potentially impact \n","cognitive functioning. However, the absence of drug effects within regions of \n","the mesolimbic pathway may suggest either a lack of addiction potential, or an \n","underlying mechanism of addiction that is distinct from other opioid analgesic \n","agents.': [('Mitragynine', 'CHEMICAL'), ('pain', 'DISEASE'), ('depression', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('HIP', 'CHEMICAL'), ('thalamus', 'CHEMICAL'), ('THAL', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('HIP', 'CHEMICAL'), ('THAL', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mesolimbic', 'CHEMICAL')]\n","Detected entities in text: 'Kratom is an herbal made from leaves of a tropical evergreen tree (Mitragyna \n","speciosa) that is native to Southeast Asia. Extracts from the leaves of the \n","kratom tree have psychotropic and opioid-like activity, which has led to their \n","use as a recreational drug. Kratom has been linked to rare instances of \n","clinically apparent acute liver injury.': []\n","Detected entities in text: 'Amidst the opioid crisis, many people are turning to plant-based \n","kratom for self-treatment of pain, opioid addiction, and for recreational use. \n","Its legality is variable and its safety and medicinal effects are not agreed \n","upon. It is broadly available from Internet Kratom Vendors (IKVs).\n","METHODS: An examination of the online marketplace for kratom was conducted to \n","provide context to the market amidst regulatory attempts by the Food and Drug \n","Administration (FDA) and state legislatures. A complex search strategy \n","identified 663 English-language IKVs selling kratom for home delivery. The 100 \n","most popular were selected for in-depth content analysis. IKVs were visited once \n","for content analysis data collection in December, 2017 and revisited in April \n","2018 to assess responses to FDA action. IKV website and social media profiles \n","were coded for topics including location, payment and shipping options, age \n","verification, health warnings and disclaimers, and grassroots advocacy regarding \n","upcoming state/federal regulations.\n","RESULTS: Forty-seven percent of IKVs claimed that kratom provides pain relief, \n","25% claimed it provides relief from opioid withdrawal, 81% featured a disclaimer \n","that kratom is addictive, 54% stated that kratom is not FDA approved, and 66% \n","featured disclaimers that it was not intended for consumption. Only 5% of \n","vendors advertised effective age verification (such as verifying age at \n","delivery). Compliance on the vendor's part with state and local bans varied by \n","ban location, with only 27% prohibiting sales to Rhode Island while 65% did not \n","ship to Indiana.\n","CONCLUSIONS: IKVs provide easy access to a wide variety of unregulated \n","intoxicating products with poor age verification and low adherence to US state- \n","and local-level restrictions. There is a high prevalence of vendors featuring \n","health claims forbidden by the Food and Drug Administration. Lessons learned \n","from regulating the Internet cigarette sales industry could be effectively \n","applied to IKVs with future efforts.': [('pain', 'DISEASE'), ('pain', 'DISEASE'), ('intoxicating', 'CHEMICAL')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa), an indigenous medicinal plant of Southeast Asia, is \n","believed to be harmful. We compared the perceptions toward kratom use among \n","kratom users and non-users in Malaysia. 356 respondents (137 kratom users and \n","219 non-users) were recruited for this cross-sectional study. The majority of \n","respondents were male (60%, n = 212/356), Malays (88%), and 51% were ≥37 years \n","old. Non-users showed higher unadjusted odds of reporting a perception that \n","kratom use can cause addiction (OR = 6.72, CI: 3.91-11.54, p < .0001), \n","withdrawal symptoms (OR = 7.58, CI: 4.62-12.42, p < .0001), illicit drug use \n","problems (OR = 10.12, CI: 6.14-16.68, p < .0001), impaired social-functioning \n","(OR = 12.05, CI: 7.24-20.05, p < .0001), and health problems (OR = 10.44, CI: \n","6.32-17.24, p < .0001). Similarly, non-users viewed kratom policies differently \n","from kratom users, displaying increased odds of reporting the belief that kratom \n","use and sales must be regulated with stringent laws (OR = 5.75, CI: 3.61-9.18, p \n","< .0001), and kratom should be regulated instead under the Dangerous Drugs Act \n","1952 to overcome kratom use problems (OR = 8.26, CI: 4.94-13.82, p < .0001). \n","Because of the disconnect in kratom use perceptions and personal experiences \n","between kratom users and non-users, hastily criminalizing kratom without \n","investigating carefully its scientific merits can significantly impede future \n","kratom research.': []\n","Detected entities in text: 'BACKGROUND AND PURPOSE: Kratom is a coffee-like plant containing compounds that \n","cause opioid and stimulant effects. The most prevalent bioactive alkaloid of \n","kratom is mitragynine (MG). Opioid effects of MG are apparent (e.g. \n","antinociception and nanomolar affinity for μ, κ and δ opioid receptors), but \n","effects encompassing interactions with additional systems, such as adrenergic \n","and dopaminergic, remain undefined. Given that enhanced adrenergic transmission \n","is a mechanism common to most first-line neuropathic pain medications, we tested \n","the hypothesis that MG reduces chemotherapy-induced neuropathic pain through a \n","mechanism involving α-adrenoceptor activation.\n","METHODS: Rats were injected once with oxaliplatin (6 mg/kg IP) to induce \n","allodynia and then treated with MG (0, 1, 5, 10 mg/kg IP) for 5-7 days. To \n","investigate receptor mechanisms, a fixed dose of MG (5 mg/kg IP) was injected \n","with yohimbine (5 mg/kg IP, α2-adrenoceptor antagonist), prazosin (5 mg/kg IP, \n","α1-adrenoceptor antagonist), or naltrexone (5 mg/kg IP, opioid antagonist).\n","KEY RESULTS: MG (5, 10 mg/kg) dose-dependently reduced mechanical sensitivity in \n","oxaliplatin-injected rats. Anti-allodynic effects of MG were completely \n","inhibited by yohimbine, and significantly reduced by prazosin and naltrexone. MG \n","produced modest hyperlocomotion but only at a dose (30 mg/kg) higher than those \n","required to reduce allodynia.\n","CONCLUSION AND IMPLICATION: The finding that MG reduced neuropathic pain through \n","a mechanism requiring active α-adrenoceptors indicates that the pharmacological \n","profile of MG includes activation of adrenergic, as well as opioid, systems.': [('mitragynine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('neuropathic pain', 'DISEASE'), ('MG', 'CHEMICAL'), ('neuropathic pain', 'DISEASE'), ('oxaliplatin', 'CHEMICAL'), ('allodynia', 'DISEASE'), ('MG', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('yohimbine', 'CHEMICAL'), ('prazosin', 'CHEMICAL'), ('naltrexone', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('yohimbine', 'CHEMICAL'), ('prazosin', 'CHEMICAL'), ('naltrexone', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('allodynia', 'DISEASE'), ('MG', 'CHEMICAL'), ('neuropathic pain', 'DISEASE')]\n","Detected entities in text: 'Kratom is a botanical substance that is marketed and promoted in the US for \n","pharmaceutical opioid indications despite having no US Food and Drug \n","Administration approved uses. Kratom contains over forty alkaloids including two \n","partial agonists at the mu opioid receptor, mitragynine and \n","7-hydroxymitragynine, that have been subjected to the FDA's scientific and \n","medical evaluation. However, pharmacological and toxicological data for the \n","remaining alkaloids are limited. Therefore, we applied the Public Health \n","Assessment via Structural Evaluation (PHASE) protocol to generate in silico \n","binding profiles for 25 kratom alkaloids to facilitate the risk evaluation of \n","kratom. PHASE demonstrates that kratom alkaloids share structural features with \n","controlled opioids, indicates that several alkaloids bind to the opioid, \n","adrenergic, and serotonin receptors, and suggests that mitragynine and \n","7-hydroxymitragynine are the strongest binders at the mu opioid receptor. \n","Subsequently, the in silico binding profiles of a subset of the alkaloids were \n","experimentally verified at the opioid, adrenergic, and serotonin receptors using \n","radioligand binding assays. The verified binding profiles demonstrate the \n","ability of PHASE to identify potential safety signals and provide a tool for \n","prioritizing experimental evaluation of high-risk compounds.': [('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('alkaloids', 'CHEMICAL'), ('serotonin', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('serotonin', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa (kratom) is a drug that is increasingly used recreationally \n","and \"therapeutically\", in the absence of medical supervision. The drug has been \n","associated with a growing number of fatalities, and although its medicinal \n","properties as an atypical opioid require further study, there are legitimate \n","concerns regarding its unregulated use. Mitragynine is the most widely reported \n","alkaloid within the plant, although more than forty other alkaloids have been \n","identified. 7-Hydroxymitragynine is reported to have greater abuse liability due \n","to its increased potency relative to mitragynine. In this report, biomarkers for \n","mitragynine were investigated using liquid chromatography-quadrupole/time of \n","flight mass spectrometry (LC-Q/TOF-MS). Speciociliatine and speciogynine were \n","identified as alternative biomarkers, often exceeding the concentration of \n","mitragynine in unhydrolyzed urine. 9-O-Demethylmitragynine and \n","7-hydroxymitragynine were identified in unhydrolyzed urine in 75% and 63% of the \n","cases. Deconjugation of phase II metabolites using chemical hydrolysis was not \n","suitable due to degradation of the Mitragyna alkaloids. Enzymatic hydrolysis was \n","evaluated using three traditional glucuronidases, four sulfatases and four \n","recombinant enzymes. Although enzymatic hydrolysis increased the concentration \n","of 16-carboxymitragynine, it had nominal benefit for other metabolites. \n","Deconjugation of urine was not necessary due to the abundance of parent drug \n","(mitragynine), its diastereoisomers (speciociliatine and speciogynine) or \n","metabolites (9-O-demethylmitragynine and 7-hydroxymitragynine).': [('fatalities', 'DISEASE'), ('Mitragynine', 'CHEMICAL'), ('alkaloids', 'CHEMICAL'), ('7-Hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('speciogynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('speciociliatine', 'CHEMICAL'), ('speciogynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Kratom, a Southeast Asian plant with opioid-receptor mediated \n","effects, has emerged as a potential substance of abuse, with limited data on its \n","use and effects. This study characterized kratom user demographics, use \n","patterns, and perceived drug effects.\n","METHODS: A cross-sectional, anonymous online survey was conducted between \n","January and December 2017.\n","RESULTS: 2,798 kratom users - mean age 40 (SD = 12); predominantly White (90 %), \n","female (61 %), and located in the US (97 %) - completed the survey. Kratom was \n","primarily taken orally in doses of 1-3 g (49 %), with daily use (59 %) being \n","most common. Kratom was used for pain (91 %), anxiety (67 %), and depression (65 \n","%), with high ratings of effectiveness. 1,144 (41 %) used kratom to stop or \n","reduce prescription or illicit opioid use, citing decreased opioid withdrawal \n","and craving related to kratom use, with 411 reporting >1-year continuous \n","abstinence from opioids attributed to kratom use. Roughly one-third of \n","respondents reported adverse effects of kratom, largely rated as mild in \n","severity and lasting ≤24 h. Seventeen participants (0.6 %) sought treatment for \n","adverse effects. Fifty-six individuals (2 %) met DSM-5 criteria for a past-year \n","moderate or severe kratom-related substance use disorder (SUD). When asked how \n","troubled they felt regarding their kratom use, the mean (SD) rating was 3.2 \n","(9.8) on a scale from 0 to 100.\n","CONCLUSION: Kratom is used among White, middle-aged Americans for symptoms of \n","pain, anxiety, depression, and opioid withdrawal. Although regular use was \n","typical, kratom-related SUD and serious adverse effects were uncommon. \n","Additional research on kratom epidemiology and pharmacology is imperative in \n","light of the present opioid epidemic.': [('pain', 'DISEASE'), ('anxiety', 'DISEASE'), ('depression', 'DISEASE'), ('DSM-5', 'CHEMICAL'), ('SUD', 'CHEMICAL'), ('pain', 'DISEASE'), ('anxiety', 'DISEASE'), ('depression', 'DISEASE'), ('SUD', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa (Kratom) has emerged as a recreational drug and a substance \n","of medicinal intrigue. Although the drug was initially used recreationally for \n","its sedating and euphoric effects, more recently its use has been associated \n","with the non-medically supervised treatment of opioid abstinence syndrome. \n","Mitragynine is the principal pharmacologically active alkaloid in kratom. \n","Although metabolites of mitragynine have been identified, the cytochrome P450 \n","(CYP450) enzymes responsible for its biotransformation are still under \n","investigation. The goal of this study was to contribute further knowledge \n","regarding CYP450 activity as it relates to mitragynine. Recombinant cytochrome \n","P450 enzymes (rCYPs) were used to investigate the isoforms involved in its \n","metabolism. Biotransformational products were identified using liquid \n","chromatography-quadrupole/time of flight-mass spectrometry. Four rCYP enzymes \n","(2C18, 2C19, 2D6 and 3A4) were found to contribute to the metabolism of \n","mitragynine. 7-Hydroxymitragynine (which has an affinity for the mu-opioid \n","receptor >10-folds that of morphine) was produced exclusively by 3A4. \n","9-O-demethylmitragynine, the most abundant metabolite in vitro (and the most \n","prevalent metabolite in urine among kratom users) was produced by 2C19, 3A4 and \n","2D6. 16-Carboxymitragynine was produced by rCYPs 2D6, 2C19 and 2C18. 2C19 was \n","solely responsible for the formation of 9-O-demethyl-16-carboxymitragynine. In \n","vitro rCYP studies were compared with phase I metabolites in urine from cases \n","involving mitragynine.': [('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-Hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Increased use of the opioid-related plant kratom as an alternative treatment for \n","opioid withdrawal symptoms has raised concerns regarding its potential for abuse \n","and severe adverse effects. A review of the literature was performed to \n","characterize kratom's pharmacology, clinical efficacy, and adverse effects to \n","increase understanding and evaluate potential use as an alternative treatment \n","for opioid dependence. Kratom use initiated as self-medication for an opioid use \n","disorder or pain syndrome in the absence of effective alternatives is associated \n","with a risk of kratom dependence, withdrawal, and life-threatening toxicity. The \n","potential for a serious adverse reaction should discourage unregulated use of \n","kratom products.': [('pain', 'DISEASE'), ('kratom dependence', 'DISEASE'), ('toxicity', 'DISEASE')]\n","Detected entities in text: 'Kratom, or Mitragyna, is a tropical plant indigenous to Southeast Asia, with \n","unique pharmacological properties. It is commonly consumed by preparing the \n","leaves into decoction or tea, or by grinding them into a powder. Recent evidence \n","has revealed that kratom has physiological effects similar to opioids, including \n","pain relief and euphoria, as well as stimulant properties, which together raise \n","potential concern for dependence and addiction. Moreover, growing evidence \n","suggests that the prevalence of kratom use is increasing in many parts of the \n","world, raising important considerations for healthcare providers. This \n","manuscript will discuss the most current epidemiology, pharmacology, toxicity, \n","and management related to kratom, while seeking to provide a contemporary \n","perspective on the issue and its role in the greater context of the opioid \n","epidemic.': [('tea', 'CHEMICAL'), ('pain', 'DISEASE'), ('toxicity', 'DISEASE')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa) leaves contain the mu opioid partial agonists \n","mitragynine and 7-hydroxymitragynine. The US Drug Enforcement Agency considers \n","it a 'drug of concern', and the US FDA is reviewing kratom, but there is a \n","paucity of information regarding health effects. Liver injury is often cited as \n","a potential health consequence, however the same few case reports are repeatedly \n","referenced, without a broader context. Furthermore, reports have largely lacked \n","standardized causality assessment methods. The objective is to evaluate \n","causality in kratom liver injury, through a comprehensive scoping review of \n","human cases, and by reviewing epidemiologic, animal, and mechanistic reports \n","that relate to kratom liver injury. Hepatotoxicity causality was systematically \n","examined using the Roussel Uclaf Causality Assessment Method (RUCAM) for case \n","reports. Biopsy findings, potential pathophysiologic mechanisms, and management \n","options are discussed. This review identified 26 case reports and abstracts, in \n","addition to 7 cases reported from the Drug-Induced Liver Injury Network, 25 in \n","FDA databases, and 27 in internet user forums. Latency periods to symptom onset \n","had a median of 20.6 days and mean of 21 days (range 2-49). Common presenting \n","signs and symptoms were abdominal discomfort, jaundice, pruritis, and dark \n","urine. Histologic findings were predominantly cholestatic, although, \n","biochemically, the condition was heterogenous or mixed; the median R ratio was \n","3.4 and the mean was 4.6 (range 0.24-10.4). Kratom likely causes liver injury \n","based on the totality of low-quality human evidence, and, in the context of \n","epidemiologic, animal, and mechanistic studies. It remains unclear which \n","subgroups of users are at heightened risk.': [('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('Liver injury', 'DISEASE'), ('liver injury', 'DISEASE'), ('liver injury', 'DISEASE'), ('Hepatotoxicity', 'DISEASE'), ('Liver Injury', 'DISEASE'), ('jaundice', 'DISEASE'), ('pruritis', 'DISEASE'), ('cholestatic', 'DISEASE'), ('liver injury', 'DISEASE')]\n","Detected entities in text: 'Mitragynine (MG) is the principal psychoactive alkaloid in kratom. The drug \n","produces a variety of dose-dependent effects that appeal to recreational drug \n","users and individuals seeking therapeutic benefits in the absence of medical \n","supervision. In light of documented intoxications, hospitalizations and \n","fatalities, MG and other alkaloids from Mitragyna speciosa are of growing \n","importance to the forensic toxicology community. However, the chemical stability \n","of these compounds has not been thoroughly described. In this report, the \n","stability of MG, 7-hydroxymitragynine (MG-OH), speciociliatine (SC), \n","speciogynine (SG) and paynantheine (PY) are investigated. Short-term stability \n","of the Mitragyna alkaloids was determined over a range of pH (2-10) and \n","temperature (4-80°C) over 8 hours. Liquid \n","chromatography--quadrupole/time-of-flight mass spectrometry was used to estimate \n","half-lives and identify degradation products where possible. The stability of MG \n","and other alkaloids was highly dependent on pH and temperature. All of the \n","Mitragyna alkaloids studied were acid labile. Under alkaline conditions, MG \n","undergoes chemical hydrolysis of the methyl ester to produce \n","16-carboxymitragynine. MG-OH was the most unstable alkaloid studied, with \n","significant drug loss at 8 hours experienced at temperatures of 40°C and above. \n","No significant drug losses were observed for MG in aqueous solution (pH 2-10) at \n","4, 20 or 40°C. Diastereoisomers of MG (SC and SG) demonstrated even greater \n","stability. These findings are discussed within the context of the identification \n","of Mitragyna alkaloids in toxicological specimens.': [('Mitragynine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('speciociliatine', 'CHEMICAL'), ('speciogynine', 'CHEMICAL'), ('paynantheine', 'CHEMICAL'), ('PY', 'CHEMICAL'), ('methyl ester', 'CHEMICAL'), ('drug loss', 'DISEASE'), ('Diastereoisomers', 'CHEMICAL'), ('MG', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa Korth (M. speciosa) has been widely used as a recreational \n","product, however, there are growing concerns on the abuse potentials and \n","toxicity of the plant. Several poisoning and fatal cases involving kratom and \n","mitragynine have been reported but the underlying causes remain unclear. The \n","human ether-a-go-go-related gene 1 (hERG1) encodes the pore-forming subunit \n","underlying cardiac rapidly delayed rectifier potassium current (IKr). \n","Pharmacological blockade of the IKr can cause acquired long QT syndrome, leading \n","to lethal cardiac arrhythmias. This study aims to elucidate the mechanisms of \n","mitragynine-induced inhibition on hERG1a/1b current. Electrophysiology \n","experiments were carried out using Port-a-Patch system. Quantitative RT-PCR, \n","Western blot analysis, immunofluorescence and co-immunoprecipitation methods \n","were used to determine the effects of mitragynine on hERG1a/1b expression and \n","hERG1-cytosolic chaperones interaction. Mitragynine was found to inhibit the IKr \n","current with an IC50 value of 332.70 nM. It causes a significant reduction of \n","the fully-glycosylated (fg) hERG1a protein expression but upregulates both \n","core-glycosylated (cg) expression and hERG1a-Hsp90 complexes, suggesting \n","possible impaired hERG1a trafficking. In conclusion, mitragynine inhibits \n","hERG1a/1b current through direct channel blockade at lower concentration, but at \n","higher concentration, it upregulates the complexation of hERG1a-Hsp90 which may \n","be inhibitory towards channel trafficking.': [('toxicity', 'DISEASE'), ('poisoning', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('potassium', 'CHEMICAL'), ('long QT syndrome', 'DISEASE'), ('cardiac arrhythmias', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'The psychoactive plant kratom is a native plant to Southeast Asia, and its major \n","bioactive alkaloid is mitragynine. Mitragynine exerts its analgesic properties \n","by acting on the opioid receptors. One of its active metabolites, \n","7-hydroxymytraginine, is found to be 40 times more potent than mitragynine and \n","10 times more potent than morphine. Interestingly, current research suggests \n","that mitragynine behaves as an atypical opioid agonist, possessing analgesic \n","activity with less severe side effects than those of typical opioids. Although \n","Thailand and Malaysia have criminalized the use, possession, growing, or selling \n","of kratom due to its abuse potential, kratom still remains unregulated in the \n","United States. The U.S. Drug Enforcement Agency (DEA) listed kratom as a \"drug \n","of concern\" in 2008 with the intent to temporarily place mitragynine and \n","7-hydroxymitragynine onto Schedule I of the Controlled Substances Act. However, \n","responses from the general public, U.S. Congress, and Kratom Alliances had the \n","DEA retract their intent. Kratom is currently marketed in the United States as a \n","dietary or herbal supplement used to treat chronic pain, anxiety, and depression \n","with over $207 million in annual sales in the United States alone. Here, we will \n","review the traditional and medicinal uses of kratom along with the synthesis of \n","its bioactive ingredients and their pharmacology, metabolism, and \n","structure-activity relationships. The importance in society of this currently \n","controversial substance will also be discussed.': [('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('chronic pain', 'DISEASE'), ('anxiety', 'DISEASE'), ('depression', 'DISEASE')]\n","Detected entities in text: 'Corynantheidine, a minor alkaloid found in Mitragyna speciosa (Korth.) Havil, \n","has been shown to bind to opioid receptors and act as a functional opioid \n","antagonist, but its unique contribution to the overall properties of kratom \n","remains relatively unexplored. The first validated bioanalytical method for the \n","quantification of corynantheidine in rat plasma is described. The method was \n","linear in the dynamic range from 1-500 ng/mL, requires a small plasma sample \n","volume (25 μL), and a simple protein precipitation method for extraction of the \n","analyte. The separation was achieved with Waters BEH C18 2.1 × 50 mm column and \n","the 3-minute gradient of 10 mM ammonium acetate buffer (pH = 3.5) and \n","acetonitrile as mobile phase. The method was validated in terms of accuracy, \n","precision, selectivity, sensitivity, recovery, stability, and dilution \n","integrity. It was applied to the analysis of the male Sprague Dawley rat plasma \n","samples obtained during pharmacokinetic studies of corynantheidine administered \n","both intravenously (I.V.) and orally (P.O.) (2.5 mg/kg and 20 mg/kg, \n","respectively). The non-compartmental analysis performed in Certara Phoenix® \n","yielded the following parameters: clearance 884.1 ± 32.3 mL/h, apparent volume \n","of distribution 8.0 ± 1.2 L, exposure up to the last measured time point \n","640.3 ± 24.0 h*ng/mL, and a mean residence time of 3.0 ± 0.2 h with I.V. dose. \n","The maximum observed concentration after a P.O. dose of 213.4 ± 40.4 ng/mL was \n","detected at 4.1 ± 1.3 h with a mean residence time of 8.8 ± 1.8 h. Absolute oral \n","bioavailability was 49.9 ± 16.4 %. Corynantheidine demonstrated adequate oral \n","bioavailability, prolonged absorption and exposure, and an extensive \n","extravascular distribution. In addition, imaging mass spectrometry analysis of \n","the brain tissue was performed to evaluate the distribution of the compound in \n","the brain. Corynantheidine was detected in the corpus callosum and some regions \n","of the hippocampus.': [('Corynantheidine', 'CHEMICAL'), ('ammonium acetate', 'CHEMICAL'), ('corynantheidine', 'CHEMICAL'), ('Corynantheidine', 'CHEMICAL')]\n","Detected entities in text: 'Selected indole-based kratom alkaloids were evaluated for their opioid and \n","adrenergic receptor binding and functional effects, in vivo antinociceptive \n","effects, plasma protein binding, and metabolic stability. Mitragynine, the major \n","alkaloid in Mitragyna speciosa (kratom), had higher affinity at opioid receptors \n","than at adrenergic receptors while the vice versa was observed for \n","corynantheidine. The observed polypharmacology of kratom alkaloids may support \n","its utilization to treat opioid use disorder and withdrawal.': [('Mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'The entire scalp hair of a self-declared Kratom consumer of 3 grams per day was \n","acquired during an ethical committee approved study. As no values of the \n","concentration in hair of the two Kratom alkaloids mitragynine or \n","7-hydroxymitragynine were found in the literature, an already established method \n","for the analysis of benzodiazepines/z-substances was extended for the detection \n","of mitragynine and 7-hydroxymitragynine with LC-MS/MS, and successfully \n","validated. The limits of detection and quantification for mitragynine were 2 \n","pg/mg and 4 pg/mg, respectively. Those of 7-hydroxymitragynine were 20 pg/mg and \n","30 pg/mg, respectively. The method was applied to the entire scalp hair, divided \n","in 91 regions, of the study participant. A narrow mitragynine concentration \n","distribution with values between 1054 pg/mg and 2244 ng/mg (mean 1517 ng/mg) and \n","no clear scalp region associated distribution pattern was obtained. \n","7-Hydroxymitragynine was not detected in any hair sample. After validation, the \n","method was established as routine and subsequently 300 samples (mainly \n","abstinence controls for drugs of abuse) were analyzed, allowing the \n","investigation of the prevalence of Kratom consumption in our population. None of \n","the analyzed routine hair samples were positive for mitragynine or \n","7-hydroxymitragynine, providing no evidence that Kratom consumption is prevalent \n","in the investigated population.': [('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-Hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'ETHNOPHARMACOLOGICAL RELEVANCE: Kratom (Mitragyna speciosa) is a native \n","medicinal plant of Southeast Asia widely reported to be used to reduce opioid \n","dependence and mitigate withdrawal symptoms. There is also evidence to suggest \n","that opioid poly-drug users were using kratom to abstain from opioids.\n","AIM OF THE STUDY: To determine the patterns and reasons for kratom use among \n","current and former opioid poly-drug users in Malaysia.\n","MATERIALS AND METHODS: A total of 204 opioid poly-drug users (142 current users \n","vs. 62 former users) with current kratom use history were enrolled into this \n","cross-sectional study. A validated UPLC-MS/MS method was used to evaluate the \n","alkaloid content of a kratom street sample.\n","RESULTS: Results from Chi-square analysis showed that there were no significant \n","differences in demographic characteristics between current and former opioid \n","poly-drug users except with respect to marital status. Current users had higher \n","odds of being single (OR: 2.2: 95%CI: 1.21-4.11; p < 0.009). Similarly, there \n","were no significant differences in the duration (OR: 1.1: 0.62-2.03; p < 0.708), \n","daily quantity (OR: 1.5: 0.85-2.82; p < 0.154) or frequency of kratom use \n","between current and former opioid poly-drug users (OR: 1.1: 0.62-2.06; \n","p < 0.680). While both current and former opioid users reported using kratom to \n","ameliorate opioid withdrawal, current users had significantly higher likelihood \n","of using kratom for that purpose (OR: 5.4: 95%CI: 2.81-10.18; p < 0.0001). In \n","contrast, former opioid users were more likely to be using kratom for its \n","euphoric (mood elevating) effects (OR: 1.9: 95%CI: 1.04-3.50; p < 0.035). \n","Results from the UPLC-MS/MS analysis indicated the major alkaloids present in \n","the representative kratom street sample (of approximately 300 mL of brewed \n","kratom) were mitragynine, followed by paynantheine, speciociliatine and \n","speciogynine, as well as low levels of 7-hydroxymitragynine.\n","CONCLUSIONS: Both current and former opioid poly-drug users regularly used \n","kratom (three glasses or about 900 mL daily or the equivalent of 170.19 mg of \n","mitragynine) to overcome opioid poly-drug use problems.': [('mitragynine', 'CHEMICAL'), ('paynantheine', 'CHEMICAL'), ('speciociliatine', 'CHEMICAL'), ('speciogynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom is an herbal drug originating from the Mitragyna speciosa, a plant \n","indigenous to Southeast Asia. Kratom has been widely used for its stimulant and \n","opioid-like effects derived from its main psychoactive alkaloid properties \n","mitragynine and 7-hydroxymitragynine. In the United States, kratom is gaining \n","popularity as an herbal and natural dietary supplement, as well as a natural and \n","legal alternative to narcotics. Kratom use is typically accompanied by \n","increasing tolerance and dependence making it highly problematic. Kratom's \n","potentially toxic and lethal properties have become an emerging public health \n","threat. Due to deficiencies of governmental controls and its rising prevalence \n","among individuals who ingest kratom, health care providers need to be familiar \n","with the pharmacology, adverse effects, and problems associated with kratom \n","ingestion when caring for individuals. [Journal of Psychosocial Nursing and \n","Mental Health Services, 57(12), 15-20.].': [('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Recently, the abuse of ketum, an indigenous psychoactive plant, has received a \n","lot of attention in Malaysia. To help national law enforcement agencies control \n","its abuse, the laboratory of the Forensic Division has developed a procedure for \n","its positive identification. Botanical identification may not be practical or \n","conclusive, owing to the wide range of ketum materials available on the market, \n","including dry macerated leaves, powdered leaves and drinks. In order to confirm \n","that a substance is, in fact, ketum or that a preparation is derived from ketum, \n","gas chromatography-mass spectrometry is used to definitively identify the \n","presence of the psychoactive principle mnitragynine.': [('mnitragynine', 'CHEMICAL')]\n","Detected entities in text: 'The leaves of a tropical plant, Mitragyna speciosa KORTH (Rubiaceae), have been \n","traditionally used as a substitute for opium. Phytochemical studies of the \n","constituents of the plant growing in Thailand and Malaysia have led to the \n","isolation of several 9-methoxy-Corynanthe-type monoterpenoid indole alkaloids, \n","including new natural products. The structures of the new compounds were \n","elucidated by spectroscopic and/or synthetic methods. The potent opioid \n","agonistic activities of mitragynine, the major constituent of this plant, and \n","its analogues were found in in vitro and in vivo experiments and the mechanisms \n","underlying the analgesic activity were clarified. The essential structural \n","features of mitragynines, which differ from those of morphine and are \n","responsible for the analgesic activity, were elucidated by pharmacological \n","evaluation of the natural and synthetic derivatives. Among the mitragynine \n","derivatives, 7-hydroxymitragynine, a minor constituent of M. speciosa, was found \n","to exhibit potent antinociceptive activity in mice.': [('opium', 'CHEMICAL'), ('indole alkaloids', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'INTRODUCTION: Kratom is derived from the plant Mitragyna speciosa which is \n","indigenous to Southeast Asia. Active compounds, mitragynine and \n","7-hydroxymitragynine, cause mild stimulant and opioid agonist effects. Although \n","reported to have potential benefits in the treatment of opioid use disorder, \n","efficacy remains uncertain while adverse health effects have been reported. A \n","compounding concern is the presence of adulterants given that this is an \n","unregulated product.\n","CASE DETAILS: A 54-year-old fitness instructor who used an online \n","purchased kratom product regularly for one year developed stimulatory effects \n","and suffered a large hemorrhagic stroke with a close temporal relationship to \n","ingestion of a different kratom product from the one he regularly used. A \n","collaborative investigation by medical toxicologists, a regional poison center, \n","the state public health laboratory, and public health officials determined that \n","his new kratom product was adulterated with phenylethylamine (PEA).\n","DISCUSSION: We report a case of PEA adulterated kratom purchased and used with \n","resultant adverse effects. PEA is structurally similar to amphetamine and is \n","known to produce sympathomimetic effects. It is possible the stimulatory effect \n","of PEA resulted in a marked and transient increase in blood pressure resulting \n","in hemorrhagic stroke.\n","CONCLUSION: Medical toxicologists should form working relationships with \n","laboratories and public health officials to aid in early identification of \n","adulterated products that carry risk to the general population.': [('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('hemorrhagic stroke', 'DISEASE'), ('phenylethylamine', 'CHEMICAL'), ('PEA', 'CHEMICAL'), ('PEA adulterated kratom', 'CHEMICAL'), ('PEA', 'CHEMICAL'), ('amphetamine', 'CHEMICAL'), ('PEA', 'CHEMICAL'), ('hemorrhagic stroke', 'DISEASE')]\n","Detected entities in text: 'In vitro cytochrome P450 inhibition of major kratom alkaloids: mitragynine \n","(MTG), speciogynine (SPG), speciocilliatine (SPC), corynantheidine (COR), \n","7-hydroxymitragynine (7HMG) and paynantheine (PAY) was evaluated using human \n","liver microsomes (HLMs) to understand their drug-drug interaction potential. \n","CYP450 isoform-specific substrates of CYP1A2, 2C8, 2C9, 2C19, 2D6, and 3A4/5 \n","were incubated in HLMs with or without alkaloids. Preliminary CYP450 inhibition \n","(IC50) data were generated for each of these isoforms. In addition, the type of \n","inhibition and estimation of the inhibition constants (Ki) of MTG and COR were \n","determined. Among the tested alkaloids, MTG and COR were potent inhibitors of \n","CYP2D6 (IC50, 2.2 and 4.2 μM, respectively). Both MTG and COR exhibited \n","competitive inhibition of CYP2D6 activity and the Ki were found to be 1.1 and \n","2.8 μM, respectively. SPG and PAY showed moderate inhibition of CYP2D6 activity. \n","Additionally, moderate inhibitory effects by SPC, MTG, and SPG were observed on \n","CYP2C19 activity. Interestingly, inhibition of only midazolam hydroxylase \n","CYP3A4/5 activity by COR, PAY, and MTG was observed while no inhibitory effect \n","was observed when testosterone was used as a probe substrate. In conclusion, MTG \n","and COR may lead to clinically significant adverse drug interactions upon \n","coadministration of drugs that are substantially metabolized by CYP2D6.': [('mitragynine', 'CHEMICAL'), ('MTG', 'CHEMICAL'), ('speciogynine', 'CHEMICAL'), ('speciocilliatine', 'CHEMICAL'), ('SPC', 'CHEMICAL'), ('corynantheidine', 'CHEMICAL'), ('COR', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('paynantheine', 'CHEMICAL'), ('MTG', 'CHEMICAL'), ('COR', 'CHEMICAL'), ('MTG', 'CHEMICAL'), ('COR', 'CHEMICAL'), ('MTG', 'CHEMICAL'), ('COR', 'CHEMICAL'), ('SPC', 'CHEMICAL'), ('MTG', 'CHEMICAL'), ('midazolam', 'CHEMICAL'), ('COR', 'CHEMICAL'), ('MTG', 'CHEMICAL'), ('testosterone', 'CHEMICAL'), ('MTG', 'CHEMICAL'), ('COR', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND AND PURPOSE: Mitragyna speciosa, more commonly known as kratom, is a \n","plant that contains opioidergic alkaloids but is unregulated in most countries. \n","Kratom is used in the self-medication of chronic pain and to reduce illicit and \n","prescription opioid dependence. Kratom may be less dangerous than typical \n","opioids because of the stronger preference of kratom alkaloids to induce \n","receptor interaction with G proteins over β-arrestin proteins. We hypothesized \n","that kratom (alkaloids) can also reduce alcohol intake.\n","EXPERIMENTAL APPROACH: We pharmacologically characterized kratom extracts, \n","kratom alkaloids (mitragynine, 7-hydroxymitragynine, paynantheine, and \n","speciogynine) and synthetic carfentanil-amide opioids for their ability to \n","interact with G proteins and β-arrestin at μ, δ, and κ opioid receptors in \n","vitro. We used C57BL/6 mice to assess to which degree these opioids could reduce \n","alcohol intake and whether they had rewarding properties.\n","KEY RESULTS: Kratom alkaloids were strongly G protein-biased at all three opioid \n","receptors and reduced alcohol intake, but kratom and 7-hydroxymitragynine were \n","rewarding. Several results indicated a key role for δ opioid receptors, \n","including that the synthetic carfentanil-amide opioid MP102-a G protein-biased \n","agonist with modest selectivity for δ opioid receptors-reduced alcohol intake, \n","whereas the G protein-biased μ opioid agonist TRV130 did not.\n","CONCLUSION AND IMPLICATIONS: Our results suggest that kratom extracts can \n","decrease alcohol intake but still carry significant risk upon prolonged use. \n","Development of more δ opioid-selective synthetic opioids may provide a safer \n","option than kratom to treat alcohol use disorder with fewer side effects.': [('pain', 'DISEASE'), ('alcohol', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('paynantheine', 'CHEMICAL'), ('speciogynine', 'CHEMICAL'), ('alcohol', 'CHEMICAL'), ('alcohol', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('alcohol', 'CHEMICAL'), ('alcohol', 'CHEMICAL'), ('alcohol', 'CHEMICAL')]\n","Detected entities in text: 'This study sought to determine the relationship between kratom (Mitragyna \n","speciosa) initiation and regular consumption of illicit drugs and HIV risk \n","behaviors in a cohort of illicit drug users in Malaysia. 260 illicit drug users \n","with current kratom use were recruited through convenience sampling for this \n","cross-sectional study. All were male, with the majority being Malays (95%, n = \n","246/260). Results suggest that kratom initiation was associated with significant \n","decrease in the regular use of heroin (odds ratio (OR) = 0.50, 95% confidence \n","interval (CI): 0.40- 0.72; p = .0001), methamphetamine (OR = 0.23, CI: 0.16- \n","0.35; p < .0001), and amphetamine (OR = 0.17, CI: 0.09- 0.34; p < .0001). Kratom \n","initiation was also associated with reduction in regular HIV risk behaviors such \n","as having sex with sex workers (OR = 0.20, CI: 0.12-0.32; p < .0001), using \n","drugs before sexual intercourse (OR = 0.20, CI: 0.13- 0.31; p < .0001), \n","injecting behaviors (OR = 0.10, CI: 0.04- 0.25; p < .0001), sharing of injection \n","equipment (OR = 0.13, CI: 0.04- 0.43; p < .0001), and injecting with other \n","injection drug users (IDUs) (OR = 0.07, CI: 0.02- 0.24; p < .0001).': [('heroin', 'CHEMICAL'), ('methamphetamine', 'CHEMICAL'), ('amphetamine', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa, commonly known as Ketum or Biak in Malaysia and Kratom in \n","Thailand, is a native plant to Southeast Asia and has various pharmacological \n","benefits. Mitragynine (MG) is the principal alkaloid found in the leaves of \n","Mitragyna speciosa and has been reported to be responsible for the plant's \n","therapeutic actions. Traditionally, local communities use Kratom preparations \n","for relief from different types of pain. The potential analgesic effects of MG \n","using rodent models have been reported in literatures. We have reviewed the \n","published analgesic and pharmacokinetic studies and all of these findings showed \n","the routes of drug administration, doses employed, and type of vehicles used to \n","solubilize the drug, varied considerably; hence this posted difficulties in \n","predicting the drug's pharmacokinetic-response relationship. A rational approach \n","is warranted for accurate prediction of dose-response relationship; as this is \n","essential for the development of MG as an alternative medicinal drug for pain \n","management. PKPD modeling would serve as a better method to understand the \n","dose-response relationship in future MG preclinical and clinical studies.': [('Mitragynine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('pain', 'DISEASE'), ('MG', 'CHEMICAL'), ('pain', 'DISEASE')]\n","Detected entities in text: 'Kratom use appears to be increasing across the United States, increasing \n","attention to deaths in which kratom use was detected. Most such deaths have been \n","ascribed to fentanyl, heroin, benzodiazepines, prescription opioids, cocaine and \n","other causes (e.g., homicide, suicide and various preexisting diseases). Because \n","kratom has certain opioid-like effects (e.g., pain relief), and is used by some \n","people as a substitute for opioids for pain or addiction, kratom has been \n","compared to \"narcotic-like opioids\" (e.g., morphine) with respect to risk of \n","death despite evidence that its primary alkaloid, mitragynine, carries little of \n","the signature respiratory depressing effects of morphine-like opioids. This \n","commentary summarizes animal toxicology data, surveys and mortality data \n","associated with opioids and kratom to provide a basis for estimating relative \n","mortality risk. Population-level mortality estimates attributed to opioids as \n","compared to kratom, and the per user mortality risks of opioids as compared to \n","kratom are provided. By any of our assessments, it appears that the risk of \n","overdose death is >1000 times greater for opioids than for kratom. The \n","limitations of the mortality risk estimate warrants caution in individuals with \n","unknown factors such as use of other substances and medications, or other \n","preexisting conditions. More research on kratom safety and risks is needed, as \n","is regulation of commercial kratom products to ensure that consumers are \n","informed by FDA labeling and that kratom products are not contaminated or \n","adulterated with other substances.': [('deaths', 'DISEASE'), ('deaths', 'DISEASE'), ('fentanyl', 'CHEMICAL'), ('heroin', 'CHEMICAL'), ('benzodiazepines', 'CHEMICAL'), ('cocaine', 'CHEMICAL'), ('pain', 'DISEASE'), ('pain', 'DISEASE'), ('morphine', 'CHEMICAL'), ('death', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('overdose death', 'DISEASE')]\n","Detected entities in text: 'Background: The use of the natural product, kratom, has increased significantly \n","in recent years. The active compounds in kratom have been shown to produce both \n","opioid and stimulant-like effects. While kratom is marketed as a safe, \n","non-addictive method to treat pain and opioid withdrawal, there have been \n","reports demonstrating that kratom is physiologically addictive and linked to \n","overdose deaths. A limited number of case-reports are available describing \n","treatment of kratom use disorder in middle-aged adults, generally in the context \n","of chronic pain and in inpatient settings. Our case is unique in that we \n","describe outpatient treatment of kratom use disorder in a young adult with \n","comorbid attention deficit hyperactivity disorder (ADHD) and in the absence of \n","chronic pain. Case: A 20-year-old college student with ADHD presented to an \n","office-based opioid agonist treatment clinic (OBOT) for treatment of kratom use \n","disorder. He was unable to attend inpatient or residential substance use \n","treatment due to work and school obligations. Additionally, he had stopped \n","taking his prescribed stimulant due to cardiac side effects. The OBOT team \n","successfully initiated buprenorphine-naloxone (BUP/NAL) sublingual films via \n","home induction to treat his kratom use disorder. The patient is being monitored \n","monthly with plans to slowly taper his BUP/NAL dose as tolerated. Discussion: We \n","present a case of a young adult male with kratom use disorder, complicated by a \n","diagnosis of ADHD, successfully treated with BUP/NAL via home induction. The \n","patient is currently kratom-free, reports improved mood and sleep patterns since \n","initiating BUP/NAL, and is able to once again tolerate his ADHD stimulant \n","medication. Healthcare providers should be aware of the use of kratom and \n","consider utilizing BUP/NAL to treat dependence to this botanical drug.': [('stimulant-like', 'CHEMICAL'), ('pain', 'DISEASE'), ('overdose', 'DISEASE'), ('pain', 'DISEASE'), ('comorbid attention deficit hyperactivity disorder', 'DISEASE'), ('ADHD', 'DISEASE'), ('chronic pain', 'DISEASE'), ('ADHD', 'DISEASE'), ('buprenorphine-naloxone', 'CHEMICAL'), ('ADHD', 'DISEASE'), ('ADHD', 'DISEASE')]\n","Detected entities in text: 'PURPOSE: This article presents updated information on kratom (Mitragyna \n","speciosa), a natural opioid with stimulant properties that is currently sold in \n","the United States without a prescription.\n","SUMMARY: Kratom exerts opioid and alpha-2 agonistic effects, as well as \n","anti-inflammatory and mild stimulant effects. Respiratory depression has not \n","been commonly reported, but kratom does cause a host of adverse effects. While \n","kratom may have a role in patients who are in chronic pain or dependent on \n","opioid painkillers or heroin, this needs to be established in clinical trials. \n","Kratom may have drug interactions as both a cytochrome P-450 system substrate \n","and inhibitor. Kratom does not appear in normal drug screens and, especially \n","when ingested with other substances of abuse, may not be recognized as an agent \n","of harm. There are numerous cases of death in kratom users, but many involved \n","polypharmaceutical ingestions. There are assessments where people have been \n","unable to stop using kratom therapy and withdrawal signs/symptoms occurred in \n","patients or their newborn babies after kratom cessation. Both banning and \n","failure to ban kratom places people at risk; a middle-ground alternative, \n","placing it behind the pharmacy counter, might be useful.\n","CONCLUSION: Kratom has a unique pharmacologic profile that might offer \n","advantages over other opioids, but its high abuse liability, potential for drug \n","interactions and adverse events, and inadequate research into the balance of \n","benefits to harm are concerning. There is mounting information on the adverse \n","events associated with kratom use and potential treatments that can be useful to \n","clinicians.': [('Respiratory depression', 'DISEASE'), ('pain', 'DISEASE'), ('death', 'DISEASE')]\n","Detected entities in text: 'OBJECTIVE: Recently, the US Food and Drug Administration investigated the \n","contamination of kratom (Mitragyna speciosa) by Salmonella, an event that caused \n","an outbreak in 20 states after its consumption. Therefore, we investigated 16 \n","different bags of kratom submitted for testing for potential contamination with \n","Salmonella and other microorganisms within the Public Health Laboratory for the \n","state of South Carolina.\n","MATERIALS AND METHODS: All kratom powders collected were analyzed for potential \n","contamination with bacteria by an in-house modified Food and Drug \n","Administration's Bacteriological Analytical Manual Salmonella procedure.\n","RESULTS: Out of 16 products analyzed, six brands have unknown manufacturers, but \n","manufacturer information was available for the other 10 products. In total, \n","three brands of kratom showed presence of any Salmonella species.\n","CONCLUSIONS: Recently analyzed kratom products show a presence of Salmonella.': []\n","Detected entities in text: 'OBJECTIVES: To determine whether diagnosed pre-existing health conditions \n","correlate with Kratom demographics and use patterns.\n","METHODS: A cross-sectional, anonymous US national online survey was conducted \n","among 8049 Kratom users in October, 2016 to obtain demographic, health, and \n","Kratom use pattern information.\n","RESULTS: People who use Kratom to mitigate illicit drug dependence self-reported \n","less pain and better overall health than individuals who used Kratom for \n","acute/chronic pain. Self-reported improvements in pre-existing mental health \n","symptoms (attention deficit and hyperactivity disorder/attention deficit \n","disorder, anxiety, bipolar disorder, post-traumatic stress disorder, and \n","depression) attributed to Kratom use were greater than those related to somatic \n","symptoms (back pain, rheumatoid arthritis, acute pain, chronic pain, \n","fibromyalgia). Demographic variables, including female sex, older age, \n","employment status, and insurance coverage correlated with increased likelihood \n","of Kratom use.\n","CONCLUSIONS: Kratom use may serve as a self-treatment strategy for a diverse \n","population of patients with pre-existing health diagnoses. Healthcare providers \n","need to be engaging with patients to address safety concerns and potential \n","limitations of its use in clinical practice for specific health conditions.': [('drug dependence', 'DISEASE'), ('pain', 'DISEASE'), ('pain', 'DISEASE'), ('attention deficit', 'DISEASE'), ('hyperactivity disorder/attention deficit', 'DISEASE'), ('anxiety', 'DISEASE'), ('bipolar disorder', 'DISEASE'), ('post-traumatic stress disorder', 'DISEASE'), ('pain', 'DISEASE'), ('rheumatoid arthritis', 'DISEASE'), ('acute pain', 'DISEASE'), ('chronic pain', 'DISEASE')]\n","Detected entities in text: 'Kratom is a plant material exhibiting both analgesic and stimulant effects and \n","is also forensically relevant since it is abused as a \"legal high.\" It is \n","regulated in several countries but not scheduled in the United States at the \n","federal level. This study used inductively coupled plasma-mass spectrometry \n","(ICP-MS) to measure the concentrations of 13 elements in 19 kratom samples \n","obtained from an online distributor selling kratom, from Borneo, Malaysia, \n","Indonesia, Thailand, and Vietnam, for the purpose of using the elements to \n","discriminate among purported country of origin, \"suborigin,\" and strain. \n","Analysis of variance revealed statistical differences in concentrations of \n","elements from each group, while discriminant function analysis (using \n","leave-one-out classification) successfully classified kratom samples by their \n","purported country of origin (100%), \"suborigin,\" (100%), and strain (86%). Our \n","method illustrates the possibility of utilizing ICP-MS for determination of \n","commercially available kratom samples by purported origin, \"subororign,\" or by \n","product line.': []\n","Detected entities in text: 'Mitragyna speciosa (MS), a plant commonly known as kratom, is a widely used \n","\"legal high\" opiate alternative for pain relief. DNA extracted from MS and 26 \n","additional plant species was amplified by PCR using primers targeting the \n","strictosidine beta-D-glucosidase (SGD) and secologanin synthase 2 (SLS2) genes \n","and detected by high-resolution melt curves using three intercalating dyes. \n","Amplicon sizes were confirmed using agarose gel electrophoresis. The observed \n","melt temperatures for SGD and SLS2 were 77.08 ± 0.38°C and 77.61 ± 0.46°C, \n","respectively, using SYBR® Green I; 80.18 ± 0.27°C and 80.59 ± 0.08°C, \n","respectively, using Radiant™ Green; and 82.19 ± 0.04°C and 82.62 ± 0.13°C, \n","respectively, using the LCGreen® PLUS dye. The SLS2 primers demonstrated higher \n","specificity and identified MS DNA at 0.05 ng/μL. In a duplex reaction, SLS2 and \n","tetrahydrocannabinoic acid synthase gene primers detected and differentiated MS \n","and Cannabis sativa (CS) by melt peaks at 82.63 ± 0.35°C and 85.58 ± 0.23°C, \n","respectively, using LCGreen® PLUS.': [('pain', 'DISEASE'), ('strictosidine', 'CHEMICAL'), ('agarose', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL'), ('Cannabis', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Kratom (Mitragyna speciosa Korth) use has increased in Western \n","countries, with a rising number of associated deaths. There is growing debate \n","about the involvement of kratom in these events.\n","AIMS: This study details the characteristics of such fatalities and provides a \n","'state-of-the-art' review.\n","METHODS: UK cases were identified from mortality registers by searching with the \n","terms 'kratom', 'mitragynine', etc. Databases and online media were searched \n","using these terms and 'death', 'fatal*', 'overdose', 'poisoning', etc. to \n","identify additional cases; details were obtained from relevant officials. Case \n","characteristics were extracted into an Excel spreadsheet, and analysed employing \n","descriptive statistics and thematic analysis.\n","RESULTS: Typical case characteristics (n = 156): male (80%), mean age 32.3 \n","years, White (100%), drug abuse history (95%); reasons for use included \n","self-medication, recreation, relaxation, bodybuilding, and avoiding positive \n","drug tests. Mitragynine alone was identified/implicated in 23% of cases. Poly \n","substance use was common (87%), typically controlled/recreational drugs, \n","therapeutic drugs, and alcohol. Death cause(s) included toxic effects of kratom \n","± other substances; underlying health issues.\n","CONCLUSIONS: These findings add substantially to the knowledge base on \n","kratom-associated deaths; these need systematic, accurate recording. Kratom's \n","safety profile remains only partially understood; toxic and fatal levels require \n","quantification.': [('deaths', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('death', 'DISEASE'), ('overdose', 'DISEASE'), ('poisoning', 'DISEASE'), ('drug abuse', 'DISEASE'), ('Mitragynine', 'CHEMICAL'), ('alcohol', 'CHEMICAL'), ('Death', 'DISEASE'), ('±', 'CHEMICAL'), ('deaths', 'DISEASE')]\n","Detected entities in text: 'Mitragynine is the primary active alkaloid in the leaves of the tropical tree \n","Mitragyna speciosa, and goes by the popular names \"Kratom\", biak-biak and maeng \n","da. Mitragynine is increasingly seen in forensic toxicology casework including \n","driving under the influence of drugs and medicolegal death investigation cases. \n","The toxicity of mitragynine continues to be debated in the scientific community \n","as advocates highlight its long history of use in Southeast Asia and \n","testimonials to its benefits by present-day users, while opponents point to an \n","increasing number of adverse events tied to mitragynine use in Western \n","societies. Quantitative reports of mitragynine in biological specimens from \n","forensic investigations in the literature are sparse and may be influenced by \n","poor analyte stability and inadequate resolution of mitragynine from its \n","diastereomers, which could lead to falsely elevated concentrations and \n","subsequently render those reported concentrations inappropriate for comparison \n","to a reference range. Over the course of 27 months, 1,001 blood specimens \n","submitted to our laboratory tested positive for mitragynine using a sensitive \n","and specific quantitative LC-MS/MS method; concentrations ranged from \n","5.6-29,000 ng/mL, with mean and median concentrations of 410 ± 1,124 and \n","130 ng/mL, respectively. Mitragynine presents an analytical challenge that \n","requires a method that appropriately separates and identifies mitragynine itself \n","from its isomers and other related natural products. We describe a validated \n","analytical method and present a short series of case reports that provide \n","examples of apparent adverse events, and the associated range of mitragynine \n","concentrations. This type of analytical specificity is required to appropriately \n","interpret mitragynine concentrations detected in biological specimens from \n","forensic casework and assess its potential toxicity.': [('Mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('death', 'DISEASE'), ('toxicity', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('toxicity', 'DISEASE')]\n","Detected entities in text: 'In the current study, the effect of methanolic extract of Mitragyna speciosa \n","leaf (MMS) against the rewarding and reinforcing properties of ethanol using a \n","mouse model of conditioned place preference (CPP) and runway model of drug \n","self-administration was studied. Subsequently, the effect of MMS on dopamine \n","level in the nucleus accumbens (NAc) of the mouse brain was further \n","investigated. From the data obtained, MMS (50 and 75 mg/kg, p.o.) significantly \n","reversed the ethanol-place preference in mice, which is similar to the effect \n","observed in the reference drugs acamprosate (300 mg/kg, p.o.) and clozapine \n","(1 mg/kg, p.o.) treatment groups in CPP test. Likewise, the escalating doses of \n","ethanol-conditioned mice reduced the runtime to reach goal box, infers the \n","positive reinforcing effects of alcohol. Interestingly, MMS (50, 75 and \n","100 mg/kg, p.o.) significantly prolonged the runtime in ethanol-conditioned \n","mice. Besides, MMS (50 and 75 mg/kg, p.o.) and reference drugs; acamprosate \n","(300 mg/kg, p.o.) and clozapine (1 mg/kg, p.o.) treated mice significantly \n","decreased the alcohol-induced elevated dopamine level in the NAc region of the \n","brain. Overall, this study provides first evidence that MMS inhibits ethanol \n","seeking behaviour in mice. Based on these findings, we suggest that Mitragyna \n","speciosa may well be utilized for novel drug development to combat alcohol \n","dependence.': [('extract', 'CHEMICAL'), ('MMS', 'CHEMICAL'), ('ethanol', 'CHEMICAL'), ('MMS', 'CHEMICAL'), ('dopamine', 'CHEMICAL'), ('MMS', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('acamprosate', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('clozapine', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('alcohol', 'CHEMICAL'), ('MMS', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('MMS', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('acamprosate', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('clozapine', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('dopamine', 'CHEMICAL'), ('MMS', 'CHEMICAL'), ('ethanol', 'CHEMICAL'), ('alcohol', 'CHEMICAL')]\n","Detected entities in text: 'Background: Mitragyna speciosa (Korth.) or kratom is an indigenous medicinal \n","plant of Southeast Asia. Kratom is widely reported to have dose-dependent \n","effects based on available literature, but to our knowledge, this has not been \n","established conclusively. Objective: This study sought to evaluate if kratom use \n","produces dose-dependent effects, with a stimulant effect at low doses and a \n","sedative effect at high doses, in a sample of regular kratom users. Methods: A \n","total of 63 regular kratom users participated in this cross-sectional study. The \n","Brief-Biphasic Alcohol Effects Scale (B-BAES) was used to determine subjects \n","self-report kratom use experiences. Results: Almost all in the sample were male \n","(98%, n = 62/63), and the majority of subjects were Malays (94%, n = 59/63). The \n","mean age of the subjects in the sample was 43.8 years (SD = 12.1). Seventy-five \n","percent (n = 47/63) have >5 years kratom use history, and 65% (n = 41/63) \n","consumed >3 glasses of kratom daily. Results from first test showed no \n","significant difference in the stimulant (t61 =0.371, p < .331) and sedative \n","effects (t61 =502, p < .759) between those who consumed >3 glasses a day or less \n","than this amount, regardless of duration of use. In the second test, no \n","significant differences in the mean scores were found among those who consumed \n",">3 glasses daily or less than this amount among short-term or long-term uses. \n","Conclusions: Daily kratom use produced both stimulant and sedative effects but \n","they were not statistically significantly associated with the dose consumed, \n","both among short-term and long-term users in our sample.': [('Alcohol', 'CHEMICAL')]\n","Detected entities in text: 'OBJECTIVE: Kratom preparations have raised concerns of public health and safety \n","in the United States. This paper analyzed the patterns and predictors of kratom \n","use by four U.S. regions according to the U.S. Census.\n","METHOD: An anonymous cross-sectional online survey yielded 8,049 valid \n","responses. The data were categorised by regions (Northeast, South, Midwest, and \n","West) and analyzed for the following predictors: age, gender, marital status, \n","ethnicity, employment status, insurance coverage, education, and household \n","income.\n","RESULTS: After adjusting for state population, the survey response rates were \n","highest from Oregon, Idaho, and Florida. Kratom use was significantly lower for \n","both prescription drug dependency and acute or chronic pain in the Northeast \n","region than the rest of the country. Multiple logistic regression models found \n","that gender, employment, and education were significant on the regional level. \n","Higher education was associated with lower kratom use for an illicit drug \n","dependency (p = .002) independent of region whereas men were less likely to use \n","kratom for acute or chronic pain in the Northeast (p < .001) but more likely in \n","the Midwest (p = .041).\n","CONCLUSIONS: The regional pattern of kratom use differed from opioid use data in \n","both demographics and trend direction warranting further investigation.': [('drug dependency', 'DISEASE'), ('pain', 'DISEASE'), ('pain', 'DISEASE')]\n","Detected entities in text: 'OBJECTIVE: Mitragynine is the main active compound of Mitragyna speciose (Kratom \n","in Thai). The understanding of mitragynine derivative metabolism in human body \n","is required to develop effective detection techniques in case of drug abuse or \n","establish an appropriate dosage in case of medicinal uses. This in silico study \n","is based upon in vivo results in rat and human by Philipp et al. (J Mass \n","Spectrom 44:1249-1261, 2009).\n","RESULTS: Gas-phase structures of mitragynine, 7-hydroxymitragynine and their \n","metabolites were obtained by quantum chemical method at B3LYP/6-311++G(d,p) \n","level. Results in terms of standard Gibbs energies of reaction for all metabolic \n","pathways are reported with solvation energy from SMD model. We found that \n","7-hydroxy substitution leads to changes in reactivity in comparison to \n","mitragynine: position 17 is more reactive towards demethylation and conjugation \n","with glucuronic acid and position 9 is less reactive towards conjugation with \n","glucuronic acid. Despite the changes, position 9 is the most reactive for \n","demethylation and position 17 is the most reactive for conjugation with \n","glucuronic acid for both mitragynine and 7-hydroxymitragynine. Our results \n","suggest that 7-hydroxy substitution could lead to different metabolic pathways \n","and raise an important question for further experimental studies of this more \n","potent derivative.': [('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('drug abuse', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('glucuronic acid', 'CHEMICAL'), ('glucuronic acid', 'CHEMICAL'), ('glucuronic acid', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom is a psychoactive herb that has stimulant properties at low doses and has \n","opioid-like properties at higher doses. It has been used for centuries in \n","southeast Asia as a stimulant but has gained increasing popularity as a \n","substitute for opioids in western countries as it is easily available. As most \n","cases of kratom use involve other drugs too, the Food and Drug Administration \n","(FDA) has stopped short of restricting kratom due to difficulty in assessing the \n","adverse effects of kratom alone. We present the case of a young healthy \n","35-year-old man who suffered a cardiac arrest due to kratom use with no other \n","coingestants. He was subsequently intubated and found to have systolic \n","dysfunction and small brain infarcts. Fortunately, he made a successful recovery \n","and was discharged after a stay at thebehavioural health centre. Our case \n","highlights the potential adverse effects of kratom and the need to regulate its \n","use.': [('cardiac arrest', 'DISEASE')]\n","Detected entities in text: 'The leaves from the tree Mitragyna speciosa, commonly known as Kratom, in the \n","coffee plant family (Rubiaceae) are commonly used in their native habitat of \n","Southeast Asia as a stimulant to sustain energy during hard day labor and as an \n","opioid-like analgesic and sedative. Traditional and modern uses overlap based on \n","the effects of the leaf extract which has also gained popularity in the United \n","States and Europe in the last two decades. Kratom has and is being used for the \n","mitigation of opioid withdrawal symptoms and as a harm reduction agent with a \n","minority of users subsequently developing a dependence on the extract. The \n","respective demographic use patterns of Kratom differ between Southeast Asia and \n","the Western world. While pure Kratom is primarily used by day laborers and \n","misused in conjunction with cough medicine by youth in Southeast Asia, a \n","majority of users in the United States is middle-aged, has at least middle \n","income, private health insurance, and completed some college. Deaths attributed \n","to the use of Kratom have been reported in Europe and the United States but not \n","in Southeast Asia. Although Kratom was detected as the alkaloid mitragynine in \n","the blood of the decedents, causality could not be established in almost all \n","cases because of poly-drug exposures. It is notable that Kratom can cause \n","herb-drug interactions, especially with other central nervous system -active \n","substances. Given the mostly unregulated market for Kratom products in Western \n","countries, consumers may be exposed to adulterated or contaminated products, \n","especially if purchased through websites or the darknet. A number of countries \n","have scheduled Kratom because of its stimulant- and opioid-like effects and the \n","established interaction of the alkaloid mitragynine with opioid receptors.': [('labor', 'DISEASE'), ('cough', 'DISEASE'), ('Deaths', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('adulterated', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Kratom is a traditional medicinal herb widely used in Malaysia and \n","Thailand. Despite its widespread use and statements by regulatory agencies on \n","the potential for kratom-associated psychosis, there is little data regarding \n","the prevalence of psychotic symptoms among kratom users. This study investigated \n","the prevalence of psychosis among kratom users, described psychotic \n","symptomatology and severity, while examining associations between kratom use \n","characteristics and the occurrence of psychotic symptoms.\n","METHODS: This cross-sectional clinical survey recruited 150 regular kratom \n","users. The Mini International Neuropsychiatric Interview (MINI) and Diagnostic \n","and Statistical Manual of Mental Disorders 5th Edition (DSM-V) diagnostic \n","criteria were used to evaluate psychotic symptomatology among kratom users, and \n","the Brief Psychiatric Rating Scale (BPRS) was used to assess the severity of \n","psychiatric symptoms. Chi-square tests with Yate's correction were performed to \n","determine the association between kratom use characteristics and the occurrence \n","of psychotic symptoms among kratom users in this study.\n","RESULTS: Six out of 150 kratom users (4%) presented with any psychotic symptoms. \n","The psychotic symptoms reported were positive symptoms and thought alienation, \n","with a mean BPRS score of 33 (i.e., mild severity). Variables related to kratom \n","use (such as intake of kratom with diphenhydramine, duration of kratom use, and \n","quantity and frequency of daily kratom use) were not associated with the \n","occurrence of psychotic symptoms among kratom users.\n","CONCLUSION: Although psychotic symptoms could occur among regular kratom users, \n","they were rare and not significantly associated with kratom use characteristics. \n","We found no evidence of elevated psychosis among regular users.': [('psychosis', 'DISEASE'), ('psychotic symptoms', 'DISEASE'), ('psychosis', 'DISEASE'), ('psychotic', 'DISEASE'), ('psychotic symptoms', 'DISEASE'), ('psychotic symptomatology', 'DISEASE'), ('psychiatric', 'DISEASE'), ('psychotic symptoms', 'DISEASE'), ('psychotic symptoms', 'DISEASE'), ('psychotic symptoms', 'DISEASE'), ('diphenhydramine', 'CHEMICAL'), ('psychotic symptoms', 'DISEASE'), ('psychotic symptoms', 'DISEASE'), ('psychosis', 'DISEASE')]\n","Detected entities in text: 'BACKGROUND: Kratom is a South Eastern Asian tree whose leaves are used to make \n","tea-like brews or swallowed in powdered form for various health and well-being \n","reasons including to relieve pain and opioid withdrawal. It is important to \n","learn more about the potential public health impact of kratom in the context of \n","the opioid epidemic.\n","METHODS: An anonymous online survey of kratom users (2867 current users and 157 \n","former users) was conducted in September 2017 through the American Kratom \n","Association and associated social media sites.\n","RESULTS: Kratom was used primarily to relieve pain (endorsed by 48% of \n","respondents), for anxiety, PTSD, or depression (22%), to increase energy or \n","focus (10%) and to help cut down on opioid use and/or relieve withdrawal (10%). \n","Over 90% of respondents who used it in place of opioids indicated that it was \n","helpful to relieve pain, reduce opioid use, and relieve withdrawal. The reported \n","incidence of bad adverse reactions was 13%, and reactions were overwhelmingly \n","mild and self-managed.\n","CONCLUSIONS: Respondents reported using kratom for conditions which often \n","require use of opioids, including pain and reduction of opioid use. The high \n","self-reported efficacy and low incidence of adverse reactions associated with \n","kratom use suggest that it may provide a potential alternative to opioids for \n","some persons even though it has not been evaluated in multi-center clinical \n","trials or approved for any therapeutic purpose. Further study of kratom, \n","including systematic characterization of its safety and efficacy for various \n","conditions is warranted.': [('pain', 'DISEASE'), ('pain', 'DISEASE'), ('anxiety', 'DISEASE'), ('PTSD', 'DISEASE'), ('depression', 'DISEASE'), ('pain', 'DISEASE'), ('bad adverse reactions', 'DISEASE'), ('pain', 'DISEASE')]\n","Detected entities in text: 'The opioid epidemic has left its toll on the United States with millions \n","suffering from an opioid use disorder and tens of thousands dying from overdoses \n","each year. With intentions to combat the crisis, health providers have been \n","prescribing less opioids, which resulted in an unintentional increase in the \n","abuse of other opioid-like substances. Three emerging drugs of abuse have been \n","noted in the literature as having increased abuse potential in light of recent \n","trends. Kratom, an herbal supplement, gabapentin, a prescription nerve pain and \n","anticonvulsant medication, and loperamide, an over-the-counter antidiarrheal \n","medication. These have all displayed opioid-like properties at high doses and \n","used to alleviate opioid withdrawal. Healthcare clinicians and patients might \n","not be aware of the potential risks involved with misusing or abusing these \n","opioid substitutes. This article discusses the increased usage of kratom, \n","gabapentin, and loperamide, the abuse potential, adverse effects and withdrawal \n","symptoms of each drug, and nursing implications that impact inpatient safety and \n","management.': [('disorder', 'DISEASE'), ('gabapentin', 'CHEMICAL'), ('pain', 'DISEASE'), ('loperamide', 'CHEMICAL'), ('gabapentin', 'CHEMICAL'), ('loperamide', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa, more commonly known as kratom, is a plant native to \n","Southeast Asia, the leaves of which have been used traditionally as a stimulant, \n","analgesic, and treatment for opioid addiction. Recently, growing use of the \n","plant in the United States and concerns that kratom represents an uncontrolled \n","drug with potential abuse liability, have highlighted the need for more careful \n","study of its pharmacological activity. The major active alkaloid found in \n","kratom, mitragynine, has been reported to have opioid agonist and analgesic \n","activity in vitro and in animal models, consistent with the purported effects of \n","kratom leaf in humans. However, preliminary research has provided some evidence \n","that mitragynine and related compounds may act as atypical opioid agonists, \n","inducing therapeutic effects such as analgesia, while limiting the negative side \n","effects typical of classical opioids. Here we report evidence that an active \n","metabolite plays an important role in mediating the analgesic effects of \n","mitragynine. We find that mitragynine is converted in vitro in both mouse and \n","human liver preparations to the much more potent mu-opioid receptor agonist \n","7-hydroxymitragynine and that this conversion is mediated by cytochrome P450 3A \n","isoforms. Further, we show that 7-hydroxymitragynine is formed from mitragynine \n","in mice and that brain concentrations of this metabolite are sufficient to \n","explain most or all of the opioid-receptor-mediated analgesic activity of \n","mitragynine. At the same time, mitragynine is found in the brains of mice at \n","very high concentrations relative to its opioid receptor binding affinity, \n","suggesting that it does not directly activate opioid receptors. The results \n","presented here provide a metabolism-dependent mechanism for the analgesic \n","effects of mitragynine and clarify the importance of route of administration for \n","determining the activity of this compound. Further, they raise important \n","questions about the interpretation of existing data on mitragynine and highlight \n","critical areas for further research in animals and humans.': [('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Mitragynine is amongst the more than 40 natural indole alkaloids derived from \n","the Mitragyna speciosa, or kratom tree, also referred to as ketum. The compound \n","is unique in that it exhibits dose-dependent clinical outcomes with stimulant \n","effects at lower doses but sedative effects at higher concentrations. It is \n","indigenous to Southeast Asia, where the local population has had extensive \n","experiences utilizing the substance for its medicinal as well as recreational \n","effects. Mitragynine is advertised as an herbal remedy and is readily accessible \n","via the Internet, resulting in its expansive distribution throughout the world. \n","The addictive potential of this substance is quickly becoming recognized and \n","mitragynine has been implicated in multidrug toxicity deaths. We present a case \n","of the first reported mitragynine-associated fatality in Canada where an \n","independently fatal mitragynine concentration was detected in the postmortem \n","femoral venous blood and the source drug was likely obtained as a powder from \n","Indonesia. Acad Forensic Pathol. 2018 8(2): 340-346.': [('Mitragynine', 'CHEMICAL'), ('indole alkaloids', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('toxicity', 'DISEASE'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'The leaves from Mitragyna speciosa (Korth.) trees, also known as kratom, are \n","traditionally used in Southeast Asia as a mild psychotropic agent. We \n","investigated the demographic characteristics of persons who used both kratom \n","cocktail and benzodiazepines (BZO) in a sample drawn from a rural area in \n","Penang, Malaysia, and the reasons for BZO use. Seventy-seven participants who \n","currently use a kratom cocktail along with BZO were recruited through snowball \n","sampling for this cross-sectional study. The participants were male, and the \n","majority were Malays (99%, n = 76/77), single (57%, n = 44/77) and employed \n","(91%, n = 70/77). BZO was used with kratom cocktail 1) to increase euphoria; 2) \n","to reduce dependence on methamphetamine; 3) to promote sleep; 4) to ease \n","methamphetamine-associated psychological symptoms and 5) to decrease the craving \n","for kratom. There were no significant differences in the intake of kratom use (p \n","= .751), BZO use duration (p = .259), frequency (p = .188) and quantity (p \n","= .888) of BZO use in the last 7 days, and quantity of BZO use in the last \n","30 days (p = .337) between kratom users and kratom poly-drug users. An awareness \n","of the health consequences of the co-use of kratom with BZO is needed to prevent \n","untoward health incidents.': [('benzodiazepines', 'CHEMICAL'), ('BZO', 'CHEMICAL'), ('BZO', 'CHEMICAL'), ('BZO', 'CHEMICAL'), ('methamphetamine', 'CHEMICAL'), ('methamphetamine-associated', 'CHEMICAL'), ('BZO', 'CHEMICAL'), ('BZO', 'CHEMICAL'), ('BZO', 'CHEMICAL'), ('BZO', 'CHEMICAL')]\n","Detected entities in text: 'Kratom is an herbal product commonly used for its effects which are similar to \n","opioids and stimulants. Few studies demonstrate the dangers and lethality of \n","Kratom, and most fatalities from Kratom involve other abused substances. In the \n","current case report, a 33-year-old white man with a known history of opioid \n","abuse and mental illnesses was found unresponsive in his basement with no \n","obvious signs of trauma. After resuscitative efforts, he was pronounced dead and \n","taken for autopsy evaluation. Blood from the inferior vena cava was analyzed for \n","common abused substances. The laboratory toxicology work-up revealed positive \n","findings of caffeine, cotinine, and naloxone with low levels of Δ-9 \n","tetrahydrocannabinol. However, a marked level of mitragynine at 1.9 mg/L was \n","observed, the highest reported to date. Given the facts and evidence, the \n","medical examiner certified the cause of death as \"mitragynine toxicity\" and the \n","manner of death was classified as an \"accident.\"': [('trauma', 'DISEASE'), ('caffeine', 'CHEMICAL'), ('cotinine', 'CHEMICAL'), ('naloxone', 'CHEMICAL'), ('Δ-9', 'CHEMICAL'), ('tetrahydrocannabinol', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('death', 'DISEASE'), ('mitragynine toxicity', 'CHEMICAL'), ('death', 'DISEASE')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa) is a tree-like plant indigenous to Southeast Asia. \n","Its leaves, and the teas brewed from them have long been used by people in that \n","region to stave off fatigue and to manage pain and opioid withdrawal. Evidence \n","suggests kratom is being increasingly used by people in the United States and \n","Europe for the self-management of opioid withdrawal and treatment of pain. \n","Recent studies have confirmed that kratom and its chemical constituents have \n","potentially useful pharmacological actions. However, there have also been \n","increasing numbers of reports of adverse effects resulting from use of kratom \n","products. In August 2016, the US Drug Enforcement Administration announced plans \n","to classify kratom and its mitragynine constituents as Schedule I Controlled \n","Substances, a move that triggered a massive response from pro-kratom advocates. \n","The debate regarding the risks, and benefits and safety of kratom continues to \n","intensify. Kratom proponents tout kratom as a safer and less addictive \n","alternative to opioids for the management of pain and opioid addiction. The \n","anti-kratom faction argues that kratom, itself, is a dangerous and addictive \n","drug that ought to be banned. Given the widespread use of kratom and the \n","extensive media attention it is receiving, it is important for physicians, \n","scientists and policy makers to be knowledgeable about the subject. The purpose \n","of this commentary is to update readers about recent developments and \n","controversies in this rapidly evolving area. All of the authors are engaged in \n","various aspects of kratom research and it is our intention to provide a fair and \n","balanced overview that can form the basis for informed decisions on kratom \n","policy. Our conclusions from these analyses are: (a) User reports and results of \n","preclinical studies in animals strongly suggest that kratom and its main \n","constituent alkaloid, mitragynine may have useful activity in alleviating pain \n","and managing symptoms of opioid withdrawal, even though well-controlled clinical \n","trials have yet to be done. (b) Even though kratom lacks many of the toxicities \n","of classic opioids, there are legitimate concerns about the safety and lack of \n","quality control of purported \"kratom\" products that are being sold in the US. \n","(c) The issues regarding the safety and efficacy of kratom and its mitragynine \n","constituent can only be resolved by additional research. Classification of the \n","Mitragyna alkaloids as Schedule I controlled substances would substantially \n","impede this important research on kratom.': [('fatigue', 'DISEASE'), ('pain', 'DISEASE'), ('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('pain', 'DISEASE'), ('toxicities', 'DISEASE'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND AND OBJECTIVE: Kratom (Mitragyna speciosa) is a tropical tree found \n","in southern Thailand and northern states of the Malay Peninsula. Kratom is \n","commercially available and used as an alternative to treat opioid withdrawal. \n","Mitragynine is the major indole alkaloid found in kratom leaves. This review \n","aimed to summarize available pharmacokinetic information about mitragynine.\n","METHODS: PubMed, Scopus, and Web of Science were systematically searched from \n","their inceptions to June 2018. All types of pharmacokinetic studies of \n","mitragynine were included for further systematic review.\n","RESULTS: Seventeen articles were reviewed. Mitragynine is a lipophilic weak base \n","passively transported across the intestinal wall and blood brain barrier. 85-95% \n","is bound to plasma protein and extensively metabolized by phase I and \n","particularly phase II enzymes. Actions on CYP enzymes are unlikely to impact \n","drug metabolism at concentrations likely to exist in kratom-consuming humans. In \n","rats and humans, mitragynine is rapidly absorbed after orally administration \n","(Tmax˜1.5 h, Cmax˜0.3-1.8 μM). Vd was 37-90 L/kg; t1/2 was 3-9 hr; mostly \n","excreted as metabolites in urine. Bioavailability was estimated as 21%. It also \n","rapidly penetrated and redistributed in brain. A quality assessment tool \n","tailored for pharmacokinetic studies was also created which rated some studies \n","of lower value.\n","CONCLUSION: Rudimentary pharmacokinetics of mitragynine was described in this \n","systematic review. However, the discovered studies provided scant information on \n","the role of metabolism and redistribution into tissues nor the rate of \n","excretion.': [('Mitragynine', 'CHEMICAL'), ('indole alkaloid', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Kratom is an herbal supplement containing alkaloids with opioid \n","properties. This review was conducted to determine toxicities associated with \n","kratom use in the United States in order to provide insight into its safety as a \n","dietary supplement.\n","METHODS: We conducted a retrospective review of kratom exposures reported to the \n","National Poison Data System to determine the toxicities associated with kratom \n","use. We also reviewed records from a county medical examiner's office in New \n","York State to identify kratom-associated fatalities.\n","RESULTS: A total of 2312 kratom exposures were reported, with 935 cases \n","involving kratom as the only substance. Kratom most commonly caused agitation \n","(18.6%), tachycardia (16.9%), drowsiness (13.6%), vomiting (11.2%), and \n","confusion (8.1%). Serious effects of seizure (6.1%), withdrawal (6.1%), \n","hallucinations (4.8%), respiratory depression (2.8%), coma (2.3%), and cardiac \n","or respiratory arrest (0.6%) were also reported. Kratom was listed as a cause or \n","contributing factor in the death of four decedents identified by the county \n","medical examiner's office.\n","CONCLUSIONS: Kratom use is increasing and is associated with significant \n","toxicities. Our findings suggest kratom is not reasonably expected to be safe \n","and poses a public health threat due to its availability as an herbal \n","supplement.': [('toxicities', 'DISEASE'), ('toxicities', 'DISEASE'), ('agitation', 'DISEASE'), ('tachycardia', 'DISEASE'), ('vomiting', 'DISEASE'), ('confusion', 'DISEASE'), ('seizure', 'DISEASE'), ('hallucinations', 'DISEASE'), ('respiratory depression', 'DISEASE'), ('coma', 'DISEASE'), ('respiratory arrest', 'DISEASE'), ('death', 'DISEASE'), ('toxicities', 'DISEASE')]\n","Detected entities in text: 'RATIONALE: Mitragyna speciosa (kratom) may hold promise as both an analgesic and \n","treatment for opioid use disorder. Mitragynine, its primary alkaloid \n","constituent, is an opioid receptor ligand. However, the extent to which the in \n","vivo effects of mitragynine are mediated by opioid receptors, or whether \n","mitragynine interacts with other opioid agonists, is not fully established.\n","OBJECTIVES: The effects of mitragynine and the prototypical opioid agonist \n","morphine were compared for their capacity to decrease operant responding for \n","food delivery, and to increase response latency to a thermal stimulus.\n","METHODS: Male and female Sprague-Dawley rats responded under a multiple cycle \n","fixed ratio 10 schedule of food delivery and were tested on a hot plate (52 °C) \n","immediately after each cycle. Morphine and mitragynine were administered alone, \n","in combination with each other, and in combination with the opioid antagonist \n","naltrexone.\n","RESULTS: Morphine and mitragynine dose-dependently decreased schedule-controlled \n","responding; the ED50 values were 7.3 and 31.5 mg/kg, respectively. Both drugs \n","increased thermal antinociception; the ED50 value for morphine was 18.3. \n","Further, doses of naltrexone that antagonized morphine did not antagonize \n","mitragynine. Mitragynine (17.8 mg/kg) did not alter the rate-decreasing or \n","antinociceptive effects of morphine.\n","CONCLUSIONS: The antinociceptive effects of mitragynine and morphine occur at \n","doses larger than those that disrupt learned behavior. Opioid receptors do not \n","appear to mediate the disruptive effects of mitragynine on learned behavior. \n","Mitragynine had lesser antinociceptive effects than morphine, and these did not \n","appear to be mediated by opioid receptors. The pharmacology of mitragynine \n","includes a substantial non-opioid mechanism.': [('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('Morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('naltrexone', 'CHEMICAL'), ('Morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('naltrexone', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Mitragynine is the major alkaloid of Mitragyna speciosa (Korth.) or \n","Kratom, a psychoactive plant widely abused in Southeast Asia. While addictive \n","effects of the substance are emerging, adverse cognitive effects of this drug \n","and neuropharmacological actions are insufficiently understood.\n","AIMS: In the present study, we investigated the effects of mitragynine on \n","spatial learning and synaptic transmission in the CA1 region of the hippocampus.\n","METHODS: Male Sprague Dawley rats received daily (for 12 days) training sessions \n","in the Morris water maze, with each session followed by treatment either with \n","mitragynine (1, 5, or 10 mg/kg; intraperitoneally), morphine (5 mg/kg; \n","intraperitoneally) or a vehicle. In the second experiment, we recorded field \n","excitatory postsynaptic potentials in the hippocampal CA1 area in anesthetized \n","rats and assessed the effects of mitragynine on baseline synaptic transmission, \n","paired-pulse facilitation, and long-term potentiation. Gene expression of major \n","memory- and addiction-related genes was investigated and the effects of \n","mitragynine on Ca2+ influx was also examined in cultured primary neurons from \n","E16-E18 rats.\n","RESULTS/OUTCOMES: Escape latency results indicate that animals treated with \n","mitragynine displayed a slower rate of acquisition as compared to their control \n","counterparts. Further, mitragynine treatment significantly reduced the amplitude \n","of baseline (i.e. non-potentiated) field excitatory postsynaptic potentials and \n","resulted in a minor suppression of long-term potentiation in CA1. Bdnf and \n","αCaMKII mRNA expressions in the brain were not affected and Ca2+ influx elicited \n","by glutamate application was inhibited in neurons pre-treated with mitragynine.\n","CONCLUSIONS/INTERPRETATION: These data suggest that high doses of mitragynine (5 \n","and 10 mg/kg) cause memory deficits, possibly via inhibition of Ca2+ influx and \n","disruption of hippocampal synaptic transmission and long-term potentiation \n","induction.': [('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('1, 5, or 10 mg/kg', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('glutamate', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('memory deficits', 'DISEASE')]\n","Detected entities in text: 'This paper aimed to summarize kratom's psychological effects on users and the \n","Islamic views on kratom use. A literature survey of published kratom studies, \n","teachings based on the holy Qur'an, the Sunnah, and views of several Islamic \n","scholars based on qualitative methodology through text analysis was conducted. \n","The results demonstrated that despite its beneficial therapeutic effects, the \n","harm induced by kratom outweighs its benefits. We concluded that kratom use for \n","medicinal purposes is only warranted if useful constituent mitragynine can be \n","extracted and used on its own, and if more rigorous human studies demonstrated \n","good safety profile and efficacy of mitragynine for therapeutic purposes.': [('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'The recent rise in the recreational use of plant-based \"legal highs\" has \n","prompted the development of methods for the identification of the bulk material, \n","and quantification of their psychoactive components. One of these plants is \n","Mitragyna speciosa, commonly referred to as Kratom. While traditional use of \n","this plant was primarily for medicinal purposes, there has been a rise in its \n","recreational use, and as a self-prescribed medication for opioid withdrawal. \n","Although Kratom contains many alkaloids, mitragynine and 7-hydroxymitragynine \n","are unique psychoactive biomarkers of the species, and are responsible for its \n","psychoactive effects. A rapid validated method for the quantification of \n","mitragynine in Kratom plant materials by direct analysis in real \n","time-high-resolution mass spectrometry (DART-HRMS) is presented. It has a linear \n","range of 5-100 μg mL-1, and a lower limit of quantification of 5 μg mL-1. The \n","protocol was applied to determination of the mitragynine content of 16 \n","commercially available Kratom plant products purchased online. The mitragynine \n","amounts in these materials ranged from 2.76 to 20.05 mg g-1 of dried plant \n","material. The utilization of DART-HRMS affords a mechanism not only for the \n","preliminary identification of bulk plant material as being M. speciosa-derived \n","(with no sample preparation required), but also provides the opportunity to \n","quantify its psychoactive components using the same technique.': [('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'ETHNOPHARMACOLOGICAL RELEVANCE: Mitragyna speciosa (Korth.) is a traditional \n","medicinal plant widely used in Southeast Asia for its opioid-like effects. \n","Although kratom produces analgesia through binding of mitragynine and other \n","alkaloids at the mu-opioid receptor (MOR), the association of long-term kratom \n","use with adverse opioid-like effects remains unknown.\n","AIM OF THE STUDY: To determine the self-reported prevalence and severity of \n","opioid-related adverse effects after kratom initiation in a cohort of illicit \n","opioid users.\n","MATERIALS AND METHODS: A total of 163 illicit opioid users with current kratom \n","use history were recruited through convenience sampling from the northern states \n","of Peninsular Malaysia. Face-to-face interviews were conducted using a \n","semi-structured questionnaire.\n","RESULTS: Respondents were all males, majority Malays (94%, n = 154/163), with a \n","mean age of 37.10 years (SD = 10.9). Most were single (65%, n = 106/163), had 11 \n","years of education (52%, n = 85/163) and employed (88%, n = 144/163). Half \n","reported using kratom for over >6 years (50%, n = 81/163), and 41% consumed >3 \n","glasses of kratom daily (n = 67/163). Results from Chi-square analysis showed \n","kratom initiation was associated with decreased prevalence of respiratory \n","depression, constipation, physical pain, insomnia, depression, loss of appetite, \n","craving, decreased sexual performance, weight loss and fatigue.\n","CONCLUSIONS: Our findings indicate that kratom initiation (approximately \n","214.29 mg of mitragynine) was associated with significant decreases in the \n","prevalence and severity of opioid adverse effects.': [('mitragynine', 'CHEMICAL'), ('alkaloids', 'CHEMICAL'), ('constipation', 'DISEASE'), ('pain', 'DISEASE'), ('insomnia', 'DISEASE'), ('depression', 'DISEASE'), ('loss of appetite', 'DISEASE'), ('weight loss', 'DISEASE'), ('fatigue', 'DISEASE'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa) is a psychoactive plant popular in the United States \n","for the self-treatment of pain and opioid addiction. For standardization and \n","quality control of raw and commercial kratom products, an ultra-performance \n","liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was developed \n","and validated for the quantification of ten key alkaloids, namely: \n","corynantheidine, corynoxine, corynoxine B, 7-hydroxymitragynine, \n","isocorynantheidine, mitragynine, mitraphylline, paynantheine, speciociliatine, \n","and speciogynine. Chromatographic separation of diastereomers, or alkaloids \n","sharing same ion transitions, was achieved on an Acquity BEH C18 column with a \n","gradient elution using a mobile phase containing acetonitrile and aqueous \n","ammonium acetate buffer (10mM, pH 3.5). The developed method was linear over a \n","concentration range of 1-200 ng/mL for each alkaloid. The total analysis time \n","per sample was 22.5 minutes. The analytical method was validated for accuracy, \n","precision, robustness, and stability. After successful validation, the method \n","was applied for the quantification of kratom alkaloids in alkaloid-rich \n","fractions, ethanolic extracts, lyophilized teas, and commercial products. \n","Mitragynine (0.7%-38.7% w/w), paynantheine (0.3%-12.8% w/w), speciociliatine \n","(0.4%-12.3% w/w), and speciogynine (0.1%-5.3% w/w) were the major alkaloids in \n","the analyzed kratom products/extracts. Minor kratom alkaloids (corynantheidine, \n","corynoxine, corynoxine B, 7-hydroxymitragynine, isocorynantheidine) were also \n","quantified (0.01%-2.8% w/w) in the analyzed products; however mitraphylline was \n","below the lower limit of quantification in all analyses.': [('pain', 'DISEASE'), ('corynoxine,', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitraphylline', 'CHEMICAL'), ('paynantheine', 'CHEMICAL'), ('speciociliatine', 'CHEMICAL'), ('speciogynine', 'CHEMICAL'), ('ammonium acetate', 'CHEMICAL'), ('10mM', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('paynantheine', 'CHEMICAL'), ('speciogynine', 'CHEMICAL'), ('alkaloids', 'CHEMICAL'), ('corynoxine, corynoxine B', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'In Asia, Mitragyna speciosa (e.g., \"kratom\") has been used to mitigate alcohol \n","and drug dependence. Some preliminary findings suggest kratom's potential use as \n","an informal harm-reduction method in the United States, such as an opioid \n","substitute or as a means of lessening opioid withdrawal symptoms. To determine \n","correlates of past-year kratom use among a sample of polysubstance users \n","enrolled in residential recovery programs in Kentucky, an anonymous survey was \n","completed by clients in April 2017. Logistic regression was used to identify \n","significant associations with past-year kratom use. Of the final sample (N = \n","478), 10.4% reported past-year kratom use. Past-year heroin use, but not \n","past-year prescription opioid (e.g., oxycodone, hydrocodone) use, was \n","significantly associated with kratom use, such that individuals who reported \n","past-year heroin use were 2.5 times more likely to also report past-year kratom \n","use. Non-prescribed buprenorphine (i.e., Suboxone) use partially mediated the \n","relationship between past-year heroin and kratom use by explaining 36% of the \n","association between the two drugs. Though amphetamines were highly preferred, \n","past-year use was negatively correlated with past-year kratom use. Rates of \n","past-year kratom use were lower than rates of alcohol and illicit drug use. \n","Kratom was not preferred over heroin or prescription opioids.': [('alcohol', 'CHEMICAL'), ('polysubstance', 'CHEMICAL'), ('heroin', 'CHEMICAL'), ('oxycodone', 'CHEMICAL'), ('hydrocodone', 'CHEMICAL'), ('heroin', 'CHEMICAL'), ('buprenorphine', 'CHEMICAL'), ('Suboxone', 'CHEMICAL'), ('amphetamines', 'CHEMICAL'), ('alcohol', 'CHEMICAL')]\n","Detected entities in text: 'Drug-induced liver injury (DILI) is a common cause of hepatotoxicity associated \n","with prescription-based and over-the-counter exposure to medications and herbal \n","supplements. Use of unapproved and inadequately tested herbal supplements can \n","cause DILI. Therefore, thorough history-taking on exposure to herbal supplements \n","must be an integral part of clinical evaluation of DILI. Kratom is an herbal \n","supplement or remedy that has been known for its analgesic effects and has also \n","been used for self-treatment of opiate withdrawals. A 52-year-old man was seen \n","for evaluation of yellow discoloration of the eyes and skin. He reported taking \n","kratom for right shoulder strain for at least a couple of months. On workup, his \n","total bilirubin was noted to be 23.2 mg/dL, which peaked at 28.9 mg/dL. He was \n","noted to have mild elevation of aspartate aminotransferase, alanine \n","aminotransferase, and alkaline phosphatase. Extensive laboratory tests were \n","ordered and known causes of chronic liver disease ruled out. Magnetic resonance \n","imaging of the abdomen was unremarkable without stigmata of portal hypertension \n","or signs of chronic liver disease. He demonstrated no evidence of coagulopathy \n","or hepatic encephalopathy during his illness. He underwent liver biopsy, which \n","demonstrated histologic evidence of acute cholestatic hepatitis highly \n","suspicious of DILI. He was advised to avoid kratom or other herbal supplements \n","in future and prescribed ursodeoxycholic acid with significant improvement in \n","his liver chemistries. Kratom is associated with significant liver enzymes \n","derangements leading to DILI. Kratom is not approved for use in the United \n","States and should be avoided.': [('liver injury', 'DISEASE'), ('DILI', 'CHEMICAL'), ('hepatotoxicity', 'DISEASE'), ('DILI', 'DISEASE'), ('DILI', 'CHEMICAL'), ('bilirubin', 'CHEMICAL'), ('aspartate', 'CHEMICAL'), ('alanine', 'CHEMICAL'), ('liver disease', 'DISEASE'), ('hypertension', 'DISEASE'), ('liver disease', 'DISEASE'), ('coagulopathy', 'DISEASE'), ('hepatic encephalopathy', 'DISEASE'), ('cholestatic hepatitis', 'DISEASE'), ('DILI', 'CHEMICAL'), ('ursodeoxycholic acid', 'CHEMICAL'), ('DILI', 'CHEMICAL')]\n","Detected entities in text: 'The abuse of psychotropic substances is a well-known phenomenon, and many of \n","them are usually associated with ancestral traditions and home remedies. This is \n","the case of Mitragyna speciosa (kratom), a tropical tree used to improve work \n","performance and to withstand great heat. According to several published studies, \n","the main reasons for kratom consumption involve improving sexual performance and \n","endurance, but also social and recreational uses for the feeling of happiness \n","and euphoria; it is also used for medical purposes as a pain reliever, and in \n","the treatment of diarrhea, fever, diabetes, and hypertension. However, this \n","plant has gained more popularity amongst young people over the last years. Since \n","it is available on the internet for purchase, its use is now widely as a drug of \n","abuse, namely as a new psychoactive substance, being a cheaper alternative to \n","opioids that does not require medical prescription in most countries. According \n","to internet surveys by the European Monitoring Centre for Drugs and Drug \n","Addiction in 2008 and 2011, kratom was one of the most widely supplied new \n","psychoactive substances. The composition of kratom is complex; in fact, more \n","than 40 different alkaloids have been identified in Mitragyna speciosa so far, \n","the major constituent being mitragynine, which is exclusive to this plant. \n","Besides mitragynine, alkaloids such as corynantheidine and 7-hydroxamitragynine \n","also present pharmacological effects, a feature that may be attributed to the \n","remaining constituents as well. The main goal of this review is not only to \n","understand the origin, chemistry, consumption, and analytical methodologies for \n","analysis and mechanism of action, but also the use of secondary metabolites of \n","kratom as therapeutic drugs and the assessment of potential risks associated \n","with its consumption, in order to aid health professionals, toxicologists, and \n","police authorities in cases where this plant is present.': [('diarrhea', 'DISEASE'), ('fever', 'DISEASE'), ('diabetes', 'DISEASE'), ('hypertension', 'DISEASE'), ('alkaloids', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('alkaloids', 'CHEMICAL'), ('corynantheidine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom ( Mitragyna speciosa) is a prevalent medicinal plant used mainly for the \n","stimulant and analgesic properties provided through multiple alkaloid compounds. \n","Over the past decade, use of kratom has increased despite the limited knowledge \n","of toxicities and adverse side effects. With the current opioid epidemic, both \n","patients and providers are seeking alternative methods to treat both addiction \n","and pain control, and kratom as an alternative means of treatment has \n","increasingly entered the mainstream. In this article, we present the clinical \n","course of a 47-year-old male who developed fatigue, pruritus, and abnormal liver \n","tests (with a mixed hepatocellular/cholestatic pattern) approximately 21 days \n","after beginning kratom. After extensive evaluation including a negligible \n","alcohol history, negative hepatitis serologies, and inconclusive imaging, the \n","patient was diagnosed with drug-induced liver injury (DILI) caused by kratom. \n","Nine months after his liver tests returned to normal, he took kratom again, and \n","after a latency of 2 days, he developed fatigue, pruritus, and loss of appetite \n","along with abnormal liver tests (with the same biochemical profile as \n","previously), consistent with a positive rechallenge. We believe, through the use \n","of the Roussel-Uclaf Causality Assessment Method and expert opinion, that this \n","is a highly likely or definite example of kratom-induced DILI. With the gaining \n","popularity of this drug, it appears that DILI may be an important complication \n","of kratom for providers to recognize.': [('toxicities', 'DISEASE'), ('pain', 'DISEASE'), ('fatigue', 'DISEASE'), ('pruritus', 'DISEASE'), ('abnormal liver', 'DISEASE'), ('alcohol', 'CHEMICAL'), ('hepatitis', 'DISEASE'), ('drug-induced liver injury', 'DISEASE'), ('DILI', 'CHEMICAL'), ('fatigue', 'DISEASE'), ('pruritus', 'DISEASE'), ('loss of appetite \\n', 'DISEASE'), ('abnormal liver', 'DISEASE'), ('DILI', 'CHEMICAL'), ('DILI', 'CHEMICAL')]\n","Detected entities in text: 'Context: Kratom, or Mitragyna speciosa, is a plant indigenous to Southeast Asia \n","that has gained national attention in the United States for its increased use in \n","the self-management of opioid withdrawal and pain, as well as for concerns about \n","its safety. Methods: This study analyzes exposures to kratom reported to poison \n","control centers (PCCs) in the United States during 2011-2017 from the National \n","Poison Data System (NPDS). Discussion: From 2011 through 2017, 1807 kratom \n","exposures were reported to United States PCCs. Almost two-thirds (65.0%) of \n","these exposures occurred during 2016-2017. Most exposures occurred among adults \n","≥20 years (88.9%), males (70.8%), at a residence (86.1%), and were intentional \n","(74.3%). Among first-ranked kratom exposures, 31.8% resulted in admission to a \n","health care facility (HCF) and 51.9% in a serious medical outcome. \n","Multiple-substance exposures were associated with greater odds of admission to a \n","HCF (OR: 2.80; 95% CI: 2.21-3.55) and a serious medical outcome (OR: 2.25; 95% \n","CI: 1.77-2.85) compared with single-substance exposures. There were 11 deaths \n","associated with kratom exposure, including two that occurred after exposure to \n","kratom only. Among kratom-only exposures, 86.1% resulted in one or more clinical \n","effects. The most common clinical effects were agitation/irritability (22.9%) \n","and tachycardia (21.4%). There were seven neonatal exposures, including five \n","experiencing withdrawal. Conclusions: Kratom is associated with a variety of \n","serious medical outcomes, especially when used with other substances. More \n","research is needed to define the human response to kratom. Increased regulation \n","of kratom products would help guarantee product quality and safety. Individuals \n","who choose to use kratom should be educated about its potential risks, including \n","the dangers of using it in combination with other substances.': [('pain', 'DISEASE'), ('single-substance', 'DISEASE'), ('deaths', 'DISEASE'), ('tachycardia', 'DISEASE')]\n","Detected entities in text: 'This case report describes an overdose on kratom, and elicits the potential \n","dangers of overdose on the regulated dietary supplement. A young male presented \n","to the emergency department intubated after being found unresponsive. He was \n","found by his family to be unarousable and agonal breathing with minimal response \n","to naloxone administered by Emergency Medical Services (EMS). Urine toxicology \n","and blood alcohol content were negative. Physical exam was significant for \n","tachycardia, hypotension, and pinpoint pupils with sluggish reactivity to light. \n","Laboratory studies were significant for elevated liver enzymes, blood urea \n","nitrogen, creatinine, lipase, amylase, troponins, and lactic acid. Family \n","members revealed that the patient consumed kratom, which he obtained through an \n","e-commerce business, and had consumed over 500 grams the previous day. Urine \n","sample for kratom on day 3 tested positive with levels of more than 500 ng/dL. \n","The patient received supportive care and, by day 10, pupillary reflexes returned \n","to normal and he was extubated by day 14. Most of the medications/drugs labelled \n","under herbal supplements by the U.S. Food and Drug Administration (FDA) are not \n","regulated and can be purchased over the counter. The safety and side-effect \n","profile of kratom is not well-studied, especially in an overdose scenario.': [('overdose', 'DISEASE'), ('overdose', 'DISEASE'), ('naloxone', 'CHEMICAL'), ('alcohol', 'CHEMICAL'), ('tachycardia', 'DISEASE'), ('hypotension', 'DISEASE'), ('urea', 'CHEMICAL'), ('nitrogen', 'CHEMICAL'), ('creatinine', 'CHEMICAL'), ('troponins', 'CHEMICAL'), ('lactic acid', 'CHEMICAL'), ('overdose', 'DISEASE')]\n","Detected entities in text: 'Recent years have seen a widespread increase in kratom use, not just for the \n","purpose of easing opioid withdrawal, but also for management of emotional and \n","mental health concerns by individuals without histories of opioid use. Chronic \n","use can lead to dependence, tolerance, and withdrawal on cessation, and \n","clinicians are seeing an increasing number of presentations involving the \n","latter. Although there is literature discussing the use of kratom to assist in \n","opioid withdrawal, this article comprehensively examines independent withdrawal \n","from kratom. We systematically review existing evidence and provide our own \n","clinical cases. Clinicians need to be aware of the withdrawal symptomatology and \n","implement a similar approach as for opioid withdrawal with long-term maintenance \n","to prevent relapse.': []\n","Detected entities in text: 'Mitragynine is a major component isolated from Mitragyna speciosa Korth or \n","kratom, a medicinal plant known for its opiate-like and euphoric properties. \n","Multiple toxicity and fatal cases involving mitragynine or kratom have been \n","reported but the underlying causes remain unclear. P-glycoprotein (P-gp) is a \n","multidrug transporter which modulates the pharmacokinetics of xenobiotics and \n","plays a key role in mediating drug-drug interactions. This study investigated \n","the effects of mitragynine on P-gp transport activity, mRNA, and protein \n","expression in Caco-2 cells using molecular docking, bidirectional assay, \n","RT-qPCR, Western blot analysis, and immunocytochemistry techniques, \n","respectively. Molecular docking simulation revealed that mitragynine interacts \n","with important residues at the nucleotide binding domain (NBD) site of the P-gp \n","structure but not with the residues from the substrate binding site. This was \n","consistent with subsequent experimental work as mitragynine exhibited low \n","permeability across the cell monolayer but inhibited digoxin transport at 10 μM, \n","similar to quinidine. The reduction of P-gp activity in vitro was further \n","contributed by the downregulation of mRNA and protein expression of P-gp. In \n","summary, mitragynine is likely a P-gp inhibitor in vitro but not a substrate. \n","Hence, concurrent administration of mitragynine-containing kratom products with \n","psychoactive drugs which are P-gp substrates may lead to clinically significant \n","toxicity. Further clinical study to prove this point is needed.': [('Mitragynine', 'CHEMICAL'), ('toxicity', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('nucleotide', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('digoxin', 'CHEMICAL'), ('quinidine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('toxicity', 'DISEASE')]\n","Detected entities in text: 'Mitragynine is an indole alkaloid isolated from the Thai medicinal plant \n","Mitragyna speciosa. We previously reported the morphine-like action of \n","mitragynine and its related compounds in the in vitro assays. In the present \n","study, we investigated the opioid effects of 7-hydroxymitragynine, which is \n","isolated as its novel constituent, on contraction of isolated ileum, binding of \n","the specific ligands to opioid receptors and nociceptive stimuli in mice. In \n","guinea-pig ileum, 7-hydroxymitragynine inhibited electrically induced \n","contraction through the opioid receptors. Receptor-binding assays revealed that \n","7-hydroxymitragynine has a higher affinity for micro-opioid receptors relative \n","to the other opioid receptors. Administration of 7-hydroxymitragynine (2.5-10 \n","mg/kg, s.c.) induced dose-dependent antinociceptive effects in tail-flick and \n","hot-plate tests in mice. Its effect was more potent than that of morphine in \n","both tests. When orally administered, 7-hydroxymitragynine (5-10 mg/kg) showed \n","potent antinociceptive activities in tail-flick and hot-plate tests. In \n","contrast, only weak antinociception was observed in the case of oral \n","administration of morphine at a dose of 20 mg/kg. It was found that \n","7-hydroxymitragynine is a novel opioid agonist that is structurally different \n","from the other opioid agonists, and has potent analgesic activity when orally \n","administered.': [('Mitragynine', 'CHEMICAL'), ('indole', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'ETHNOPHARMACOLOGICAL RELEVANCE: The leaves of Mitragyna speciosa (Korth.) or \n","kratom have been traditionally used in Malaysia and Thailand mainly to enhance \n","work productivity, as a folk remedy for treating common ailments, and as a mood \n","enhancer.\n","AIM OF THE STUDY: This present study sought to investigate kratom use motives \n","among regular kratom users in Malaysia.\n","MATERIALS AND METHODS: A total of 116 regular kratom users were recruited for \n","this cross-sectional survey. The Drinking Motives Questionnaire (DMQ) was \n","administered to measure kratom use motives.\n","RESULTS: Our results indicate that heavy (>3 glasses daily, each glass contains \n","48.24-50.4 mg of mitragynine) kratom use was associated with coping (t87.09 \n","=3.544, p < 0.001), and enhancement (t114 =2.180, p = 003). Single subjects had \n","higher mean scores on the coping domain, relative to married subject (t113.89 \n","=3.029, p < 0.003), while those earning more than RM1500 per month had higher \n","mean scores on the enhancement domain, compare to those earning less than RM1500 \n","per month (t107 =2.151, p < 0.034). Higher scores on the coping domain was \n","significantly associated with higher (>3 glasses daily) kratom consumption \n","(p < 0.0045).\n","CONCLUSIONS: Coping was associated with high (>3 glasses daily) kratom \n","consumption among regular kratom users in traditional, rural settings.': [('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom or Mitragyna speciosa (Korth.) is a medicinal plant of Southeast Asia. As \n","a result of its opioid-like effects, it remains unknown whether consumption of \n","kratom tea is associated with impaired cognitive function. We assessed the \n","cognitive function of 70 regular kratom users and 25 control participants using \n","the Cambridge Neuropsychological Test Automated Battery. Participants performed \n","six neuropsychological tasks that assessed motor, learning and memory, attention \n","and executive function. Relative to control participants, higher consumption (>3 \n","glasses daily or mitragynine doses between 72.5 mg and 74.9 mg) of kratom tea \n","was selectively associated with impaired performance on the Paired Associates \n","Learning task, reflecting deficits in visual episodic memory and new learning. \n","Overall, the performance of kratom users compared to control participants, and \n","the performance of high (>3 glasses per day) as well as low (≤3 glasses per day) \n","kratom using groups, were comparable on all neuropsychological domains. Higher \n","intake of kratom juice (>3 glasses daily) did not appear to impair motor, \n","memory, attention or executive function of regular kratom users.': [('tea', 'CHEMICAL'), ('impaired cognitive function', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('kratom tea', 'CHEMICAL'), ('deficits in visual episodic memory and new learning.', 'DISEASE')]\n","Detected entities in text: ' Mitragynine is the major indole-based alkaloid of Mitragyna speciosa \n","(kratom). Decoctions (teas) of the plant leaves have been used traditionally for \n","cough, diarrhoea, pain, hypertension and for the treatment of opioid addiction. \n","In the West, kratom has become increasingly utilized for mood elevation, pain \n","treatment and as a means of self-treating opioid addiction. 2. Metabolic \n","pathways of mitragynine were identified in human liver microsomes (HLM) and S9 \n","fractions. A total of thirteen metabolites were identified, four oxidative \n","metabolites and a metabolite formed by demethylation at the 9-methoxy group were \n","the major metabolites of mitragynine. 3. The cytochrome P450 enzymes involved in \n","the metabolism of mitragynine were identified using selective chemical \n","inhibitors of HLM and recombinant cytochrome P450. The metabolism of mitragynine \n","was predominantly carried out through the CYP3A4 with minor contributions by \n","CYP2D6 and CYP2C9. The formation of five oxidative metabolites (Met2, Met4, \n","Met6, Met8 and Met11) was catalyzed by the CYP3A4. 4. In summary, mitragynine \n","was extensively metabolized in HLM primarily to O-demethylated and \n","mono-oxidative metabolites. The CYP3A4 enzyme plays a predominant role in the \n","metabolic clearance of mitragynine and also in the formation of \n","7-hydroxymitragynine (Met2), a known active minor alkaloid identified in the \n","leaf material.': [('Mitragynine', 'CHEMICAL'), ('cough', 'DISEASE'), ('diarrhoea', 'DISEASE'), ('pain', 'DISEASE'), ('hypertension', 'DISEASE'), ('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'A structure-activity relationship study of active molecules against \n","chloroquine-resistant Plasmodium falciparum K1 strain is reported. Structurally \n","simplified analogues of antiplasmodial active alkaloids presented similar levels \n","of activity as their corresponding natural products extracted from Guiera \n","senegalensis and Mitragyna inermis with IC50 values on chloroquine-resistant P. \n","falciparum K1 strain of up to 10.6 μM for spirooxindoles and 13.8 μM for \n","β-carbolines. The identification of such simpler and cheaper structural \n","analogues is crucial to efficiently study these natural products' action mode as \n","well as developing new cures against malaria.': [('chloroquine-resistant Plasmodium', 'DISEASE'), ('chloroquine-resistant P.', 'CHEMICAL'), ('β-carbolines', 'CHEMICAL')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa) has been examined for its opioid activity, \n","especially for the treatment of opioid withdrawal and pain. Mitragynine, the \n","most abundant alkaloid in kratom, is thought to be the major psychoactive \n","alkaloid. An HPLC method was developed for the quantification of mitragynine in \n","kratom leaf extracts. In addition, a multiple reaction mode based UPLC-MS/MS \n","method was developed and validated for the quantification of mitragynine in rat \n","plasma. Pharmacokinetic studies were performed by comparing a single intravenous \n","dose of mitragynine (5 mg/kg, mitragynine hydrochloride) to a single oral dose \n","of mitragynine (20 mg/kg, mitragynine hydrochloride), lyophilized kratom tea, \n","and the organic fraction of the lyophilized kratom tea at an equivalent \n","mitragynine dose of 20 mg/kg in rats. After intravenous administration, \n","mitragynine exhibited a biexponential decrease in the concentration-time \n","profile, indicating the fast distribution of mitragynine from the systemic \n","circulation or central compartment to the peripheral compartments. Mitragynine \n","hydrochloride, lyophilized kratom tea, and the lyophilized kratom tea organic \n","fraction were dosed orally and the absolute oral bioavailability of mitragynine \n","in rats was found to be 1.5- and 1.8-fold higher than that of mitragynine dosed \n","alone. The results provide evidence that an equivalent oral dose of the \n","traditional preparation (lyophilized kratom tea) and formulated/manufactured \n","products (organic fraction) of kratom leaves provide better systemic exposure of \n","mitragynine than that of mitragynine dosed alone.': [('pain', 'DISEASE'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine hydrochloride', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine hydrochloride', 'CHEMICAL'), ('kratom tea', 'CHEMICAL'), ('tea', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('hydrochloride', 'CHEMICAL'), ('kratom tea', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('kratom tea', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'OBJECTIVE: To study the constituents of Mitragyna inermis that have an \n","anti-tumor activity on Bel-7402 of hepatic carcinoma.\n","METHOD: The compounds were isolated by column chromatography on silica gel, ODS, \n","Sephadex LH-20 separately and their structures were elucidated by chemical and \n","spectral technology.\n","RESULT: Three quinovic acid glycosides, quinovic acid 3 \n","beta-beta-D-glucopyranosyl-(1-->4)-alpha-L-rhamnopyranosyl-28-O-beta- \n","D-glucopyranoside(I), quinovic acid 3 beta-O-beta-D-quinovopyranoside(II), \n","quinovic acid 3 beta-O-beta-D-glucopyranoside(III), were obtained.\n","CONCLUSION: I, II were isolated from Mitragyna for the first time.': [('hepatic carcinoma', 'DISEASE'), ('silica', 'CHEMICAL'), ('ODS', 'CHEMICAL'), ('quinovic acid glycosides', 'CHEMICAL'), ('quinovic acid', 'CHEMICAL'), ('quinovic acid', 'CHEMICAL'), ('quinovic acid', 'CHEMICAL')]\n","Detected entities in text: 'Neonatal abstinence syndrome (NAS) is increasing in incidence and most commonly \n","associated with maternal opioid use during pregnancy. Nonopioid alternatives to \n","treat opioid dependence are highly sought after in the country's current opioid \n","epidemic. Whether Kratom, a legal, widely available herbal supplement, should be \n","classified as an opioid is contentious. Although the US Food and Drug \n","Administration has recently addressed this controversy, Kratom continues to be \n","marketed as a nonopioid remedy for opioid withdrawal. Its use is increasing in \n","the United States. We describe an infant with NAS born to a mother with daily \n","Kratom tea ingestion to self-treat opioid dependence. Pediatricians and parents \n","should be aware of the risk of NAS due to Kratom use during pregnancy.': [('opioid dependence', 'DISEASE'), ('tea', 'CHEMICAL'), ('opioid dependence', 'DISEASE'), ('NAS', 'CHEMICAL')]\n","Detected entities in text: 'In this article, we describe a middle-aged woman with a history of addiction \n","to opioid medications who eventually became dependent on kratom. Her \n","kratom-related withdrawal symptoms responded to a trial of \n","buprenorphine-naloxone. Subsequently, she was maintained on this medication.': [('buprenorphine-naloxone', 'CHEMICAL')]\n","Detected entities in text: 'The leaves of the Mitragynine speciosia tree (also known as Kratom) have long \n","been chewed, smoked, or brewed into a tea by people in Southeastern Asian \n","countries, such as Malaysia and Thailand. Just this past year, the plant Kratom \n","gained popularity in the United States as a \"legal opioid\" and scheduling it as \n","a drug of abuse is currently pending. The primary alkaloid found in Kratom is a \n","μ-opioid receptor agonist, mitragynine, whose structure contains a promising \n","scaffold for immunopharmacological use. Although Kratom is regarded as a safe \n","opioid alternative, here we report the LD50 values determined for its two main \n","psychoactive alkaloids, mitragynine and 7-hydroxymitragynine, as comparable to \n","heroin in mice when administered intravenously. Given Kratom's recent emergence \n","in the U.S., there is currently no diagnostic test available for law enforcement \n","or health professionals, so we sought to design such an assay. Mitragynine was \n","used as a starting point for hapten design, resulting in a hapten with an ether \n","linker extending from the C9 position of the alkaloid. Bacterial flagellin \n","(FliC) was chosen as a carrier protein for active immunization in mice, yielding \n","32 potential monoclonal antibodies (mAbs) for assay development. Antimitragynine \n","mAbs in the range of micro- to nanomolar affinities were uncovered and their \n","utility in producing a convenient lateral flow detection assay of human fluid \n","samples was examined. Antibodies were screened for binding to mitragynine, \n","7-hydroxymitragynine, and performance in lateral flow assays. Two monoclonal \n","antibodies were subcloned and further purified with 93 and 362 nM affinity to \n","mitragynine. Test strip assays were optimized with a detection cut off of 0.5 \n","μg/mL for mitragynine in buffer and urine (reflecting projected clinically \n","relevant levels of drug in urine), which could be beneficial to law enforcement \n","agencies and health professionals as the opioid epidemic in America continues to \n","evolve.': [('Mitragynine', 'CHEMICAL'), ('tea', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('Antimitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Kratom (Mitragyna speciosa) is an herbal preparation with \n","opioid-like effects made from a tree native to Southeast Asia and the Pacific \n","Islands. Increasingly, kratom is used for self-treatment of opioid use disorder \n","and recently has been associated with a multistate outbreak of salmonellosis. \n","Few data are available on the clinical outcomes of kratom use in pregnancy.\n","CASES: We present two cases of pregnant women presenting with kratom dependence. \n","Both women presented with symptoms consistent with opioid withdrawal. Both women \n","were initiated on opioid replacement, with successful treatment of symptoms.\n","CONCLUSIONS: Kratom is an emerging self-treatment for opioid use disorder in the \n","obstetric population. Obstetric care providers should be aware of kratom and \n","consider opioid replacement for pregnant women with kratom dependence.': [('salmonellosis', 'DISEASE'), ('kratom dependence', 'DISEASE'), ('kratom dependence', 'DISEASE')]\n","Detected entities in text: 'Kratom leaves (Mitragyna speciosa Korth.) are traditionally used in Southeast \n","Asia for their medicinal value. Self-report studies suggest that cessation from \n","chronic kratom tea consumption (freshly brewed kratom tea) was associated with \n","unpleasant psychological symptoms. This study sought to assess the severity of \n","anxiety and depression during kratom cessation. Regular kratom users (N = 150) \n","were recruited from the northern state of Penang (Malaysia) for this \n","retrospective study. The Beck Depression Inventory (BDI) and Beck Anxiety \n","Inventory (BAI) scales were used to assess the severity of the symptoms of \n","anxiety and depression. Most respondents (70%) experienced symptoms of mild \n","anxiety, while 81% experienced symptoms of mild depression during kratom \n","cessation. Those who consumed higher quantities of kratom tea daily (≥4 glasses) \n","had higher odds of reporting longer duration of kratom use history (OR = 4.8, \n","95% CI 2.3 -10.1, p < 0.001), higher frequency of daily kratom use (≥4 times) \n","(OR = 72, CI 9.5- 543.1, p < 0.001), and were more likely to experience moderate \n","symptoms of depression (OR = 2.9, CI 1.1-7.3, p = 0.020) during kratom cessation \n","than those who consumed between one and three glasses of kratom tea per day. \n","Cessation from regular and long-term kratom tea consumption was not associated \n","with symptoms of high anxiety or depression.': [('brewed kratom tea', 'CHEMICAL'), ('anxiety', 'DISEASE'), ('depression', 'DISEASE'), ('Depression', 'DISEASE'), ('Anxiety', 'DISEASE'), ('anxiety', 'DISEASE'), ('depression', 'DISEASE'), ('anxiety', 'DISEASE'), ('depression', 'DISEASE'), ('kratom tea', 'CHEMICAL'), ('depression', 'DISEASE'), ('kratom tea', 'CHEMICAL'), ('kratom tea', 'CHEMICAL'), ('anxiety', 'DISEASE'), ('depression', 'DISEASE')]\n","Detected entities in text: 'BACKGROUND: Mitragyna speciosa, also known as kratom, is obtained from the \n","coffee plant family 'Rubiaceae.' Kratom is available in the form of capsules, \n","whole, processed and powdered leaves, and as liquids. Secondary to its 'natural \n","herb' status and opioid effects, it is misconceived to be a safe alternative for \n","the treatment of chronic pain. The use of kratom has increased by tenfold in the \n","United States since 2010.\n","METHODS AND RESULTS: We report a term neonate who was born to a chronic kratom \n","user and required treatment with opiates for neonatal drug withdrawal.\n","CONCLUSION: Physicians should be aware of these herbal supplements and its \n","potential withdrawal effects in newborn which cannot be picked up by the \n","standard toxicology screen.': [('chronic pain', 'DISEASE')]\n","Detected entities in text: 'Mitragyna speciosa is reported to be beneficial for the management of chronic \n","pain and opioid withdrawal in the evolving opioid epidemic. Data on the \n","blood-brain barrier (BBB) transport of mitragynine and 7-hydroxymitragynine, the \n","active compounds of the plant, are still lacking and inconclusive. Here, we \n","present for the first time the rate and the extent of mitragynine and \n","7-hydroxymitragynine transport across the BBB, with an investigation of their \n","post-BBB intra-brain distribution. We utilized an in vitro BBB model to study \n","the rate of BBB permeation of the compounds and their interaction with efflux \n","transporter P-glycoprotein (P-gp). Mitragynine showed higher \n","apical-to-basolateral (A-B, i.e. blood-to-brain side) permeability than \n","7-hydroxymitragynine. 7-Hydroxymitragynine showed a tendency to efflux, with \n","efflux ratio (B-A/A-B) of 1.39. Both were found to inhibit the P-gp and are also \n","subject to efflux by the P-gp. Assessment of the extent of BBB transport in vivo \n","in rats from unbound brain to plasma concentration ratios (Kp,uu,brain ) \n","revealed extensive efflux of both compounds, with less than 10 percent of \n","unbound mitragynine and 7-hydroxymitragynine in plasma crossing the BBB. By \n","contrast, the extent of intra-brain distribution was significantly different, \n","with mitragynine having 18-fold higher brain tissue uptake in brain slice assay \n","compared with 7-hydroxymitragynine. Mitragynine showed a moderate capacity to \n","accumulate inside brain parenchymal cells, while 7-hydroxymitragynine showed \n","restricted cellular barrier transport. The presented findings from this \n","systematic investigation of brain pharmacokinetics of mitragynine and \n","7-hydroxymitragynine are essential for design and interpretation of in vivo \n","experiments aiming to establish exposure-response relationship.': [('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7-Hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom is a botanical substance derived from the Mitragyna speciosa plant, which \n","grows naturally in Southeast Asia. Its active compounds include alkaloids with \n","psychoactive and opioid properties. Low doses act as a stimulant, while higher \n","doses cause analgesia and euphoria. As a drug of abuse, there are reports of \n","seizure, acute psychosis, and death. Both the US Food and Drug Administration \n","and the Drug Enforcement Agency warn against the use of kratom. Here is the \n","first reported case of an anesthetic in a patient using kratom for chronic pain.': [('seizure', 'DISEASE'), ('acute psychosis', 'DISEASE'), ('death', 'DISEASE'), ('pain', 'DISEASE')]\n","Detected entities in text: 'Kratom, derived from the plant Mitragyna speciosa, is receiving increased \n","attention as an alternative to traditional opiates and as a replacement therapy \n","for opiate dependence. Mitragynine (MG) and 7-hydroxymitragynine (7-HMG) are \n","major psychoactive constituents of kratom. While MG and 7-HMG share behavioral \n","and analgesic properties with morphine, their reinforcing effects have not been \n","examined to date. 7-HMG, but not MG, substituted for morphine \n","self-administration in a dose-dependent manner in the rat self-administration \n","paradigm. Following the substitution procedure, re-assessment of morphine \n","self-administration revealed a significant increase following 7-HMG and a \n","significant decrease following MG substitution. In a separate cohort, 7-HMG, but \n","not MG, engendered and maintained intravenous self-administration in a \n","dose-dependent manner. The effects of pretreatment with nalxonaxine (NLXZ), a μ1 \n","opiate receptor antagonist, and naltrindole (NTI), a δ opiate receptor \n","antagonist, on 7-HMG and morphine self-administration were also examined. Both \n","NLXZ and NTI reduced 7-HMG self-administration, whereas only NLXZ decreased \n","morphine intake. The present results are the first to demonstrate that 7-HMG is \n","readily self-administered, and the reinforcing effects of 7-HMG are mediated in \n","part by μ and δ opiate receptors. In addition, prior exposure to 7-HMG increased \n","subsequent morphine intake whereas prior exposure to MG decreased morphine \n","intake. The present findings indicate that MG does not have abuse potential and \n","reduces morphine intake, desired characteristics of candidate pharmacotherapies \n","for opiate addiction and withdrawal, whereas 7-HMG should be considered a kratom \n","constituent with high abuse potential that may also increase the intake of other \n","opiates.': [('Mitragynine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('naltrindole', 'CHEMICAL'), ('NTI', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('NTI', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('opiate addiction', 'DISEASE')]\n","Detected entities in text: 'Mitragynine, an indole alkaloid from Thai folk medicine Mitragyna speciosa, \n","exerts agonistic effects on opioid receptors. Gastric acid secretion is proposed \n","to be regulated by opioid receptors in the central nervous system (CNS). \n","Previously, we reported the dual roles (inhibition via micro-opioid receptors \n","and stimulation via kappa-opioid receptors) of the opioid system in the central \n","control of gastric acid secretion. We investigated whether mitragynine affects \n","gastric acid secretion via opioid receptors in the CNS. Injection of mitragynine \n","(30 microg) alone into the lateral cerebroventricle did not have a significant \n","effect on basal gastric acid secretion in the perfused stomach of anesthetized \n","rats. Injection of mitragynine (3-30 microg) into the fourth cerebroventricle, \n","like morphine, inhibited 2-deoxy-D-glucose-stimulated gastric acid secretion. \n","The inhibitory effect of mitragynine (30 microg) was reversed by naloxone (100 \n","microg). These results suggest that mitragynine has a morphine-like action on \n","gastric acid secretion in the CNS.': [('Mitragynine', 'CHEMICAL'), ('indole', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('naloxone', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'INTRODUCTION: Use of the unregulated herbal supplement kratom is on the rise in \n","the United States. We present a case series of 2 patients who developed kratom \n","dependence and withdrawal who were successfully transitioned to \n","buprenorphine-naloxone maintenance.\n","CASE SUMMARY: Two patients using kratom to self-treat chronic pain after \n","prescription opioids were discontinued presenting to our clinic with evidence of \n","kratom dependence and withdrawal. On examination, both patients showed signs of \n","mild opioid withdrawal. Both patients were successfully transitioned to \n","buprenorphine-naloxone maintenance via home initiation with control of both \n","their opioid withdrawal and chronic pain.\n","CONCLUSIONS: Kratom use is on the rise and with increasing evidence of \n","developing opioid-type dependence due to chronic kratom use. This case series \n","shows that buprenorphine can be used to treat kratom dependence and underlying \n","chronic pain that drives it use.': [('buprenorphine-naloxone', 'CHEMICAL'), ('pain', 'DISEASE'), ('buprenorphine-naloxone', 'CHEMICAL'), ('pain', 'DISEASE'), ('buprenorphine', 'CHEMICAL'), ('chronic pain', 'DISEASE')]\n","Detected entities in text: 'Mitragynine (1) is a major alkaloidal component in the Thai traditional \n","medicinal herb, Mitragyna speciosa, and has been proven to exhibit analgesic \n","activity mediated by opioid receptors. By utilizing this natural product as a \n","lead compound, synthesis of some derivatives, evaluations of the \n","structure-activity relationship, and surveys of the intrinsic activities and \n","potencies on opioid receptors were performed with guinea pig ileum. The \n","affinities of some compounds for mu-, delta-, and kappa-receptors were \n","determined in a receptor binding assay. The essential structural moieties in the \n","Corynanthe type indole alkaloids for inducing the opioid agonistic activity were \n","also clarified. The oxidative derivatives of mitragynine, i.e., mitragynine \n","pseudoindoxyl (2) and 7-hydroxymitragynine (12), were found as opioid agonists \n","with higher potency than morphine in the experiment with guinea pig ileum. In \n","addition, 2 induced an analgesic activity in the tail flick test in mice.': [('Mitragynine', 'CHEMICAL'), ('indole alkaloids', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('pseudoindoxyl', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa is a psychoactive plant known as \"ketum\" in Malaysia and \n","\"kratom\" in Thailand. This plant is distinctly known to produce two important \n","alkaloids, namely mitragynine (MG) and 7-hydroxymitragynine (7-OH-MG) that can \n","bind to opioid receptors [1]. MG was reported to exhibit antidepressant \n","properties in animal studies [2]. These compounds were also proposed to have the \n","potential to replace opioid analgesics with much lower risks of side effects \n","[3]. To date, there are only over 40 metabolites identified in M. speciosa \n","[4,5]. To obtain a more complete profile of secondary metabolites in ketum, we \n","performed metabolomics study using mature leaves of the green M. speciosa \n","variety. The leaf samples were extracted using methanol prior to liquid \n","chromatography-electrospray ionization-time of flight-mass spectrometry \n","(LC-ESI-TOF-MS) analysis. This data can be useful to for the identification of \n","unknown metabolites that are associated with alkaloid biosynthesis pathway in M. \n","speciosa.': [('mitragynine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('antidepressant', 'CHEMICAL'), ('methanol', 'CHEMICAL')]\n","Detected entities in text: 'Chronic neuropathic pain is a common significant and debilitating problem that \n","presents a major challenge to health-care. Despite the large number of available \n","drugs, there are no curative conventional treatments for neuropathic pain. \n","Nowadays, more attention has been focused on the herbal formulation in the field \n","of drug discovery. Therefore, we performed an extensive review about herbal \n","drugs and plants that exhibited protective effects on neuropathic pain. In this \n","review, the beneficial effects of each plant in different neuropathic pain \n","model, either in animals or in patients are reported. Moreover, the possible \n","involved mechanisms for the protective effects are discussed. The more common \n","plants which are used for the treatment of neuropathic pain are included as: \n","Acorus calamus, Artemisia dracunculus, Butea monosperma, Citrullus colocynthis, \n","Curcuma longa, Crocus sativus, Elaeagnus angustifolia, Ginkgo biloba, Mitragyna \n","speciosa, Momordica charantia, Nigella sativa, Ocimum sanctum, Phyllanthus \n","amarus, Pterodon pubescens Benth, Rubia cordifolia and Salvia officinalis. \n","Furthermore, the most pathways which are known to be involved in pain relief by \n","means of herbal remedies are anti-oxidant activity, anti-inflammatory, \n","anti-apoptotic, neuroprotective and calcium inhibitory actions. In conclusion, \n","this review suggests that some herbal plants can be suitable candidates for the \n","treatment of neuropathic pain.': [('neuropathic pain', 'DISEASE'), ('neuropathic pain', 'DISEASE'), ('neuropathic pain', 'DISEASE'), ('neuropathic pain', 'DISEASE'), ('neuropathic pain', 'DISEASE'), ('Curcuma longa', 'CHEMICAL'), ('biloba', 'CHEMICAL'), ('pain', 'DISEASE'), ('calcium', 'CHEMICAL'), ('neuropathic pain', 'DISEASE')]\n","Detected entities in text: 'ETHNOPHARMACOLOGICAL RELEVANCE: Mitragyna speciosa (Korth.) also known as \n","kratom, is a native medicinal plant of Southeast Asia with opioid-like effects. \n","Kratom tea/juice have been traditionally used as a folk remedy and for \n","controlling opiate withdrawal in Malaysia. Long-term opioid use is associated \n","with depletion in testosterone levels.\n","AIM OF THE STUDY: Since kratom is reported to deform sperm morphology and reduce \n","sperm motility, we aimed to clinically investigate the testosterone levels \n","following long-term kratom tea/juice use in regular kratom users.\n","METHODS: A total of 19 regular kratom users were recruited for this \n","cross-sectional study. A full-blood test was conducted including determination \n","of testosterone level, follicle stimulating hormone (FSH) and luteinizing \n","hormone (LH) profile, as well as hematological and biochemical parameters of \n","participants.\n","RESULTS: We found long-term kratom tea/juice consumption with a daily \n","mitragynine dose of 76.23-94.15 mg did not impair testosterone levels, or \n","gonadotrophins, hematological and biochemical parameters in regular kratom \n","users.\n","CONCLUSION: Regular kratom tea/juice consumption over prolonged periods (>2 \n","years) was not associated with testosterone impairing effects in humans.': [('testosterone', 'CHEMICAL'), ('testosterone', 'CHEMICAL'), ('testosterone', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('testosterone', 'CHEMICAL'), ('gonadotrophins', 'CHEMICAL'), ('testosterone', 'CHEMICAL')]\n","Detected entities in text: 'Background. Kratom is a drug derived from the leaves of the tree Mitragyna \n","speciose, which is native to southern Thailand. The route of administration is \n","oral. Kratom has become increasingly available in the United States. The active \n","ingredients in the drug bind the opioid mu-receptor; therefore, kratom has \n","similar physiological effects as mu-opioids. Elevated prolactin is a common \n","medical condition frequently caused by a variety drugs, including opioids. Case \n","Report. A 42-year-old man presented with poor energy and low libido. He had \n","mildly elevated serum prolactin with hypogonadotropic hypogonadism as evidenced \n","by low serum testosterone with luteinizing hormone and follicle-stimulating \n","hormone in the normal range. At his initial visit, he reported no use of any \n","recreational or therapeutic drug. Two months later when seen in follow-up, both \n","the testosterone and prolactin levels had returned to normal. At that visit he \n","reported frequent use of kratom, which he had discontinued a few days after the \n","first visit. Discussion. Kratom is now widely available in health food stores \n","and online and is considered an emerging drug of abuse. At present kratom is \n","legal in the United States, but recently the Drug Enforcement Administration \n","served noticed of its intention of making kratom a Schedule I drug. A number of \n","adverse events or side effects have been reported, but this is the first report \n","of hyperprolactinemia as the result of ingestion of kratom.': [('hypogonadotropic hypogonadism', 'DISEASE'), ('testosterone', 'CHEMICAL'), ('testosterone', 'CHEMICAL'), ('hyperprolactinemia', 'DISEASE')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa Korth.) is traditionally used in Southeast Asia for \n","its medicinal value and psychoactive properties. Nonetheless, cessation from \n","regular kratom use is reported to cause unpleasant dose-dependent withdrawal \n","symptoms. This study aims to evaluate the severity of pain and sleep problems \n","following the cessation of kratom tea/juice consumption among regular kratom \n","users. A total of 170 regular users were recruited through snowball sampling for \n","this cross-sectional study. The Brief Pain Inventory (BPI) and Pittsburgh Sleep \n","Quality Index (PSQI) scales were administered to assess the severity of pain and \n","sleep problems. Most participants experienced moderate pain intensity (84%) and \n","moderate pain interference (70%) during kratom cessation; 46% experienced more \n","sleep problems during kratom cessation. Individuals who consumed ≥4 glasses of \n","kratom tea/juice (about 76-115 mg of mitragynine) daily had higher odds of \n","reporting some pain interference (OR: 2.0; CI: 1.04-3.93: p < .028), and sleep \n","problems during kratom cessation (OR: 2.0; CI: 1.08-3.68: p < .020), as compared \n","to those who consumed 1-3 glasses of kratom tea/juice daily. However, the \n","effects were still relatively mild. Cessation from regular kratom tea/juice \n","consumption is not associated with prolonged pain and sleep problems, as \n","compared to those reported for opioid analgesics.': [('pain', 'DISEASE'), ('Pain', 'DISEASE'), ('pain', 'DISEASE'), ('pain', 'DISEASE'), ('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('pain', 'DISEASE'), ('pain', 'DISEASE')]\n","Detected entities in text: 'Kratom is an herbal product derived from the leaves of Southeast Asian Mitragyna \n","speciosa trees. It has traditionally been used by indigenous people to relieve \n","fatigue and manage pain, diarrhea, or opioid withdrawal. The use of kratom has \n","become more commonplace in the United States for similar purposes. Only rare \n","reports of kratom liver toxicity exist in the literature but without histologic \n","characterization. Herein, we report one case of kratom use-associated liver \n","toxicity in a 38-year-old patient. The patient complained of dark colored urine \n","and light colored stools after using kratom. He had unremarkable physical \n","examination. Laboratory testing at presentation revealed elevated alanine \n","aminotransferase (389 U/L), aspartate aminotransferase (220 U/L), total \n","bilirubin (5.1 mg/dL), and alkaline phosphatase (304 U/L). There was no serology \n","evidence of viral hepatitis A, B, and C. The acetaminophen level at presentation \n","was below detectable limits. Ultrasound examination of the right upper quadrant \n","revealed normal echogenicity and contour of the liver without bile ductal \n","dilatation or disease of the gallbladder. The patient underwent liver biopsy 4 \n","days after the initial presentation which revealed a pattern of acute \n","cholestatic liver injury including zone 3 hepatocellular and canalicular \n","cholestasis, focal hepatocyte dropout, mild portal inflammation, and bile duct \n","injury. Kratom was stopped, the patient improved clinically and biochemically \n","and was discharged 8 days after the initial presentation. To our best knowledge, \n","this is the first case report detailing the histology of kratom use-associated \n","liver injury.': [('fatigue', 'DISEASE'), ('pain', 'DISEASE'), ('diarrhea', 'DISEASE'), ('liver toxicity', 'DISEASE'), ('toxicity', 'DISEASE'), ('alanine', 'CHEMICAL'), ('aspartate', 'CHEMICAL'), ('bilirubin', 'CHEMICAL'), ('viral hepatitis A', 'DISEASE'), ('acetaminophen', 'CHEMICAL'), ('cholestatic liver injury', 'DISEASE'), ('cholestasis', 'DISEASE'), ('liver injury', 'DISEASE')]\n","Detected entities in text: 'We present the case of a 26-year-old man who was brought into our emergency \n","department in cardiorespiratory arrest, having taken Kratom 24 h previously. \n","Despite multi-organ support, he deteriorated and died from cardiorespiratory \n","failure and hypoxic brain damage 12 h later. Lipid emulsion was given, with \n","significant temporary improvement in the cardiorespiratory failure. Kratom is \n","derived from Mitragyna speciosa, a tropical deciduous and evergreen tree in the \n","coffee family, and is native to Southeast Asia, and its leaves are used as a \n","legal high in some parts of the world. Here, we review the pharmacochemistry of \n","the drug, and wish to highlight that the effects of Kratom may not be as benign \n","as are commonly reported, and the possible role of intralipid in managing the \n","Kratom toxicity in this case.': [('cardiorespiratory arrest', 'DISEASE'), ('multi-organ', 'DISEASE'), ('cardiorespiratory failure', 'DISEASE'), ('toxicity', 'DISEASE')]\n","Detected entities in text: 'RATIONALE: Consideration by the US Drug Enforcement Administration and Food and \n","Drug Administration of placing kratom into Schedule I of the Controlled \n","Substances Act (CSA) requires its evaluation of abuse potential in the context \n","of public health.\n","OBJECTIVE: The objective of the study is to provide a review of kratom abuse \n","potential and its evaluation according to the 8 factors of the CSA.\n","RESULTS: Kratom leaves and extracts have been used for centuries in Southeast \n","Asia and elsewhere to manage pain and other disorders and, by mid-twentieth \n","century, to manage opioid withdrawal. Kratom has some opioid effects but low \n","respiratory depression and abuse potential compared to opioids of abuse. This \n","appears due to its non-opioid-derived and resembling molecular structure \n","recently referred to as biased agonists. By the early 2000s, kratom was \n","increasingly used in the US as a natural remedy to improve mood and quality of \n","life and as substitutes for prescription and illicit opioids for managing pain \n","and opioid withdrawal by people seeking abstinence from opioids. There has been \n","no documented threat to public health that would appear to warrant emergency \n","scheduling of the products and placement in Schedule I of the CSA carries risks \n","of creating serious public health problems.\n","CONCLUSIONS: Although kratom appears to have pharmacological properties that \n","support some level of scheduling, if it was an approved drug, placing it into \n","Schedule I, thus banning it, risks creating public health problems that do not \n","presently exist. Furthermore, appropriate regulation by FDA is vital to ensure \n","appropriate and safe use.': [('kratom abuse', 'DISEASE'), ('pain', 'DISEASE'), ('respiratory depression', 'DISEASE'), ('pain', 'DISEASE'), ('CSA', 'CHEMICAL')]\n","Detected entities in text: 'PURPOSE: This article reviews the pharmacology, clinical utility, adverse \n","effects, and abuse potential of kratom.\n","SUMMARY: The leaves of Mitragyna speciosa contain the biologically active \n","alkaloids of kratom. Kratom exerts opioid and α-2 receptor agonistic effects as \n","well as antiinflammatory and parasympathetic-impeding effects. There are no \n","published human pharmacologic, pharmacokinetic, or drug interaction studies on \n","kratom or mitragynine, making it virtually impossible to fully understand \n","kratom's therapeutic potential and risks and the populations most likely to \n","benefit or experience harm from its use. Kratom has been used to ameliorate \n","opioid withdrawal symptoms but also induces withdrawal. Human pharmacologic, \n","pharmacokinetic, and clinical data are of low quality, precluding any firm \n","conclusions regarding safety and efficacy. Respiratory depression has not been \n","commonly reported, but kratom does cause a host of adverse effects without clear \n","guidance for how they should be treated. There are numerous assessments where \n","people have been unable to stop using kratom therapy, and withdrawal signs and \n","symptoms are problematic. Kratom does not appear in normal drug screens and, \n","when taken with other substances of abuse, may not be recognized. Thirty-six \n","deaths have been attributed to kratom, and the Food and Drug Administration \n","issued a public health warning about the substance in November 2017.\n","CONCLUSION: Kratom exerts opioid and α-2 receptor agonistic effects as well as \n","antiinflammatory and parasympathetic-impeding effects. Human pharmacologic, \n","pharmacokinetic, and clinical data are of low quality, precluding any firm \n","conclusions regarding safety and efficacy.': [('mitragynine', 'CHEMICAL'), ('Respiratory depression', 'DISEASE'), ('deaths', 'DISEASE')]\n","Detected entities in text: 'BACKGROUND: Kratom (Mitragyna speciosa) is a psychoactive plant native to \n","Southeastern Asia that is receiving increased international attention as a \n","potential therapeutic agent. While much of the limited scientific research on \n","kratom is focused on its analgesic potential, kratom use also has important \n","risks and benefits in the domain of mental health.\n","METHODS: We conducted a comprehensive systematic review of all studies on kratom \n","use and mental health published between January 1960 and July 2017.\n","RESULTS: Findings indicate kratom's potential as a harm reduction tool, most \n","notably as a substitute for opioids among people who are addicted. Kratom also \n","enhances mood and relieves anxiety among many users. For many, kratom's negative \n","mental health effects - primarily withdrawal symptoms - appear to be mild \n","relative to those of opioids. For some users, however, withdrawal is highly \n","uncomfortable and maintaining abstinence becomes difficult.\n","CONCLUSION: Results inform clinicians working in the mental health and substance \n","use fields, policy-makers, and researchers about the mental health effects of \n","this plant.': [('anxiety', 'DISEASE')]\n","Detected entities in text: 'ETHNOPHARMACOLOGICAL RELEVANCE: Kratom (Mitragyna speciosa Korth.) from the \n","Rubiaceae family is an indigenous tropical medicinal tree of Southeast Asia. \n","Kratom leaves have been used for decades in Malaysia and Thailand in traditional \n","context for its perceived vast medicinal value, and as a mild stimulant among \n","manual labourers. Kratom consumption has been reported to cause side-effects in \n","kratom users.\n","AIM OF THE STUDY: To evaluate kratom's effects towards hematological and \n","clinical-chemistry parameters among regular kratom users in Malaysia.\n","METHODS: A total of 77 subjects (n=58 regular kratom users, and n=19 healthy \n","controls) participated in this cross-sectional study. All the surveys were \n","conducted through face-to-face interview to elicit subject's socio-demographic \n","characteristics and kratom use history. A full-blood test was also administered. \n","Laboratory analysis was conducted using GC-MS to determine mitragynine content \n","in the acquired kratom samples in order to relate mitragynine consumption with \n","possible alterations in the blood parameters of kratom users.\n","RESULTS: Findings showed that there were no significant differences in the \n","hematological and clinical-chemistry parameters of traditional kratom users and \n","healthy controls, except for HDL and LDL cholesterol values; these were found to \n","be above the normal reference range for the former. Similarly, long-term kratom \n","consumption (>5 years), and quantity of daily kratom use (≥3 ½ glasses; \n","mitragynine content 76.3-114.8mg) did not appear to alter the hematological and \n","biochemical parameters of kratom users.\n","CONCLUSION: These data suggest that even long-term and heavy kratom consumption \n","did not significantly alter the hematological and clinical-chemistry parameters \n","of kratom users in a traditional setting.': [('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('cholesterol', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'AIM AND OBJECTIVE: Mitragynine, a major active alkaloid of Mitragyna speciosa, \n","acts as an agonist on µ-opioid receptors, producing effects similar to morphine \n","and other opioids. It has been traditionally utilized to alleviate opiate \n","withdrawal symptoms. Besides consideration about potency and selectivity, a good \n","drug must possess a suitable pharmacokinetic profile, with suitable absorption, \n","distribution, metabolism, excretion and toxicity (ADME-Tox) profile, in order to \n","have a high chance of success in clinical trials.\n","MATERIAL AND METHOD: The purity of mitragynine in a Mitragyna speciosa alkaloid \n","extract (MSAE) was determined using Ultra-Fast Liquid Chromatography (UFLC). In \n","vitro high throughput ADMETox studies such as aqueous solubility, plasma protein \n","binding, metabolic stability, permeability and cytotoxicity tests were carried \n","out to analyze the physicochemical properties of MSAE and mitragynine. The UFLC \n","quantification revealed that the purity of mitragynine in the MSAE was 40.9%.\n","RESULTS: MSAE and mitragynine are highly soluble in aqueous solution at pH 4.0 \n","but less soluble at pH 7.4. A parallel artificial membrane permeability assay \n","demonstrated that it is extensively absorbed through the semi-permeable membrane \n","at pH 7.4 but very poorly at pH 4.0. Both are relatively highly bound to plasma \n","proteins (> 85 % bound) and are metabolically stable to liver microsomes (> 84 % \n","remained unchanged). In comparison to MSAE, mitragynine showed higher \n","cytotoxicity against WRL 68, HepG2 and Clone 9 hepatocytes after 72 h treatment.\n","CONCLUSION: The obtained ADME and cytotoxicity data demonstrated that both MSAE \n","and mitragynine have poor bioavailability and have the potential to be \n","significantly cytotoxic.': [('Mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('toxicity', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('extract', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('WRL', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa), a native herb of Southeast Asia, is widely known \n","for its psychoactive properties. Recent increase in the use of kratom as a \n","recreational drug has increased the risk of its interaction with conventional \n","drugs if taken concomitantly. A few reports are available related to the effects \n","of kratom on the activity of cytochrome P450 enzymes (CYPs), but there are no \n","reports of its effects on pregnane X receptor (PXR), a transcription factor that \n","regulates the expression of CYPs and P-glycoprotein (P-gp). This study was \n","carried out to evaluate the effects of a methanolic extract of kratom leaves, an \n","alkaloid rich fraction and its 5 indole and 4 oxindole alkaloids on PXR \n","activation and the resulting changes in the mRNA expression of PXR target genes \n","(CYP3A4, CYP1A2, and P-gp). A significant activation of PXR was observed by the \n","extract (3-fold), alkaloidal fraction (4-fold) and all 9 alkaloids (4- to \n","6-fold) that was associated with an increased mRNA expression which resulted \n","into an increase in the activity of CYP3A4, CYP1A2, and P-gp. These results \n","indicate that high consumption of Mitragyna speciosa extract along with the \n","conventional drugs may lead to potential herb-drug interactions due to its \n","effects on PXR.': [('extract of kratom leaves', 'CHEMICAL'), ('indole', 'CHEMICAL'), ('4 oxindole alkaloids', 'CHEMICAL'), ('extract', 'CHEMICAL'), ('Mitragyna speciosa extract', 'CHEMICAL')]\n","Detected entities in text: 'Persistent inhalation of mitragynine (MG), a major alkaloid in the leaves of \n","Mitragyna speciosa, causes various systemic adverse effects such as seizure, \n","diarrhea and arthralgias, but its toxicity to endothelial cells and effects on \n","barrier function of the cells are poorly understood. In this study, we compared \n","toxicities of MG and mitraphylline, another constituent of the leaves, against \n","human aortic endothelial (HAE), bronchial BEAS-2B, neuronal SK-N-SH, hepatic \n","HepG2, kidney HEK293, gastric MKN45, colon DLD1, lung A549, breast MCF7 and \n","prostate LNCaP cells, and found that MG, but not mitraphylline, shows higher \n","toxicity to HAE cells compared to the other cells. Forty-eight-hours incubation \n","of HAE cells with a high concentration of MG (60 µM) provoked apoptotic cell \n","death, which was probably due to signaling through enhanced reactive oxygen \n","species (ROS) generation and resultant caspase activation. Treatment of the \n","cells with MG at sublethal concentrations less than 20 µM significantly lowered \n","transendothelial electrical resistance and elevated paracellular permeability, \n","without affecting the cell viability. In addition, the MG-elicited lowering of \n","the resistance was abolished by a ROS inhibitor N-acetyl-L-cysteine and \n","augmented by H2O2 and 9,10-phenanthrenequinone, which generates ROS through its \n","redox cycle. These results suggest the contribution of ROS generation to the \n","increase in endothelial barrier permeability.': [('mitragynine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('seizure', 'DISEASE'), ('diarrhea', 'DISEASE'), ('arthralgias', 'DISEASE'), ('toxicity', 'DISEASE'), ('toxicities', 'DISEASE'), ('MG', 'CHEMICAL'), ('HAE', 'DISEASE'), ('SK-N-SH', 'CHEMICAL'), ('colon DLD1', 'DISEASE'), ('breast MCF7', 'DISEASE'), ('toxicity', 'DISEASE'), ('HAE', 'DISEASE'), ('HAE', 'DISEASE'), ('MG', 'CHEMICAL'), ('death', 'DISEASE'), ('oxygen', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('sublethal', 'CHEMICAL'), ('N-acetyl-L-cysteine', 'CHEMICAL'), ('H2O2', 'CHEMICAL'), ('9,10-phenanthrenequinone', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa is a tropical plant with narcotic effects. The \n","antinociceptive effects of its crude extracts, bioactive compounds and \n","structurally modified derivatives have been examined in rodent models. This \n","review aims to summarize the evidence on the antinociceptive effects of M. \n","speciosa and its derivatives and explore whether they can offer an alternative \n","to morphine in pain management. Methanolic and alkaloid extracts of M. speciosa \n","were shown to attenuate the nociceptive response in rodents. Mitragynine and \n","7-hydroxymitragynine offered better antinociceptive effects than crude extracts. \n","Structurally modified derivatives of 7-hydroxymitragynine, such as MGM-9, MGM- \n","15, MGM-16, demonstrated superior antinociceptive effects compared to morphine. \n","M. speciosa and its derivatives mainly act on the opioid receptor, but receptor \n","subtypes specificity differs between each compound. The tolerance and adverse \n","side effects of M. speciosa and its derivatives are similar with morphine. The \n","affinity of MGM-9 on kappa-opioid receptor could potentially limit the effects \n","of drug dependence. In conclusion, M speciosa derivatives can offer alternatives \n","to morphine in controlling chronic pain. Structural modification of mitragynine \n","and 7-hydroxymitragynine can generate compounds with higher potency and lesser \n","side-effects. Human clinical trials are required to validate the use of these \n","compounds in clinical setting.': [('morphine', 'CHEMICAL'), ('pain', 'DISEASE'), ('Mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('drug dependence', 'DISEASE'), ('morphine', 'CHEMICAL'), ('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Kratom use in the West has increased recently, yet the prevalence \n","and motives for use among individuals with a history of substance use disorder \n","(SUD) have not been fully examined. Kratom has been documented as a means of \n","treating chronic pain, mitigating drug dependence, and easing withdrawal \n","symptoms, yet it is unclear if substance users are utilizing kratom as a \n","self-medication. Abuse liability, side effects, and overall appeal of kratom \n","remain uncertain.\n","METHODS: In April 2017, an anonymous survey regarding kratom use and motivations \n","was completed by clients enrolled in a 12-Step-oriented residential program. 500 \n","respondents with a self-reported history of SUD completed the survey.\n","RESULTS: 20.8% of respondents endorsed lifetime kratom use and 10.2% reported \n","past-12-month use. Kratom-users were younger (=32.1 vs. 35.9, p<0.001) and were \n","more versatile substance users. A majority (68.9%) of kratom-users reported \n","having used the drug as a means of reducing or abstaining from non-prescription \n","opioids (NPO) and/or heroin, and 64.1% reported using kratom as a substitute for \n","NPO/heroin. 18.4% of kratom-users reported using the drug due to a disability or \n","chronic pain. One-third of kratom-users stated that kratom was a helpful \n","substance and that they would try it again. However, kratom was not preferred \n","and was indicated as having less appeal than NPO, heroin, amphetamines, and \n","Suboxone.\n","CONCLUSIONS: Among substance users, kratom use may be initiated for a variety of \n","reasons, including as a novel form of harm-reduction or drug substitution, \n","particularly in the context of dependence and withdrawal from other substances.': [('SUD', 'CHEMICAL'), ('chronic pain', 'DISEASE'), ('drug dependence', 'DISEASE'), ('SUD', 'CHEMICAL'), ('chronic pain', 'DISEASE'), ('amphetamines', 'CHEMICAL'), ('Suboxone', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa, also known as kratom, has the potential meet the need for \n","pain medications that lack the addictiveness and overdose risk of classical \n","opioid analgesics, such as morphine. This need is urgent because opioid \n","addiction and overdose deaths have risen throughout diverse segments of U.S. \n","society. Some opioid addicts have found relief in kratom preparations. The use \n","of kratom as an analgesic has been validated by historical accounts and \n","contemporary pharmacological research. Although kratom is a promising source of \n","analgesic candidates, it is a euphoriant with potential for both abuse and \n","addiction. However, kratom appears to be less addictive and to have milder \n","withdrawal symptoms than opioid drugs. Thus, there is a need to balance the \n","potential medical benefits and abuse of M. speciosa.': [('pain', 'DISEASE'), ('overdose', 'DISEASE'), ('morphine', 'CHEMICAL'), ('overdose deaths', 'DISEASE')]\n","Detected entities in text: 'Kratom is a traditional drug from Southeast Asia that has been an emerging new \n","substance in the United States. On August 30, 2016, the DEA announced the \n","intention to emergency schedule kratom into Schedule I. To support this \n","decision, the DEA cited an increase in drug seizures of kratom and an increase \n","in calls to poison control concerning kratom. However, a short time later, on \n","October 12, 2016, the DEA withdrew the intent to schedule kratom after public \n","and congressional backlash. The withdrawal by the DEA was somewhat \n","unprecedented. To better understand both decisions, the current article examines \n","the evidence the DEA cited to support their decision to emergency schedule \n","kratom and the degree and type of media coverage of kratom to determine if a \n","media-driven drug panic occurred.': [('DEA', 'CHEMICAL'), ('DEA', 'CHEMICAL'), ('seizures', 'DISEASE'), ('DEA', 'CHEMICAL'), ('DEA', 'CHEMICAL'), ('DEA', 'CHEMICAL'), ('media-driven drug panic', 'DISEASE')]\n","Detected entities in text: 'The leaves of Mitragyna speciosa (commonly known as kratom), a tree endogenous \n","to parts of Southeast Asia, have been used traditionally for their stimulant, \n","mood-elevating, and analgesic effects and have recently attracted significant \n","attention due to increased use in Western cultures as an alternative medicine. \n","The plant's active alkaloid constituents, mitragynine and 7-hydroxymitragynine, \n","have been shown to modulate opioid receptors, acting as partial agonists at \n","mu-opioid receptors and competitive antagonists at kappa- and delta-opioid \n","receptors. Furthermore, both alkaloids are G protein-biased agonists of the \n","mu-opioid receptor and therefore, may induce less respiratory depression than \n","classical opioid agonists. The Mitragyna alkaloids also appear to exert diverse \n","activities at other brain receptors (including adrenergic, serotonergic, and \n","dopaminergic receptors), which may explain the complex pharmacological profile \n","of raw kratom extracts, although characterization of effects at these other \n","targets remains extremely limited. Through allometric scaling, doses of pure \n","mitragynine and 7-hydroxymitragynine used in animal studies can be related to \n","single doses of raw kratom plant commonly consumed by humans, permitting \n","preliminary interpretation of expected behavioral and physiological effects in \n","man based on this preclinical data and comparison to both anecdotal human \n","experience and multiple epidemiological surveys. Kratom exposure alone has not \n","been causally associated with human fatalities to date. However, further \n","research is needed to clarify the complex mechanism of action of the Mitragyna \n","alkaloids and unlock their full therapeutic potential. This article is part of \n","the Special Issue entitled 'Designer Drugs and Legal Highs.'': [('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('alkaloids', 'CHEMICAL'), ('respiratory depression', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'ETHNOPHARMACOLOGICAL RELEVANCE: Mitragyna speciosa (Korth.) Havil. (M. speciosa) \n","is among the most well-known plants used in ethnic practice of Southeast Asia. \n","It has gained increasing attention as a plant with potential to substitute \n","morphine in addiction treatment program. However, its action on the central \n","nervous system is controversial.\n","AIM OF THE STUDY: This study investigated the effects of M. speciosa alkaloid \n","extract on naloxone-precipitated morphine withdrawal and neural signaling in the \n","nucleus accumbens (NAc, brain reward center) of mice.\n","MATERIALS AND METHODS: The effects of M. speciosa alkaloid extract and \n","mitragynine, a pure major constituent, on naloxone-precipitated morphine \n","withdrawal were examined. Male Swiss Albino (ICR) mice were rendered dependent \n","on morphine before injection with naloxone, a nonspecific opioid antagonist, to \n","induce morphine withdrawal symptoms. The intensity of naloxone-precipitated \n","morphine withdrawal was assessed from jumping behavior and diarrhea induced \n","during a period of morphine withdrawal. To test possible addictive effect of M. \n","speciosa alkaloid extract, mice were implanted with intracranial electrode into \n","the NAc for local field potential (LFP) recording. Following M. speciosa \n","alkaloid extract (80mg/kg) and morphine (15mg/kg) treatment, LFP power spectra \n","and spontaneous motor activity were analyzed in comparison to control levels.\n","RESULTS: One-way ANOVA and multiple comparisons revealed that M. speciosa \n","alkaloid extract (80 and 100mg/kg) significantly decreased the number of jumping \n","behavior induced by morphine withdrawal whereas mitragynine did not. \n","Additionally, M. speciosa alkaloid extract significantly decreased dry and wet \n","fecal excretions induced by morphine withdrawal. LFP analysis revealed that \n","morphine significantly decreased alpha (9.7-12Hz) and increased low gamma \n","(30.3-44.9Hz) and high gamma (60.5-95.7Hz) powers in the NAc whereas M. speciosa \n","alkaloid extract did not. Spontaneous motor activity was significantly increased \n","by morphine but not M. speciosa alkaloid extract.\n","CONCLUSIONS: Taken together, M. speciosa alkaloid extract, but not mitragynine, \n","attenuated the severity of naloxone-precipitated morphine withdrawal symptoms. \n","Neural signaling in the NAc and spontaneous motor activity were sensitive to \n","morphine but not M. speciosa alkaloid extract. Therefore, treatment with the M. \n","speciosa alkaloid extract may be useful for opiate addiction treatment program.': [('morphine', 'CHEMICAL'), ('extract', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('naloxone', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('diarrhea', 'DISEASE'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('15mg/kg', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('speciosa alkaloid extract', 'CHEMICAL'), ('excretions', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('speciosa alkaloid extract', 'CHEMICAL'), ('speciosa alkaloid extract', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('speciosa alkaloid extract', 'CHEMICAL'), ('opiate addiction', 'DISEASE')]\n","Detected entities in text: 'Mitragynine is the main psychoactive ingredient of the herbal drug preparation \n","Kratom (Ketum), derived from the plant Mitragyna speciosa. Kratom is a widely \n","abused drug in Southeast Asian and has a psychostimulant profile at low-medium \n","doses, while high doses have opioidergic effects. Mitragynine was shown to \n","possess opiate receptor affinity. However, its role in the behavioural effects \n","of mitragynine is unclear. Here we asked whether the reinforcing effects of \n","mitragynine are mediated by opiate receptors using a conditioned place \n","preference (CPP) paradigm in rats. In the first experiment we tested the effects \n","of the opiate receptor antagonist naloxone (0.1, 0.3 and 1.0mg/kg) on the \n","acquisition of mitragynine (10mg/kg)-induced CPP. In the second experiment, we \n","tested the involvement of opiate receptors in the expression of \n","mitragynine-induced CPP in rats. We found that naloxone suppresses the \n","acquisition of mitragynine-induced CPP. This effect was already evident at a \n","dose of naloxone (0.1mg/kg) which, by itself, had no conditioned place aversion \n","(CPA) effect. Higher doses of naloxone induced a CPA and blocked \n","mitragynine-induced CPP. In contrast, naloxone had no effect on the expression \n","of mitragynine-induced CPP. These findings suggest that the acquisition, but not \n","the expression of the reinforcing effects of mitragynine is mediated by opiate \n","receptors.': [('Mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('naloxone', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('naloxone', 'CHEMICAL'), ('naloxone', 'CHEMICAL'), ('CPA', 'CHEMICAL'), ('naloxone', 'CHEMICAL'), ('CPA', 'CHEMICAL'), ('naloxone', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'A microdialysis system coupled with a sensitive ultra-fast liquid \n","chromatography-mass spectrometry (UFLC-MS) method was developed for the \n","pharmacokinetic analysis of mitragynine in rat blood and striatum. Mitragynine \n","is an active alkaloid of Mitragyna speciosa and has been proposed to be used for \n","opioid withdrawal therapy. In this study, chromatographic separation was \n","performed in a gradient elution mode with 0.1% formic acid and acetonitrile on a \n","Zorbax Eclipse C18 column. The mass spectrometric (MS) analysis was carried out \n","in a positive electrospray mode and mitragynine ion (m/z 399.2) was monitored in \n","extracted ion chromatography. A good linearity range was obtained from \n","10-1000ng/mL with acceptable accuracy and precision parameters. The \n","microdialysate was collected simultaneously from the striatum and the right \n","jugular vein using microdialysis probes. After a single intravenous \n","administration of 10mg/kg mitragynine, mitragynine showed a two-compartmental \n","drug elimination pattern with half-life (T1/2) of approximately 13h. The percent \n","of AUCbrain/AUCplasma of mitragynine was calculated and shown to be 65.8±4.5%. \n","The results indicated that mitragynine could be a suitable molecule to develop \n","into an opioid replacement drug based on its ideal pharmacokinetic properties, \n","namely, small molecular size, lipophilic in nature and with excellent \n","blood-brain barrier (BBB) permeability.': [('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('formic acid', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('1000ng/mL', 'CHEMICAL'), ('10mg/kg mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('AUCbrain/AUCplasma', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'OBJECTIVE: Kratom (Mitragyna speciosa. Korth) is an indigenous medicinal plant \n","of Southeast Asia. This review paper aims to describe the trends of kratom use \n","in Southeast Asia.\n","DESIGN: A literature review search was conducted through ScienceDirect, Scopus, \n","ProMed and Google Scholar. Twenty-five articles illustrating kratom use in \n","humans in Southeast Asia were reviewed.\n","RESULTS: Kratom has long been used by rural populations in Southeast Asia as a \n","remedy for common ailments, to fight fatigue from hard manual work, as a drink \n","during social interaction among men, and in village religious functions. Studies \n","based on self-reports suggest that prolonged kratom use does not result in \n","serious health risks or impair social functioning. Two recent trends have also \n","emerged: (a) Kratom is reportedly being used to ease withdrawal from opioid \n","dependence in rural settings; whereas (b) in urban areas, adulterated kratom \n","cocktails are being consumed by younger people to induce euphoria.\n","CONCLUSIONS: Legal sanctions appear to have preceded serious scientific \n","investigations into the claimed benefits of ketum. More objective-controlled \n","trials and experiments on humans need to be conducted to validate self-report \n","claims by kratom users in the community.': [('fatigue', 'DISEASE')]\n","Detected entities in text: 'BACKGROUND: Kratom preparations have raised concerns of public health and safety \n","in the US. Investigation into the demographics, perceived beneficial and \n","detrimental effects of Kratom as well as common doses and purposes of its use \n","are important to properly evaluate its potential health impact.\n","METHODS: An anonymous cross-sectional online survey was conducted in October \n","2016 of 10,000 current Kratom users through available social media and online \n","resources from the American Kratom Association. A total of 8049 respondents \n","completed the survey.\n","RESULTS: Kratom is primarily used by a middle-aged (31-50 years), middle-income \n","($35,000 and above) population for purposes of self-treating pain (68%) and \n","emotional or mental conditions (66%). Kratom preparations present with a \n","dose-dependent effect with negative effects, which were primarily \n","gastrointestinal related including nausea and constipation, mainly presenting at \n","high (5g or more/dose) and more frequent (22 or more doses/week) dosing.\n","CONCLUSIONS: Kratom shows a dose-dependent opioid-like effect providing \n","self-reported perceived beneficial effects in alleviating pain and relieving \n","mood disorders. Kratom was primarily used for self-treatment of pain, mood \n","disorders, and withdrawal symptoms associated with prescription opioid use.': [('pain', 'DISEASE'), ('nausea', 'DISEASE'), ('constipation', 'DISEASE'), ('pain', 'DISEASE'), ('mood disorders', 'DISEASE'), ('pain', 'DISEASE')]\n","Detected entities in text: 'ETHNOPHARMACOLOGICAL RELEVANCE: Mitragyna speciosa and its extracts are called \n","kratom (dried leaves, extract). They contain several alkaloids with an affinity \n","for different opioid receptors. They are used in traditional medicine for the \n","treatment of different diseases, as a substitute by opiate addicts, and to \n","mitigate opioid withdrawal symptoms. Apart from their medical properties, they \n","are used to enhance physical endurance and as a means of overcoming stress.\n","PURPOSE: The aim of this study was to determine the mechanisms underlying the \n","effects of kratom on restraint-stress-induced analgesia which occurs during or \n","following exposure to a stressful or fearful stimulus.\n","METHODS: To gain further insights into the action of kratom on stress, we \n","conducted experiments using restraint stress as a test system and stress-induced \n","analgesia as a test parameter. Using transgenic mu opioid-receptor (MOR) \n","deficient mice, we studied the involvement of this receptor type. We used \n","nor-binaltorphimine (BNT), an antagonist at kappa opioid receptors (KOR), to \n","study functions of this type of receptor. Membrane potential assay was also \n","employed to measure the intrinsic activity of kratom in comparison to U50,488, a \n","highly selective kappa agonist.\n","RESULTS: Treatment with kratom diminished stress-induced analgesia in wildtype \n","and MOR knockout animals. Pretreatment of MOR deficient mice with BNT resulted \n","in similar effects. In comparison to U50,488, kratom exhibited negligible \n","intrinsic activity at KOR alone.\n","CONCLUSIONS: The results suggest that the use of kratom as a pharmacological \n","tool to mitigate withdrawal symptoms is related to its action on KOR.': [('nor-binaltorphimine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Kratom (Mitragyna speciosa) is a tropical tree with a long history \n","of traditional use in parts of Africa and Southeast Asia. Kratom is also known \n","as Thom, Thang, and Biak. Its leaves and the teas brewed from them have long \n","been used by people in that region to manage pain and opioid withdrawal and to \n","stave off fatigue. Kratom is actually consumed throughout the world for its \n","stimulant effects and as an opioid substitute (in form of tea, chewed, smoked, \n","or ingested in capsules). Some case reports have associated kratom exposure with \n","psychosis, seizures, intrahepatic cholestasis, other medical conditions, and \n","deaths. The clinical manifestations of kratom effects are not well defined and \n","the clinical studies are limited. Data research suggest that both stimulant and \n","sedative dose-dependent effects do exist, in addition to antinociceptive, \n","antidepressant activity, anxiolytic-like effects, and anorectic effects, but a \n","growing concern for the drug's effects and safety of use has resulted in \n","national and international attention primarily due to an increase in hospital \n","visits and deaths in several countries that are believed to have been caused by \n","extracts of the plant. There is a dearth of double blind controlled studies. In \n","this study, we aim to use existing literature to clarify both benefits and risks \n","of kratom as well as its diagnosis evaluation as kratom misuse is an emerging \n","trend in the Western world.\n","METHODS: Literature review using databases such as Embase, Medline, PubMed, \n","Cochrane Library, and Mendeley from 2007 to 2017 were evaluated by all authors \n","to analyze current state on benefits, risks, and diagnosis evaluation of kratom \n","(M. speciosa).\n","RESULTS: Data analysis suggested that kratom possesses some benefits such as \n","stimulant and sedative effects as wells as antinociceptive effects. It seems to \n","inhibit pro-inflammatory mediator release and vascular permeability and can \n","enhance immunity. In addition, it may be an antidepressant and anorectic. \n","However, kratom can cause intrahepatic cholestasis, seizure, arrhythmia, impair \n","memory function, coma, and death. Psychological manifestations described are \n","euphoria and feeling relaxed to severe symptoms such as aggression, hostility, \n","and psychosis. Medical manifestations described are polyuria, dry mouth, \n","vomiting, and jerky movements. Currently, liquid chromatography/mass \n","spectrometry and ion mobility spectrometry (IMS) are suggested as the most \n","promising to rapidly screen kratom products providing a positive success rate.\n","CONCLUSION: Our data analysis has not determined if biochemical benefits of \n","kratom may prove to outweigh its toxicity and risks. On the contrary, it seems \n","that its potential side effects outweigh the benefits, and severe and real \n","health hazards can, insidiously, lead to death. Kratom clinical, psychological, \n","and medical manifestations can be disturbing. Kratom (M. speciosa) use, among \n","multiple compounds of the leaf, appear to be increasing in the Western world. \n","Promising methods to accurately identify kratom compounds are still ongoing.': [('pain', 'DISEASE'), ('fatigue', 'DISEASE'), ('tea', 'CHEMICAL'), ('psychosis', 'DISEASE'), ('seizures', 'DISEASE'), ('intrahepatic cholestasis', 'DISEASE'), ('antidepressant', 'CHEMICAL'), ('deaths', 'DISEASE'), ('antidepressant', 'CHEMICAL'), ('intrahepatic cholestasis', 'DISEASE'), ('seizure', 'DISEASE'), ('arrhythmia', 'DISEASE'), ('coma', 'DISEASE'), ('death', 'DISEASE'), ('aggression', 'DISEASE'), ('hostility', 'DISEASE'), ('psychosis', 'DISEASE'), ('polyuria', 'DISEASE'), ('dry mouth', 'DISEASE'), ('vomiting', 'DISEASE'), ('jerky movements', 'DISEASE'), ('IMS', 'CHEMICAL'), ('toxicity', 'DISEASE'), ('death', 'DISEASE')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa), a naturally existing plant found in South-East \n","Asia, is traditionally used as a herb to help elevate a person's energy and also \n","to treat numerous medical ailments. Other than the analgesic property, kratom \n","has been used as an agent to overcome opioid withdrawal as it contains natural \n","alkaloids, i.e. mitragynine, 7-hydroxymitragynine, and MGM-9, which has agonist \n","affinity on the opioid receptors, including mu (µ) and kappa (κ). The role of \n","neural reward pathways linked to µ-opioid receptors and both dopaminergic and \n","gamma-Aminobutyric acid (GABA)-ergic interneurons that express µ-opioid \n","receptors were deliberated. However, kratom has been reported to be abused \n","together with other illicit substances with high risk of potential addiction. \n","There are also anecdotes of adverse effects and toxicity of kratom, i.e. tremor, \n","fatigue, seizure, and death. Different countries have distinctive regulation and \n","policy on the plantation and use of this plant when most of the countries banned \n","the use of it because of its addiction problems and side effects. The aim of \n","this review is to highlight on the potential use of kratom, unique 'herbs\" as a \n","substitution therapy for chronic pain and opioid addiction, based on the \n","neurobiological perspective of pain and the underlying mechanism of actions of \n","drug addiction.': [('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('gamma-Aminobutyric acid', 'CHEMICAL'), ('toxicity', 'DISEASE'), ('tremor', 'DISEASE'), ('fatigue', 'DISEASE'), ('seizure', 'DISEASE'), ('death', 'DISEASE'), ('chronic pain', 'DISEASE'), ('pain', 'DISEASE')]\n","Detected entities in text: 'Depression is the most common illness observed in the elderly, adults, and \n","children. Antidepressants prescribed are usually synthetic drugs and these can \n","sometimes cause a wide range of unpleasant side effects. Current research is \n","focussed on natural products from plants as they are a rich source of potent new \n","drug leads. Besides Hypericum perforatum (St. John's wort), the plants studied \n","include Passiflora incarnata L. (passion flower), Mitragyna speciosa (kratom), \n","Piper methysticum G. Forst (kava) and Valeriana officinalis L. Harman, harmol, \n","harmine, harmalol and harmaline are indole alkaloids isolated from P. incarnata, \n","while mitragynine is isolated from M. speciosa. The structure of isolated \n","compounds from P. methysticum G. Forst and V. officinalis L. contains an indole \n","moiety. The indole moiety is related to the neurotransmitter serotonin which is \n","widely implicated for brain function and cognition as the endogenous receptor \n","agonist. An imbalance in serotonin levels may influence mood in a way that leads \n","to depression. The moiety is present in a number of antidepressants already on \n","the market. Hence, the objective of this review is to discuss bioactive \n","compounds containing the indole moiety from plants that can serve as potent \n","antidepressants.': [('Depression', 'DISEASE'), ('Antidepressants', 'CHEMICAL'), ('wort', 'CHEMICAL'), ('kava', 'CHEMICAL'), ('harmol', 'CHEMICAL'), ('harmine', 'CHEMICAL'), ('harmalol', 'CHEMICAL'), ('harmaline', 'CHEMICAL'), ('indole alkaloids', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('indole', 'CHEMICAL'), ('indole', 'CHEMICAL'), ('serotonin', 'CHEMICAL'), ('serotonin', 'CHEMICAL'), ('depression', 'DISEASE'), ('antidepressants', 'CHEMICAL'), ('indole', 'CHEMICAL'), ('antidepressants', 'CHEMICAL')]\n","Detected entities in text: 'Two cases of fatalities are reported of which the recreational use of Mitragyna \n","speciosa (\"kratom\") could be confirmed. One of these cases presents with one of \n","the highest postmortem mitragynine concentrations published to date. Our results \n","show that even extremely high mitragynine blood concentrations following the \n","consumption of kratom do not necessarily have to be the direct cause of death in \n","such fatalities as a result of an acute overdose. The two cases are compared \n","with regard to the differences in mitragynine concentrations detected and the \n","role of mitragynine in the death of the subjects. Irrespective of the big \n","differences in mitragynine concentrations in the postmortem blood samples, \n","mitragynine was not the primary cause of death in either of the two cases \n","reported here. Additionally, by rough estimation, a significant difference in \n","ratio of mitragynine to its diastereomers in the blood and urine samples between \n","the two cases could be seen.': [('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('death', 'DISEASE'), ('acute overdose', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('death', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('death', 'DISEASE'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'In this study, we investigated the antipsychotic-like effect of methanolic \n","extract of Mitragyna speciosa leaf (MMS) using in vivo and ex vivo studies. In \n","vivo studies comprised of apomorphine-induced climbing behavior, \n","haloperidol-induced catalepsy, and ketamine-induced social withdrawal tests in \n","mice whereas the ex vivo study was conducted utilizing isolated rat vas deferens \n","preparation. Acute oral administration of MMS (50-500 mg/kg) showed an inverted \n","bell-shaped dose-response in apomorphine-induced cage climbing behavior in mice. \n","The effective inhibitory doses of MMS (75 and 100 mg/kg, p.o.) obtained from the \n","apomorphine study was further tested on haloperidol (subcataleptic dose; 0.1 \n","mg/kg, i.p.)-induced catalepsy in the mouse bar test. MMS (75 and 100 mg/kg, \n","p.o.) significantly potentiated the haloperidol-induced catalepsy in mice. \n","Interestingly, MMS at the same effective doses (75 and 100 mg/kg, p.o.) \n","significantly facilitated the social interaction in ketamine-induced social \n","withdrawal mice. Furthermore, MMS inhibited the dopamine-induced contractile \n","response dose-dependently in the isolated rat vas deferens preparations. In \n","conclusion, this investigation provides first evidence that MMS exhibits \n","antipsychotic-like activity with potential to alleviate positive as well as \n","negative symptoms of psychosis in mice. This study also suggests the \n","antidopaminergic activity of MMS that could be responsible for alleviating \n","positive symptoms of psychosis.': [('MMS', 'CHEMICAL'), ('catalepsy', 'DISEASE'), ('MMS', 'CHEMICAL'), ('MMS', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('apomorphine', 'CHEMICAL'), ('haloperidol', 'CHEMICAL'), ('catalepsy', 'DISEASE'), ('MMS', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('catalepsy', 'DISEASE'), ('MMS', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('MMS', 'CHEMICAL'), ('MMS', 'CHEMICAL'), ('psychosis', 'DISEASE'), ('MMS', 'CHEMICAL'), ('psychosis', 'DISEASE')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa) is a plant indigenous to Southeast Asia. Its leaves \n","and the teas brewed from them have long been used by people in that region to \n","stave off fatigue and to manage pain and opioid withdrawal. In a comprehensive \n","review published in 2012, Prozialeck et al presented evidence that kratom had \n","been increasingly used for the self-management of opioid withdrawal and pain in \n","the United States. At the time, kratom was classified as a legal herbal product \n","by the US Drug Enforcement Administration. Recent studies have confirmed that \n","kratom and its chemical constituents do have useful pharmacologic actions. \n","However, there have also been increasing numbers of reports of adverse effects \n","resulting from use of kratom products. In August 2016, the US Drug Enforcement \n","Administration announced plans to classify kratom and its mitragynine \n","constituents as Schedule 1 controlled substances, a move that triggered a \n","massive response from kratom advocates. The purpose of this report is to \n","highlight the current scientific and legal controversies regarding kratom.': [('fatigue', 'DISEASE'), ('pain', 'DISEASE'), ('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: A new trend among users of new psychoactive substances' the \n","consumption of \"herbal highs\": plant parts containing psychoactive substances. \n","Most of the substances extracted from herbs, in old centuries were at the centre \n","of religious ceremonies of ancient civilizations. Currently, these herbal \n","products are mainly sold by internet web sites and easily obtained since some of \n","them have no legal restriction.\n","OBJECTIVE: We reviewed psychoactive effects and neuropharmacology of the most \n","used \"herbal highs\" with characterized active principles, with studies reporting \n","mechanisms of action, pharmacological and subjective effects, eventual secondary \n","effects including intoxications and/or fatalities Method: The PubMed database \n","was searched using the following key.words: herbal highs, Argyreia nervosa, \n","Ipomoea violacea and Rivea corymbosa; Catha edulis; Datura stramonium; Piper \n","methysticum; Mitragyna speciosa.\n","RESULTS: Psychoactive plants here reviewed have been known and used from ancient \n","times, even if for some of them limited information still exist regarding \n","subjective and neuropharmacological effects and consequent eventual toxicity \n","when plants are used alone or in combination with \"classical\" drugs of abuse.\n","CONCLUSION: Some \"herbal highs\" should be classified as harmful drugs since \n","chronic administration has been linked with addiction and cognitive impairment; \n","for some others taking into consideration only the recent trends of abuse, \n","studies investigating these aspects are lacking.': [('Argyreia nervosa', 'DISEASE'), ('toxicity', 'DISEASE'), ('addiction and cognitive impairment', 'DISEASE')]\n","Detected entities in text: 'INTRODUCTION: Kratom (Mitragyna speciosa), a plant native to Southeast Asia, has \n","been used for centuries for its stimulant and opium-like effects. Mitragynine \n","and 7-hydroxymitragynine, exclusive to M. speciosa, are the alkaloids primary \n","responsible for Kratom's biologic and psychoactive profile, and likely \n","contribute to its problematic use. We purchased several commercially available \n","Kratom analogs for analysis and through our results, present evidence of \n","probable adulteration with the highly potent and addictive plant alkaloid, \n","7-hydroxymitragynine.\n","METHODS: A simple and sensitive LC-MS/MS method was developed for simultaneous \n","quantification of mitragynine and 7-hydroxymitragynine in methanol extract of \n","marketed Kratom supplements.\n","RESULTS: We found multiple commercial Kratom products to have concentrations of \n","7-hydroxymitragynine that are substantially higher than those found in raw M. \n","speciosa leaves.\n","CONCLUSIONS: We have found multiple packaged commercial Kratom products likely \n","to contain artificially elevated concentrations of 7-hydroxymitragynine, the \n","alkaloid responsible for M. speciosa's concerning mechanistic and side effect \n","profile. This study describes a unique form of product adulteration, which \n","stresses the importance of increased dietary supplement oversight of \n","Kratom-containing supplements.': [('Mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('methanol extract', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Natural products found in Mitragyna speciosa, commonly known as kratom, \n","represent diverse scaffolds (indole, indolenine, and spiro pseudoindoxyl) with \n","opioid activity, providing opportunities to better understand opioid \n","pharmacology. Herein, we report the pharmacology and SAR studies both in vitro \n","and in vivo of mitragynine pseudoindoxyl (3), an oxidative rearrangement product \n","of the corynanthe alkaloid mitragynine. 3 and its corresponding corynantheidine \n","analogs show promise as potent analgesics with a mechanism of action that \n","includes mu opioid receptor agonism/delta opioid receptor antagonism. In vitro, \n","3 and its analogs were potent agonists in [(35)S]GTPγS assays at the mu opioid \n","receptor but failed to recruit β-arrestin-2, which is associated with opioid \n","side effects. Additionally, 3 developed analgesic tolerance more slowly than \n","morphine, showed limited physical dependence, respiratory depression, \n","constipation, and displayed no reward or aversion in CPP/CPA assays, suggesting \n","that analogs might represent a promising new generation of novel pain relievers.': [('indole', 'CHEMICAL'), ('indolenine', 'CHEMICAL'), ('pseudoindoxyl', 'CHEMICAL'), ('mitragynine pseudoindoxyl', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('respiratory depression', 'DISEASE'), ('constipation', 'DISEASE'), ('pain', 'DISEASE')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa) is a plant consumed throughout the world for its \n","stimulant effects and as an opioid substitute (1). It is typically brewed into a \n","tea, chewed, smoked, or ingested in capsules (2). It is also known as Thang, \n","Kakuam, Thom, Ketum, and Biak (3). The Drug Enforcement Administration includes \n","kratom on its Drugs of Concern list (substances that are not currently regulated \n","by the Controlled Substances Act, but that pose risks to persons who abuse \n","them), and the National Institute of Drug Abuse has identified kratom as an \n","emerging drug of abuse (3,4). Published case reports have associated kratom \n","exposure with psychosis, seizures, and deaths (5,6). Because deaths have been \n","attributed to kratom in the United States (7), some jurisdictions have passed or \n","are considering legislation to make kratom use a felony (8). CDC characterized \n","kratom exposures that were reported to poison centers and uploaded to the \n","National Poison Data System (NPDS) during January 2010-December 2015. The NPDS \n","is a national database of information logged by the country's regional poison \n","centers serving all 50 United States, the District of Columbia, and Puerto Rico \n","and is maintained by the American Association of Poison Control Centers. NPDS \n","case records are the result of call reports made by the public and health care \n","providers.': [('tea', 'CHEMICAL'), ('psychosis', 'DISEASE'), ('seizures', 'DISEASE'), ('deaths', 'DISEASE'), ('deaths', 'DISEASE')]\n","Detected entities in text: 'Mitragyna speciosa Korth is known for its euphoric properties and is frequently \n","used for recreational purposes. Several poisoning and fatal cases involving \n","mitragynine have been reported but the underlying causes remain unclear. Human \n","ether-a-go-go-related gene (hERG) encodes the cardiac IKr current which is a \n","determinant of the duration of ventricular action potentials and QT interval. On \n","the other hand, IK1, a Kir current mediated by Kir2.1 channel and IKACh, a \n","receptor-activated Kir current mediated by GIRK channel are also known to be \n","important in maintaining the cardiac function. This study investigated the \n","effects of mitragynine on the current, mRNA and protein expression of hERG \n","channel in hERG-transfected HEK293 cells and Xenopus oocytes. The effects on \n","Kir2.1 and GIRK channels currents were also determined in the oocytes. The hERG \n","tail currents following depolarization pulses were inhibited by mitragynine with \n","an IC50 value of 1.62μM and 1.15μM in the transfected cell line and Xenopus \n","oocytes, respectively. The S6 point mutations of Y652A and F656A attenuated the \n","inhibitor effects of mitragynine, indicating that mitragynine interacts with \n","these high affinity drug-binding sites in the hERG channel pore cavity which was \n","consistent with the molecular docking simulation. Interestingly, mitragynine \n","does not affect the hERG expression at the transcriptional level but inhibits \n","the protein expression. Mitragynine is also found to inhibit IKACh current with \n","an IC50 value of 3.32μM but has no significant effects on IK1. Blocking of both \n","hERG and GIRK channels may cause additive cardiotoxicity risks.': [('poisoning', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('1.15μM', 'CHEMICAL'), ('Y652A', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('IKACh', 'CHEMICAL'), ('cardiotoxicity', 'DISEASE')]\n","Detected entities in text: 'Mu-opioid receptor agonists represent mainstays of pain management. However, the \n","therapeutic use of these agents is associated with serious side effects, \n","including potentially lethal respiratory depression. Accordingly, there is a \n","longstanding interest in the development of new opioid analgesics with improved \n","therapeutic profiles. The alkaloids of the Southeast Asian plant Mitragyna \n","speciosa, represented by the prototypical member mitragynine, are an unusual \n","class of opioid receptor modulators with distinct pharmacological properties. \n","Here we describe the first receptor-level functional characterization of \n","mitragynine and related natural alkaloids at the human mu-, kappa-, and \n","delta-opioid receptors. These results show that mitragynine and the oxidized \n","analogue 7-hydroxymitragynine, are partial agonists of the human mu-opioid \n","receptor and competitive antagonists at the kappa- and delta-opioid receptors. \n","We also show that mitragynine and 7-hydroxymitragynine are G-protein-biased \n","agonists of the mu-opioid receptor, which do not recruit β-arrestin following \n","receptor activation. Therefore, the Mitragyna alkaloid scaffold represents a \n","novel framework for the development of functionally biased opioid modulators, \n","which may exhibit improved therapeutic profiles. Also presented is an \n","enantioselective total synthesis of both (-)-mitragynine and its unnatural \n","enantiomer, (+)-mitragynine, employing a proline-catalyzed Mannich-Michael \n","reaction sequence as the key transformation. Pharmacological evaluation of \n","(+)-mitragynine revealed its much weaker opioid activity. Likewise, the \n","intermediates and chemical transformations developed in the total synthesis \n","allowed the elucidation of previously unexplored structure-activity \n","relationships (SAR) within the Mitragyna scaffold. Molecular docking studies, in \n","combination with the observed chemical SAR, suggest that Mitragyna alkaloids \n","adopt a binding pose at the mu-opioid receptor that is distinct from that of \n","classical opioids.': [('pain', 'DISEASE'), ('respiratory depression', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('alkaloids', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('enantiomer', 'CHEMICAL')]\n","Detected entities in text: 'INTRODUCTION: The objective of the paper was to highlight the differences in the \n","traditional and non-traditional users of kratom in the South East Asian and \n","Western contexts.\n","METHOD: A literature survey of published kratom studies among humans was \n","conducted. Forty published studies relevant to the objective were reviewed.\n","RESULTS: Apart from the differences in the sources of supply, patterns of use \n","and social acceptability of kratom within these two regions, the most \n","interesting finding is its evolution to a recreational drug in both settings and \n","the severity of the adverse effects of kratom use reported in the West. While \n","several cases of toxicity and death have emerged in the West, such reports have \n","been non-existent in South East Asia where kratom has had a longer history of \n","use. We highlight the possible reasons for this as discussed in the literature. \n","More importantly, it should be borne in mind that the individual clinical \n","case-reports emerging from the West that link kratom use to adverse reactions or \n","fatalities frequently pertained to kratom used together with other substances. \n","Therefore, there is a danger of these reports being used to strengthen the case \n","for legal sanction against kratom. This would be unfortunate since the \n","experiences from South East Asia suggest considerable potential for therapeutic \n","use among people who use drugs.\n","CONCLUSION: Despite its addictive properties, reported side-effects and its \n","tendency to be used a recreational drug, more scientific clinical human studies \n","are necessary to determine its potential therapeutic value.': [('toxicity', 'DISEASE'), ('death', 'DISEASE')]\n","Detected entities in text: 'The 3Ks (kava, kratom and khat) are herbals that can potentially induce liver \n","injuries. On the one hand, growing controversial data have been reported about \n","the hepatotoxicity of kratom, while, on the other hand, even though kava and \n","khat hepatotoxicity has been investigated, the hepatotoxic effects are still not \n","clear. Chronic recreational use of kratom has been associated with rare \n","instances of acute liver injury. Several studies and case reports have suggested \n","that khat is hepatotoxic, leading to deranged liver enzymes and also \n","histopathological evidence of acute hepatocellular degeneration. Numerous \n","reports of severe hepatotoxicity potentially induced by kava have also been \n","highlighted, both in the USA and Europe. The aim of this review is to focus on \n","the different patterns and the mechanisms of hepatotoxicity induced by \"the \n","3Ks\", while trying to clarify the numerous aspects that still need to be \n","addressed.': [('3Ks (kava, kratom', 'CHEMICAL'), ('khat', 'CHEMICAL'), ('hepatotoxicity', 'DISEASE'), ('kava', 'CHEMICAL'), ('khat hepatotoxicity', 'CHEMICAL'), ('hepatotoxic', 'DISEASE'), ('khat', 'CHEMICAL'), ('hepatotoxic', 'DISEASE'), ('acute hepatocellular degeneration', 'DISEASE'), ('hepatotoxicity', 'DISEASE'), ('kava', 'CHEMICAL'), ('hepatotoxicity', 'DISEASE')]\n","Detected entities in text: 'Kratom, a relatively unknown herb among physicians in the western world, is \n","advertised on the Internet as an alternative to opioid analgesics, as a \n","potential treatment for oploid withdrawal and as a \"legal high\" with minimal \n","addiction potential. This report describes a case of kratom addiction in a \n","37-year-old woman with a severe oploid-like withdrawal syndrome that was managed \n","successfully with symptom-triggered clonidine therapy and scheduled hydroxyzine. \n","A review of other case reports of kratom toxicity, the herb's addiction \n","potential, and the kratom withdrawal syndrome is discussed. Physicians in the \n","United States should be aware of the growing availability and abuse of kratom \n","and the herb's potential adverse health effects, with particular attention to \n","kratom's toxicity, addictive potential, and associated withdrawal syndrome.': [('withdrawal syndrome', 'DISEASE'), ('clonidine', 'CHEMICAL'), ('hydroxyzine', 'CHEMICAL'), ('toxicity', 'DISEASE'), ('withdrawal syndrome', 'DISEASE'), ('toxicity', 'DISEASE'), ('withdrawal syndrome', 'DISEASE')]\n","Detected entities in text: 'Kratom or its main alkaloid, mitragynine is derived from the plant Mitragyna \n","speciosa Korth which is indigenous to Southeast Asian countries. This substance \n","has become widely available in other countries like Europe and United States due \n","to its opium- and coca-like effects. In this article, we have reviewed available \n","reports on mitragynine and other M. speciosa extracts. M. speciosa has been \n","proven to have a rewarding effect and is effective in alleviating the morphine \n","and ethanol withdrawal effects. However, studies in human revealed that \n","prolonged consumption of this plant led to dependence and tolerance while \n","cessation caused a series of aversive withdrawal symptoms. Findings also showed \n","that M. speciosa extracts possess antinociceptive, anti-inflammatory, \n","anti-depressant, and muscle relaxant properties. Available evidence further \n","supports the adverse effects of M. speciosa preparations, mitragynine on \n","cognition. Pharmacological activities are mainly mediated via opioid receptors \n","as well as neuronal Ca2+ channels, expression of cAMP and CREB protein and via \n","descending monoaminergic system. Physicochemical properties of mitragynine have \n","been documented which may further explain the variation in pharmacological \n","responses. In summary, current researchs on its main indole alkaloid, \n","mitragynine suggest both therapeutic and addictive potential but further \n","research on its molecular effects is needed.': [('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('ethanol', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('indole', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Krathom (Mitragyna speciosa Korth.) is an addictive and illicit substance used \n","in Thailand and other Southeast Asian countries. It has become the most commonly \n","used substance among villagers. The study aimed to explore the factor structure \n","of the krathom withdrawal syndrome based on the findings of an earlier \n","qualitative study. The current study was divided into two stages. \n","Cross-sectional data collections were employed in both phases. The samples \n","comprised, respectively, 196 and 330 krathom users aged over 25 years. The \n","characteristics of krathom withdrawal symptoms and signs were identified and the \n","factor structure examined using exploratory factor analysis (EFA). Confirmatory \n","Factor Analysis (CFA) was used to examine the construct validity and \n","multivariate linear regression was used to identify factors predicting the \n","intensity of krathom withdrawal symptoms. The final scale comprised 20 items \n","with four factors: craving-fatigue syndrome; musculoskeletal system and \n","insomnia; mood symptoms; and autonomic nervous system/physical sickness. \n","Symptoms and signs of krathom withdrawal similar to those of the withdrawal \n","syndrome of opioid substances appear to be present in regular krathom users. The \n","krathom withdrawal intensity is predicted by duration of krathom use, frequency, \n","and daily amount of krathom use.': [('Krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('insomnia', 'DISEASE'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Mitragyna speciosa (MS) or ketum is primarily found in Southeast \n","Asia, particularly in northern Malaysia and Thailand. The medicinal value of \n","this plant has attracted significant attention from both herbal medicine \n","practitioners and scientists worldwide. Despite having illegal consumption \n","status, the plant merits study. We conducted a series of experiments to test our \n","hypothesis that ketum impairs both learning and memory in rats.\n","METHODS: Ketum leaves were extracted using methanol and standardised for the \n","amount of its pure compound, mitragynine. Rats were divided into groups for a \n","passive avoidance task and long-term potentiation (LTP) extracellular recording. \n","In the extracellular recording condition, rats were grouped into control, MS100 \n","(100 mg/kg of ketum extract), MS200 (200 mg/kg of ketum extract), and MS500 (500 \n","mg/kg of ketum extract) groups. An additional group that received morphine was \n","included in the passive avoidance task (10 mg/kg), and there were six animals \n","per group. Rats received daily treatments orally for 28 days for both \n","experiments.\n","RESULT: Using a passive avoidance task, our data revealed that the rats' memory \n","significantly increased with increasing doses of MS compared to the \n","morphine-treated group. Our findings from LTP recordings showed that LTP was \n","fully blocked by the higher doses of MS.\n","CONCLUSION: We speculate on the possibility that additional factors were \n","involved in the passive avoidance task because it was an in vivo animal study, \n","while the LTP experiment solely involved brain slices.': [('methanol', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('extract', 'CHEMICAL'), ('extract', 'CHEMICAL'), ('morphine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa) is a widely abused herbal drug preparation in \n","Southeast Asia. It is often consumed as a substitute for heroin, but imposing \n","itself unknown harms and addictive burdens. Mitragynine is the major \n","psychostimulant constituent of kratom that has recently been reported to induce \n","morphine-like behavioural and cognitive effects in rodents. The effects of \n","chronic consumption on non-drug related behaviours are still unclear. In the \n","present study, we investigated the effects of chronic mitragynine treatment on \n","spontaneous activity, reward-related behaviour and cognition in mice in an \n","IntelliCage® system, and compared them with those of morphine and \n","Δ-9-tetrahydrocannabinol (THC). We found that chronic mitragynine treatment \n","significantly potentiated horizontal exploratory activity. It enhanced \n","spontaneous sucrose preference and also its persistence when the preference had \n","aversive consequences. Furthermore, mitragynine impaired place learning and its \n","reversal. Thereby, mitragynine effects closely resembled that of morphine and \n","THC sensitisation. These findings suggest that chronic mitragynine exposure \n","enhances spontaneous locomotor activity and the preference for natural rewards, \n","but impairs learning and memory. These findings confirm pleiotropic effects of \n","mitragynine (kratom) on human lifestyle, but may also support the recognition of \n","the drug's harm potential.': [('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('THC', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('sucrose', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('THC', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'This study sought to compare the effects of Mitragyna speciosa (Korth.) Havil. \n","extract, alkaloids fraction, and mitragynine, a μ-opioid receptor agonist, to \n","that of morphine and oxycodone in a test of thermal nociception. In Experiment \n","1, male Sprague-Dawley rats were administered test articles intraperitoneally \n","(IP) 30 min prior to testing to compare the effects of M. speciosa articles to \n","opioid reference compounds on the hotplate assay. Test articles were vehicle, 10 \n","mg/kg morphine, 3 mg/kg oxycodone, 300 mg/kg M. speciosa extract, 75 mg/kg M. \n","speciosa alkaloids fraction, or 30 mg/kg mitragynine. To mirror consumer usage, \n","Experiment 2 sought to determine whether M. speciosa articles retained their \n","biological activity when given orally (PO). Test articles were vehicle, 6 mg/kg \n","oxycodone, 300 mg/kg M. speciosa extract, or 100mg/kg mitragynine with hotplate \n","tests conducted 30 and 60 min after administration. Mitragynine produced \n","antinociceptive effects similar to the reference opioid agonists when \n","administered IP and PO routes. These data suggest that M. speciosa extracts \n","containing significant quantities of mitragynine may warrant consideration for \n","further studies in primate self-administration models to yield insight into the \n","abuse liability of this commercially available product.': [('extract', 'CHEMICAL'), ('alkaloids', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('oxycodone', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('oxycodone', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('oxycodone', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Herbal products have gained popularity over the past few decades. The reasons \n","attributed to the rise in popularity are cheaper costs, easy availability, \n","patient compliance and fewer side effects. However, liver toxicity following \n","consumption of herbal remedies is on the increase. Thus, there is an urgent need \n","to understand the mechanism of action of the herbal supplements on the liver. \n","Occasionally, herbal supplements may also interact with conventional drugs. The \n","present review focusses on a few herbs such as Aloe barbadensis, Atractylis \n","gummifera, Centella asiatica, Mitragyna speciosa, Morinda citrifolia, Larea \n","tridentata, Symphytum officinale, Teucrium chamaedrys and Xanthium strumarium, \n","which are reported to cause hepatotoxicity in humans and animals. Prior \n","knowledge on hepatotoxicity caused by herbs may be beneficial for clinicians and \n","medical practitioners.': [('liver toxicity', 'DISEASE'), ('Aloe barbadensis', 'CHEMICAL'), ('hepatotoxicity', 'DISEASE'), ('hepatotoxicity', 'DISEASE')]\n","Detected entities in text: 'The use of substances to enhance human abilities is a constant and \n","cross-cultural feature in the evolution of humanity. Although much has changed \n","over time, the availability on the Internet, often supported by misleading \n","marketing strategies, has made their use even more likely and risky. This paper \n","will explore the case of Mitragyna speciosa Korth. (kratom), a tropical tree \n","used traditionally to combat fatigue and improve work productivity among farm \n","populations in Southeast Asia, which has recently become popular as novel \n","psychoactive substance in Western countries. Specifically, it (i) reviews the \n","state of the art on kratom pharmacology and identification; (ii) provides a \n","comprehensive overview of kratom use cross-culturally; (iii) explores the \n","subjective experiences of users; (iv) identifies potential risks and \n","side-effects related to its consumption. Finally, it concludes that the use of \n","kratom is not negligible, especially for self-medication, and more clinical, \n","pharmacological, and socioanthropological studies as well as a better \n","international collaboration are needed to tackle this marginally explored \n","phenomenon.': [('fatigue', 'DISEASE')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa) is a psychoactive plant that has been used since at \n","least 1836 in folk medicine in Southeast Asian countries. More recently, kratom \n","has become widely available in the West and is used for both recreational and \n","medicinal purposes. There has, however, been little scientific research into the \n","short- and long-term effects of kratom in humans, and much of the information \n","available is anecdotal. To supplement the increasing scientific understanding of \n","kratom's pharmacology and research into its effects in animals, we report the \n","results of a qualitative analysis of first-hand descriptions of human kratom use \n","that were submitted to, and published by, a psychoactive substance information \n","website (Erowid.org). Themes that emerged from these experience reports indicate \n","that kratom may be useful for analgesia, mood elevation, anxiety reduction, and \n","may aid opioid withdrawal management. Negative response themes also emerged, \n","indicating potential problems and unfavorable \"side\" effects, especially stomach \n","upset and vomiting. Based on our analyses, we present preliminary hypotheses for \n","future examination in controlled, quantitative studies of kratom.': [('anxiety', 'DISEASE')]\n","Detected entities in text: 'Mitragyna speciosa (Rubiaceae), commonly known as kratom, is a tropical tree \n","with a long history of traditional use in parts of Africa and Southeast Asia. In \n","recent years, kratom has gained popularity for use as a recreational drug across \n","the globe. Relatively new to the illicit market and used in a manner different \n","from its traditional applications, preparations of kratom are touted by many as \n","a safe and legal psychoactive product that improves mood, relieves pain, and may \n","provide benefits in opiate addiction. Available literature was reviewed for M. \n","speciosa via PubMed, Google Scholar, CINAHL, and EBSCO to summarize its \n","traditional uses, phytochemical composition, pharmacology and toxicology of \n","proposed active constituents, and potential for misuse and abuse. Research has \n","demonstrated that both stimulant and sedative dose-dependent effects do exist, \n","but a growing concern for the drug's effects and safety of use has resulted in \n","national and international attention primarily due to an increase in hospital \n","visits and deaths in several countries that are said to have been caused by \n","extracts of the plant. The main active alkaloid substances in kratom, \n","mitragynine and 7-hydroxymitragynine, present with a range of CNS stimulant and \n","depressant effects mediated primarily through monoaminergic and opioid \n","receptors. Recently, Palm Beach County, located in the southeastern corridor of \n","Florida, has considered regulating kratom due to public safety concerns \n","following the death of a young adult. At the local, state, and even federal \n","levels, governments are now being confronted with the task of determining the \n","safety and the possible regulation of kratom extracts. There are currently no \n","standard analytical screening techniques for mitragynine and its metabolites \n","following ingestion limiting its detection to more sophisticated techniques like \n","liquid chromatography-mass spectrometry to determine kratom use. The growing \n","concern of the abuse potential of kratom requires careful evaluation of its \n","benefits and potential toxicities.': [('pain', 'DISEASE'), ('deaths', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('death', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('toxicities', 'DISEASE')]\n","Detected entities in text: 'BACKGROUND: Many antidepressants are effective in alleviating ethanol withdrawal \n","symptoms. However, most of them suppress rapid eye movement (REM) sleep. Thus, \n","development of antidepressants without undesirable side effects would be \n","preferable. Previously, crude alkaloid extract from Mitragyna speciosa (MS) \n","Korth was found to produce antidepressant activities. It was hypothesized that \n","the alkaloid extract from MS may attenuate ethanol withdrawal without REM sleep \n","disturbance.\n","METHODS: Adult male Wistar rats implanted with electrodes over the frontal and \n","parietal cortices were used for two separated studies. For an acute study, 10 \n","mg/kg fluoxetine or 60 mg/kg alkaloid extract from MS were administered \n","intragastrically. Electroencephalographic (EEG) signals were recorded for 3 h to \n","examine sleep profiles and EEG fingerprints. Another set of animal was used for \n","an ethanol withdrawal study. They were rendered dependent on ethanol via a \n","modified liquid diet (MLD) containing ethanol ad libitum for 28 days. On day 29, \n","fluoxetine (10 mg/kg) or alkaloid extract from MS (60 mg/kg) were administered \n","15 min before the ethanol-containing MLD was replaced with an isocaloric \n","ethanol-free MLD to induced ethanol withdrawal symptoms.\n","RESULTS: The sleep analysis revealed that alkaloid extract from MS did not \n","change any REM parameters which included average duration of each REM episode, \n","total REM time, number of REM episode and REM latency whereas fluoxetine \n","significantly suppressed all REM parameters and delayed REM latency. However, \n","power spectral analysis revealed similar fingerprints for fluoxetine and \n","alkaloid extract from MS characterized by decreasing powers in the slow \n","frequency range in frontal and parietal cortical EEG. Neither treatment affected \n","spontaneous motor activity. Finally, both alkaloid extract from MS and \n","fluoxetine were found to significantly attenuate ethanol withdrawal-induced \n","hyperexcitability (increases gamma activity) in both cortices and to reduce \n","locomotor activity.\n","CONCLUSION: The present study demonstrated that the alkaloid extract from MS \n","alleviates ethanol withdrawal severity with no side effect on REM sleep. In \n","addition, these data suggest that suppressive effects on slow frequency powers \n","but not REM sleep may be hallmarks of effective antidepressants for ethanol \n","withdrawal treatment.': [('antidepressants', 'CHEMICAL'), ('ethanol', 'CHEMICAL'), ('antidepressants', 'CHEMICAL'), ('antidepressant', 'CHEMICAL'), ('ethanol', 'CHEMICAL'), ('fluoxetine', 'CHEMICAL'), ('mg/kg alkaloid extract', 'CHEMICAL'), ('ethanol', 'CHEMICAL'), ('ethanol', 'CHEMICAL'), ('MLD', 'CHEMICAL'), ('ethanol', 'CHEMICAL'), ('fluoxetine', 'CHEMICAL'), ('MLD', 'CHEMICAL'), ('MLD', 'CHEMICAL'), ('ethanol', 'CHEMICAL'), ('fluoxetine', 'CHEMICAL'), ('fluoxetine', 'CHEMICAL'), ('fluoxetine', 'CHEMICAL'), ('ethanol', 'CHEMICAL'), ('hyperexcitability', 'DISEASE'), ('ethanol', 'CHEMICAL'), ('antidepressants', 'CHEMICAL'), ('ethanol', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa Korth, or better known as ketum, has long been used by \n","traditional folk around Southeast Asia to prevent fatigue from working under hot \n","tropical weather and as a replacement of opium, which can then cause addiction. \n","To date, no findings have been reported of the toxic effect of ketum \n","subchronically (28 days). Hence, the aim of this study was to investigate the \n","toxicity of subchronic effect of standardized methanolic extract of ketum \n","(SMEMS) in Sprague-Dawley rats. Rats were orally administered with 100, 200, and \n","500 mg/kg of SMEMS for 28 days. Body weights were recorded daily. They were \n","terminated at day 28 to obtain data for hematology, biochemistry, and \n","histopathology of the brain, liver, kidney, lung, heart, sciatic nerve, and \n","spinal cord. The SMEMS affected body weight compared to control group. \n","Biochemistry findings showed that liver and kidney were affected with the \n","abnormal values in AST, creatinine, globulin, glucose, total protein, and urea. \n","However, SMEMS produced toxic effect more to liver, kidney, and lung than other \n","organs as observed histopathologically. The results suggested subchronic \n","exposure of ketum is toxic to the physiology of the animals.': [('fatigue', 'DISEASE'), ('opium', 'CHEMICAL'), ('toxicity', 'DISEASE'), ('creatinine', 'CHEMICAL'), ('globulin', 'CHEMICAL'), ('glucose', 'CHEMICAL'), ('urea', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Kratom, known botanically as Mitragyna speciosa (Korth.), is an \n","indigenous tree in Southeast Asia. Kratom is currently easily available \n","worldwide via special shops and the Internet to use as a drug of abuse, opioid \n","alternative, or pain killer. So far, the pharmacokinetics of this plant has been \n","studied only in animals, and there is no such study in humans. The major \n","abundant active alkaloid in Kratom, mitragynine, is one of the promising new \n","chemical substances to be developed as a new drug. The aim of this study was to \n","examine the pharmacokinetics of mitragynine and assess the linearity in \n","pharmacokinetics in chronic users.\n","METHODS: Since Kratom is illegal in Thailand, studies in healthy subjects would \n","be unethical. We therefore conducted a prospective study by enrolling ten \n","chronic, regular, healthy users. We adjusted the steady state in each subject by \n","giving a known amount of Kratom tea for 7 days before commencement of the \n","experiment. We admitted and gave different oral doses to subjects to confirm \n","linearity in pharmacokinetics. The mitragynine blood concentrations at 17 times \n","points and the urine concentrations during the 24-hour period were collected and \n","measured by liquid chromatography-tandem mass spectrometry method.\n","RESULTS: Ten male subjects completed the study without adverse reactions. The \n","median duration of abuse was 1.75 years. We analyzed one subject separately due \n","to the abnormal behavior of blood concentration. From data of nine subjects, the \n","pharmacokinetic parameters established were time to reach the maximum plasma \n","concentration (0.83±0.35 hour), terminal half-life (23.24±16.07 hours), and the \n","apparent volume of distribution (38.04±24.32 L/kg). The urine excretion of \n","unchanged form was 0.14%. The pharmacokinetics were observed to be oral \n","two-compartment model.\n","CONCLUSION: This was the first pharmacokinetic study in humans, which \n","demonstrated linearity and was consistent with the oral two-compartment model \n","with a terminal half-life of about 1 day. The pharmacokinetic linearity and \n","parameters reported are necessary pharmacological information of Kratom, and \n","there is a possibility for it to be developed medically as a pain killer or \n","better opioid substitute in the future.': [('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('tea', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('abnormal behavior of blood concentration', 'DISEASE'), ('pain', 'DISEASE')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa) is an indigenous plant known for its traditional \n","medicinal use, and for its addiction potential, in Southeast Asia. In recent \n","years, kratom and its major alkaloid, mitragynine, spread worldwide with largely \n","unknown effects on behavior and mental health. Recent studies show that kratom \n","use can lead to dependence and that mitragynine works as an addictive drug in \n","animal studies. Nevertheless, kratom preparations were also suggested as a less \n","harmful substitute in opiate withdrawal. Potential side-effects of prolonged \n","kratom use, however, are currently unclear. The aim of this study was to \n","investigate the social functioning of regular kratom users in Malaysia. A \n","cross-sectional survey was carried out in three northern states of Peninsular \n","Malaysia investigating 293 regular kratom consumers using the Addiction Severity \n","Index in a snowball sampling technique. Findings showed that regular kratom \n","users do not experience major impairments in their social functioning, despite \n","being dependent on kratom for prolonged periods. Our findings suggest that \n","chronic kratom administration does not significantly impair social functioning \n","of users in a natural context in Malaysia.': [('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Detoxification and elimination of permethrin (PM) are mediated by hydrolysis via \n","carboxylesterase (CES). Mitragyna speciosa (kratom) contains mitragynine (MG) \n","and other bioactive alkaloids. Since PM and MG have the same catalytic site and \n","M. speciosa is usually abused by adding other ingredients such as pyrethroid \n","insecticides, the effects of MG and an alkaloid extract (AE) on the elimination \n","of PM were investigated in rats. Rats were subjected to single and multiple \n","pretreatment with MG and AE prior to receiving a single oral dose (460 mg/kg) of \n","PM. Plasma concentrations of trans-PM and its metabolite phenoxybenzylalcohol \n","(PBAlc) were measured. The elimination rate constant (kel) and the elimination \n","half-life (t1/2 el) of PM were determined, as well as the metabolic ratio (PMR). \n","A single and multiple oral pretreatment with MG and AE altered the plasma \n","concentration-time courses of both trans-PM and PBAlc during 8-22 h, decreased \n","the PMRs, delayed elimination of PM, but enhanced elimination of PBAlc. Results \n","indicated that PM-MG or AE toxicokinetic interactions might have resulted from \n","the MG and AE interfering with PM hydrolysis. The results obtained in rats \n","suggest that in humans using kratom cocktails containing PM, there might be an \n","increased risk of PM toxicity due to inhibition of PM metabolism and \n","elimination.': [('permethrin', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('phenoxybenzylalcohol', 'CHEMICAL'), ('PBAlc', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('PBAlc', 'CHEMICAL'), ('PBAlc', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('toxicity', 'DISEASE')]\n","Detected entities in text: 'RATIONALE: Mitragynine (MG) is the primary active alkaloid extracted from the \n","leaves of Mitragyna speciosa or kratom and exhibits pharmacological activities \n","mediated by opioid receptors. The plant has been traditionally used for its \n","opium and psychostimulant-like effects to increase work efficiency or as a \n","substitute in the self-treatment of opiate addiction.\n","OBJECTIVES: The present study was performed to investigate the discriminative \n","stimulus effects of MG in rats. The pharmacological mechanism of MG action and \n","its derivative, 7-hydroxymitragynine (7-HMG) with a specific focus on opioid \n","receptor involvement was examined in rats trained to discriminate morphine from \n","vehicle. In order to study the dual actions of MG, the effect of cocaine \n","substitution to the MG discriminative stimulus was also performed in MG-trained \n","rats.\n","METHODS: Male Sprague Dawley rats were trained to discriminate MG from vehicle \n","in a two-lever drug discrimination procedure under a tandem variable-interval \n","(VI 60') fixed-ratio (FR 10) schedule of food reinforcement.\n","RESULTS: Rats acquired the MG discrimination (15.0 mg/kg, i.p.) which was \n","similar to the acquisition of morphine discrimination (5.0 mg/kg, i.p.) in \n","another group of rats. MG substituted fully to the morphine discriminative \n","stimulus in a dose-dependent manner, suggesting pharmacological similarities \n","between the two drugs. The administration of 7-HMG derivative in 3.0 mg/kg \n","(i.p.) dose engendered full generalisation to the morphine discriminative \n","stimulus. In addition, the MG stimulus also partially generalised to cocaine \n","(10.0 mg/kg, i.p.) stimulus.\n","CONCLUSION: The present study demonstrates that the discriminative stimulus \n","effect of MG possesses both opioid- and psychostimulant-like subjective effects.': [('Mitragynine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('opium', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('cocaine', 'CHEMICAL'), ('VI', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('cocaine', 'CHEMICAL')]\n","Detected entities in text: 'INTRODUCTION: Mitragynine is a major bioactive compound of Kratom, which is \n","derived from the leave extracts of Mitragyna speciosa Korth or Mitragyna \n","speciosa (M. speciosa), a medicinal plant from South East Asia used legally in \n","many countries as stimulant with opioid-like effects for the treatment of \n","chronic pain and opioid-withdrawal symptoms. Fatal incidents with Mitragynine \n","have been associated with cardiac arrest. In this study, we determined the \n","cardiotoxicity of Mitragynine and other chemical constituents isolated using \n","human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs).\n","METHODS AND RESULTS: The rapid delayed rectifier potassium current (IKr), L-type \n","Ca2+ current (ICa,L) and action potential duration (APD) were measured by whole \n","cell patch-clamp. The expression of KCNH2 and cytotoxicity was determined by \n","real-time PCR and Caspase activity measurements. After significant IKr \n","suppression by Mitragynine (10 µM) was confirmed in hERG-HEK cells, we \n","systematically examined the effects of Mitragynine and other chemical \n","constituents in hiPSC-CMs. Mitragynine, Paynantheine, Speciogynine and \n","Speciociliatine, dosage-dependently (0.1∼100 µM) suppressed IKr in hiPSC-CMs by \n","67%∼84% with IC50 ranged from 0.91 to 2.47 µM. Moreover, Mitragynine (10 µM) \n","significantly prolonged APD at 50 and 90% repolarization (APD50 and APD90) \n","(439.0±11.6 vs. 585.2±45.5 ms and 536.0±22.6 vs. 705.9±46.1 ms, respectively) \n","and induced arrhythmia, without altering the L-type Ca2+ current. Neither the \n","expression, and intracellular distribution of KCNH2/Kv11.1, nor the Caspase 3 \n","activity were significantly affected by Mitragynine.\n","CONCLUSIONS: Our study indicates that Mitragynine and its analogues may \n","potentiate Torsade de Pointes through inhibition of IKr in human cardiomyocytes.': [('Mitragynine', 'CHEMICAL'), ('pain', 'DISEASE'), ('Mitragynine', 'CHEMICAL'), ('cardiac arrest', 'DISEASE'), ('cardiotoxicity', 'DISEASE'), ('Mitragynine', 'CHEMICAL'), ('potassium', 'CHEMICAL'), ('ICa', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('Paynantheine', 'CHEMICAL'), ('Speciogynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('arrhythmia', 'DISEASE'), ('Mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('Torsade de Pointes', 'DISEASE')]\n","Detected entities in text: 'An increasing number of drugs of abuse are sold word wide over the internet. \n","Names like \"legal highs\", \"herbal highs\" etc. give the impression that these are \n","safe products, although the risk of fatal reactions might be substantial. Leaves \n","from the plant Mitragyna speciosa, contain active compounds like mitragynine and \n","7-hydroxymitragynine. It has been reported that the potency of \n","7-hydroxymitragynine at the μ-opioid receptor is 30 times higher than that of \n","mitragynine and 17 times higher than that of morphine. Case reports regarding \n","poisoning with Kratom are reported, but the toxic or lethal ranges for the \n","concentrations of the active substances have not been established, and \n","concentrations of 7-hydroxymitragynine have not been reported previously. We \n","present a case report where a middle aged man was found dead at home. The \n","deceased had a history of drug abuse and mental illness for several years. At \n","autopsy, there were no significant pathological findings. Post-mortem analysis \n","of peripheral blood revealed: zopiclone 0.043mg/L, citalopram 0.36mg/L and \n","lamotrigine 5.4mg/L, i.e. concentrations regularly seen after therapeutic \n","ingestion of these drugs. Additionally mitragynine 1.06mg/L and \n","7-hydroxymitragynine 0.15mg/L were detected in blood and both also in urine. The \n","high concentrations of mitragynine and 7-hydroxymitragynine indicate that the \n","cause of death is intoxication by these substances; and the circumstances point \n","toward the manner of death being accidental. We recommend that both mitragynine \n","and 7-hydroxymitragynine are analyzed for in cases with suspected Kratom \n","intoxication.': [('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('poisoning', 'DISEASE'), ('7-hydroxymitragynine', 'CHEMICAL'), ('drug abuse', 'DISEASE'), ('zopiclone', 'CHEMICAL'), ('citalopram', 'CHEMICAL'), ('lamotrigine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('death', 'DISEASE'), ('death', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Effects of mitragynine and 7-hydroxymitragynine (the alkaloids of Mitragyna \n","speciosa Korth) on 4-methylumbelliferone glucuronidation in rat and human liver \n","microsomes and recombinant human uridine 5'-diphospho-glucuronosyltransferase \n","isoforms.': [('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('4-methylumbelliferone', 'CHEMICAL'), ('uridine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Glucuronidation catalyzed by uridine 5'- \n","diphospho-glucuronosyltransferase (UGT) is a major phase II drug metabolism \n","reaction which facilitates drug elimination. Inhibition of UGT activity can \n","cause drug-drug interaction. Therefore, it is important to determine the \n","inhibitory potentials of drugs on glucuronidation.\n","OBJECTIVE: The objective was to evaluate the inhibitory potentials of \n","mitragynine, 7-hydroxymitragynine, ketamine and buprenorphine, respectively on \n","4-methylumbelliferone (4-MU) glucuronidation in rat liver microsomes, human \n","liver microsomes and recombinant human UGT1A1 and UGT2B7 isoforms.\n","MATERIALS AND METHODS: The effects of the above four compounds on the formation \n","of 4-MU glucuronide from 4-MU by rat liver microsomes, human liver microsomes, \n","recombinant human UGT1A1 and UGT2B7 isoforms were determined using \n","high-performance liquid chromatography with ultraviolet detection.\n","RESULTS: For rat liver microsomes, ketamine strongly inhibited 4-MU \n","glucuronidation with an IC50 value of 6.21 ± 1.51 μM followed by buprenorphine \n","with an IC50 value of 73.22 ± 1.63 μM. For human liver microsomes, buprenorphine \n","strongly inhibited 4-MU glucuronidation with an IC50 value of 6.32 ± 1.39 μM. \n","For human UGT1A1 isoform, 7-hydroxymitragynine strongly inhibited 4-MU \n","glucuronidation with an IC50 value of 7.13 ± 1.16 μM. For human UGT2B7 isoform, \n","buprenorphine strongly inhibited 4-MU glucuronidation followed by \n","7-hydroxymitragynine and ketamine with respective IC50 values of 5.14 ± 1.30, \n","26.44 ± 1.31, and 27.28 ± 1.18 μM.\n","CONCLUSIONS: These data indicate the possibility of drug-drug interaction if \n","7-hydroxymitragynine, ketamine, and buprenorphine are co-administered with drugs \n","that are UGT2B7 substrates since these three compounds showed significant \n","inhibition on UGT2B7 activity. In addition, if 7-hydroxymitragynine is to be \n","taken with other drugs that are highly metabolized by UGT1A1, there is a \n","possibility of drug-drug interaction to occur.': [('uridine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('ketamine', 'CHEMICAL'), ('buprenorphine', 'CHEMICAL'), ('4-methylumbelliferone', 'CHEMICAL'), ('4-MU glucuronide', 'CHEMICAL'), ('ketamine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('buprenorphine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('buprenorphine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('buprenorphine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('ketamine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('ketamine', 'CHEMICAL'), ('buprenorphine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Krathom (Mitragyna speciosa Korth.) is the most commonly used \n","illicit substance in Thailand, and its use has become widespread \n","internationally. Studies on krathom dependence and its health impact are scarce, \n","as there has been no instrument to measure its dependence syndrome and classify \n","krathom users. This study aimed to develop and explore the factor structure, \n","reliability, and validity of a Krathom Dependence Scale (KDS).\n","METHODS: This study comprised 2 phases. First, cross-sectional surveys were \n","conducted with 523 (Phase I) and 595 (Phase II) male villagers aged >25 years \n","who were regular, occasional, ex-, or nonusers of krathom. Scale construction \n","was based on the qualitative results from users and previous literature. \n","Exploratory factor analysis (EFA) using maximum likelihood extraction with \n","oblimin rotation was conducted in Phase I and confirmatory factor analysis (CFA) \n","in Phase II to confirm the construct of the scale. Internal consistency of the \n","KDS was assessed using Cronbach's alpha coefficient. Discriminative validity was \n","examined by checking its ability to differentiate between regular and occasional \n","users and patterns of krathom use and its concurrent validity by comparing its \n","levels of score with the Fagerstrom Test for Nicotine Dependence (FTND). The KDS \n","contains 16 items on a 0-3 (never-always) rating scale, making a total score of \n","0-48.\n","RESULTS: Phase I EFA revealed a single-factor solution for the scale, which was \n","confirmed by the CFA in Phase II, with an alpha coefficient of .98. The KDS \n","discriminates regular from occasional users reasonably well and is highly \n","correlated with the FTND score. Two cutoffs were suggested: 34/35 for \n","distinguishing moderate from high dependence and 13/14 for low from moderate.\n","CONCLUSIONS: The KDS appears to capture key theoretical constructs and \n","correlates with indices of drug dependence by standard criteria. It should be \n","useful in early intervention for those with krathom use disorders in community \n","and primary care settings.': [('Krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('Krathom', 'CHEMICAL'), ('KDS', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('KDS', 'DISEASE'), ('krathom', 'CHEMICAL'), ('Nicotine', 'CHEMICAL'), ('KDS', 'DISEASE'), ('KDS', 'DISEASE'), ('KDS', 'DISEASE'), ('drug dependence', 'DISEASE'), ('krathom', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa (kratom) is a popular herb in Southeast Asia, which is \n","traditionally used to treat withdrawal symptoms associated with opiate \n","addiction. Mitragynine, 7-hydroxymitragynine, and mitraphylline are reported to \n","be the central nervous system active alkaloids which bind to the opiate \n","receptors. Mitraphylline is also present in the bark of Uncaria tomentosa (cat's \n","claw). Several therapeutic properties have been reported for these compounds but \n","limited information is available on the absorption and distribution properties. \n","This study focuses on evaluating the absorption, distribution, metabolism, and \n","excretion (ADME) properties of these compounds and their effect on major efflux \n","transporter P-glycoprotein, using in vitro methods. Quantitative analysis was \n","performed by the Q-TOF LC-MS system. Mitragynine was unstable in simulated \n","gastric fluid with 26 % degradation but stable in simulated intestinal fluid. \n","7-Hydroxymitragynine degraded up to 27 % in simulated gastric fluid, which could \n","account for its conversion to mitragynine (23 %), while only 6 % degradation was \n","seen in simulated intestinal fluid. Mitraphylline was stable in simulated \n","gastric fluid but unstable in simulated intestinal fluid (13.6 % degradation). \n","Mitragynine and 7-hydroxymitragynine showed moderate permeability across Caco-2 \n","and MDR-MDCK monolayers with no significant efflux. However, mitraphylline was \n","subjected to efflux mediated by P-glycoprotein in both Caco-2 and MDR-MDCK \n","monolayers. Mitragynine was found to be metabolically stable in both human liver \n","microsomes and S9 fractions. In contrast, both 7-hydroxymitragynine and \n","mitraphylline were metabolized by human liver microsomes with half-lives of 24 \n","and 50 min, respectively. All three compounds exhibited high plasma protein \n","binding (> 90 %) determined by equilibrium dialysis. Mitragynine and \n","7-hydroxymitragynine inhibited P-glycoprotein with EC50 values of 18.2 ± 3.6 µM \n","and 32.4 ± 1.9 µM, respectively, determined by the calcein-AM fluorescent assay, \n","while no inhibition was seen with mitraphylline. These data indicate the \n","possibility of a drug interaction if mitragynine and 7-hydroxymitragynine are \n","coadministered with drugs that are P-glycoprotein substrates.': [('Mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('Mitraphylline', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('7-Hydroxymitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitraphylline', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('±', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'The leaves of a tropical plant, Mitragyna speciosa Korth. (Rubiaceae), have been \n","traditionally used as a substitute for opium. By phytochemical studies on the \n","constituents of the plant growing in Thailand as well as in Malaysia, several \n","9-methoxy-Corynanthe-type monoterpenoid indole alkaloids including new natural \n","products were isolated. The structures of these new compounds were elucidated by \n","the modern spectroscopic methods and/or chiral-total syntheses. The chiral total \n","synthesis of (-)-mitragynine, a major component of this plant, was achieved. \n","Potent opioid agonistic properties of mitragynine, which acts on mu- and \n","delta-opioid subtype receptors, and of mitragynine pseudoindoxyl, whose \n","analgesic activity is more potent than that of morphine, were clarified in in \n","vitro experiments. The essential structural features in mitragynine for \n","revealing the analgesic activity were elucidated by pharmacological evaluation \n","of the natural and synthetic mitragynine derivatives.': [('opium', 'CHEMICAL'), ('indole alkaloids', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine pseudoindoxyl', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Kratom (Mitragyna speciosa) preparations have been traditionally \n","used in Southeast Asia for its medicinal properties. Lately, Kratom use has \n","spread to Europe and the US, where abuse potential and health hazards \n","increasingly emerge. This study is the first to measure systematically Kratom \n","dependence, withdrawal symptoms, and drug craving in regular Kratom users in \n","Malaysia.\n","METHODS: A cross-sectional survey of 293 regular Kratom users was conducted in \n","the community across three northern peninsular states of Malaysia. The Leeds \n","Dependence Questionnaire, Marijuana Withdrawal Checklist, and Marijuana Craving \n","Questionnaire-Short Form were used to measure Kratom dependence, withdrawal and \n","craving.\n","RESULTS: More than half of the regular users (>6 month of use) developed severe \n","Kratom dependence problems, while 45% showed a moderate Kratom dependence. \n","Physical withdrawal symptoms commonly experienced include muscle spasms and \n","pain, sleeping difficulty, watery eyes/nose, hot flashes, fever, decreased \n","appetite, and diarrhoea. Psychological withdrawal symptoms commonly reported \n","were restlessness, tension, anger, sadness, and nervousness. The average amount \n","of the psychoactive compound, mitragynine, in a single dose of a Kratom drink \n","was 79mg, suggesting an average daily intake of 276.5mg. Regular users who \n","consumed ≥3 glasses Kratom per day, had higher odds of developing severe Kratom \n","dependence, withdrawal symptoms, and inability to control Kratom craving.\n","CONCLUSIONS: The findings from this study show that regular Kratom use is \n","associated with drug dependency, development of withdrawal symptoms, and \n","craving. These symptoms become more severe with prolonged use and suggest a \n","stronger control of the drug.': [('Kratom dependence problems', 'DISEASE'), ('muscle spasms', 'DISEASE'), ('pain', 'DISEASE'), ('watery', 'DISEASE'), ('fever', 'DISEASE'), ('diarrhoea', 'DISEASE'), ('anger', 'DISEASE'), ('nervousness', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('drug dependency', 'DISEASE')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa Korth), a native tree in Southeast Asia, is misused \n","as an abuse drug and becomes legally widespread to several countries. Currently, \n","it is available through the online market or by some shops. The clinical \n","manifestations of Kratom's effects are not well-defined and the clinical studies \n","are limited. This study was designed to identify the characteristics of Kratom \n","poisoning and withdrawal cases from Kratom exposure cases in Ramathibodi Poison \n","Center (RPC), Thailand, during a five-year period. We used a retrospective \n","review of Kratom exposure cases from the RPC toxic surveillance system. A total \n","of 52 Kratom exposure cases were identified. The trend of case consultations has \n","been increasing. There were Kratom poisoning cases (76.9%) and withdrawal cases \n","(23.1%). Common presenting symptoms in the poisoning group were palpitation \n","(22.5%), followed by seizure (17.5%). For the withdrawal group, the common \n","presenting symptoms were myalgia (33.3%), insomnia (16.67%), fatigue (16.67%), \n","and chest discomfort (16.67%). There was a baby with withdrawal symptoms who was \n","delivered from a chronic Kratom-abusing mother, suggesting possible exposure via \n","the transplacental route. There were no deaths in either group. Kratom abuse can \n","cause either poisoning or withdrawal. Most cases in both groups had good \n","prognostic outcome.': [('poisoning', 'DISEASE'), ('RPC', 'CHEMICAL'), ('poisoning', 'DISEASE'), ('poisoning', 'DISEASE'), ('palpitation', 'DISEASE'), ('seizure', 'DISEASE'), ('myalgia', 'DISEASE'), ('insomnia', 'DISEASE'), ('fatigue', 'DISEASE'), ('deaths', 'DISEASE'), ('Kratom abuse', 'DISEASE'), ('poisoning', 'DISEASE')]\n","Detected entities in text: '(E)-Methyl \n","2-((2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate \n","(7-hydroxymitragynine), a main active constituent of the traditional herbal \n","medicine Mitragyna speciosa, is an indole alkaloid that is structurally \n","different from morphine. 7-Hydroxymitragynine induces a potent antinociceptive \n","effect on mouse acute pain through μ-opioid receptors. In this study, we \n","developed dual-acting μ- and δ-opioid agonists MGM-15 and MGM-16 from \n","7-hydroxymitragynine for the treatment of acute and chronic pain. MGM-16 showed \n","a higher potency than that of 7-hydroxymitragynine and MGM-15 in in vitro and in \n","vivo assays. MGM-16 exhibited a high affinity for μ- and δ-opioid receptors, \n","with K(i) values of 2.1 and 7.0 nM, respectively. MGM-16 showed μ- and δ-opioid \n","full agonistic effects in a guanosine 5'-O-(3-[(35)S]thiotriphosphate) binding \n","assay and in a functional test using electrically elicited guinea pig ileum and \n","mouse vas deferens contractions. Systemic administration of MGM-16 produced \n","antinociceptive effects in a mouse acute pain model and antiallodynic effects in \n","a chronic pain model. The antinociceptive effect of MGM-16 was approximately 240 \n","times more potent than that of morphine in a mouse tail-flick test, and its \n","antiallodynic effect was approximately 100 times more potent than that of \n","gabapentin in partial sciatic nerve-ligated mice, especially with oral \n","administration. The antinociceptive effect of MGM-16 was completely and \n","partially blocked by the μ-selective antagonist β-funaltrexamine hydrochloride \n","(β-FNA) and by the δ-selective antagonist naltrindole, respectively, in a \n","tail-flick test. The antiallodynic effect of MGM-16 was completely blocked by \n","β-FNA and naltrindole in a neuropathic pain model. These findings suggest that \n","MGM-16 could become a class of a compound with potential therapeutic utility for \n","treating neuropathic pain.': [('7-hydroxymitragynine', 'CHEMICAL'), ('indole', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('7-Hydroxymitragynine', 'CHEMICAL'), ('pain', 'DISEASE'), ('μ-', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('pain', 'DISEASE'), ('7-hydroxymitragynine', 'CHEMICAL'), ('μ-', 'DISEASE'), ('μ-', 'CHEMICAL'), ('guanosine', 'CHEMICAL'), ('pain', 'DISEASE'), ('pain', 'DISEASE'), ('morphine', 'CHEMICAL'), ('gabapentin', 'CHEMICAL'), ('hydrochloride', 'CHEMICAL'), ('naltrindole', 'CHEMICAL'), ('naltrindole', 'CHEMICAL'), ('neuropathic pain', 'DISEASE'), ('neuropathic pain', 'DISEASE')]\n","Detected entities in text: 'Kratom use is a growing problem in the United States. Kratom exposures reported \n","to Texas poison centers between January 1998 and September 2013 were identified. \n","No kratom exposures were reported from 1998 to 2008 and 14 exposures were \n","reported from 2009 to September 2013. Eleven patients were male, and 11 patients \n","were in their 20s. The kratom was ingested in 12 patients, inhaled in 1, and \n","both ingested and inhaled in 1. Twelve patients were managed at a healthcare \n","facility and the remaining 2 were managed at home.': []\n","Detected entities in text: 'ETHNOPHARMACOLOGICAL RELEVANCE: Consumer use of botanicals has increased \n","despite, in many instances, the paucity of research demonstrating efficacy or \n","identifying liabilities. This research employed the place preference/aversion \n","paradigm to characterize the psychoactive properties of Salvia divinorum extract \n","(10, 30, 100mg/kg), salvinorin A (0.1, 0.3, 1.0mg/kg), Mitragyna speciosa MeOH \n","extract (50, 100, 300 mg/kg), Mitragyna speciosa alkaloid-enriched fraction \n","(12.5, 25, 75 mg/kg) and mitragynine (5, 10, 30 mg/kg) in rats.\n","MATERIAL AND METHODS: Following apparatus habituation and baseline preference \n","scores, male Sprague-Dawley rats were given eight counter-balanced drug versus \n","vehicle conditioning trials followed by a preference test conducted under \n","drug-free states. S(+)-amphetamine (1mg/kg) served as the positive control (in \n","Exp. 2) and haloperidol (0.8, 1.0mg/kg) served as the negative control in both \n","studies.\n","RESULTS: Rats displayed place aversion to both Salvia divinorum and salvinorin A \n","that exceeded that of haloperidol. Rats showed place preference to mitragynine \n","that was similar to that of S(+)-amphetamine. This CPP effect was much less \n","pronounced with the Mitragyna speciosa extract and its fraction.\n","CONCLUSIONS: These findings suggest that both botanicals possess liabilities, \n","albeit somewhat different, that warrant caution in their use.': [('Salvia divinorum extract', 'CHEMICAL'), ('extract', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('S(+)-amphetamine', 'CHEMICAL'), ('haloperidol', 'CHEMICAL'), ('haloperidol', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('S(+)-amphetamine', 'CHEMICAL'), ('Mitragyna speciosa extract', 'CHEMICAL')]\n","Detected entities in text: 'OBJECTIVE: Mitragyna speciosa and its extracts are named kratom (dried leaves, \n","extract). It contains several alkaloids and is used in traditional medicine to \n","alleviate musculoskeletal pain, hypertension, coughing, diarrhea, and as an \n","opiate substitute for addicts. Abuse and addiction to kratom is described, and \n","kratom has attracted increasing interest in Western countries. Individual \n","effects of kratom on opioidergic, adrenergic, serotonergic, and dopaminergic \n","receptors are known, but not all of the effects have been explained. \n","Pharmacokinetic and pharmacodynamic data are needed.\n","METHODS: The effects of kratom extract on mice behavior were investigated \n","following oral (po), intraperitoneal (ip), and intracerebroventricular (icv) \n","application. Receptor-binding studies were performed.\n","RESULTS: In μ opioid receptor knockout mice (-/-) and wild type (+/+) animals, \n","the extract reduced locomotor activity after ip and low po doses in +/+ animals, \n","but not after icv administration. The ip effect was counteracted by 0.3 mg/kg of \n","apomorphine sc, suggesting dopaminergic presynaptic activity. An analgesic \n","effect was only found in -/- mice after icv application. Norbinaltorphimine \n","abolished the analgesic effect, but not the inhibitory effect, on locomotor \n","activity, indicating that the analgesic effect is mediated via κ opioid \n","receptors. Oral doses, which did not diminish locomotor activity, impaired the \n","acquisition of shuttle box avoidance learning. There was no effect on \n","consolidation. Binding studies showed affinity of kratom to μ, δ, and κ opioid \n","receptors and to dopamine D1 receptors.\n","CONCLUSIONS: The results obtained in drug-naïve mice demonstrate weak behavioral \n","effects mediated via μ and κ opioid receptors.': [('extract', 'CHEMICAL'), ('musculoskeletal pain', 'DISEASE'), ('hypertension', 'DISEASE'), ('diarrhea', 'DISEASE'), ('kratom extract', 'CHEMICAL'), ('extract', 'CHEMICAL'), ('apomorphine', 'CHEMICAL'), ('Norbinaltorphimine', 'CHEMICAL'), ('dopamine', 'CHEMICAL')]\n","Detected entities in text: 'ETHNOPHARMACOLOGICAL RELEVANCE: [corrected] Mitragynine is an indole alkaloid \n","compound of Mitragyna speciosa (M. speciosa) Korth. (Rubiaceae). This plant is \n","native to the southern regions of Thailand and northern regions of Malaysia and \n","is frequently used to manage the withdrawal symptoms in both countries.\n","AIM OF STUDY: To investigate the effect of mitragynine after chronic morphine \n","treatment on cyclic AMP (cAMP) level and mRNA expression of mu-opioid receptor \n","(MOR) in human neuroblastoma SK-N-SH cell.\n","METHOD AND MATERIALS: Mitragynine was isolated from the Mitragyna speciosa plant \n","using the acid-base extraction method. The cAMP level upon forskolin stimulation \n","in the cells was determined using the Calbiochem(®) Direct Immunoassay Kit. The \n","mRNA expression of the MOR was carried out using quantitative RT-PCR.\n","RESULT: Cotreatment and pretreatment of morphine and mitragynine significantly \n","reduced the production of cAMP level at a lower concentration of mitragynine \n","while the higher concentration of this compound could lead to the development of \n","tolerance and dependence as shown by the increase of the cAMP level production \n","in foskolin stimulation. In MOR mRNA expression study, cotreatment of morphine \n","with mitragynine significantly reduced the down-regulation of MOR mRNA \n","expression as compared to morphine treatment only.\n","CONCLUSION: These finding suggest that mitragynine could possibly avoid the \n","tolerance and dependence on chronic morphine treatment by reducing the \n","up-regulation of cAMP level as well as reducing the down-regulation of MOR at a \n","lower concentration of mitragynine.': [('Mitragynine', 'CHEMICAL'), ('indole', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('AMP', 'CHEMICAL'), ('neuroblastoma SK-N-SH', 'DISEASE'), ('Mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('foskolin', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Mitragyna speciosa leaves have been abused by drug addicts as some \n","of the alkaloids (mainly mitragynine) from the plant possess opiate and \n","cocaine-like effects. These bring to its prohibition in Malaysia in 2004 as \n","consumption of M. speciosa leaves has been perceived to lead to the abuse of \n","other drugs such as cannabis and heroin.\n","METHODS: In the current study, the in vitro and in vivo effects of M. speciosa \n","methanolic, aqueous and total alkaloid leaves extracts on drug metabolizing \n","enzymes, namely, cytochrome P450s (CYP450s) and UDP-glucuronosyl transferase \n","(UGT) had been evaluated in rat liver cytosolic fraction and microsomes. \n","Aminopyrine and p-nitrophenol (pNP) were employed as probe substrates in \n","aminopyrine N-demethylase (APND) and UGT enzyme assays, respectively. \n","Furthermore, mitragynine was also tested in vitro for its likelihood to inhibit \n","APND and UGT activity. The assessment of the enzyme activity was conducted using \n","spectrophotometric methods.\n","RESULTS: In vitro, the IC50 value could only be obtained for the methanolic \n","extract in APND study (595.30±30.78 µg/mL) and not in other studies due to the \n","enzyme percentage inhibitions being <70%. In contrast to the in vitro study, the \n","oral treatment of male Sprague-Dawley rats for 14 days with 50, 100 and 200 \n","mg/kg of methanolic and aqueous extracts and with 5, 10 and 20 mg/kg of total \n","alkaloid extract showed a profound increment on the APND and UGT activities.\n","CONCLUSIONS: The current findings showed that possibilities exist for herb-drug \n","interaction with increased clearance of drugs, which are primarily metabolized \n","by CYP450s and UGT1A6 among M. speciosa leaves extract users.': [('mitragynine', 'CHEMICAL'), ('cocaine-like', 'CHEMICAL'), ('cannabis', 'CHEMICAL'), ('heroin', 'CHEMICAL'), ('Aminopyrine', 'CHEMICAL'), ('p-nitrophenol', 'CHEMICAL'), ('pNP', 'CHEMICAL'), ('aminopyrine', 'CHEMICAL'), ('APND', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('APND', 'CHEMICAL')]\n","Detected entities in text: 'ETHNOPHARMACOLOGICAL RELEVANCE: Mitragyna speciosa is a popular medicinal plant \n","in Southeast Asia which is commonly used for its morphine-like effects. Although \n","the analgesic properties of Mitragyna speciosa and its ability to ameliorate \n","withdrawal signs after abrupt cessation of opioid abuse are well known, \n","information about the long-term safety of the plant's active compounds is \n","lacking. In this work, we evaluated the effects of sub-chronic exposure to \n","mitragynine, the principal alkaloid of Mitragyna speciosa leaves in rats.\n","MATERIALS AND METHODS: Male and female Sprague-Dawley rats received three doses \n","of mitragynine (1, 10, 100mg/kg, p.o) for 28 days respectively. Food intake and \n","relative body weight were measured during the experiment. After completion of \n","drug treatment biochemical, hematological, and histological analyses were \n","performed.\n","RESULTS: No mortality was observed in any of the treatment groups. The groups of \n","rats treated with the lower and intermediate doses showed no toxic effects \n","during the study. However, the relative body weight of the group of female rats \n","treated with the 100mg/kg dose was decreased significantly. Food intake also \n","tended to decrease in the same group. Only relative liver weight increased after \n","treatment with the high dose of mitragynine (100mg/ kg) in both the male and \n","female treatment groups of rats. Biochemical and hematological parameters were \n","also altered especially in high dose treatment group which corresponds to the \n","histopathological changes.\n","CONCLUSIONS: The study demonstrated that mitragynine is relatively safe at lower \n","sub-chronic doses (1-10mg/kg) but exhibited toxicity at a highest dose \n","(sub-chronic 28 days: 100mg/kg). This was confirmed by liver, kidney, and brain \n","histopathological changes, as well as hematological and biochemical changes.': [('opioid abuse', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('1-10mg/kg', 'CHEMICAL'), ('toxicity', 'DISEASE')]\n","Detected entities in text: 'Mitragyna speciosa, a native plant of Thailand and Malaysia known as 'ketum', is \n","a plant of considerable interest. It exhibits strong antinociceptive effect and \n","yet, acts like a psychostimulant. Due to the affordability and its ease of \n","availability, the abuse of this plant as a substitute for other banned narcotics \n","has become a major concern in many societies. In countries such as Thailand, \n","Myanmar, Australia and Malaysia, the use of ketum is illegal. However, for a \n","person to be charged for possessing or selling ketum, a reliable analytical \n","method is needed in order to detect and identify the plant and its products. \n","Mitragynine is the major alkaloid of ketum. This compound manifests its \n","antinociceptive effects by acting on the opioid receptors. Since M. speciosa \n","contain large quantity of mitragynine and it is exclusive to the species, the \n","present analytical method is developed and validated for the purpose of \n","screening ketum products based on this unique compound as the analytical marker. \n","The method uses a HPLC-DAD system with Inertsil C8 (4.6 mm × 150 mm, 5 μm) as \n","the column and a mixture of acetonitrile and formic acid, 50:50 (v/v), as the \n","mobile phase. This method not only detects mitragynine, it can also be used to \n","quantify the amount of mitragynine in the sample. The limit of detection is 0.25 \n","μg/ml, while the limit of quantification is 0.50 μg/ml. The method is quick, \n","simple and reliable with an accuracy of 97.27-101.74% and coefficient of \n","variations of between 0.91 and 3.96%. The method has been tested and found \n","suitable for the identification and quantification of mitragynine in dried \n","plants, a variety of ketum extracts, as well as ketum drink obtained from the \n","market.': [('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('HPLC-DAD', 'CHEMICAL'), ('formic acid', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Mitragynine (MG) is the major active alkaloid found in Mitragyna speciosa Korth. \n","In the present study, we investigated the enhancement of analgesic action of MG \n","when combined with morphine and the effect of the combination on the development \n","of tolerance towards morphine. Mice were administered intraperitoneally with a \n","dose of MG (15 and 25 mg/kg b.wt) combined with morphine (5 mg/kg b.wt) \n","respectively for 9 days. The antinociceptive effect was evaluated by a hot plate \n","test. The protein expression of cyclic adenosine monophosphate (cAMP) and cAMP \n","response element binding (CREB) was analyzed by immunoblot. Toxicological \n","parameters especially liver and kidney function tests were assessed after the \n","combination treatment with MG and morphine. The concurrent administration of MG \n","and morphine showed significant (p < 0.05) increase in latency time when \n","compared to morphine alone group and the outstanding analgesic effects in the \n","combination regimens were maintained until day 9. For the protein expression, \n","there was a significant increment of cAMP and CREB levels (p < 0.05) in group \n","treated with 5 mg/kg morphine but there was no significant change of these \n","protein expressions when MG was combined with morphine. There was a significant \n","changes in toxicological parameters of various treated groups. The combination \n","treatment of MG and morphine effectively reduce the tolerance due to the chronic \n","administration of morphine.': [('Mitragynine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('adenosine monophosphate', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa) is a plant indigenous to Thailand and Southeast \n","Asia. Kratom leaves produce complex stimulant and opioid-like analgesic effects. \n","In Asia, kratom has been used to stave off fatigue and to manage pain, diarrhea, \n","cough, and opioid withdrawal. Recently, kratom has become widely available in \n","the United States and Europe by means of smoke shops and the Internet. Analyses \n","of the medical literature and select Internet sites indicate that individuals in \n","the United States are increasingly using kratom for the self-management of pain \n","and opioid withdrawal. Kratom contains pharmacologically active constituents, \n","most notably mitragynine and 7-hydroxymitragynine. Kratom is illegal in many \n","countries. Although it is still legal in the United States, the US Drug \n","Enforcement Administration has placed kratom on its \"Drugs and Chemicals of \n","Concern\" list. Physicians should be aware of the availability, user habits, and \n","health effects of kratom. Further research on the therapeutic uses, toxic \n","effects, and abuse potential of kratom and its constituent compounds are needed.': [('fatigue', 'DISEASE'), ('pain', 'DISEASE'), ('diarrhea', 'DISEASE'), ('cough', 'DISEASE'), ('smoke', 'CHEMICAL'), ('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Kratom (or Ketum) is a psychoactive plant preparation used in Southeast Asia. It \n","is derived from the plant Mitragyna speciosa Korth. Kratom as well as its main \n","alkaloid, mitragynine, currently spreads around the world. Thus, addiction \n","potential and adverse health consequences are becoming an important issue for \n","health authorities. Here we reviewed the available evidence and identified \n","future research needs. It was found that mitragynine and M. speciosa \n","preparations are systematically consumed with rather well defined \n","instrumentalization goals, e.g. to enhance tolerance for hard work or as a \n","substitute in the self-treatment of opiate addiction. There is also evidence \n","from experimental animal models supporting analgesic, muscle relaxant, \n","anti-inflammatory as well as strong anorectic effects. In humans, regular \n","consumption may escalate, lead to tolerance and may yield aversive withdrawal \n","effects. Mitragynine and its derivatives actions in the central nervous system \n","involve μ-opioid receptors, neuronal Ca²⁺ channels and descending monoaminergic \n","projections. Altogether, available data currently suggest both, a therapeutic as \n","well as an abuse potential.': [('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Cannabinoids and opioids systems share numerous pharmacological properties and \n","antinociception is one of them. Previous findings have shown that mitragynine \n","(MG), a major indole alkaloid found in Mitragyna speciosa (MS) can exert its \n","antinociceptive effects through the opioids system. In the present study, the \n","action of MG was investigated as the antinociceptive agent acting on Cannabinoid \n","receptor type 1 (CB1) and effects on the opioids receptor. The latency time was \n","recorded until the mice showed pain responses such as shaking, licking or \n","jumping and the duration of latency was measured for 2 h at every 15 min \n","interval by hot plate analysis. To investigate the beneficial effects of MG as \n","antinociceptive agent, it was administered intraperitoneally 15 min prior to \n","pain induction with a single dosage (3, 10, 15, 30, and 35 mg/kg b.wt). In this \n","investigation, 35 mg/kg of MG showed significant increase in the latency time \n","and this dosage was used in the antagonist receptor study. The treated groups \n","were administered with AM251 (cannabinoid receptor-1 antagonist), naloxone \n","(non-selective opioid antagonist), naltrindole (δ-opioid antagonist) \n","naloxonazine (μ(1)-receptor antagonist) and norbinaltorpimine (κ-opioid \n","antagonist) respectively, prior to administration of MG (35 mg/kg). The results \n","showed that the antinociceptive effect of MG was not antagonized by AM251; \n","naloxone and naltrindole were effectively blocked; and norbinaltorpimine \n","partially blocked the antinociceptive effect of MG. Naloxonazine did inhibit the \n","effect of MG, but it was not statistically significant. These results \n","demonstrate that CB1 does not directly have a role in the antinociceptive action \n","of MG where the effect was observed with the activation of opioid receptor.': [('mitragynine', 'CHEMICAL'), ('indole alkaloid', 'CHEMICAL'), ('pain', 'DISEASE'), ('MG', 'CHEMICAL'), ('pain', 'DISEASE'), ('MG', 'CHEMICAL'), ('AM251', 'CHEMICAL'), ('naloxone', 'CHEMICAL'), ('naltrindole', 'CHEMICAL'), ('naloxonazine', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('AM251', 'CHEMICAL'), ('naloxone', 'CHEMICAL'), ('naltrindole', 'CHEMICAL'), ('MG', 'CHEMICAL'), ('Naloxonazine', 'CHEMICAL'), ('MG', 'CHEMICAL')]\n","Detected entities in text: 'In recent years, various herbal products adulterated with synthetic cannabinoids \n","have been distributed worldwide via the Internet. These herbal products are \n","mostly sold as incense, and advertised as not for human consumption. Although \n","their labels indicate that they contain mixtures of several potentially \n","psychoactive plants, and numerous studies have reported that they contain a \n","variety of synthetic cannabinoids, their exact botanical contents are not always \n","clear. In this study, we investigated the origins of botanical materials in 62 \n","Spice-like herbal products distributed on the illegal drug market in Japan, by \n","DNA sequence analyses and BLAST searches. The nucleotide sequences of four \n","regions were analyzed to identify the origins of each plant species in the \n","herbal mixtures. The sequences of \"Damiana\" (Turnera diffusa) and Lamiaceae \n","herbs (Mellissa, Mentha and Thymus) were frequently detected in a number of \n","products. However, the sequences of other plant species indicated on the \n","packaging labels were not detected. In a few products, DNA fragments of potent \n","psychotropic plants were found, including marijuana (Cannabis sativa), \n","\"Diviner's Sage\" (Salvia divinorum) and \"Kratom\" (Mitragyna speciosa). Their \n","active constituents were also confirmed using gas chromatography-mass \n","spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS), \n","although these plant names were never indicated on the labels. Most plant \n","species identified in the products were different from the plants indicated on \n","the labels. The plant materials would be used mainly as diluents for the \n","psychoactive synthetic compounds, because no reliable psychoactive effects have \n","been reported for most of the identified plants, with the exception of the \n","psychotropic plants named above.': [('nucleotide', 'CHEMICAL'), ('Cannabis', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Krathom is currently the most popular illicit substance in use in \n","southern Thailand. Research regarding its effects and health impacts is scarce. \n","This study explored the pattern of krathom use and users' perceptions of the \n","consequences of its use.\n","METHODS: An in-depth qualitative interview. A group of 34 self-identified \n","regular users, occasional users, non-users and ex-users of krathom was used in \n","this study. Health volunteer as a key-contact person helped the researcher to \n","invite villagers to participate in the study using snowballing technique. The \n","process of data analysis was guided by Strauss and Corbin's grounded theory.\n","RESULTS: The core category, 'Understanding krathom use', was generated from \n","three inter-related categories: (i) reasons for continuing krathom use, (ii) the \n","way of applying krathom, and (iii) perceiving positive and realizing the \n","negative effects of krathom use and their 18 subcategories.\n","CONCLUSIONS: The study findings reveal the importance of considering krathom use \n","from the perspective and belief of the villagers. Krathom is addictive with its \n","own characteristic symptoms and signs. The results provide support for policy \n","interventions to control the availability of krathom according to the community \n","context. In addition, krathom misuse by adolescents must be considered.': [('Krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('Krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL'), ('krathom', 'CHEMICAL')]\n","Detected entities in text: 'A 17-year-old white man who showed no obvious signs of trauma was found \n","unresponsive in bed and was pronounced dead at the scene. The decedent had a \n","documented history of heroin abuse and chronic back pain and reportedly \n","self-medicated with Kratom (mitragynine). The autopsy was remarkable only for \n","pulmonary congestion and edema and a distended bladder, both of which are \n","consistent with, though not diagnostic of, opiate use. A laboratory work-up \n","revealed therapeutic levels of over-the-counter cold medications and \n","benzodiazepines. However, of interest was a level of mitragynine at 0.60 mg/L. \n","Given the facts of the case, the Medical Examiner certified the cause of death \n","as \"possible Kratom toxicity\" and the manner of death was classified as \n","\"accident.\"': [('trauma', 'DISEASE'), ('heroin abuse', 'DISEASE'), ('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('pulmonary congestion', 'DISEASE'), ('edema', 'DISEASE'), ('benzodiazepines', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('death', 'DISEASE'), ('toxicity', 'DISEASE'), ('death', 'DISEASE')]\n","Detected entities in text: 'The leaves of the South Asian plant kratom are described as having stimulating \n","effects at low doses, and opiate-like analgesic and euphoric effects at high \n","doses. A long history of use and abuse has led to the classification of kratom \n","as a controlled substance in its native Thailand and other South Asian \n","countries. However, kratom is not controlled in the United States, and the ready \n","availability of kratom has led to its emergence as an herbal drug of abuse. With \n","the growing popularity of kratom, efficient procedures are needed to detect \n","kratom use. In the current study, both ultra-high-performance liquid \n","chromatography and high-performance liquid chromatography-tandem mass \n","spectrometry methods have been developed and validated for monitoring the major \n","alkaloids and metabolites found in urine following kratom use. The primary \n","unique alkaloid mitragynine is quantified in human urine from 1.00-500.00 ng/mL \n","using mitraphylline as an internal standard. In addition, two metabolites \n","(5-desmethylmitragynine and 17-desmethyldihydromitragynine) and the related \n","active, alkaloid 7-hydroxy-mitragynine, are simultaneously qualitatively \n","monitored. The presence of analytes are confirmed by an information-dependent \n","acquisition-enhanced product ion procedure generating full fragmentation data \n","used to positively identify detected analytes. The validated method has been \n","utilized for clinical and forensic analyses of urine for the detection of kratom \n","use.': [('mitragynine', 'CHEMICAL'), ('17-desmethyldihydromitragynine', 'CHEMICAL')]\n","Detected entities in text: 'There have been numerous non-scientific reports on the behavioural effects of \n","Asian plants in humans who consumed these plants wholly or part thereof. \n","Knowledge passed from generation to generation informs us of plants that \n","increase effort and stamina, such as during paddy planting after the ingestion \n","of Mitragyna speciosa Korth (ketum) as a tea supplement. Centella asiatica and \n","Myristica fragrans are used as herbs to improve memory and to treat epilepsy, \n","respectively. Zizyphus mauritiana is used to treat headache and burn pain, acts \n","as an antitussive, and reduces rigor mortis immediately after death. These \n","plants, which have been identified to exhibit analgaesic, muscle-relaxing, and \n","nootropic effects, may contain important bio-compounds for medicinal chemistry \n","and pharmaceutical research in Malaysia. The electrophysiology properties of \n","these plants and their effects on epilepsy, behaviour, and pain will lead \n","Malaysia to future new drug discoveries.': [('tea', 'CHEMICAL'), ('epilepsy', 'DISEASE'), ('headache', 'DISEASE'), ('pain', 'DISEASE'), ('mortis', 'DISEASE'), ('death', 'DISEASE'), ('epilepsy', 'DISEASE'), ('pain', 'DISEASE')]\n","Detected entities in text: 'ETHNOPHARMACOLOGICAL RELEVANCE: The consumption of Mitragyna speciosa (MS) for \n","its psychoactive effects is widely reported amongst people in the villages in \n","Thailand and Malaysia even though its use is illegal.\n","AIM OF THE STUDY: This study examined the pattern of MS use, its reported \n","effects and explored its potential to cause dependence.\n","MATERIALS AND METHODS: We used both convenience and snowball-sampling methods to \n","recruit participants in a border town between two northern states in Malaysia. \n","Face-to-face interviews were conducted with the use of a structured \n","questionnaire on 562 respondents who gave oral consent to participate in the \n","study.\n","RESULTS: The response rate was 91%. The majority of the respondents (88%) \n","reported daily use of MS. The main mode of using MS was by drinking the MS \n","extract as tea (90%). The mean age of starting MS use was 28.3 (SD=8.1) years. A \n","variety of reasons were given for using MS including for social and recreational \n","needs, stamina and physical endurance, pain relief and improved sexual \n","performance. Despite its reported usefulness in weaning off opiate addiction, \n","460 (87%) admitted they were not able to stop using MS. Only education level had \n","a statistically significant association with the ability to stop or not stop the \n","use of MS (χ(2)=31.0, df=1, p<0.001). Significantly higher proportions of those \n","with a lower education level (38%) were able to stop using MS compared to \n","respondents with a higher education level.\n","CONCLUSIONS: Our study provides important information on the pattern of MS use, \n","its effects and its potential to cause addiction, as there has been growing \n","interest in MS as evidenced by the number of advertisements for its sale on the \n","Internet. Future study is required to explore its psychological and social \n","impact on users.': [('extract', 'CHEMICAL'), ('tea', 'CHEMICAL'), ('pain', 'DISEASE')]\n","Detected entities in text: 'A major obstacle in treating drug addiction is the severity of opiate withdrawal \n","syndrome, which can lead to unwanted relapse. Mitragynine is the major alkaloid \n","compound found in leaves of Mitragyna speciosa, a plant widely used by opiate \n","addicts to mitigate the harshness of drug withdrawal. A series of experiments \n","was conducted to investigate the effect of mitragynine on anxiety behavior, \n","cortisol level and expression of stress pathway related genes in zebrafish \n","undergoing morphine withdrawal phase. Adult zebrafish were subjected to two \n","weeks chronic morphine exposure at 1.5 mg/L, followed by withdrawal for 24 hours \n","prior to tests. Using the novel tank diving tests, we first showed that \n","morphine-withdrawn zebrafish display anxiety-related swimming behaviors such as \n","decreased exploratory behavior and increased erratic movement. Morphine \n","withdrawal also elevated whole-body cortisol levels, which confirms the \n","phenotypic stress-like behaviors. Exposing morphine-withdrawn fish to \n","mitragynine however attenuates majority of the stress-related swimming behaviors \n","and concomitantly lower whole-body cortisol level. Using real-time PCR gene \n","expression analysis, we also showed that mitragynine reduces the mRNA expression \n","of corticotropin releasing factor receptors and prodynorphin in zebrafish brain \n","during morphine withdrawal phase, revealing for the first time a possible link \n","between mitragynine's ability to attenuate anxiety during opiate withdrawal with \n","the stress-related corticotropin pathway.': [('drug addiction', 'DISEASE'), ('Mitragynine', 'CHEMICAL'), ('harshness', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('anxiety', 'DISEASE'), ('cortisol', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('Morphine', 'CHEMICAL'), ('cortisol', 'CHEMICAL'), ('stress-like behaviors', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('cortisol', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('anxiety', 'DISEASE')]\n","Detected entities in text: 'Mitragyna speciosa, a tropical plant indigenous to Southeast Asia, is well known \n","for its psychoactive properties. Its leaves are traditionally chewed by Thai and \n","Malaysian farmers and manual labourers as it causes a numbing, stimulating \n","effect. The present study aims to evaluate alkaloid yield and composition in the \n","leaf extracts. For this purpose we have compared several non-conventional \n","extraction techniques with classic procedures (room temperature or under \n","heating). Dried M. speciosa leaves belonging to three batches of different \n","origin (from Thailand, Malaysia and Indonesia) were extracted using \n","ultrasound-assisted extraction (UAE), microwave-assisted extraction (MAE) and \n","supercritical carbon dioxide extraction SFE-CO(2), using methanol, ethanol, \n","water and binary mixtures. The extracts were compared using an HPLC/ESI-MS \n","analysis of mitragynine and four other related alkaloids which were present in \n","the alkaloid fraction. The extraction technique influences both the raw product \n","yield and the relative alkaloid content of M. speciosa leaves. Of the several \n","methods tested, MAE in a closed vessel at 110 °C (60 W, methanol/water 1:1) gave \n","the highest alkaloid fraction amount, while UAE with an immersion horn at 25 °C \n","(21.4 kHz, 50 W, methanol) showed the best yield for mitragynine. This work may \n","prove to be a useful contribution to forensic, toxicological and pharmacognosy \n","studies. Although the potential applications of M. speciosa alkaloids clearly \n","need further investigation, these results may facilitate the scaling-up of their \n","extraction.': [('carbon dioxide', 'CHEMICAL'), ('methanol', 'CHEMICAL'), ('ethanol', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'The extract from Mitragyna speciosa has been widely used as an opium substitute, \n","mainly due to its morphine-like pharmacological effects. This study investigated \n","the effects of M. speciosa alkaloid extract (MSE) on human recombinant \n","cytochrome P450 (CYP) enzyme activities using a modified Crespi method. As \n","compared with the liquid chromatography-mass spectrometry method, this method \n","has shown to be a fast and cost-effective way to perform CYP inhibition studies. \n","The results indicated that MSE has the most potent inhibitory effect on CYP3A4 \n","and CYP2D6, with apparent half-maximal inhibitory concentration (IC(50)) values \n","of 0.78 µg/mL and 0.636 µg/mL, respectively. In addition, moderate inhibition \n","was observed for CYP1A2, with an IC(50) of 39 µg/mL, and weak inhibition was \n","detected for CYP2C19. The IC(50) of CYP2C19 could not be determined, however, \n","because inhibition was <50%. Competitive inhibition was found for the \n","MSE-treated CYP2D6 inhibition assay, whereas non-competitive inhibition was \n","shown in inhibition assays using CYP3A4, CYP1A2 and CYP2C19. Quinidine (CYP2D6), \n","ketoconazole (CYP3A4), tranylcypromine (CYP2C19) and furafylline (CYP1A2) were \n","ACCESSused as positive controls throughout the experiments. This study shows \n","that MSE may contribute to an herb-drug interaction if administered \n","concomitantly with drugs that are substrates for CYP3A4, CYP2D6 and CYP1A2.': [('opium', 'CHEMICAL'), ('Quinidine', 'CHEMICAL'), ('ketoconazole', 'CHEMICAL'), ('tranylcypromine', 'CHEMICAL')]\n","Detected entities in text: 'Here we present a case of a coincidence of addiction to \"Kratom\" (botanically \n","known as Mitragyna speciosa Korth) and developed severe primary hypothyroidism. \n","We are discussing a possibility that high dose of indole alkaloid mitragynine \n","(the major alkaloid identified from \"Kratom\") might reduce the normal response \n","of the thyroid gland to thyroid-stimulating hormone resulting in primary \n","hypothyroidism. Further experimental investigations of mitragynine as a possible \n","suppressor of thyroid gland function would be a matter of interest.': [('primary hypothyroidism', 'DISEASE'), ('indole alkaloid', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('hypothyroidism', 'DISEASE'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'INTRODUCTION: Kratom (Mitragyna speciosa) is a common medical plant in Thailand \n","and is known to contain mitragynine as the main alkaloid. According to an \n","increase in published reports and calls at German poison control centers, it has \n","been used more frequently as a drug of abuse in the western hemisphere during \n","the last couple of years. Despite this increase, reports of severe toxicity are \n","rare within the literature.\n","CASE REPORT: We describe a case of a young man who presented with jaundice and \n","pruritus after intake of kratom for 2 weeks in the absence of any other \n","causative agent. Alkaloids of M. speciosa were detected in the urine.\n","CONCLUSION: While M. speciosa is gaining in popularity among illicit drug users, \n","its adverse effects remain poorly understood. This is the first published case \n","of intrahepatic cholestasis after kratom abuse.': [('mitragynine', 'CHEMICAL'), ('toxicity', 'DISEASE'), ('jaundice', 'DISEASE'), ('pruritus', 'DISEASE'), ('intrahepatic cholestasis', 'DISEASE'), ('kratom abuse', 'DISEASE')]\n","Detected entities in text: 'ETHNOPHARMACOLOGICAL RELEVANCE: [corrected] Mitragyna speciosa Korth (Rubiaceae) \n","is one of the medicinal plants used traditionally to treat various types of \n","diseases especially in Thailand and Malaysia. Its anti-inflammatory and \n","analgesic properties in its crude form are well documented. In this study, the \n","cellular mechanism involved in the anti-inflammatory effects of mitragynine, the \n","major bioactive constituent, was investigated.\n","MATERIALS AND METHODS: The effects of mitragynine on the mRNA and protein \n","expression of COX-1 and COX-2 and the production of prostaglandin E(2) (PGE(2)) \n","were investigated in LPS-treated RAW264.7 macrophage cells. Quantitative RT-PCR \n","was used to assess the mRNA expression of COX-1 and COX-2. Protein expression of \n","COX-1 and COX-2 were assessed using Western blot analysis and the level of \n","PGE(2) production was quantified using Parameter™ PGE(2) Assay (R&D Systems).\n","RESULTS: Mitragynine produced a significant inhibition on the mRNA expression of \n","COX-2 induced by LPS, in a dose dependent manner and this was followed by the \n","reduction of PGE(2) production. On the other hand, the effects of mitragynine on \n","COX-1 mRNA expression were found to be insignificant as compared to the control \n","cells. However, the effect of mitragynine on COX-1 protein expression is \n","dependent on concentration, with higher concentration of mitragynine producing a \n","further reduction of COX-1 expression in LPS-treated cells.\n","CONCLUSIONS: These findings suggest that mitragynine suppressed PGE(2) \n","production by inhibiting COX-2 expression in LPS-stimulated RAW264.7 macrophage \n","cells. Mitragynine may be useful for the treatment of inflammatory conditions.': [('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('prostaglandin E(2', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa (Kratom in Thai), native in Southeast Asia, is increasingly \n","misused as a herbal drug of abuse. During metabolism studies on the Kratom \n","alkaloids mitragynine, its diastereomers speciogynine and speciociliatine as \n","well as paynantheine in rats and humans, further isomeric compounds were \n","detected in Kratom users' urine. The question arose whether these compounds were \n","formed from the low abundant, isomeric alkaloids mitraciliatine (MC) and \n","isopaynantheine (ISO-PAY). Therefore, the aim of the presented study was to \n","identify using liquid chromatography-linear ion trap-mass spectrometry their \n","phase I and II metabolites in rat urine after administration of pure MC or \n","ISO-PAY, to confirm their formation in humans, and finally to confirm whether \n","the above-mentioned isomeric compounds in human urine represent MC and ISO-PAY \n","and/or their metabolites. The metabolic pathways of both alkaloids in rats were \n","found to be comparable to those of their corresponding diastereomers. In the \n","human urines tested, not all metabolites found in rats could be detected because \n","of the much lower amounts of MC and ISO-PAY in Kratom. However, all the \n","above-mentioned so far unknown isomeric compounds could be identified in the \n","human urine samples as MC, ISO-PAY and/or their metabolites. The used LC \n","separation was also suitable for the differentiation of all other Kratom \n","alkaloids and their metabolites in human urine.': [('drug of abuse', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('speciogynine', 'CHEMICAL'), ('speciociliatine', 'CHEMICAL'), ('paynantheine', 'CHEMICAL'), ('isomeric alkaloids mitraciliatine', 'CHEMICAL'), ('isopaynantheine', 'CHEMICAL'), ('ISO-PAY', 'CHEMICAL'), ('ISO-PAY', 'CHEMICAL'), ('ISO-PAY', 'CHEMICAL'), ('ISO-PAY', 'CHEMICAL'), ('ISO-PAY', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa Korth. (Rubiaceae) is a tree that is commonly found in \n","Southeast Asia. Leaves from this tree have been traditionally been used for both \n","their stimulant properties as well as an opium substitute. The tree/leaves are \n","currently illegal in four countries, but is currently legal and widely available \n","in the United States. To date over 40 compounds have been isolated from the \n","leaves. The major alkaloid found within the crude extract, mitragynine, has been \n","the subject of many pharmacological studies. In addition to the pharmacological \n","studies, two total syntheses of mitragynine have been published as well as \n","general structure-activity relationships (SARs) with respect to opioid activity.': [('opium', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Mitragyna speciosa Korth. leaves have been used for decades as a traditional \n","medicine to treat diarrhea, diabetes and to improve blood circulation by natives \n","of Malaysia, Thailand and other regions of Southeast Asia. Mitragynine is the \n","major active alkaloid in the plant. To date, the role of mitragynine in \n","psychological disorders such as depression is not scientifically evaluated. \n","Hence, the present investigation evaluates the antidepressant effect of \n","mitragynine in the mouse forced swim test (FST) and tail suspension test (TST), \n","two models predictive of antidepressant activity and the effect of mitragynine \n","towards neuroendocrine system of hypothalamic-pituitary-adrenal (HPA) axis by \n","measuring the corticosterone concentration of mice exposed to FST and TST. An \n","open-field test (OFT) was used to detect any association of immobility in the \n","FST and TST with changes in motor activity of mice treated with mitragynine. In \n","the present study, mitragynine at dose of 10 mg/kg and 30 mg/kg i.p. injected \n","significantly reduced the immobility time of mice in both FST and TST without \n","any significant effect on locomotor activity in OFT. Moreover, mitragynine \n","significantly reduced the released of corticosterone in mice exposed to FST and \n","TST at dose of 10 mg/kg and 30 mg/kg. Overall, the present study clearly \n","demonstrated that mitragynine exerts an antidepressant effect in animal \n","behavioral model of depression (FST and TST) and the effect appears to be \n","mediated by an interaction with neuroendocrine HPA axis systems.': [('diarrhea', 'DISEASE'), ('diabetes', 'DISEASE'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('depression', 'DISEASE'), ('antidepressant', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('antidepressant', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('corticosterone', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('corticosterone', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('antidepressant', 'CHEMICAL'), ('depression', 'DISEASE')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa) has been used for medicinal and recreational \n","purposes. It has reported analgesic, euphoric and antitussive effects via its \n","action as an agonist at opioid receptors. It is illegal in many countries \n","including Thailand, Malaysia, Myanmar, South Korea and Australia; however, it \n","remains legal or uncontrolled in the UK and USA, where it is easily available \n","over the Internet. We describe a case of kratom dependence in a 44-year-old man \n","with a history of alcohol dependence and anxiety disorder. He demonstrated \n","dependence on kratom with withdrawal symptoms consisting of anxiety, \n","restlessness, tremor, sweating and cravings for the substance. A reducing regime \n","of dihydrocodeine and lofexidine proved effective in treating subjective and \n","objective measures of opioid-like withdrawal phenomena, and withdrawal was \n","relatively short and benign. There are only few reports in the literature of \n","supervised detoxification and drug treatment for kratom dependence. Our \n","observations support the idea that kratom dependence syndrome is due to \n","short-acting opioid receptor agonist activity, and suggest that dihydrocodeine \n","and lofexidine are effective in supporting detoxification.': [('alcohol dependence', 'DISEASE'), ('anxiety disorder', 'DISEASE'), ('anxiety', 'DISEASE'), ('tremor', 'DISEASE'), ('dihydrocodeine', 'CHEMICAL'), ('lofexidine', 'CHEMICAL'), ('kratom dependence', 'DISEASE'), ('kratom dependence syndrome', 'DISEASE'), ('dihydrocodeine', 'CHEMICAL'), ('lofexidine', 'CHEMICAL')]\n","Detected entities in text: 'ETHNOPHARMACOLOGICAL RELEVANCE: Mitragyna speciosa Korth (ketum) is widely used \n","in Malaysia as a medicinal agent for treating diarrhea, worm infestations and \n","also acts as an analgesic and antipyretic.\n","AIM: The aim of the study is to determine the acute toxicity of Mitragyna \n","speciosa Korth standardized methanol extract in vivo in 4-weeks-old \n","Sprague-Dawley rats.\n","METHODOLOGY: Rats were orally administrated single dose of 100, 500 and 1000 \n","mg/kg Mitragyna speciosa Korth standardized methanol extract and the control \n","group received 430 mg/kg of morphine orally. There were 10 rats in each group. \n","All animals were sacrificed after 14 days of treatment. Eight parameters were \n","tested: cage side observation, body weight measurement, food and water \n","consumption, blood pressure, absolute and relative organ weight, hematology, \n","biochemical analysis and histopathology, to look for evidence of toxicity.\n","RESULT: No mortality was noted after 14 days of treatment. In general, behavior, \n","food and water consumption, hematological studies and organ weights showed no \n","significant changes. The standardized methanol extraction of Mitragyna speciosa \n","Korth increased rat blood pressure (systolic: 147.4+/-1.01, 131.64+/-4.94 and \n","137.8+/-4.46) after an hour of 100, 500 and 1000 mg/kg doses, respectively. \n","Biochemical studies showed significant elevation of ALT, AST, albumin, \n","triglycerides, cholesterol and albumin (p>0.05), at all levels of doses. But, \n","nephrotoxicity evidenced by elevated creatinine was seen only at a dose of 1000 \n","mg/kg. Histological examination showed congestion of sinusoids, hemorrhage \n","hepatocytes, fatty change, centrilobular necrosis and increased number of \n","Kuppfer cells in the liver of all Mitragyna speciosa Korth standardized methanol \n","extract treated groups.\n","CONCLUSION: Oral administration of standardized methanolic extraction of \n","Mitragyna speciosa Korth resulted in increasing rat blood pressure after an hour \n","of drug administration. The highest dose of extract also induced acute severe \n","hepatotoxicity and mild nephrotoxicity. However, Mitragyna speciosa Korth shows \n","no effects on body weight, food and water consumption, absolute and relative \n","organ weight and also hematology parameters.': [('diarrhea', 'DISEASE'), ('toxicity', 'DISEASE'), ('methanol extract', 'CHEMICAL'), ('methanol extract', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('toxicity', 'DISEASE'), ('cholesterol', 'CHEMICAL'), ('nephrotoxicity', 'DISEASE'), ('creatinine', 'CHEMICAL'), ('hemorrhage', 'DISEASE'), ('fatty', 'DISEASE'), ('necrosis', 'DISEASE'), ('extract', 'CHEMICAL'), ('extract', 'CHEMICAL'), ('hepatotoxicity', 'DISEASE'), ('nephrotoxicity', 'DISEASE')]\n","Detected entities in text: 'Mitragyna speciosa Korth is a medicinal plant indigenous to Thailand and \n","Malaysia and has been known for its narcotic and coca-like effects. Many studies \n","have been performed on the antinociceptive effect of the plant extracts of Thai \n","origin; however, limited studies have been reported till date on M. speciosa \n","extracts of Malaysian origin. Various concentrations of alkaloid (5-20 mg/kg), \n","methanolic (50-200 mg/kg), and aqueous (100-400 mg/kg) extracts of Malaysian M. \n","speciosa leaves were prepared and orally administered to nine groups of rats. \n","Morphine (5 mg/kg, s.c.) and aspirin (300 mg/kg, p.o.) were used as control. \n","Antagonism of the antinociceptive activity was evaluated by pretreatment with \n","naloxone at a dose of 2 mg/kg (i.p.). Results showed that oral administration of \n","the alkaloid (20 mg/kg), methanolic (200 mg/kg), and aqueous (400 mg/kg) \n","extracts significantly prolonged the latency of nociceptive response compared \n","with control groups in both hot plate and tail flick tests (P < 0.05). \n","Antinociceptive action of the alkaloid (20 mg/kg), methanolic (200 mg/kg), and \n","aqueous (400 mg/kg) extracts was significantly blocked by naloxone. In \n","conclusion, these results suggest the presence of antinociceptive effect in \n","various extracts of Malaysian M. speciosa leaves. In addition, the \n","antinociceptive effective doses vary depending on the type of solvents used for \n","extraction.': [('Morphine', 'CHEMICAL'), ('aspirin', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('naloxone', 'CHEMICAL'), ('naloxone', 'CHEMICAL')]\n","Detected entities in text: 'Reports of toxicity secondary to Kratom are rare and lack of diagnostic testing \n","in human specimens has prevented confirmatory explanation of observed clinical \n","effects. We present a novel case of serious human toxicity following Kratom use \n","confirmed via quantitative analysis of urine by high performance liquid \n","chromatography coupled to electrospray tandem mass spectrometry. A 64 year-old \n","male was witnessed to have a seizure at home following kratom consumption. Upon \n","arrival to the emergency department (ED), the patient was unresponsive. While in \n","the ED, the patient sustained a second seizure. He was intubated to protect his \n","airway. The remainder of his hospital course was uneventful. A urine specimen \n","was collected shortly after admission and sent for analysis. The mitragynine \n","concentration in the urine was 167 ± 15 ng/ml. We report a rare case of Kratom \n","toxicity characterized by a seizure and coma confirmed by urinary analysis of \n","mitragynine by high performance liquid chromatography coupled to electrospray \n","tandem mass spectrometry. The proposed mechanism for this reaction is unclear \n","but suggested mechanisms include adenosine binding or stimulation of adrenergic \n","and/or serotonergic receptors similar to tramadol.': [('toxicity', 'DISEASE'), ('toxicity', 'DISEASE'), ('seizure', 'DISEASE'), ('seizure', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('±', 'CHEMICAL'), ('toxicity', 'DISEASE'), ('seizure', 'DISEASE'), ('coma', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('adenosine', 'CHEMICAL'), ('tramadol', 'CHEMICAL')]\n","Detected entities in text: 'AIM OF THE STUDY: The effects of pure alkaloid, mitragynine and a methanolic \n","extract of kratom leaves were investigated on neuromuscular junction and \n","compound nerve action potential.\n","MATERIALS AND METHODS: Wistar rats were killed by cervical dislocation and \n","decapitated. The phrenic nerve-hemidiaphragms, hemidiaphragms and sciatic nerve \n","were isolated.\n","RESULTS: Kratom methanolic extract present at 0.1-1 mg/mL and mitragynine \n","(0.0156 mg/mL) decreased the muscle twitch on the isolated phrenic \n","nerve-hemidiaphragm and hemidiaphragm preparation. Muscle relaxation caused by \n","kratom extract (1 mg/mL) was greater than the effect of mitragynine. Pancuronium \n","and succinylcholine potentiated the effect of kratom extract. It also had a \n","direct relaxation effect on the hemidiaphragm muscle. The muscle relaxation \n","caused by kratom extract was not antagonized by neostigmine, tetraethylammonium \n","and calcium chloride. High concentrations of kratom extract (10-40 mg/mL) and \n","mitragynine (2 mg/mL) blocked the nerve conduction, amplitude and duration of \n","compound nerve action potential.\n","CONCLUSIONS: The mechanism of action of kratom extract might not act as a \n","competitive antagonist of acetylcholine yet its dominant effect was at the \n","neuromuscular junction and not at the skeletal muscle or somatic nerve.': [('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('muscle twitch', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('Pancuronium', 'CHEMICAL'), ('succinylcholine', 'CHEMICAL'), ('kratom extract', 'CHEMICAL'), ('kratom extract', 'CHEMICAL'), ('neostigmine', 'CHEMICAL'), ('tetraethylammonium', 'CHEMICAL'), ('calcium chloride', 'CHEMICAL'), ('kratom extract', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('kratom extract', 'CHEMICAL'), ('acetylcholine', 'CHEMICAL')]\n","Detected entities in text: 'AIM OF THE STUDY: Mitragyna speciosa Korth from Rubiaceae family is a tropical \n","plant indigenous to Southeast Asia particularly in Thailand, Peninsular of \n","Malaysia and Indonesia. The leaves have been used by natives for their \n","opium-like effect and cocaine-like stimulant ability to combat fatigue and \n","enhance tolerance to hard work. However there is no scientific information about \n","the effect of mitragynine on the cognitive performances. This study is designed \n","to examine the working memory effects of mitragynine which is extracted from \n","Mitragyna speciosa mature leaves.\n","MATERIALS AND METHODS: The cognitive effect was studied using object location \n","task and the motor activity in open-field test. Mitragynine 5, 10 and 15 mg/kg \n","and were administered by intraperitoneal (IP) for 28 consecutive days and \n","evaluated on day 28 after the last dose treatment. Scopolamine was used as the \n","control positive drug.\n","RESULTS: In this study there is prominent effects on horizontal locomotor \n","activity was observed. Mitragynine significantly reduced locomotor activity in \n","open-field test compared with vehicle. In object location task mitragynine (5, \n","10 and 15 mg/kg) did not showed any significances discrimination between the \n","object that had changed position than the object that had remain in a constant \n","position.\n","CONCLUSION: Our results suggest that chronic administration of mitragynine can \n","altered the cognitive behavioral function in mice.': [('cocaine-like', 'CHEMICAL'), ('fatigue', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('Scopolamine', 'CHEMICAL'), ('Mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'In the present study, we investigate the effects of three different Mitragyna \n","speciosa extracts, namely methanolic, aqueous and total alkaloid extracts, on \n","glutathione transferase-specific activity in male Sprague Dawley rat liver \n","cytosol in vitro and in vivo. In the in vitro study, the effect of Mitragyna \n","speciosa extracts (0.01 to 750 microg/mL) against the specific activity of \n","glutathione transferases was examined in rat liver cytosolic fraction from \n","untreated rats. Our data show concentration dependent inhibition of cytosolic \n","GSTs when Mitragyna speciosa extract was added into the reaction mixture. At the \n","highest concentration used, the methanolic extract showed the highest GSTs \n","specific activity inhibition (61%), followed by aqueous (50%) and total alkaloid \n","extract (43%), respectively. In in vivo study, three different dosages; 50, 100 \n","and 200 mg/kg for methanolic and aqueous extracts and 5, 10 and 20 mg/kg for \n","total alkaloid extract were given orally for 14 days. An increase in GST \n","specific activity was generally observed. However, only Mitragyna speciosa \n","aqueous extract with a dosage of 100 mg/kg showed significant results: 129% \n","compared to control.': [('glutathione', 'CHEMICAL'), ('glutathione', 'CHEMICAL'), ('Mitragyna speciosa extract', 'CHEMICAL'), ('extract', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Ketum (krathom) has been mentioned in the literature as a \n","traditional alternative to manage drug withdrawal symptoms though there are no \n","studies indicating its widespread use for this purpose. This study examines the \n","reasons for ketum consumption in the northern areas of peninsular Malaysia where \n","it is widely used.\n","METHODS: A cross-sectional survey of 136 active users was conducted in the \n","northern states of Kedah and Penang in Malaysia. On-site urine screening was \n","done for other substance use.\n","FINDINGS: Ketum users were relatively older (mean 38.7 years) than the larger \n","substance using group. Nearly 77% (104 subjects) had previous drug use history, \n","whilst urine screening confirmed 62 subjects were also using other substances. \n","Longer-term users (use >2 years) had higher odds of being married, of consuming \n","more than the average three glasses of ketum a day and reporting better \n","appetite. Short-term users had higher odds of having ever used heroin, testing \n","positive for heroin and of using ketum to reduce addiction to other drugs. Both \n","groups used ketum to reduce their intake of more expensive opiates, to manage \n","withdrawal symptoms and because it was cheaper than heroin. These findings \n","differ from those in neighbouring Thailand where ketum was used primarily to \n","increase physical endurance.\n","CONCLUSIONS: No previous study has shown the use of ketum to manage opioid \n","withdrawal symptoms except for a single case reported in the US. Ketum was \n","described as affordable, easily available and having no serious side effects \n","despite prolonged use. It also permitted self-treatment that avoids \n","stigmatisation as a drug dependent. The claims of so many subjects on the \n","benefits of ketum merits serious scientific investigation. If prolonged use is \n","safe, the potential for widening the scope and reach of substitution therapy and \n","lowering its cost are tremendous, particularly in developing countries.': [('krathom', 'CHEMICAL')]\n","Detected entities in text: 'Studies on the antioxidant and antimicrobial activities of Mitragyna speciosa \n","leaf extracts are lacking. In this study the antioxidant properties of water, \n","methanolic and alkaloid M. speciosa leaf extracts were evaluated using the DPPH \n","(2,2-diphenyl-1- picrylhydrazyl) radical scavenging method. The amount of total \n","phenolics and flavanoid contents were also estimated. The DPPH IC(50) values of \n","the aqueous, alkaloid and methanolic extracts were 213.4, 104.81 and 37.08 \n","microg/mL, respectively. The total phenolic content of the aqueous, alkaloid and \n","methanolic extracts were 66.0 mg, 88.4, 105.6 mg GAE/g, respectively, while the \n","total flavanoid were 28.2, 20.0 and 91.1 mg CAE/g respectively. The antioxidant \n","activities were correlated with the total phenolic content. This result suggests \n","that the relatively high antioxidant activity of the methanolic extract compared \n","to aqueous and alkaloid extract could be possibly be due to its high phenolic \n","content. The aqueous, alkaloid and methanolic extracts were screened for \n","antimicrobial activity. The extracts showed antimicrobial activity against \n","Salmonella typhi and Bacillus subtilis. The minimum inhibitory concentrations \n","(MICs) of extracts determined by the broth dilution method ranged from 3.12 to \n","6.25 mg/mL. The alkaloid extract was found to be most effective against all of \n","the tested organisms.': []\n","Detected entities in text: 'OBJECTIVES: To determine the anti-inflammatory and antinociceptive activities of \n","Mitragyna speciosa Korth methanol extract in rodents.\n","MATERIALS AND METHODS: Anti-inflammatory activity was evaluated using \n","carrageenan-induced paw edema and cotton pellet-induced granuloma tests in rats. \n","Antinociceptive activity was measured using the writhing test and the hot plate \n","test in mice, and the formalin test in rats. All drugs and extracts were diluted \n","in dH(2)O and administered through the intraperitoneal route. Results were \n","analyzed using one-way ANOVA followed by Dunnett's test for multiple comparisons \n","among groups.\n","RESULTS: Results showed that intraperitoneal administration of the extract at \n","doses of 100 and 200 mg/kg produced significant dose-dependent activity in all \n","of the nociceptive models evaluated (p < 0.05). With the formalin test, the \n","antinociceptive activity in mice was inhibited only at the highest dose of the \n","extract (200 mg/kg). The study also showed that intraperitoneal administration \n","of the methanol extract of M. speciosa (100 and 200 mg/kg) significantly and \n","dose-dependently suppressed the development of carrageenan-induced rat paw edema \n","(p < 0.05). In the chronic test, however, significant reduction in granulomatous \n","tissue formation in rats was observed only at the highest dose of the methanol \n","extract of M. speciosa (200 mg/kg, p < 0.05).\n","CONCLUSION: The present study suggests the presence of potent antinociceptive \n","and anti-inflammatory principles in the extract, supporting its folkloric use \n","for the treatment of these conditions.': [('Korth methanol extract', 'CHEMICAL'), ('edema', 'DISEASE'), ('granuloma', 'DISEASE'), ('extract', 'CHEMICAL'), ('extract', 'CHEMICAL'), ('methanol extract', 'CHEMICAL'), ('edema', 'DISEASE'), ('granulomatous', 'DISEASE')]\n","Detected entities in text: 'Kratom is the leaves of Mitragyna speciosa (Rubiaceae). Recently, kratom has \n","been sold in street shops or on the Internet in Japan for the purpose of abuse \n","due to its opium-like effects. In this study, we investigated the botanical \n","origin of the commercial kratom products using the internal transcribed spacer \n","(ITS) sequence analysis of rDNA in preparation for future regulation of this \n","product. In addition, a previously reported method to authenticate the plant, \n","utilizing polymerase chain reaction-restriction fragment length polymorphism \n","(PCR-RFLP) was applied to the same products in order to estimate the method's \n","accuracy and utility. The ITS sequence analysis of the commercial kratoms \n","revealed that most of them were derived from M. speciosa or closely related \n","plants, while the others were made from the same tribe plant as M. speciosa. The \n","reported PCR-RFLP method could clearly distinguish kratoms from the other \n","psychoactive plants available in the Japanese markets and also from related \n","plants. The authentication method is considered to be useful for the practical \n","regulation of the plant due to its wide range of application, high accuracy and \n","simplicity.': []\n","Detected entities in text: 'The leaves of Mitragyna speciosa Korth (Rubiaceae) have been used in folk \n","medicine for its unique medicinal properties. This study examined the water, \n","methanolic and crude alkaloidal extracts from M. speciosa leaves and its major \n","constituent mitragynine for the enhancement of glucose transport. Cellular \n","uptake of radioactive 2-deoxyglucose was determined in rat L8 myotubes. \n","Involving signalling pathway was determined with the specific inhibitors. Cell \n","cytotoxicity was monitored by lactate dehydrogenase assay. Protein levels of \n","glucose transporters (GLUTs) were measured by Western blotting. The results show \n","that test samples significantly increased the rate of glucose uptake. The uptake \n","was associated with increase in GLUT1 protein content. Co-incubation with \n","insulin had no additional effect, but the cellular uptake was decreased by \n","wortmannin and SB 203580, specific inhibitors of phosphatidylinositol 3-kinase \n","(PI3K) and p38 mitogen-activated protein kinase (p38 MAPK), respectively. It is \n","concluded that the increased glucose transport activity of M. speciosa is \n","associated with increases in activities of the key enzymes dependent to the \n","insulin-stimulated glucose transport for its acute action, and increases in the \n","GLUT1 content for its long-term effect. This study demonstrated the effect of M. \n","speciosa in stimulating glucose transport in muscle cells, implicating the \n","folkloric use of M. speciosa leaves for treating diabetes.': [('mitragynine', 'CHEMICAL'), ('glucose', 'CHEMICAL'), ('2-deoxyglucose', 'CHEMICAL'), ('lactate', 'CHEMICAL'), ('glucose', 'CHEMICAL'), ('glucose', 'CHEMICAL'), ('wortmannin', 'CHEMICAL'), ('SB 203580', 'CHEMICAL'), ('phosphatidylinositol', 'CHEMICAL'), ('K', 'CHEMICAL'), ('glucose', 'CHEMICAL'), ('glucose', 'CHEMICAL'), ('glucose', 'CHEMICAL'), ('diabetes', 'DISEASE')]\n","Detected entities in text: 'Mitragynine is a major indole alkaloid isolated from the Thai medicinal plant \n","Mitragyna speciosa that has opium-like properties, although its chemical \n","structure is quite different from that of morphine. We attempted to develop \n","novel analgesics derived from mitragynine, and thus synthesized the ethylene \n","glycol-bridged and C10-fluorinated derivative of mitragynine, MGM-9 [(E)-methyl \n","2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate]. \n","We hypothesized that a dual-acting mu- and kappa-opioid agonist could produce \n","potent antinociceptive effects with fewer rewarding effects compared with mu \n","agonists. In this study, MGM-9 exhibited high affinity for mu- and kappa-opioid \n","receptors with Ki values of 7.3 and 18 nM, respectively. MGM-9 showed a potent \n","opioid agonistic effect, and its effects were meditated by mu- and kappa-opioid \n","receptor mechanisms in in vitro assays. Subcutaneous and oral administration of \n","MGM-9 produced potent antinociceptive effects in mouse tail-flick, hot-plate, \n","and writhing tests. When administered orally, the antinociceptive effect of \n","MGM-9 was seven to 22 times more potent than that of morphine. The \n","antinociceptive effects of MGM-9 were mediated by both mu- and kappa-opioid \n","receptors. Subcutaneous administration of MGM-9 twice daily for 5 days led to \n","antinociceptive tolerance. In the gastrointestinal transit study, MGM-9 \n","inhibited gastrointestinal transit, but its effect was weaker than that of \n","morphine at equi-antinociceptive doses. Furthermore, MGM-9 induced less \n","hyperlocomotion and fewer rewarding effects than morphine. The rewarding effect \n","of MGM-9 was blocked by a mu antagonist and enhanced by a kappa antagonist. \n","Taken together, the results suggest that MGM-9 is a promising novel analgesic \n","that has a stronger antinociceptive effect and weaker adverse effects than \n","morphine.': [('Mitragynine', 'CHEMICAL'), ('indole alkaloid', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('ethylene', 'CHEMICAL'), ('mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('equi-antinociceptive', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('morphine', 'CHEMICAL')]\n","Detected entities in text: 'BACKGROUND: Kratom (Mitragynia speciosa korth) is recognized increasingly as a \n","remedy for opioid withdrawal by individuals who self-treat chronic pain.\n","CASE DESCRIPTION: A patient who had abruptly ceased injection hydromorphone \n","abuse self-managed opioid withdrawal and chronic pain using kratom. After \n","co-administering the herb with modafinil he experienced a tonic-clonic seizure, \n","but he reported only modest abstinence once kratom administration stopped. We \n","confirmed the identity of the plant matter he ingested as kratom and identified \n","no contaminants or adulterants. We also conducted high-throughput molecular \n","screening and the binding affinity at mu, delta and kappa receptors of \n","mitragynine.\n","CONCLUSION: We report the self-treatment of chronic pain and opioid withdrawal \n","with kratom. The predominant alkaloid of kratom, mitragynine, binds mu- and \n","kappa-opioid receptors, but has additional receptor affinities that might \n","augment its effectiveness at mitigating opioid withdrawal. The natural history \n","of kratom use, including its clinical pharmacology and toxicology, are poorly \n","understood.': [('chronic pain', 'DISEASE'), ('hydromorphone', 'CHEMICAL'), ('pain', 'DISEASE'), ('modafinil', 'CHEMICAL'), ('seizure', 'DISEASE'), ('mitragynine', 'CHEMICAL'), ('pain', 'DISEASE'), ('mitragynine', 'CHEMICAL')]\n","Detected entities in text: 'Salvia divinorum and Mitragyna speciosa (\"Kratom\"), two unscheduled dietary \n","supplements whose active agents are opioid receptor agonists, have discrete \n","psychoactive effects that have contributed to their increasing popularity. \n","Salvia divinorum contains the highly selective kappa- opioid receptor agonist \n","salvinorin A; this compound produces visual hallucinations and synesthesia. \n","Mitragynine, the major alkaloid identified from Kratom, has been reported as a \n","partial opioid agonist producing similar effects to morphine. An interesting \n","minor alkaloid of Kratom, 7-hydroxymitragynine, has been reported to be more \n","potent than morphine. Both Kratom alkaloids are reported to activate supraspinal \n","mu- and delta- opioid receptors, explaining their use by chronic narcotics users \n","to ameliorate opioid withdrawal symptoms. Despite their widespread Internet \n","availability, use of Salvia divinorum and Kratom represents an emerging trend \n","that escapes traditional methods of toxicologic monitoring. The purpose of this \n","article is to familiarize toxicologists and poison control specialists with \n","these emerging psychoactive dietary supplements.': [('Salvia divinorum and Mitragyna speciosa', 'CHEMICAL'), ('visual hallucinations', 'DISEASE'), ('Mitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('7-hydroxymitragynine', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('alkaloids', 'CHEMICAL')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa Korth.) is an indigenous plant of Thailand used \n","traditionally in folk medicine although it is claimed to cause addiction. It is \n","used to treat diarrhea, however, there is no scientific evidence to support the \n","use. The aim of this study is to investigate the effect of methanolic extract of \n","kratom leaves on the rat gastrointestinal tract. Kratom extract at 50, 100, 200 \n","and 400 mg/kg (p.o.) caused a dose dependent protection against castor \n","oil-induced diarrhea in rats and also inhibited intestinal transit. The \n","antidiarrheal effect was not antagonized by naloxzone. The inhibition of \n","intestinal transit by kratom extract was significantly different from the \n","control when treated with a single dose for 1 day. For longer-term treatments of \n","15 and 30 days, kratom extract did not decrease the intestinal transit time \n","indicating that adaptation had occurred. Kratom extract at a dose level of 200 \n","and 400 mg/kg for 30 days and morphine at 3 mg/kg (i.p.) caused a decrease in \n","the increment of body weight that was significantly different from the control \n","and kratom extract at lower doses (50 and 100 mg/kg). However it had no effect \n","on the level of plasma cholecystokinin. The results suggested that methanolic \n","kratom extract exhibited its antidiarrheal effect on rat gastrointestinal tract. \n","The effects may occur via pathways in addition to the action on opioid \n","receptors. High does of kratom extract decreased the increment of body weight \n","similar to the effect of morphine.': [('diarrhea', 'DISEASE'), ('extract', 'CHEMICAL'), ('p.o', 'CHEMICAL'), ('diarrhea', 'DISEASE'), ('kratom extract', 'CHEMICAL'), ('extract', 'CHEMICAL'), ('extract', 'CHEMICAL'), ('morphine', 'CHEMICAL'), ('extract', 'CHEMICAL'), ('cholecystokinin', 'CHEMICAL'), ('kratom extract', 'CHEMICAL'), ('morphine', 'CHEMICAL')]\n","Detected entities in text: 'We examined the use of Kratom (Mitragyna sp.), a dietary supplement with \n","mu-opioid agonist activity, by members of a cybercommunity who self-treat \n","chronic pain with opioid analgesics from Internet pharmacies. Within one year, \n","an increase in the number of mentions on Drugbuyers.com, a Web site that \n","facilitates the online purchase of opioid analgesics, suggested that members \n","began managing opioid withdrawal with Kratom. This study demonstrates the \n","rapidity with which information on psychoactive substances disseminates through \n","online communities and suggests that online surveillance may be important to the \n","generation of effective opioid analgesic abuse prevention strategies.': [('chronic pain', 'DISEASE')]\n","Detected entities in text: 'In Thailand, there are four Mitragyna species; M. speciosa, M. hirsuta, M. \n","diversifolia, and M. rotundifolia. One, M. speciosa, is a narcotic plant and has \n","medicinal importance for its opium-like effect. Since the use of M. speciosa has \n","been forbidden in Thailand, the leaves of M. diversifolia or others are \n","frequently used as substitutes but are not considered as effective. Therefore, \n","accurate authentication of M. speciosa is essential for both medicinal and \n","forensic purposes. The nucleotide sequences of internal transcribed spacers \n","(ITS) and the 5.8S coding region of nuclear ribosomal DNA (rDNA) of the \n","Mitragyna species were analyzed. The whole length of ITS1-5.8S-ITS2 region was \n","608 bp in M. speciosa, 607 bp in the other species. Nineteen sites of nucleotide \n","substitutions and 3 sites of 1-bp indels were observed, and M. speciosa showed \n","specific sequence differed from the others. Based on the ITS sequences, a \n","distinctive site recognized by a restriction enzyme XmaI in M. speciosa was \n","found and then PCR-restriction fragment length polymorphism (RFLP) analysis was \n","established to differentiate M. speciosa from the others. By the method, a \n","409-bp PCR fragment of ITS1-5.8S (partial) rDNA region from M. speciosa was \n","cleaved into two fragments of 119 bp and 290 bp while the other species remained \n","undigested. This method provides an effective and accurate identification of M. \n","speciosa.': [('nucleotide', 'CHEMICAL'), ('nucleotide', 'CHEMICAL')]\n","Detected entities in text: 'Administration of the aqueous extract of Mitragyna speciosa at a dose of 300 \n","mg/kg significantly inhibited ethanol withdrawal-induced behaviors that included \n","rearing, displacement and head weaving. The results also showed that at doses of \n","100, 300 and 500 mg/kg M. speciosa showed antidepressant activity without effect \n","on the spontaneous motor activity.': [('ethanol', 'CHEMICAL'), ('antidepressant', 'CHEMICAL')]\n","Detected entities in text: 'Kratom (Mitragyna speciosa) is a tropical plant species that is indigenous to Southeast Asia. The leaves of the kratom plant have traditionally been consumed for the stimulant and opioid-like effects it can produce. In the United States, kratom is gaining popularity as an herbal supplement, and a natural alternative to traditional prescription opioids. Kratom is a controversial substance in America as it is not currently regulated on a federal level in the United states and can be legally obtained and used in many areas of the country without a prescription. The Drug Enforcement Agency (DEA) has listed kratom on a list of drugs of concern, but kratom has yet to be scheduled under the Controlled Substances Act. On the state level, kratom laws are constantly changing and vary greatly from state-to-state with some states completely banning the substance and other states adopting legislation that protects kratom consumers by regulating its manufacturing and sale. Most states have no kratom laws and have ultimately left the decision up to the federal government. There are even instances where local counties and cities have abolished kratom in opposition to their own state laws. The majority of readily available legal information on kratom is dispersed amongst individual state government databases. Most of the consolidated legal information on kratom can only be found on websites supported by pro-kratom lobbying organizations which are inherently biased in their representation of the laws in place. The purpose of this article is to provide a complete, current, and unbiased review of federal, state, and local kratom laws in the United states while exploring state and local rationales for such legal variance. This article concludes by discussing possible implications of these differing laws on legislators, consumers, and the healthcare providers moving forward.': [('DEA', 'CHEMICAL')]\n","Detected entities in text: 'The kratom story in Malaysia is a bit intricate. Kratom (Mitragyna speciosa Korth) or by the local name ketum is a local plant where ‘mitragynine’ (alkaloid in kratom leaves) is listed as a psychotropic substance under the Malaysian Poison Act 1952. The law states that any activity related to possessing, selling, using, transporting, processing, importing, or exporting kratom is considered illegal and can be prosecuted. Interestingly, kratom trees are not illegal plants and no laws in Malaysia forbid the cultivation or the presence of naturally growing kratom. On the prosecution side, the current laws do little to prosecute kratom addicts for rehabilitation due to no available kratom test kits which can assist the enforcement agency to arrest and prosecute kratom addicts. Therefore, the enforcement of law on kratom has been largely applied for transporting, processing and selling. Though the Poison Act cannot stop anyone who wants to plant or grow kratom, there are land laws that prohibit the plantation of kratom on land specified for agricultural purpose, adding a tricky situation to the present circumstances related to kratom. In pharmacology, there is research and demand for the development of kratom, and demands from international pharmaceutical companies for kratom had created an illegal rational economic exploitation of Malaysia’s kratom by individuals, resulting in more intricacies to the existing complication. This paper intended to discuss the legal status of kratom in Malaysia which we believe is facing its crossroad. The paper used the rational approach of economic and criminologyarguments to establish kratom offences in the northern states of Malaysia, thus offering a review of the current state-of-affair. Police statistics and data on kratom offences were then presented to discuss the current status and its implication.': [('mitragynine', 'CHEMICAL')]\n","Entities DataFrame:\n","          type            text\n","0     CHEMICAL     Mitragynine\n","1     CHEMICAL       uric acid\n","2      DISEASE        toxicity\n","3      DISEASE        toxicity\n","4      DISEASE        toxicity\n","...        ...             ...\n","3659  CHEMICAL      nucleotide\n","3660  CHEMICAL         ethanol\n","3661  CHEMICAL  antidepressant\n","3662  CHEMICAL             DEA\n","3663  CHEMICAL     mitragynine\n","\n","[3664 rows x 2 columns]\n","\n","Relations DataFrame:\n","             Chemical   Disease       Verb\n","0         mitragynine      pain       used\n","1         mitragynine      pain   remained\n","2         mitragynine      pain       used\n","3         mitragynine      pain   remained\n","4         mitragynine      pain       used\n","...               ...       ...        ...\n","11499         extract  diarrhea  exhibited\n","11500  kratom extract  diarrhea  suggested\n","11501  kratom extract  diarrhea  exhibited\n","11502  kratom extract  diarrhea  suggested\n","11503  kratom extract  diarrhea  exhibited\n","\n","[11504 rows x 3 columns]\n"]}],"source":["# Contoh input berupa daftar teks\n","#sample_transcription = [\n","#    \"Aspirin is known to cause gastric bleeding.\",\n","#    \"Paracetamol can lead to liver damage in high doses.\",\n","#    \"Ibuprofen is associated with kidney problems.\"\n","#]\n","\n","def extract_entities_and_relations(transcriptions):\n","    \"\"\"\n","    Ekstraksi entitas Chemical dan Disease serta relasi antara keduanya dari daftar teks.\n","\n","    Args:\n","    - transcriptions (list of str): Daftar teks transkripsi.\n","\n","    Returns:\n","    - entities (list of dict): Daftar entitas Chemical dan Disease.\n","    - relations (list of tuple): Daftar relasi (Chemical, Disease, Verb) yang terdeteksi.\n","    \"\"\"\n","    entities = []\n","    relations = []\n","\n","    for text in transcriptions:\n","        doc = nlp(text)\n","\n","        # Debugging untuk melihat entitas yang terdeteksi\n","        detected_ents = [(ent.text, ent.label_) for ent in doc.ents]\n","        print(f\"Detected entities in text: '{text}': {detected_ents}\")\n","\n","        # Mengumpulkan entitas Chemical dan Disease\n","        text_chemicals = [ent.text for ent in doc.ents if ent.label_ == \"CHEMICAL\"]\n","        text_diseases = [ent.text for ent in doc.ents if ent.label_ == \"DISEASE\"]\n","\n","        for chemical in text_chemicals:\n","            entities.append({\"type\": \"CHEMICAL\", \"text\": chemical})\n","        for disease in text_diseases:\n","            entities.append({\"type\": \"DISEASE\", \"text\": disease})\n","\n","        # Menemukan relasi antara Chemical dan Disease dengan konteks kata kerja\n","        for chemical in text_chemicals:\n","            for disease in text_diseases:\n","                for token in doc:\n","                    if token.pos_ == \"VERB\" or token.dep_ == \"ROOT\":\n","                        if chemical in token.sent.text and disease in token.sent.text:\n","                            relations.append((chemical, disease, token.text))\n","\n","    return entities, relations\n","\n","# Panggil fungsi untuk mengekstraksi entitas dan relasi\n","entities, relations = extract_entities_and_relations(sample_transcription)\n","\n","# Buat DataFrame untuk entitas\n","entities_df = pd.DataFrame(entities)\n","\n","# Buat DataFrame untuk relasi\n","if relations:\n","    relations_df = pd.DataFrame(relations, columns=[\"Chemical\", \"Disease\", \"Verb\"])\n","else:\n","    relations_df = pd.DataFrame(columns=[\"Chemical\", \"Disease\", \"Verb\"])\n","\n","# Tampilkan hasil\n","print(\"Entities DataFrame:\")\n","print(entities_df)\n","\n","print(\"\\nRelations DataFrame:\")\n","print(relations_df)\n"]},{"cell_type":"code","source":["def save_relations_to_csv(relations_df, filename):\n","    \"\"\"\n","    Menyimpan DataFrame relasi ke file CSV.\n","\n","    Args:\n","    - relations_df (DataFrame): DataFrame dengan kolom [\"Chemical\", \"Disease\", \"Verb\"].\n","    - filename (str): Nama file untuk menyimpan CSV (contoh: \"relations.csv\").\n","\n","    Returns:\n","    - None\n","    \"\"\"\n","    try:\n","        # Simpan DataFrame ke file CSV\n","        relations_df.to_csv(filename, index=False)\n","        print(f\"Relations saved successfully to {filename}.\")\n","    except Exception as e:\n","        print(f\"Error saving relations to CSV: {e}\")\n","\n","# Panggil fungsi untuk menyimpan DataFrame ke CSV\n","save_relations_to_csv(relations_df, \"/content/drive/MyDrive/Text Classification 2023/relations.csv\")\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"PPjICSNOFRdq","executionInfo":{"status":"ok","timestamp":1736409749839,"user_tz":-420,"elapsed":311,"user":{"displayName":"Nurul Mutiah","userId":"18371090533349483196"}},"outputId":"3578b6fd-4f71-44fe-eb8b-8922985053e4"},"execution_count":15,"outputs":[{"output_type":"stream","name":"stdout","text":["Relations saved successfully to /content/drive/MyDrive/Text Classification 2023/relations.csv.\n"]}]},{"cell_type":"code","source":["import networkx as nx\n","import matplotlib.pyplot as plt\n","\n","def create_knowledge_graph(relations_df):\n","    \"\"\"\n","    Membuat dan memvisualisasikan knowledge graph dari Relations DataFrame.\n","\n","    Args:\n","    - relations_df (DataFrame): DataFrame dengan kolom [\"Chemical\", \"Disease\", \"Verb\"].\n","\n","    Returns:\n","    - None (Knowledge graph divisualisasikan menggunakan matplotlib).\n","    \"\"\"\n","    # Inisialisasi graph\n","    G = nx.DiGraph()\n","\n","    # Tambahkan node dan edge ke graph\n","    for _, row in relations_df.iterrows():\n","        chemical = row[\"Chemical\"]\n","        disease = row[\"Disease\"]\n","        verb = row[\"Verb\"]\n","\n","        # Tambahkan edge dengan verb sebagai label\n","        G.add_edge(chemical, disease, label=verb)\n","\n","    # Posisi node menggunakan layout spring\n","    pos = nx.spring_layout(G)\n","\n","    # Gambar node dan edge\n","    plt.figure(figsize=(10, 7))\n","    nx.draw(G, pos, with_labels=True, node_color=\"lightblue\", edge_color=\"gray\", node_size=2000, font_size=10, font_weight=\"bold\")\n","\n","    # Tambahkan label untuk edge\n","    edge_labels = nx.get_edge_attributes(G, \"label\")\n","    nx.draw_networkx_edge_labels(G, pos, edge_labels=edge_labels, font_color=\"red\", font_size=10)\n","\n","    # Tampilkan graph\n","    plt.title(\"Knowledge Graph: Chemical-Disease Relations\", fontsize=14, fontweight=\"bold\")\n","    plt.show()\n","\n","\n","# Panggil fungsi untuk membuat knowledge graph\n","create_knowledge_graph(relations_df)\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":760},"id":"ABkscPZ7Cf4Z","executionInfo":{"status":"ok","timestamp":1736409008500,"user_tz":-420,"elapsed":12972,"user":{"displayName":"Nurul Mutiah","userId":"18371090533349483196"}},"outputId":"0e599e80-25d4-4059-a07c-94ed26a097f0"},"execution_count":10,"outputs":[{"output_type":"display_data","data":{"text/plain":["<Figure size 1000x700 with 1 Axes>"],"image/png":"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\n"},"metadata":{}}]},{"cell_type":"code","source":["import networkx as nx\n","import matplotlib.pyplot as plt\n","\n","def create_filtered_knowledge_graph(relations_df, target_verb):\n","    \"\"\"\n","    Membuat dan memvisualisasikan knowledge graph yang hanya menyertakan relasi dengan kata kerja tertentu.\n","\n","    Args:\n","    - relations_df (DataFrame): DataFrame dengan kolom [\"Chemical\", \"Disease\", \"Verb\"].\n","    - target_verb (str): Kata kerja yang menjadi filter untuk relasi.\n","\n","    Returns:\n","    - None (Knowledge graph divisualisasikan menggunakan matplotlib).\n","    \"\"\"\n","    # Filter DataFrame untuk hanya menyertakan relasi dengan kata kerja target\n","    filtered_df = relations_df[relations_df[\"Verb\"] == target_verb]\n","\n","    # Inisialisasi graph\n","    G = nx.DiGraph()\n","\n","    # Tambahkan node dan edge ke graph\n","    for _, row in filtered_df.iterrows():\n","        chemical = row[\"Chemical\"]\n","        disease = row[\"Disease\"]\n","        verb = row[\"Verb\"]\n","\n","        # Tambahkan edge dengan verb sebagai label\n","        G.add_edge(chemical, disease, label=verb)\n","\n","    # Jika tidak ada relasi yang cocok, beri pesan dan hentikan\n","    if filtered_df.empty:\n","        print(f\"No relations found with verb '{target_verb}'.\")\n","        return\n","\n","    # Posisi node menggunakan layout spring\n","    pos = nx.spring_layout(G)\n","\n","    # Gambar node dan edge\n","    plt.figure(figsize=(10, 7))\n","    nx.draw(G, pos, with_labels=True, node_color=\"lightblue\", edge_color=\"gray\", node_size=2000, font_size=10, font_weight=\"bold\")\n","\n","    # Tambahkan label untuk edge\n","    edge_labels = nx.get_edge_attributes(G, \"label\")\n","    nx.draw_networkx_edge_labels(G, pos, edge_labels=edge_labels, font_color=\"red\", font_size=10)\n","\n","    # Tampilkan graph\n","    plt.title(f\"Knowledge Graph: Relations with Verb '{target_verb}'\", fontsize=14, fontweight=\"bold\")\n","    plt.show()\n","\n","# Panggil fungsi untuk membuat knowledge graph dengan filter \"exhibited\"\n","create_filtered_knowledge_graph(relations_df, target_verb=\"suggested\")\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":760},"id":"_dcrMHcGC7CM","executionInfo":{"status":"ok","timestamp":1736409387093,"user_tz":-420,"elapsed":953,"user":{"displayName":"Nurul Mutiah","userId":"18371090533349483196"}},"outputId":"e3181f03-4a02-4e50-8e84-2e9bc0482a3a"},"execution_count":14,"outputs":[{"output_type":"display_data","data":{"text/plain":["<Figure size 1000x700 with 1 Axes>"],"image/png":"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\n"},"metadata":{}}]},{"cell_type":"code","source":["import networkx as nx\n","import matplotlib.pyplot as plt\n","\n","def create_filtered_knowledge_graph_by_chemical(relations_df, target_chemicals):\n","    \"\"\"\n","    Membuat dan memvisualisasikan knowledge graph yang hanya menyertakan relasi dengan chemicals tertentu.\n","\n","    Args:\n","    - relations_df (DataFrame): DataFrame dengan kolom [\"Chemical\", \"Disease\", \"Verb\"].\n","    - target_chemicals (list): Daftar chemicals yang menjadi filter untuk relasi.\n","\n","    Returns:\n","    - None (Knowledge graph divisualisasikan menggunakan matplotlib).\n","    \"\"\"\n","    # Filter DataFrame untuk hanya menyertakan relasi yang melibatkan chemicals yang ditargetkan\n","    filtered_df = relations_df[relations_df[\"Chemical\"].isin(target_chemicals)]\n","\n","    # Inisialisasi graph\n","    G = nx.DiGraph()\n","\n","    # Tambahkan node dan edge ke graph\n","    for _, row in filtered_df.iterrows():\n","        chemical = row[\"Chemical\"]\n","        disease = row[\"Disease\"]\n","        verb = row[\"Verb\"]\n","\n","        # Tambahkan edge dengan verb sebagai label\n","        G.add_edge(chemical, disease, label=verb)\n","\n","    # Jika tidak ada relasi yang cocok, beri pesan dan hentikan\n","    if filtered_df.empty:\n","        print(f\"No relations found for chemicals: {target_chemicals}.\")\n","        return\n","\n","    # Posisi node menggunakan layout spring\n","    pos = nx.spring_layout(G)\n","\n","    # Gambar node dan edge\n","    plt.figure(figsize=(10, 7))\n","    nx.draw(G, pos, with_labels=True, node_color=\"lightblue\", edge_color=\"gray\", node_size=2000, font_size=10, font_weight=\"bold\")\n","\n","    # Tambahkan label untuk edge\n","    edge_labels = nx.get_edge_attributes(G, \"label\")\n","    nx.draw_networkx_edge_labels(G, pos, edge_labels=edge_labels, font_color=\"red\", font_size=10)\n","\n","    # Tampilkan graph\n","    plt.title(f\"Knowledge Graph: Relations for Chemicals {', '.join(target_chemicals)}\", fontsize=14, fontweight=\"bold\")\n","    plt.show()\n","\n","\n","# Panggil fungsi untuk membuat knowledge graph untuk Mitragynine dan Kratom\n","create_filtered_knowledge_graph_by_chemical(relations_df, target_chemicals=[\"Mitragynine\"])\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":760},"id":"0O4LrdtwGpit","executionInfo":{"status":"ok","timestamp":1736410100756,"user_tz":-420,"elapsed":1184,"user":{"displayName":"Nurul Mutiah","userId":"18371090533349483196"}},"outputId":"1ab88591-7d8e-4b65-ad55-01c57b84c6ca"},"execution_count":17,"outputs":[{"output_type":"display_data","data":{"text/plain":["<Figure size 1000x700 with 1 Axes>"],"image/png":"iVBORw0KGgoAAAANSUhEUgAAA/sAAALnCAYAAADWG1duAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjAsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvlHJYcgAAAAlwSFlzAAAPYQAAD2EBqD+naQABAABJREFUeJzs3XdYFGfXBvB7G7D0Lk0BETsWLAhq1Fij0dhL7EZNTKKJSb60N5b0YorRqIkmRlPsGmPs3djA3o2iAoqIIr0sZXfn+2NkZekgMLDcv+viUnZnZs/MFvY85TwyQRAEEBEREREREZHJkEsdABERERERERFVLCb7RERERERERCaGyT4RERERERGRiWGyT0RERERERGRimOwTERERERERmRgm+0REREREREQmhsk+ERERERERkYlhsk9ERERERERkYpjsExEREREREZkYJvtEVGoymczws2LFikp9rK5duxoea8KECZX6WCRasWKF0XNsiiZMmGA4v65du1bJY86dO9fwmD4+PlXymFXhzz//RPv27WFtbW04v1atWkkdVrnU9OeoKj+b85PiPfUkasPnXGWJjIw0unYHDx6UOiQiKgGTfaJyOnjwYLFfsBITE9G+fXvD/XK5HEuWLJEmWKpU2dnZ+O233zB06FD4+vrC2toaKpUKTk5OaNOmDaZOnYqNGzciMzNT6lCrHR8fH6P3Ue6PpaUl6tevj5EjR+LAgQNSh1mkmp4klteuXbswZswYnDx5Eunp6VKHU4AgCNi+fTvGjh2Lhg0bwtbWFiqVCnXq1EH37t3x5Zdf4t69e1KHSaWUt0Eh92fTpk2Fbjtq1KgC25Y2KWVDABGZGqXUARCZori4OPTs2RPnz58HAMjlcvz888+YOHGixJFRRTt69CjGjBmDyMjIAvclJCQgISEBZ86cwbJly7B69WqMHDmy6oOsgTQaDSIiIhAREYG1a9fip59+wtSpU6UOq1x69eoFa2trAICdnZ3E0VSMNWvWGP7v6OiIV199FTY2NnB1dZUwKtGdO3fw/PPP48iRIwXue/DgAfbv34/9+/fj6tWrVd4LXlnmzZtn+H+7du0kjKTqLFiwAIMHDza6LSYmBhs2bCh2v3bt2hldLyo9R0dHo2vn5+cnYTREVBpM9okqWGxsLLp3744rV64AABQKBX777Tc8//zzEkdGFe3w4cPo1auXUY998+bN0bNnT7i6uiItLQ1Xr17FoUOHEB8fX6Zjp6SkwNbWtqJDrtbq16+PadOmITs7GxcuXMC6desgCAIA4P3338fkyZMhl9e8AWkhISEICQmROowKFRUVZfh/37598eGHH1b6Y5bmPXH//n106dIFERERhtt8fX0xYMAA1KlTB4mJiQgNDS20IaAme+utt6QOocodOnQIFy5cQIsWLQy3LV68GFqtttj9mjVrhmbNmlVaXKb82W1ra1srX2tENZpAROVy4MABAYDh59dffxXu3LkjNGzY0HCbSqUSNmzYUGDfX3/91WjfzMxM4ZNPPhH8/f0FMzMzwdPTU3jzzTeFzMzMQh97w4YNQt++fYU6deoIKpVKsLe3F4KDg4Wvv/5aSE9PN9q2VatWhsf58MMPDbdfu3bNcLujo6Og1+sN9/Xp08dw30svvWS4Pf/55vfvv/8KI0aMEOrWrSuYmZkJNjY2QocOHYQffvhByM7OLvRcNm3aJLRr106wsLAQXF1dhUmTJgn3798XunTpYnis8ePHF9hv2bJlQvPmzQVzc3PBy8tLePPNN4W0tDTB29vbsN+cOXMK7Hfu3Dlh4sSJQv369QULCwvByspKaNWqlfDpp58KaWlphcZYmMzMTMHHx8fwWDKZTFiyZEmh22q1WmHLli3CyZMnjW7Pfz03b94sBAcHC1ZWVoKdnZ0gCIIQHx8v/N///Z/w9NNPC97e3oK1tbWgUqkEV1dXoUePHsJvv/1m9NwJQsHX5s2bN4XvvvtOaNKkiWBubi54eHgIM2fOFFJSUoz2y/+6zM7OFr788kuhUaNGJb4u8+5X2HUvSt7nq0uXLkb3jRgxwui49+7dK7B/bGys8N577wktW7YUrK2tBXNzc8HPz094+eWXhaioqALbjx8/vsjH++WXX4Rhw4YJjRs3FpycnASlUinY2NgILVu2FN5++20hLi6uyGtc2E/ue2TOnDmG27y9vQvElJCQIHz44YdCmzZtBFtbW0GlUgkeHh7CoEGDhN27dxfYvryfHzk5OcJ3330ndOjQQbCzsxMUCoXg6OgoNG3aVBg7dqywevXqIp6lx/KeS2E/eZ/7jIwM4dtvvxVCQkIEe3t7w+v2mWeeEdauXVvg2PmvaXh4uDBv3jyhcePGgpmZmfDcc8+VGN/IkSONjjFt2jQhJyenwHbXr18X/vjjj0LPy9vbW0hLSxPee+89wcfHRzAzMxN8fX2FTz/9tMB7TRAEQafTCb/99pvQs2dPwcXFRVCpVIKzs7PQt29fYdu2bSWe53///SfMnj1bqFevnqBWq4V27doJO3bsEARBEB48eCBMmjRJcHZ2FiwsLISOHTsK//77b4FjlvTZfOLECWHChAmCn5+foFarBSsrK8Hf31+YMGGCcOPGDaPYJk2aJLRu3Vpwc3MTzMzMBLVaLfj5+QkTJkwQLly4UODYxb2nLly4IIwePVrw9vYWzMzMBAsLC6Fu3bpCt27dhHfffVeIjo4ucLzC5H0MuVxu+P8LL7xg2CYzM1NwcXERAAgKhcLomhw4cMCwXf73jyAIQkRERInv59zXdv7909PThffff1/w9fUVlEql8Nprr5X7WgqCIERGRgqjRo0SHB0dBSsrK6Fz587Cvn37Co1bp9MJvr6+htvee++9Asd76623DPc3adLEcHv+18zu3buFrl27ClZWVoK1tbXQp08f4dKlS0bHyn+d8l7X/O+hpKQk4a233hLq1asnqFSqCn0PEVHpMdknKqf8X9jmzJlj9EfX3Nxc2LJlS6H75v+j3alTp0K/XIwdO9ZoP61WKwwfPrzYLyRNmjQRYmJiDPvMnDnTcF/Pnj0Nt//8889G++X+UdfpdIKtra3h9nXr1hn2Ke4L5fvvv19sXJ07dy6QTC9ZsqTQbX19fYWmTZsafs+f7L/77ruF7te+fXuhTp06hSYegiAIixcvFpRKZZExNm3atNCEsjBr1qwx2veVV14p1X555b8+eX/PTfYvXrxY4pfQiRMnGh03/2vz6aefLnS/du3aCRqNxrBf/tdl7969S/W6zH8uFZXsv/HGG4b75HJ5geT12LFjgrOzc5HXxc7OrkBiVFxi0qZNm2Kvs6enp3D37t1Cr3FhP6VJ9q9cuSJ4eXkVe5zc5CFXeT8/8p57YT9BQUElPl+lTfbv3bsnNGvWrNhthwwZYpSI57+m+d8TJSX7MTExgkwmM2zfqlUrQafTlXhO+c/LxcVFCAwMLDTmWbNmGe2XkZEh9OjRo9jzfOONN4z2yX+ehb3u5HK5sGbNGqO/Kbk/5ubmwpUrV4yOWdjrLteHH35odF3y//z111+Gbd98881iz8XMzEzYs2eP0fGLek9dvnxZsLS0LPZ4uY0aJcn7GE5OTobXvFqtFh4+fCgIgiAsX77csM2gQYOMHqcyk/38r9Pc92t5rmVERITg5uZW6OuhX79+BeIWBEGYN2+e4TYPDw9Bq9UaHTPvZ+xXX31luD3vsTp27Fjoa8TJyUl48OCBUXxFXde87yEnJyehSZMmlfYeIqLS4zB+ogry0UcfGYYcq9VqbN68Gb169SrVvkeOHMGgQYPQtGlT/Pnnn4b533/++Se++OILeHh4AAA+++wzrFu3zrBfhw4d0KtXL1y9ehXr168HAFy9ehWjR4/G/v37AQDdunXDd999BwA4fvw4dDodFAoFDh8+bBTDv//+i2bNmuH8+fNISUkBgFJXV16zZg0+++wzw++9e/dGx44dcf/+faxcuRJpaWk4fPgwZs6ciaVLlwIAoqOjMXPmTMM+NjY2eOGFFyCXy7F8+XKjYbh5nTx5El9++aXhd1dXV4wfPx6pqalYvnw5srOzC93v2LFjePXVV6HX6w3Xrk+fPkhNTcXKlSvx8OFDXLlyBePGjcPu3btLPOd9+/YZ/T558uQS9ynO4cOH4ezsjJEjR8LJyQmXL18GINZ7aNKkCdq3bw83NzfY29sjMzMTZ8+exT///ANBEPDrr7/ipZdeQvv27Qs99v79+/Hcc8+hZcuW2LFjB06ePAlAvJZfffUVZs+eXeh+u3btKtXrsqLl5OQYhvHneu6552Bubm74PSUlBQMHDsTDhw8BAN7e3hgxYgTUajU2bNiAy5cvIzk5GUOGDEF4eHip5sq7urqif//+8PPzg6OjIxQKBe7evYu1a9ciPj4ed+/exSeffILFixfDz88P8+bNw+7du7Fnzx4AgIODA95//33D8UqaO63VajFo0CBER0cDEKf8jB07Fl5eXti8eTMuXboEAPj+++8RGBiIcePGFXqc0nx+pKWl4Y8//jDsM2TIEAQGBiI5ORlRUVE4dOhQidcHeFx/YMmSJbh16xYAoG3bthgxYgQAGKYrjB492vAaBoChQ4eiadOm2LNnD44fPw4A2LhxIz777LMiX3+HDx9Gs2bN0L9/fwiCAIVCUWxsBw4cMHwGA8D48ePLNe0jLi4O8fHxGDduHDw8PPDzzz8bXmfff/89PvjgA5iZmQEAZs6cib179wIAzMzMMHLkSPj7++PixYtYv349BEHAt99+izZt2hQ5lev06dMYMWIE6tevjx9++AGpqanQ6/WG+h5jx46Fs7MzFi5cCK1Wi6ysLHz//ff48ccfSzyX9evXY86cOYbfLS0tMXLkSHh7eyMiIgL//POP0fZWVlbo0qULAgIC4OjoCLVajfj4eGzbtg1Xr15FdnY2ZsyYYZimVpyVK1ciIyMDAODl5YUxY8bAysoK0dHRuHTpEkJDQ0s8RlFee+01HDlyBBqNBsuWLcO7776LBQsWABD/lkycOBF//fVXqY+XOxf91KlTWLt2reH2vPPTi5qKc/jwYQQFBaFnz55IT09HvXr1AJTvWr766quIjY01/N63b1+0adMG27Ztw7Zt2wp9/BdeeAFz5sxBRkYGYmJisG3bNgwYMAAAcOLECcOUG6VSibFjxxZ6jKNHj6Jx48YYPHgwzp07h+3btwMA4uPj8csvv+Ddd98t8RrmFR8fj8TExCp7DxFRMaRsaSCqyYrr2Vu1alWx++bvGXj99dcN9507d87ovtzRATqdTnB0dDTcHhwcbNSC//bbbxvtd/bsWUEQBCE5OdloSGPuUPL69esbWuABCKNGjRIEQRDmz59v2DYgIMAo7rzHz9t71Lp1a8Pt48aNM9pn3bp1hvuUSqUQHx8vCIIgfP7550bH27t3r2Gfo0ePGt2Xt2f/xRdfNOrtyDvMMP91zdvDnLenp2vXrkY9fidOnDDa7/z588U+f4IgCH379jXaJyMjw+j+vCMMcn/y9+rmvc/W1rbQYee5oqKihA0bNgg//PCD8PXXXwvz5s0TPD09Dft/9NFHhm3zvzanTJliuC87O9uox9XLy6vI61ea12Vh51Lenv2ifvr06WN43eT6/vvvDfc7ODgY3Z+WlmYYzgtA+P777w33FdezLwiCkJ6eLuzdu1dYunSp8O233wrz5s0TnnvuOcM+9evXN9q+pCH6xW3z119/GZ3n4sWLDfdlZGQYXZuWLVsa7ivP85SQkGD0WsvKyjKKUa/XC7du3So0/sIUN83m7NmzRjG8/fbbhvu0Wq0QHBxsuM/R0dHwXsz/uu3QoYPRyJOSfPXVV0b7l7bXWBAKjliYP3++4b7Nmzcb3Zc7/Do+Pt5opNDy5cuNjvnyyy8b7mvdurXh9vznOXnyZMN97733ntF9eUcM5Z2iEBgYaPRYRX025x2hYGVlJVy7ds1ov7S0NOH+/ftGt+l0OiEsLExYsWKFMH/+fGHevHlGo2wACLdv3zZsX9R7asaMGYbbP//88wLXPCEhQUhISChwe2Hy9+xrtVqhXr16AgChbt26wv79+w33T58+vcA1LqlnvzT3FbXN4MGDixxBUpZrmX9kyogRIwzHyczMFBo1alRkbFOmTDHc3r9/f8PteUcX5L1dEIxfM3Xr1jWa1pX3b/rgwYMNt5e2Z7+y30NEVHrs2SeqBLNnz0anTp1Qt27dUm3/8ssvG/7fqFEjo/sSExMBANeuXUNCQoLh9jFjxhj1dI0fPx5fffWV4ffjx4+jVatWsLW1RWBgoKE398iRI/D09DT0ys2YMQNz5swx9PTn7fHv1q1bibFnZGTg3Llzht9/++03/Pbbb4Vuq9VqceLECfTp0wenTp0y3J67HFaukJAQ+Pr6Ftq7n3e/Nm3aGBVaGjNmDKZMmVJogaajR48a/n/w4MFiewmPHTtmVPSpNJ50maZx48YZeoTyio+Px/jx44vs1cmV2ztcmLy9OSqVCsOHDzf09kVHR+P+/fuoU6dOgf1K87rMJeTpUa1IDRo0wEcffQRHR0ej2/M+n4mJiXByciryGMeOHcOMGTNKfKxvv/0Wc+bMQVpaWpHbFHedyyq3hztX3p57tVqN4cOHG3oWL1y4gIyMDFhaWhY4TmmeJwcHBzRr1gyXL19GSkoKfH190a5dO/j7+yMgIADdu3eHr69vpZzX+PHjDf9XKBQYM2aMYZuEhARcu3YNTZo0KXCct956CxYWFhUSU1koFAq8+OKLht+LuqZhYWFGnzWTJk3CpEmTCj3muXPninz+xowZY/h//uUbhw8fbvh/3srn+d9/hcnIyMDZs2cNv48bNw4NGzY02sbKygpWVlaG3/fs2YPJkyfj9u3bxR47Ojq6xL9vnTt3NvS2f/DBB9iyZQsaN26MRo0aISgoCJ07dy5xtEZRFAoFXnnlFbzzzju4c+eO4TNOJpNh+vTpuHv3brmOWx7vv/9+oSNIynotT58+bfQ5mvfzwNzcHKNGjcLcuXMLPcb06dOxbNkyAMD27dsRExMDDw8Po5UJilsNaOzYsbCxsTH83rBhQ8NrpzSvtfyq+j1EREWreWWNiaqp+vXrG/5/48YNdOnSpdDl2AqT9wte3qHKAAzDzvMm+gAKJGf5f8/7B/rpp582/P/w4cOGhN7Dw8PwRTw6OhoRERFGVarz7leUxMTEMiV6cXFxAICkpCTDbYUt11VY8pl/Pzc3N6P7lEolnJ2dC90v//UrTYzF8fT0NPr92rVrRr/PmTMH8+bNQ0BAQKkes3HjxoXe/sILL5SY6ANAVlZWkfflv775r23ea5pXaV6XFal+/fqYN28eZsyYYahmfePGDXTr1q3AsOGKfj43b96MN998s9hEH0CR00TKI+85WFtbGyVdgPHzJAjCEz9Pq1atQtOmTQGIS5T9/fff+PrrrzF+/HjUq1cPb7zxRnlPxciTfFblVdR7oij535P//fdfmfbPVadOHaNGhtJ+JhdHEIQiV+TIOx0md2hzYfcplY/7Z0rz/sv/2VxSY05MTAwGDhxYYnIKFP95k2vo0KF46623YG5uDp1Oh+PHj+PXX3/Fu+++i27dusHPz89oqkdZTZ482ZD45Sb3zzzzDPz9/ct9zPIo7HVanmuZ//2d/+9b/t/zCggIMEy50+l0+PXXXxEWFmYYwu/i4oJnn322yP3zNzLlfc2X57O+qt9DRFQ09uwTVZAPPvgAp06dwuLFiwEAERER6NKlC/bv31/iWrQqlcrw/6J6iPP3bN6/f7/Y3x0cHAz/79atm2Ge+5EjRwxfIDt16gRvb2/UrVsXd+7cwc8//2w4jlwuR5cuXYqNGwDs7e2Nfh8wYAA6d+5c5PaBgYEF9nvw4EGB7fKfT2GPl38/rVZrmBeYn6Ojo2H7Tp064bnnnisyxtIsk9a9e3dDTwoArFixwlAbAQCmTZsGAAgNDcXFixdLPF7+RA8A0tPTsXXrVqPHXLp0Kby9vaFQKNC+fXvDiI3iPHjwwKhnJf+1zf8c5irN67Ii1a1b17Cs0/Dhw/HUU09Br9cjPT0d06dPN6qTkPf94O7uXmyiWpoRNnnn6VpbW2PTpk3o3LkzLCwssHjxYrzyyivlOaVi5T2HtLQ0pKenG70O8j5PMpnsiZ+nFi1a4PLly7h48SLOnDmD8PBwnDlzBjt27IBer8d3332H/v37l2pET3EK+6zKO/KiuM+qvAp7TxSnW7dukMlkhgT3t99+w4wZM8o8bz/v9QRK/5k8c+bMYutYFFU3Iv/j5ZU3wS8rBwcHo+tRVB2UXP/8849hjj0AfPPNN3jhhRdgZ2eHK1eulGu5unnz5uGDDz7AsWPH8N9//+H69evYsmULYmJiEBUVhZdffrnU9SLyc3R0xJgxYwx1YACUagRPRSvsdVqea5n//Z3/71veufyFmT59Og4ePAgAWL58uVFiPGbMmGJfZ6V9zZdWVb+HiKhoTPaJKohMJsOiRYtgZmaG+fPnAwBu375tSPjzD58sq0aNGsHR0dHQEv7HH3/gxRdfNAyDXLlypdH2eRPWTp06QaVSIScnBw8ePMCaNWsAwJCUd+7cGatWrcKiRYsM+7Ru3brI5CIvKysrtGrVyjCUPz4+Hq+99lqBP/bJycnYsWOH4UtO27ZtsXHjRgDil/99+/YZhvIfO3asyC+mbdu2xenTpwGIQ/pv3LiBBg0aGK5JUWssh4SEYPPmzQDEL01Tp04tsBayRqPB+vXrS5XsDxw4EN7e3oaek4ULF6Jt27YYPXp0ifuWVnJyMnQ6neH3fv36GUaQXLt2DRcuXCjVcX7//XfDc52Tk2NU+M7T07PIURRlkffL3Jw5c4ocblpaHTt2xNixYw2v6/379+PQoUOGBqiQkBDDecTFxaFXr14Fpl4IgoB9+/aV2NgGwOiLcf369dGzZ08AYg9U3qGw+eV9nef9cl8a+V9nv/32m6GRSKPRGD1PLVu2fOLhq+fOnUOrVq0QEBBgNOKkZcuWhtfSmTNnnjjZz39eK1euNDQ26nQ6o0KBjo6OBYb4lpe7uzuGDx9uaLg5e/YsXnvtNcyfP7/AcPHw8HCcOHHiid6vQUFBUCgUhveoSqUqdA3yyMhIXLt2rcrXXre0tETr1q1x5swZAOLnwBtvvGH4vATE11lqaipcXV0L9JpOnDjRkFzlfS2WVkREBBwcHGBvb49nnnkGzzzzDACxyOPgwYMBwBBbec2YMcOQ7Ddu3LjURXGLkv/vVnmHjZfnWrZp08aocWb16tXo06cPALH3f/Xq1cU+5nPPPYd69erh9u3buHXrFpYsWWK4r6ih8VKr7u8hIlPAZJ+ogn333XcwNzc3fLm9e/euIeEvbF5qacnlcsycOROzZs0CIM6L7dSpE3r16oX//vvP6AtEt27d0LJlS8PvVlZWaN++vWGec27vd/5kPzk52egYpfV///d/hi/NR48eRYsWLdC/f384ODggPj4eZ8+exZEjR+Du7m6oMD169GjMnTvXMIRx0KBBmDx5MmQyGZYvX17kY73wwgtYunQpBEGATqfDU089hXHjxiElJQW//PJLkfu9+eab+PvvvyEIAm7cuIHmzZtj8ODBqFOnDpKTk3Hx4kUcOnQI6enpRVY9z8vc3BwrVqxA7969kZ2dDZ1OhzFjxmDBggXo1q0b7O3tcf/+faO55WXl6uoKe3t7w/DOTz75BA8ePIBWq8Xy5ctLNZQWAJYtW4a4uDi0aNECO3bsMBo6O2XKlHLHV9nee+89/P7774Yhn59++qkh2Z8wYQI++eQTPHz4EFqtFh07dsSwYcPQoEEDZGVl4dq1azh48CDu37+PAwcOlDiEuVGjRoaq+hcuXMCoUaPQpEkT7Nixo9iq4XmHjsfFxWHixIlo2rQpZDIZXnnlFajV6iL37devHxo1amSYAjJ9+nScPHkSnp6e2Lx5s6EhCYDRyhXl1aFDB3h4eKBz587w8PCAra0tzp8/b9RoVJoGvpK0bNkS3bt3N4zE+Oqrr3Dr1i00a9YMu3fvNprT/9prr5WrYn5RvvvuO4SGhhqu3Q8//IAdO3agf//+qFOnDhISEhAWFobDhw9j3LhxT5TsOzo6YtKkSYYRPl999RVOnTqFkJAQWFhY4O7duwgNDcXZs2cxfvx49O7du0LOsSzeffddw7z/tLQ0tGrVylCN/86dO9i6dSsWL16MgQMHFmh06devH5555hlcuHCh2AavoqxduxZz5sxB165d4e/vD3d3d6SnpxslrU/6emvWrBl27dqFjIwM+Pn5PXGPdP6pIM8//zxCQkIgl8sxduzYUjeMludauru7o1+/fobRXL/99huSk5PRsmVLbN26tcBUsfwUCgWmTZuG9957DwCQmZkJQGwgb968eanirmo14T1EVONJUhaQyATkr/abf23jDz74wOh+V1dXQwXakir+FnVcrVYrDBs2zOj+/D9NmjQxrAWe16xZs4y2s7OzM1QQvnTpUoHjbN++vdRxCULBKtKF/eSvVv7DDz8Uup2Hh4fg7+9v+D1/te9333230P0CAwONquB/+OGHRvstWrTIqPJvUT9lsX//fsHDw6PEY+bGV9rrmeuLL74o9FjNmzc3Wp877zXK/9rMvz5z7k+bNm2MVhEo7+sy/33lrcZfWHX8oUOHGh07LCzMcN/Ro0cFZ2fnEq973orRRVUODw8PF2xsbArsq1QqhdGjRxd5Xe7du1fkWuJxcXGCIBRfsf/KlSuCl5dXsfHPmDHDaJ/yPk/m5ubFPo6vr6+QlJRUwjMmKq4af+51adq0abGPN2TIECEnJ8ewT/7XbURERKliyS8yMtKo4n9RP3njLu45Kq4CeXp6eolrhJf0/sx7nvmf27z3FRdjce/NuXPnFrqGeu7PX3/9JQiCuFJHQEBAkfGX9T2Vf8WVwn4WLFhQ8hMqFKzGX5LyVuPPzMwU3N3dC401dyWb0lTsL++1jIiIENzc3ArsI5PJhD59+hj9XpiHDx8KFhYWRvsuWrSo0G2Le80U9ZyWthp/Zb+HiKj0WKCPqJJ8/PHH+Pjjjw2/P3jwAN26dTOqXF9WCoUC69atw/r169G3b1+4urpCqVTCzs4OQUFBmDdvHk6ePFnonLf8PfW5vRUA0LRpU6O5c0qlsth594X57LPPcPToUYwZMwa+vr4wNzeHSqWCp6cnevXqhc8++6zA2vSvvPIKNmzYgDZt2sDc3BzOzs4YO3YswsLCip239/nnn2Pp0qVo1qwZzMzM4O7ujldffRX79u1DSkqKYbv8vUYvv/wyzp49i6lTp6Jhw4awtLSEUqlEnTp10KVLF8yaNQvnz58v03l369YN4eHh+PHHH9GvXz94enrCwsICZmZmcHV1RUhICF5//XXs3LkTJ06cKNOxAeCdd97BokWL0LBhQ6hUKri5uWHKlCk4dOgQrK2tS3WMhQsX4ocffkDTpk1hbm4Od3d3vPbaa9i/f3+xPc/VQd516wFxdEOukJAQXL58GbNmzUKbNm1ga2sLhUIBe3t7tGnTBq+++ir27NmDp556qsTHadCgAf7991/06tULlpaWsLa2RpcuXbBv3z706NGjyP3c3Nzwzz//oGPHjmWeYw4ATZo0wfnz5zF37lwEBgbC2toaSqUS7u7uGDRoEHbt2oXvv/++zMctzJIlSzBx4kS0aNECLi4uUCqVsLa2RosWLfD2228jLCyswubEurm54eTJk/jmm28QHBwMOzs7KJVKuLi4oE+fPlizZg02bNjwRHPSi+Lt7Y2jR4/in3/+wejRo9GgQQNYWVlBqVTC1dUVPXr0wKJFi4xWLykvS0tL7Nq1C6tWrULfvn1Rp04dKJVKqNVq+Pn5YejQoVi6dCm+/fbbCjiz8pkzZw5CQ0Mxfvx41K9fHxYWFrC0tET9+vUxduxYQ6+vSqXC/v37MWHCBDg5OcHc3BzNmzfH0qVLyzUtZ+DAgZg9ezZ69OgBHx8fw+dtbg/2li1bMH369Ao+2ydjbm6O7du3o1evXk80ZLy819LHxwehoaEYOXIk7O3toVarERwcjG3bthnV0ClqRISTk5PRWvQWFhbVfm36mvAeIqrJZIJQSeslERFVEo1GU2iSunXrVvTv39/w+9GjR0s1/97UHDx40KhxJyIiokC1ZSIiql70ej20Wm2BVRl0Oh1CQkIMDcY9e/bE7t27Cz3GF198YRjKP3LkyBLn+hORaeOcfSKqcd5//32cO3cO/fv3h6+vL7RardFKCIA4TzE4OFjCKImIiEovJSUF/v7+eP7559GqVSu4urri7t27WLFihdHIsPyrDsTGxuLq1auIiorC119/bbj91VdfrbLYiah6YrJPRDWOIAg4ePCgYZmh/Bo0aID169dXyXJxREREFeXhw4dYsGBBoffJZDJ8+OGHePbZZ41u37lzJyZOnGh027Bhw9CxY8dKi5OIagYm+0RU4wwcOBD3799HWFgY4uLikJmZCXt7ezRv3txQ1f9JlykjIiKqSpaWlnjvvfdw4MAB3Lp1C4mJiVCpVKhbty46deqEF198Ee3atStyf7lcDi8vL4waNQpz5sypwsiJqLrinH0iIiIiIiIiE8Nq/EREREREREQmhsk+ERERERERkYlhsk9ERERERERkYpjsExEREREREZkYJvtEREREREREJobJPhEREREREZGJYbJPREREREREZGKY7BMRERERERGZGCb7RERERERERCaGyT4RERERERGRiWGyT0RERERERGRimOwTERERERERmRgm+0REREREREQmhsk+ERERERERkYlhsk9ERERERERkYpjsExEREREREZkYJvtEREREREREJobJPhEREREREZGJYbJPREREREREZGKY7BMRERERERGZGCb7RERERERERCaGyT4RERERERGRiWGyT0RERERERGRimOwTERERERERmRgm+0REREREREQmhsk+ERERERERkYlhsk9ERERERERkYpjsExEREREREZkYJvtEREREREREJobJPhEREREREZGJYbJPREREREREZGKY7BMRERERERGZGKXUARAREVHR9IKAjBwdtHoBekH8kctkkMtkUMplsFQpIJfJpA6TiIiIqhkm+0RERNWEXhCQkqVFUlYOkjJzkKDJQUpWDvTF7CMHYGuugqNaBXsLFezNVbA1V7IBgIiIqJaTCYIgSB0EERFRbZagycatpAxEp2qgf/RXWQagLH+g824vlwFeNmr4OVjCwcKsYoMlIiKiGoHJPhERkQR0egF3UjW4mZiO5CxtmZP7kuQez85ciQYOVvCyUUMhZ28/ERFRbcFkn4iIqArp9AL+i0/DzaR0aPVV9ydYKZfBz8EKjR2tmfQTERHVAkz2iYiIqki8Jhun7iUhPUcnWQxWKgXaudvDUc3h/URERKaMyT4REVEl0+kFXHmYivDE9Aofrl9WuY/v72CFps427OUnIiIyUUz2iYiIKlGCJhsnJe7NLwp7+YmIiEwXk30iIqJKcjdVgxMxSQCk7c0vSm6ffnsPe3jaqCWNhYiIiCoWk30iIqJKEJmUgTP3k6UOo9QC3ezgY2cpdRhERERUQeRSB0BERGRqalqiDwBnYpMRmZwhdRhERERUQZjsExERVaC7qZoal+jnOhObjLupGqnDICIiogrAZJ+IiKiCJGiyDXP0a6oTMUlI0GRLHQYRERE9ISb7REREFUCnF3DyXpLUYVSIk/eSoNOzpA8REVFNxmSfiIioAlx5mIr0HF21rLpfFgKA9BwdrjxMlToUIiIiegJM9omIiJ5QvCYb4YnpUodRocIT0zmcn4iIqAZjsk9ERPQEdHoBp+4lGdasNxUycDg/ERFRTcZkn4iI6An8l5BmEsP388sdzv9fQprUoRAREVE5MNknIiIqJ51ewE0TG76f383EdPbuExER1UBM9omIiMopOlUDrYknwlq9gOhUjdRhEBERURkx2SciIiqnGybeq5+rtpwnERGRKWGyT0REVA4JmmwkZ2mlDqNKJGdpWZmfiIiohmGyT0REVA63kjJMrgJ/UWQQz5eIiIhqDib7REREZaQXxHnspj1b/zEBYn0CvVBbzpiIiKjmY7JPRERURilZWph4Xb4C9AKQWkumLRAREZkCJvtERERllJSVU+jtD6LvYEhjDwxp7IH9m9YCAPZvWmu4raZLLOK8iYiIqPphsk9ERFRGSZk5pZ6vb+foBP+WgfBvGVipMVU2GcTzrgg+Pj6QyWSYO3duhRyPiIiIClJKHQAREVFNcz85HUIp0/02XXugTdcelRzRk8vJzobKzKzY+xI07NknIiKqKdizT0REJkkQBCxevBitW7eGWq2GjY0N2rdvj3PnzgEA9uzZg86dO8PV1RVmZmawtbVF586dsWPHDsMxIiMjIZPJIJPJ8PPPP6N79+6wsLDA8gXfAAAuhh7F6/27YWQLX/zv+edw5+b1AnEUNoz/33824Z1hfTGhQzMMb14P49o3wUcvjEL4hbNG+ybGPcCSWf+HqV3bYESANyZ1bIHv3ny52PNe+M5reKV3R4wO9MeIAG+8+HQ7/PLJB8hIS328zbuvY0hjD8weOwSbf16EKV3aYFRLXwDA7LFDMKSxB75/ezpWfvURJoYEYMYznQEASZoszJ8/H82bN4eFhQUcHBwwbNgwREREGI6dlpaGadOmoW7dujA3N4eLiws6duyIlStXGq5nVFQUAODDDz80XF8iIiKqWOzZJyIikzRjxgz88MMPAAAnJye4ubnh/PnziIyMRKtWrXD58mWEhYWhbt268PLyQnh4OI4cOYIBAwbg1KlTaNmypdHxXnnlFdjY2MC3vh/kCgUS4x7gi5fHIzMjA+ZqNVKTEvHtzBdLFduNi+dw+/p/cHb3gJObO+7euonzRw/h+rnTWLjzCBxcXJGamID3RjyLuJhoAIC7d33k5GTh7OEDxR77xP5dUCgUcKvnDU16Ou7ficL2P5YjMe4B3vp+qdG2186dxtXTYfDw9UNOlr3Rfcd2/ANAgIePH2RysW9g6cf/w67VKwEAzZo1Q2xsLDZs2IAjR47g/PnzcHV1xezZs/Hjjz/C3NwczZo1Q1JSEsLCwuDv749evXohKCgIZ8+eRXZ2Njw9PeHl5VWqa0ZERERlw2SfiIhMTmRkJBYtWgQAGDRoENasWQMzMzPExcUhKyvLcPuECRNgb28PAEhMTIS3tzdSU1OxYcOGAsl+cHAwdu7ciUwosOfWfaz74RtkZmRArlDgi3XbUc+/EVZ//xU2LJlfYnx9np+A0TPfhbnaEgBwLyoCr/buCE16Gk4f2oseQ5/HjlUrDIn+m/N/Qkif/gCAW1cuFnvsj3/fCJ/GzQy/r5r/JTb++D1O7NuJ7KxMmJlbGO7T5mTjf0v/QOBTT0On0xU41pfrt8OncTPodDrcj76N3Wt+AwCsXLkS48aNQ1paGpo0aYLo6GgsXLgQH3/8McLDwwEAs2bNwv/+9z8AQEJCAu7cuQN3d3eEhobCx8cHUVFRmDx5MuftExERVRIO4yciIpNz8uRJCI/WhH/zzTdh9mguuouLi6EnOSsrCxMmTICrqysUCgUcHR2RmioOdY+JiSlwzJdeegkWFhbQCwIUCgXu3LgGAPDw9UM9/0YAYEjIS5KekowvXpmI8UFNMbSJJ17t3dFwX+KD+wBgGNLv5u1rdNz6TQOKPfaFY4fxev9uGNWyPoY09sDGH78HAOi0WqQkxBtt6+Hrh8CnngYAKBQKo/uaB4UYGg0UCgVuXjpvuKbjx4+HTCaDjY0NoqPFBonQ0FAAQP/+YqyzZs2Ct7c3evfujYULF6JOnTqlujZERERUMdizT0REtVK/fv1w48YNKJVKBAQEwMLCwjC8vLBe7txkVf8o4S0vTXo6Pp78PNJTkmFmbgHfJs2hUKkQfv6MePxCHru0/v1nE1Z+9REAwMGlDrzdmyAlMQH370Q9OrbeaHt7J5cij1Xcfa1atYK5ubnRbd7e3gCAqVOnonHjxtiyZQsuXryI06dPY/fu3Vi/fj0uXbpUrvMiIiKismPPPhERmZx27doZir7Nnz8f2dnZAID4+HhER0cjPj4eN27cAAB89NFHOHfuHNasWVNsobjc++SP/q3bQOzNj4m4ieib4tD147u2lhhbTMRNpKckAwBe/vQbzNu0C5Pe+7DAdv4tWgMAYqMiELp7u+H2iKtFJ8zXz50GAKitrLFkXyi+WLcNLTt2KfGcirjT6Nf6zVoYtp8wYQJCQ0MRGhqK48ePY968eZgxYwYA4MSJE2jWrBm+/vpr7Nq1C1u3itfk8uXLiI8XRxZYWorTF9LT04t+fCIiInoiTPaJqErpBQFp2VokZeYgQZONhxlZSNBkIykzB2nZ2ifuNSUCxHXcX3nlFQDAhg0b4OnpiYCAAHh6euLUqVNwdHQ0DOefM2cOAgICEBgYCKWy5AFvucl+n1HjYa5WQ6/T4e2hfTCj71P4+5clJe5fp249WDxKdhd/8CZmDuiOL1+dVGC7Z56fABcPMcZ5MyZjep9OmNY9CHPGDyvy2N6NmgIANOlpeLlHMKb16PCo0N6Tc6vrjR7DRgMAXn/9ddSvXx8tWrSAvb09nnrqKZw5I45MWLBgAdzc3ODr64s2bdqgd+/eAABPT084OjoCABo3bmzYtl27dpg4cWKFxEhERESPMdknokqjFwQkZeYgMjkD5+4nY3/kQ2y5HovdEXHYH/UQB2/H4987CTh4Ox77ox5id0QctlyPxf7Ihzh3PxmRyRlIysxhAwCVy4IFC7Bo0SK0atUKaWlpiIiIQIsWLeDj4wOZTIaNGzeiXbt2UCgU0Ol0+PPPP+Hs7FzicZVyMdl3cK2DdxevgFeDhtBpdVBbWeO1eT+UuL+1nT3enL8UXg0aQtALUKlUeG/JygLb2Tg44vO1W9Fj2Gg41nHH/ejbyMrUoFWnrkUeu/vQUeg/4UXYOjhCk56G5u2DMXLGWyXGVFpT536BL+Z9jYCAAMTExCAqKgo+Pj5444030LWrGFe/fv3QuXNnaDQaXLx4ERYWFujfvz+2b99uGBnwySefoEOHDpDL5Th16hQuXiy+6CARERGVnUwQ+C2aiCpWgiYbt5IyEJ2qgf7RJ4wMQFk+bPJuL5cBXjZq+DlYwsHCrGKDJSojvSDg7+uxZXo9mwo5gAEN3QyjG4iIiKj6YoE+IqoQOr2AO6ka3ExMR3KWtkByX9bEKO/2egG4k6LB7RQN7MyVaOBgBS8bNRRyJhxU9eQyGezMVUjKypE6lCpna65iok9ERFRDMNknoiei0wv4Lz4NN5PSodU/TtErutcz93jJWVqcjk3G+Qcp8HOwQmNHayb9VOUc1SokZ+XUqt59GcTzJiIiopqByT4RlVu8Jhun7iUhPaf8S4WVl1Yv4Fp8GqJTNGjnbg9HNYf3U9Wxt1DVqkQfEBvc7C2Y7BMREdUUTPaJqMx0egFXHqYiPDEdUvepZ+TocPB2PPwdrNDU2Ya9/FQl7M1rZ9LrUEvPm4iIqCZisk9EZZKgycbJPL35Uvdu5j5+eGI6YtIy2ctPVcLWXAm5DNBL/QaoQnIZYGPOrw1EREQ1BZfeI6JSu5uqwaHb8ciQYNh+aWTk6HDodjzupmqkDoVMnFwmg5eNWvKRLVVFBnFFDBbnIyIiqjmY7BNRqUQmZSAsJgkCpO/NL0pubGExSYhMzpA6HDJx9e0tq+17oaIJAPwcLKUOg4iIiMqAyT4RlSgyKQNn7idLHUaZnIlNZsJPlcpRbQa7WjKs3c5cCQcLTo8hIiKqSZjsE1Gx7qZqalyin+tMbDKH9FOlauBgJXUIVaK2nCcREZEpYbJPREVK0GTjREyS1GE8kRMxSUjQZEsdBpkoLxs1lCa+AoRSLtYnICIiopqFyT4RFUqnF3DyXpLUYVSIk/eSoKtNZdOpyijkMviZeK+3n4MVl7QkIiKqgZjsE1GhrjxMRXqOrsYXIBMApOfocOVhqtShkIlq7GgNK5XC5CrzywBYqRRo7GgtdShERERUDkz2iaiAeE02whPTpQ6jQoUnpnM4P1UKhVyGtu72Nb5hLD8BQDt3e/bqExER1VBM9onIiE4v4NS9JJPspeRwfqosTmoz+JvYcH5/Bys4qlmBn4iIqKZisk9ERv5LSDOJ4fv55Q7n/y8hTepQyEQ1dbYxieH8ucP3mzrbSB0KERERPQEm+0RkoNMLuGliw/fzu5mYzt59qhQKuQzt3O2lDqNCcPg+ERFRzcdkn4gMolM10Jp4IqzVC4hO1UgdBpkoR7UZ2nvYSx3GE2nvYc/h+0RERCaAyT4RGdww8V79XLXlPEkanjZqBLrZSR1GuQS62cHTRi11GERERFQBmOwTEQAgQZON5Cyt1GFUieQsLSvzU6XysbOscQl/oJsdfOwspQ6DiIiIKgiTfSICANxKyqjxhcVKSwbxfIkqk4+dJYI87CEDqu17Kze2IA97JvpEREQmhsk+EUEviPPYTXu2/mMCxPoEeqG2nDFJxdNGjS71nGCpUkgdSqEsVQp0qefEoftEREQmiMk+ESElSwsTr8tXgF4AUmvJtAWSlqPaDD18XODvYAVA+l7+3Mf3d7BCDx8XFuMjIiIyUUz2iQhJWTmSPO7ahV9jSGMPvPR0e0keP1Gi86baRyGXIcDVtlr08luqFOhazwkBrrZcXo9qFL0gIC1bi6TMHCRosvEwIwsJmmwkZeYgLVvL0VpERPkopQ6AiKSXlJkDGVDlw/id3Nzh3zIQDi6uZdrvQfQdTOsRBAD4cOUGNA8KKfNjyyCeN2pWDTWq4Zwe9fL/l5CGm4npVbrUpVIug5+DFRo7WjPJp2pPLwhIydIiKSvnUXKfg5SsHOiL2UcOwNZcBUe1CvYWKtibq2BrroRcxtc7EdVOTPaJCAmaHEnm6/cYNho9ho2W4JHFho0EDXv2qeop5DI0c7ZBY0drRKdqcCMxHclZ2gpvcMs9nr25En4OVvCyUTPJp2ovQZONW0kZj+qqiLeV9r2hhzhSLTnr8d80uQzwslHDz8ESDhacskJEtYtMEDjmiag20wsC/r4ea/hi9M+KpTi4eR0e3ouBJj0NVja2aNI2CGPeeB8evn7Yv2ktFr0/EwAwd8V6rPzqQ9y9eQOefg0wdfbnaNiqDTLSUvHGgO6Ii4lGt0HD8ern86FJT8cbA57Gg7t30OW5oZjx5QKsXfg11i36Fi4eXvhx/wkxHr0e2/9Yjr3r/0RsVCTMLCzQIrgzxv7fB6jjVc/o8fNq1i4YTdoGYcOS+XB298CSfScgl4szlb6aPhlhe7ajVaeumPXzKsM+cgADGrqx14ck9yQJTq682zPBoZpEpxdwJ1WDm5Xc8GVnrkQDNnwRUS3COftEtVxGjs7oS9Xlk8cRezsS9s4u8PRtgLSUZITt2YG5E4cjOyvTaN9Pp45BlkYDnU6LiCuX8O0b06DTamFpbYPpXy6AXC7Hgb/W4fzRQ/jjm0/w4O4duHrWxeRZnxYZz88f/w+/fjYbd8Kvwc3bB3K5HMd3bcX7owYgOf4h7Byd4NukmWF7Lz9/+LcMhFeDhug5fDTkCgUe3ovBhWP/AgCyNBk4d+QAAKDrwGFGj6V/dP5EUnNUm6Gtuz0G+Luhu7czAt3s4GtvCXtzVYl/qOUA7M1V8LW3RKCbHbp7O2OAvxvautsz0adqTacXcDkuFdtu3seZ2GQkPyqaWtG9ULnHS87S4nRsMrbdvI/LD1Ohq22VaYmo1uEwfqJaLv+c4dEz34P7/KVQqlQAgPPH/sVHk0YiPvYe/jtz0mjbcf/3AfqOfQHbfvsZyz+bjbiYaNy7HQGv+v5o1q4DBrwwDZuXLcL3b09HSkI85HI5Zny1AJbWNoXGcj/6Nnav+Q0AMP2L79F14DBo0tPxWr+nEB97D9v/WI5Rr72Nug0aGebsT5n9udGc/TZduuPk/t3Yv2kNWnXqijP/HkCWRgNLaxu079GnxPMnkpJcJoOdhQp2FipDPQm9ICAjRwetXoBeEHDi1ClcOHcOnTqGoEXz5rBUKTg6hWqceE02Tt1LQroEDa5avYBr8WmITtGgnbs9V6QgIpPFZJ+olstfvTguJho/zv4/RF27isyMdOSd6ZPw4L7Rtl2eGwoA8GrQ0HBb8sOH8KrvDwAYOf3/cO7wAUT+dwUA8Nzkl9GkTVCRsdy8dN7weAvffQ0L333N6P7r50+XeD69R43Hyf27cWLvLqQlJyF09zYAQHCfZ2FuUXAtcVZvpupOLpPB2kz8cy0IAq6cDIUmNRWhB/cjqGUAE32qUXR6AVcepiI8MV3yZSgzcnQ4eDse/g5WaOpsw6H9RGRymOwT1XJ5k93YO1H48pVJ0OZkQ21ljfrNWkCv0yLi6mVxW51xD4yVrdj1qFA8/ijJ2ziQpclASmKi4ff7t6NKHZdvk2ZQmpkb3ebi4VXifq06dYVbPR/E3o7E/k1rcfrgXgBA14HDC92eyT7VJNevX0dqaioAIDU1FadOnUJQUNENaETVSYImGyfz9OZL/emb+/jhiemISctkLz8RmRwm+0S1XN5ewYgrl6DNyQYAzPp5FRq1bosj2zbjuzdfLtexf5r7DhLu34Nn/QZ4EH0Hx3dtxcHN6wvMnc9Vv1kLyGQyCIKAroNG4NlxkwGIDQhXT5+ApY04/N9c/biHPkuTYXQMmUyGniPG4Pd5n2DtwnnIzMiAq1c9NGnTvsTzJ6rujh49aniPAMCBAwfQsmVLWFhYSBwZUfHupmpwIiZJ6jCKlJGjw6Hb8WjvYQ9Pm4KjwIiIaiIW6COq5fImu3X9G0KuUAAAPpkyGjP7P41fPvmgXMc9tGUjju34B0qVGd787ieMmP4mAOCXTz5AXEx0ofu41fU2LMX362ezMa1HB8wc0B3j2jXGrDGDcOvyRQCAraMTbOwdAAAL3pmBd4f3w/bffzEcp/vgkVCZmSMzQ2wI6PrcUMiKSOqZ7FNNcffuXdy5c8do9Ex2djYOHz4sYVREJYtMykBYTBIESN+bX5Tc2MJikhCZnFHS5kRENQKTfaJaTplnjqJXfX+88um3cPWqB21ODmwcHPH6N4vLfMy4mGj8/PH/AABDp70G70ZNMGDSNDRsKS7Lt/Cd16DX6wvdd+rcLzDxvQ9Rr2ETJD64j4cx0XDxrIv+E15E8/ZiIT6ZTIZpH38NN29fZKSlIvzCWaMGBBsHR4Q809/we5ciRhLkP3+i6iwsLAwADA1XuT38YWFh0Gq1UoZGVKTIpAycuZ8sdRhlciY2mQk/EZkEmSBwwipRbaYXBPx9Pbba9raU16alC/Hnt5+jSdsgfPLHX4VuIwcwoKEbe/epRjhz5gxu3rwJlUqF8+fPw8/PD56enrC3t0erVq2KHL1CJJW7qRqEVeOh+yUJ4pB+IqrhOGefqJaTy2SwM1chKStH6lAqROju7Ti89S+cPbwfAPDcpGlFbmtrrmKiTzVGYGAgAgMDAQCXLl1Cw4YN0b594bUoiKSWoMmu1nP0S+NETBK61FOwaB8R1Vgcxk9EcFSrJF8CqaJEXbuC0N3bYK62xPOvv4t2T/cqdDsZxPMmqolUKhVyckyjgY5Mj04v4OS9JKnDqBAn7yVBpze1sW9EVFuwZ5+IYG+hMplh/COmv4UR098qcTsB4nkT1URM9qk6u/Iw1bC8Xk0mAEjP0eHKw1QEuNpKHQ4RUZmxZ5+IYG9eO5Neh1p63lTzMdmn6ipek43wxHSpw6hQ4YnpSNBkSx0GEVGZMdknItiaK1HbitLLZYCNOQc3Uc3EZJ+qI51ewKl7SSYzLSyXDBzOT0Q1E5N9IoJcJoOXjdrkvqAVRQbAy0bN4nxUYzHZp+rov4Q0pOfoTGZaWK7c4fz/JaRJHQoRUZkw2SciAEB9e0uT+4JWFAGAn4Ol1GEQlZuZmRmTfapWdHoBN01s+H5+NxPT2btPRDUKk30iAgA4qs1gV0uGtduZK+FgwaWUqOZizz5VN9GpGmhNPBHW6gVEp2qkDoOIqNSY7BORQQMHK6lDqBK15TzJdDHZp+rmhon36ueqLedJRKaByT4RGXjZqKE08Up9SrlYn4CoJlMqlUz2qdpI0GQjOUsrdRhVIjlLy8r8RFRjMNknIgOFXAY/E+/19nOwgsLEGzTI9HHOPlUnt5IyalWB11tJGVKHQURUKkz2ichIY0drWKkUJvfFTQbASqVAY0drqUMhemIqlQrZ2exdJOnpBXEeu2nP1n9MgFifQC/UljMmopqMyT4RGVHIZWjrbm9yX9wEAO3c7dmrTyaBc/apukjJ0sLE6/IVoBeA1FoybYGIajYm+0RUgJPaDP4mNpzf38EKjmpW4CfTwGSfqoukrNK/Dhe++zqGNPbA7LFDKi2eB9F3MKSxB4Y09sClsGOV8hgvPd0e9mozzJ07t1KOT0RUUZjsE1GhmjrbmMRw/tzh+02dbaQOhajCMNmn6iIpM0eSvxNrF36NIY098NLT7av8sX2bNkdAYFt4eXlV+WMTEZVF7VhUm4jKTCGXoZ27PQ7djpc6lCfG4ftkalQqFfR6PXQ6HRQKhdThUC2WoMmBAEAQBOi0WihVqgLb6HS6qg+sEr3zw3LYm6vwtI+z1KEQERWLPftEVCRHtRnae9hLHcYTae9hz+H7ZHJUjxIq9u5TZfjuu+/QqlUrODo6QqVSwcXFBYMHD8b169cBACtWrIBMJoNMJsOBvbvx2rNdMbx5Pfx35qRRj/vBzevxcs9gjAzwRvy9GKPH2Lv+T0zrHoTRgf747MVxSIx7AABY/f1XGNLYAy92awu9Xm/Y/qvpkzGksQc+nvw8Zo8dgnWLvgUAxMVEG4bt79+01ugxEh7E4stXJ+H51n6Y1j0IezesMtx3KeyYYb+96//EB2MGYVTL+nh/ZH/E3o7EiX078WrvThjbthG+feMlZKSlGvZ96en26O7rgjlz5gAANBoNBg4cCF9fX1hZWcHc3Bz+/v6YPXs2C2kSkaSY7BNRsTxt1Ah0s5M6jHIJdLODp41a6jCIKhyTfapMhw4dwo0bN+Dm5obGjRsjMTERf/31F7p3747MzEyjbb94eSKyNRo4u3kY3Z4Ydx8/vPc6FAoF7JxcjO4Lv3gWv3wyCwqlCpkZ6Th9aC9WfvkhAKDn8NGQKxR4eC8GF479CwDI0mTg3JEDAICuA4fBq0FDONZxBwAoVWbwbxkI/5aBsHN0MnqcJbPeQuTVy1AolHhw9w5+mv02om+FFzjfnz/+AMkP46DX63Ht3Gl8PGU0vp05DXKFHJr0NBzdvgWbflpYYL+cR5UJs7Ky8Pfff0Oj0aBhw4ZwdXXFjRs38PHHH+N///tfqa87EVFFY7JPRCXysbOscQl/oJsdfOwspQ6DqFIw2afK9NlnnyExMRFXrlzBxYsXsXPnTgBAdHQ0jh49arTtsxOmYMm+MCzZF4YmbYMMt2tzcjBlzudYuPMIlv17Bs4eno/vy87G52v/wQ+7jiCo5zMAgIuhRwAAzu6eaNOlOwBg/6Y1AIAz/x5AlkYDS2sbtO/RB1PnfI4eQ0cBABxcXPHF2q34Yu1WtOnawyi2Nl16YPHeUHz8518AAL1ej8snjhc43y7PDcHCnUfw3AvTAACxUREY+vLrWLD9X3TuPxgAcOlEwWJ/ucvvWVlZ4fLly4iNjcXZs2dx584djBkzBgCwZs2aEq42EVHlYbJPRKXiY2eJIA97yIBqW7RPBgCCAMf0ONSzsZA6HKJKY2YmTk1hsk+VISoqCt26dYOtrS3kcjl69uxpuC8mxng4/rPjphj+n7d+hJmFBXoOFxNemUwGufzxV856DRvDp3EzAICXX0MAQNLDOMP9vUeNBwCc2LsLaclJCN29DQAQ3OdZmFuUfrRW5/6DIJPJUPfRYwBAcp7HydW2m3h+rp5eBW6r41WvyP0e5fqQy+X4448/0LBhQ5ibm0Mmk+GPP/4AUPB6ERFVJRboI6JS87RRo0s9BU7eS0J6TvUruGSpUuDK7i24eP8uTh/Yg5CQELRu3RoWFkz8ybSwZ58qy61btzBw4EBkZ2fDxsYGbdq0gVarxblz5wAULLZn7+xSyFEAW0cnowQ/LyubxyPFCisw2apTV7jV80Hs7Ujs37QWpw/uBQB0HTi8TOeS+zgK5eOvu0Juhp6H2kpcrUWueLyd5aPbZDJZkfsJEG/74osv8PnnnwMAvL294ebmhujoaNy9e9eo7gARUVVjzz4RlYmj2gw9fFzg72AFQPpe/tzH93ewQg8fF3i7OgIA0tLSsHv3bnzzzTfYvn074uNr/qoCRLmY7FNlOXv2rKGo3K5du3Dy5Em88847RW6fmwwXuP0J/jrIZDL0HCGOCli7cB406Wlw9aqHJm0eL7NnrhZ7+LMyNYUm4lUh9xxDQ0MBAA0bNkRkZCSOHj2Kli1bShITEVFeTPaJqMwUchkCXG3RpZ4TLFXSLvtlqVKgaz0nBLjaQiGXwc/Pz+h+rVaLkydPYsmSJQUKSxHVVEz2qbI0a9bM0Nvep08fBAQEYPr06VUeR/fBI6EyM0dmRgYAoOtzQ40aFjzrNwAApCTEY3qfznh3xLOIvRNVpTHmhtOiRQsAwPXr1+Hr6wtvb29DAwARkZSY7BNRuTk96uVv5GQNZRWvY6+Uy9DIyRo9fFyMltbz9vYudPuQkBAO5yeTwWSfKkvjxo2xfPly+Pr6Ijs7G87Ozli9enWVx2Hj4IiQZ/obfu8ycJjR/W269kSPYaNhY++Ae1G3EH7+DLI1miqNUf4o23///fcxfvx42NvbIyUlBSNHjsTLL79cpbEQERVGJkg19omITIpOLyA6VYMbielIztJCBqAiP1xyj2dvroSfgxW8bNRQFNLAIAgCvvnmG6Snpxtua9euHfr27VuB0RBJS6/X4+OPP8Zzzz2HVq1aSR0O1VJ6QcDf12Mr9LM+r01LF+LPbz9Hk7ZB+OSPvyrpUcpHDmBAQzdDwk9EVB2xQB8RVQiFXAZvO0t421kiQZONW0kZiE7V4NEyxGVO/vNuL5cBXjZq+DlYwsHCrLjdIJPJ4Ovri0uXLkGtVsPT0xNnzpxBQEAA6tatW44zI6p+5HI5FAqFYW41kRTkMhnszFVIyqrYESahu7fj8Na/cPbwfgDAc5OmVejxK4KtuYqJPhFVe0z2iajCOarN4Kg2Q6CbHVKztEjMykFSZg4SNDlIycpBcbWJ5RC/RDmqVbC3UMHBXAUbc2WZvlS1atUKGo0G/fv3h5WVFX777TesXbsWkydPhr29/ZOeHlG1oFKpOIyfJOeoViE5K6dCe/ejrl1B6O5tsHV0wpAXX0O7p3tV4NGfnAzieRMRVXccxk9EVUovCMjI0UGrF6AXxB+5TAa5TAalXAZLlaLCe0vS09Px888/w9zcHJMmTTKsUU5Uk3377bcIDAxE165dpQ6FarHI5AyciU2WOowqF+hmBx87S6nDICIqFgv0EVGVkstksDZTwt5CBUe1GZwtzeGoNoO9hQrWZmXrwS8tKysrjBo1ComJidi0aRPXPSaTwJ59qg7szWtnD7dDLT1vIqpZmOwTUa3g6uqKoUOH4vr169i3b5/U4RA9MSb7VB3YmitRxYuxSE4uA2zMOROWiKo/JvtEVGv4+/ujZ8+eOHbsGM6dOyd1OERPhMk+VQdymQxeNmrUlnxfBrFgLIvzEVFNwGSfiGqVDh06IDAwEP/88w+ioqKkDoeo3JjsU3VR396y0pbfq24EAH4OnKtPRDUDk30iqlVkMhn69u2LevXqYe3atUhMTJQ6JKJyYbJP1YWj2gx2tWRYu525ssQlYImIqgsm+0RU6ygUCgwbNgxqtRqrV69GVlaW1CERlZmZmRmTfao2GjhYSR1Clagt50lEpoHJPhHVSpaWlhg1ahRSUlKwYcMGVuinGkepVDLZp2rDy0YNpYlX6lPKxfoEREQ1BZN9Iqq1nJ2dMWzYMNy8eRO7d++WOhyiMuEwfqpOFHIZ/Ey819vPwQoKE2/QICLTwmSfiGo1Pz8/9OnTB2FhYTh9+rTU4RCVGpN9qm4aO1rDSqUwucr8MgBWKgUaO1pLHQoRUZkw2SeiWq99+/Zo164dtm/fjoiICKnDISoVJvtU3SjkMrR1tze5yvwCgHbu9uzVJ6Iah8k+ERGAPn36wMfHB+vWrUN8fLzU4RCVyMzMDNnZ2VKHQWTESW0GfxMbzu/vYAVHNSvwE1HNw2SfiAiAXC7HsGHDYGVlhdWrV0Oj0UgdElGx2LNP1VVTZxuTGM6fO3y/qbON1KEQEZULk30iokcsLCzw/PPPIz09HevXr4dOp5M6JKIiqVQq6PV6vk6p2lHIZWjnbi91GBWCw/eJqCZjsk9ElIejoyOGDx+OqKgo7Ny5U+pwiIqkUqkAAFqtVuJIiApyVJuhvYe91GE8kfYe9hy+T0Q1GpN9IqJ8fH190bdvX5w6dQonTpyQOhyiQuUm+xzKT9WVp40agW52UodRLoFudvC0UUsdBhHRE1FKHQARUXXUpk0bPHz4EDt37oSTkxP8/PykDonISG6yzyJ9VJ352FkCAM7EJkscSekFutkZ4iYiqsnYs09EVISePXuiQYMGWL9+PeLi4qQOh8gIe/appvCxs0SgqzVkQLUt2pcbW5CHPRN9IjIZTPaJiIogl8sxZMgQ2NraYvXq1cjIyJA6JCIDJvtUE2RmZuLQoUP4/Yf5uHN4JyxVCqlDKpSlSoEu9Zw4dJ+ITAqTfSKiYpibm2PUqFHIysrCunXrWPmcqg0m+1SdpaWlYe/evfj2229x8OBB6PV62Jsp0MPHBf4OVgCk7+XPfXx/Byv08HFhMT4iMjlM9omISuDg4IARI0bgzp072LZtGwRBkDokIpiZiYkJk32qTgRBwM6dOzF//nwcO3bM6PXZsGFDKOQyBLjaoks9J8l7+S1VCnSt54QAV1sur0dEJonJPhFRKdSrVw/9+/fH2bNnERoaKnU4ROzZp2opOzsb58+fh06nK9Aw6uHhYfi/k9oMPXxc0MjJGsoqTrSVchkaOVmzN5+ITB6r8RMRlVKrVq3w8OFD7N69G05OTmjYsKHUIVEtplSKf8KZ7FN1Ym5ujqlTp2L16tVGhU1lMhnc3NyMtlXIZWjmbIPGjtaITtXgRmI6krO0kAGoyPFTucezN1fCz8EKXjZq9uQTUa3Ann0iojLo3r07GjVqhI0bN+LBgwdSh0O1mEKhgFwuZ7JP1Y69vT1cXFwgkz1OqB0dHQ1TT/JTyGXwtrNEdx8XdK3nhLq2auTNxcualufdXi4D6tqq0c3bCU/7uMDbzpKJPhHVGuzZJyIqA5lMhsGDB2P58uVYtWoVpkyZAisrK6nDolrKzMyMyT5VO2FhYbhy5QqGDBmCrKwsbN++Hd7e3qXa11FtBke1GQLd7JCapUViVg6SMnOQoMlBSlYO9MXsKwdga66Co1oFewsVHMxVsDFXQi5jck9EtROTfSKiMjIzM8OoUaOwbNkyrF27FuPGjTMMqSaqSiqVCtnZ2VKHQWQQFRWFPXv2IDg4GM2bNwcA+Pn5wcLCokzHkctksLNQwc5CBdiJt+kFARk5Omj1AvSC+COXySCXyaCUy2CpUjCxJyLKg8P4iYjKwc7ODiNHjkRMTAy2bt3KCv0kCZVKxZ59qjZSU1OxYcMG1K1bFz169DDcbm9vX+ZkvzBymQzWZkrYW6jgqDaDs6U5HNVmsLdQwdqMPfhERPkx2SciKicvLy8899xzOH/+PI4ePSp1OFQLMdmn6kKn02HDhg2QyWQYOnQo5HJ+xSQikhrHnRIRPYGAgAA8fPgQ+/btg5OTE5o0aSJ1SFSLMNmn6mLPnj2Ijo7GhAkTYG1tLXU4REQEJvtERE+sa9euePjwIf766y/Y29vD3d1d6pCollCpVNBqtVKHQbXcxYsXERYWhmeeeQZ169aVOhwiInqEY6yIiJ6QTCbDwIED4ezsjDVr1iA1NVXqkKiWYIE+ktqDBw/wzz//ICAgAO3atZM6HCIiyoPJPhFRBVCpVBg5ciQEQcDatWs5tJqqBIfxk5QyMzOxdu1aODo6on///pCxQB4RUbXCZJ+IqILY2tpi5MiRuH//PrZs2cIK/VTpmOyTVARBwObNm5Geno7hw4dDpVJJHRIREeXDZJ+IqAJ5eHhg0KBBuHTpEv7991+pwyETx2SfpHL06FFcu3YNgwYNgqOjo9ThEBFRIVigj4iogjVt2hTdunXDgQMH4OzsjGbNmkkdEpkoJvskhVu3bmH//v3o3LkzGjVqJHU4RNWSXhCQkaODVi9AL4g/cpkMcpkMSrkMlioF5Jz6QpWMyT4RUSXo3LkzHj58iM2bN8Pe3h6enp5Sh0QmiMk+VbXk5GRs2LAB9evXR9euXaUOh6ha0AsCUrK0SMrKQVJmDhI0OUjJyoG+mH3kAGzNVXBUq2BvoYK9uQq25ko2AFCFYrJP5cYWS6KiyWQyDBgwAAkJCVizZg2mTJkCW1tbqcMiE8Nkn6qSVqvFunXrYGZmhsGDB0Mu52xQqt0SNNm4lZSB6FQN9I/K9MgAlKZijx5AUlYOkrNyDNvLZYCXjRp+DpZwsDCrnKCpVmGyT6XCFkuislMqlRg5ciSWLVuGNWvWYMKECTAz4x9vqjhM9qkq7dixA/fv38ekSZNgaWkpdThEktDpBdxJ1eBmYjqSs7QFkvuylubNu71eAO6kaHA7RQM7cyUaOFjBy0YNhZzfnal8ZALLRVMxnqTFMlfe7dliSbVRbGwsli9fjgYNGmDYsGFcnooqzN27dxEeHo4uXbrwdUWV6uzZs9iyZQsGDBiA1q1bSx0OUZXT6QX8F5+Gm0np0OqrLn1SymXwc7BCY0drJv1UZkz2qYCSWiyfVO7x2GJJtcm1a9ewZs0adO7cGU8//bTU4ZCJEAQBer0ecrmcyT5VmpiYGCxfvhwtW7ZE//79pQ6HqMrFa7Jx6l4S0nN0ksVgpVKgnbs9HNXsLKPSY7JPBmyxJKpcR48exd69ezFo0CC0aNFC6nCIiEqUkZGBpUuXwsrKChMnToRSyRmgVHvo9AKuPExFeGJ6hXd+lVXu4/s7WKGpsw2/M1Op8BObAEjbYqnVC7gWn4boFA1bLMmkhYSEIC4uDlu2bIGDgwPq1q0rdUhEREXS6/XYtGkTsrOzmehTrZOgycbJPN+Npe4dzX388MR0xKRl8jszlQrLqNZyOr2Aiw9ScOh2PDIkHJoEABk5Ohy8HY+LD1Kgq8KRBURVRSaT4dlnn4WnpyfWrl2LpKQkqUMiIirSoUOHcOvWLQwdOhR2dnZSh0NUZe6maqrFd+OiZOTocOh2PO6maqQOhao5Jvu1WIImG3sj4xCemA6gerVY7o2MQ4ImW9J4iCqDUqnE8OHDoVKpsHr1amRlZUkdEhFRAdevX8e///6Lbt26oX79+lKHQ1RlIpMyEBaTBAHSfzcuSm5sYTFJiEzOkDocqsaY7NdSbLEkko6VlRVGjRqFpKQkbNq0CXp9cYtYEhFVrYSEBGzatAmNGjVCp06dpA6HqMpEJmXgzP1kqcMokzOxyUz4qUhM9mshtlgSSc/V1RVDhw5FeHg49u3bJ3U4VFMlJABnzgBRUUBuvd2HD4HUVGnjohorJycHa9euhZWVFQYOHMhVHqjWuJuqqXGJfq4zscnsIKNCMdmvZdhiSVR9+Pv7o1evXjh27BjOnj0rdThU0xw4APj7A0FBQOvWwK5d4u379wOLFwM5OdLGRzWOIAjYunUrEhMTMWLECFhYWEgdElGVSNBk40RMktRhPJETMUmcAksFMNmvRdhiSVT9BAUFITAwEFu3bkVUVJTU4VBN8n//B/TtC/z3HzBmDPDxx0BaGtCoEbB0KZBcMz/vSTonT57EhQsX0L9/f7i6ukodDlGV0OkFnLyXJHUYFeLkvSQWuSYjTPZrCbZYElVPMpkMffv2Rb169bB27VokJiZKHRLVFLdvA5MnA35+wMyZQHS0OIS/ZUsgJYVD+alM7ty5g127diEoKAgBAQFSh0NUZa48TEV6jq7aTm0tLQFAeo4OVx7ys58eY7JfC7DFkqh6UygUGDZsGNRqNVavXo3MzEypQ6KaIDgYuHQJyMoC6tUDsrMBuRwIDwfMzDiMn0otLS0N69evh6enJ3r27Cl1OERVJl6TbViVylSEJ6azc4wMmOzXAmyxJKr+LC0tMWrUKKSkpGDjxo2s0E8l++orYMUK4OuvgVOnAI0G2LgReOUVoGtXwMVF6gipBtDr9diwYQMEQcCwYcOgUCikDomoSuj0Ak7dS4KplaCUgZ1j9BiTfRPHFkuimsPZ2RnDhg3DzZs3sXv3bqnDoepu8mTg9Gngyy+BTp0AGxvg++8BtRqYMwdwcJA6QqoB9u7dizt37mDo0KGwsbGROhyiKvNfQppJdIbll9s59l9CmtShUDWglDoAqjx5WyxN6YMst8Wyh48LFHJTa4+l2s7Pzw/PPPMMtm/fDmdnZ7Rt21bqkKi6mj8fuHdPTOotLQGVClAogLp1AWtrqaOjGuDy5cs4fvw4evfuDW9vb6nDIaoyOr2AmybWGZbfzcR0NHa05nflWo49+yaMLZZENVO7du3Qrl077NixAxEREVKHQ9VVYiJw7Bjg7i4uvafTAd98A/TvD6xaxTn7VKy4uDj8/fffaN68OYKCgqQOh6hKRadqoDXxYe5avYBormRV6zHZN1G1pcWS85HIVPXp0we+vr5Yt24d4uPjpQ6HqqN//gHu3wfs7cXf330XuHwZ8PUFPv8cOHhQvJ31HyifrKwsrF27Fvb29ujfvz9kMvb8Ue1yw8S/I+eqLedJRWOyb6LYYklUs8nlcgwdOhRWVlZYvXo1NBq+1imfhARxfr6jI3D1KpCRAfzvf8Dy5WJv/9mz4naCaf8toLIRBAF///03UlNTMWLECJiZmUkdElGVStBkIzlLK3UYVSI5S8s6V7Uck30TVVta8mrLeVLtZGFhgeeffx4ZGRlYv349dDqd1CFRdWJnB6SkiP8/dUos0OfuLv5uYfH4PqI8jh07hqtXr2LQoEFwcnKSOhyiKncrKcPkKvAXRQbxfKn2YrJvgthiSWQ6HB0dMXz4cERFRWHHjh0Q2EtLuTp2BK5dE5fgW7VKTPbbtAHi4sT/u7mJ23GINj0SERGBffv2oVOnTmjcuLHU4RBVOb0gjgqtLX9JBYijffX87lBrMdk3QWyxJDItPj4+6NevH06fPo2TJ09KHQ5VFyNHAsOGAR9+KM7dnzZNvF2nE2/v1Uv8Xc4/9QSkpKRgw4YN8PX1Rbdu3aQOh0gSKVlamPgs1wL0ApBaSzoBqSB+AzAxbLEkMk2BgYHo0KEDdu7ciRs3bkgdDlUHMhnw1ltAejpw5gzw1FNAdrY4j3/gQKBhQ87XJwCAVqvFunXroFQqMXjwYMjZAEQ1jI+PD2QyGebOnftEx0nKqppVSl56uj2GNPbA2oVfV8njlSQx33kfPHgQMpkMMpkMkZGR0gRFVYKf9iaGLZZEpqtnz55o0KABNmzYgLi4OKnDIanFxADz5wN794q/JyQAP/4IvPACsHAhkJbGIfwEANi1axdiY2MxfPhwWFlZSR0OkWSSMnMqbPTrpbBjGNLYA0Mae+BB9J0KOmrFk0E877xsbW0RFBSEoKAgmJubSxMYVQkm+yamuBbLB9F3DB9K+zetBQDs37TWcFt1VNqW0bwtlrktlStWrKjk6Iiqllwux5AhQ2BnZ4fVq1cjI4NTWGq1K1eANWuA3CJrW7YA778vJvg//gj89JN4O5feq9XOnTuHU6dO4ZlnnoGnp6fU4RBJKkGTYxKjX3U6XamL9goQzzuvwMBAhIaGIjQ0FO65hV3JJDHZNzFlbbG0c3SCf8tA+LcMLPNjVcUQJd+mzeHfMhBObkV/EOVvscxtqXRxcQEAREZGGhoADuauO01UQ5mbm2PUqFHIysrCunXrWKG/NsvKApKTgdatxV7806eBESOA9euBSZOATZvE7TiUv9aKjY3Ftm3b0KpVKwQGlv3vPFF1k52djTfeeANOTk5wdXXFa6+9Bq1Wi86dO0Mmk2HMmDGGbXU6HVxdXSGTyfDFF19ALwjo7uuCIY09sOXXnzD/rVcwOtAfE4ObY/WCr4wK4KYmJWLZR+9hatc2GN68HiZ1bIHv/+9VxMVEAwDWLvwac8YPNWw/rUcQhjT2wMJ3XzeKV5uTg18/n4vxQc0wMSQAv3w6Czrt49GoOdlZWLNgHl7p3REjArwxMSQAi96fiZTEeMM2axd+jSGNPfDS0+1xcPN6vNwzGCMDvBF/LwYL333dcN+Bv9Zhatc2GNOmIZZ/NhtZmRos/2w2xrZthBEhLbF4yRLDMQsbxr9nzx507twZrq6uMDMzg62tLTp37owdO3ZUyHNH0lBKHQBVrARNDrKzs6Eq5bq5bbr2QJuuPSo5qvJ754flJW6Tv8UyNDS0EiMikp69vT1GjBiB3377DVu3bsWAAQMg43Dt2sfKCsjMFP8fHw/cuAEMGSL+7uQkNgRQraXRaLB27Vq4uLigb9++/IwgkzB//nyo1Wqo1WrcvXsXCxYsQPPmzTFt2jQcOXIEmzZtQnJyMuzs7HD48GHExcVBLpdjzJgxyMh53Di+6rsvYGPvAEsbWyTcv4cNi+fD1t4R/cZNRnZWJmaPHYLb4f9BoVTC3ac+Hty5jX//2YRLYcfw9eY9cHJzh5efP6JvhgMAfJs0g9LMHG71vI3i3frbMpiZq2FmYYGE+/ew/fdfUM+/MXoOHw0A+Gr6ZJw5tA9yhQJ1GzRC3N072L9pLa5fOIuvNuyAuYXacKzEuPv44b3X4e7tCzsnF6PHSYx7gGUfvQcHlzrQpN/Dtt9+xvmjh5BwPxaWNjZ4eC8G0199Fd26dkWTJk0KvbaXL19GWFgY6tatCy8vL4SHh+PIkSMYMGAATp06hZYtW1bIc0hViz37EhIEAYsXL0br1q2hVqthY2OD9u3b49y5c6VqXcvbY/3zzz+je/fu6NPIC5t+WgAAuBh6FK/374aRLXzxv+efw52b1wvEUNQw/v0b1+D/BvfGqJb18XxrP7w/agBO7NsJ4PF0gNzWzXWLvi1wjKunw/DRC6PE1sQAH8zo+xQ2/7LY0At5Yt9ODGnsgaFNPHEp7BgA4NSBPYbbLhw/DKDw0QOJcQ+wZNb/YWrXNhgR4I1JHVtg7qtTDEX68g7jX7FiBXx9fQ37duvWDTKZDF27dsWsWbMgk8lQr1496PMMcx0yZAhkMhn69OlT1qeUqMrUq1cP/fv3x7lz59jAVVt5eQHOzsDnnwPbt4vD+p95RqzG/+AB4P3oSyeTvFpHEAT89ddfyMrKwvDhw6FSqaQOiahCuLm54datW7hx4wY8PMTvnfv27cPQoUPh4uICjUaD1atXAwA2btwIAHj66afh5eUFbZ6iVg1atMKSfWFYsjcUTdoGAQA2LV0IADiydTNuh/8HAHhz/k/4futBfLpqM+RyORIexGLHH8vRY9hoTJn9ueF4by9cji/WbsWwl2caxWvv7IrFe49j0e6jcHQVl0O9GCp+x7184jjOHNoHAJi7Yj2+/XsvFmz/F2YWFoi+cR2Ht/5ldCxtTg6mzPkcC3cewbJ/z8DZwzPPfdmY/ctqLNx5BM7u4nWJvR2Jbzbvxfyth2BmbgG9Xo9Dhw4VeW0HDRqEBw8e4ObNmzhz5gxu374NGxsbaLVabNiwoeQnh6olJvsSmjFjBl555RWcO3cOVlZW8Pb2xvnz5xEZGWloXbOxsUHz5s0hCIKhde38+fMFjvXKK6/g3PnzqFPPG3KFAolxD/DFy+NxJ/wa5Ao5UpMS8e3MF0sV14Yl87Hof2/g1pWLsHVygtraBtfOnsKXr0zCoS0boTIzg3/LQChV4ugBxzruRlMBLoUdw5zxw3D+6CHIFQq4eHjh7q0b+H3eJ1g69x0AQPvufdBj2PMQBAFLZv8fEh/cx09zxPv6jZuCFsGdC40tNTEB7414FnvX/4n42Htw8agLlbk5zhw+YNRim8vFxQWtWrUy/N6kSRMEBQWhadOmmDp1KhQKBe7cuYO9jwpcZWRkYOdOsVFj/PjxpbpeRFJp2bIlOnbsiN27d+P69YKNeWTi/PyAt98GPvoI+N//gIkTAU9PQKMB6tUDXnlF3I6V12udf//9F+Hh4Rg8eDDs7e2lDoeowgwYMAB2dnawsLAwdObcv38fZmZmmDRpEgBg+fLlhgYv4PH3ubwrNwX36gelSgWlSoXgXv0AAEkP45CcEI8bl8Tv2eZqNYJ6PAMAqN+sBTx8/QAANy9fKHW87Z7uBSsbW5iZW8DVq+6jx3kIAAi/eNaw3eyxgzGksQcmP9Ua2Y9GbIWfP2N0LDMLC/QcLk5TkMlkRqtqWNvZo3Fge8jlcji7i40Adf0bwdWrLtRWVrB9VNvl/v37RcaalZWFCRMmwNXVFQqFAo6OjkhNTQUAxMTElPqcqXrhNwCJREZGYtGiRQDElrSYmBhcunQJ0dHRaNu2bZlb14KDg3H5RgS+33oQg1+cgZ2rViAzIwNyhQJfrNuOBdv/xbPjp5YYV2ZGBjY+GhkQ1PMZLNkbhh/3hcG/RWsAwOr5X8LBtQ6+WLsVDi6uAIAeQ0fhi7Vb8cXarQDEuUU6rRYuHl5YvOc4fth1BP3GTQYA7NuwGrF3ogAAE979EG71fBAbFYG3BvdCwoNY1GvYBGPefK/I+HasWmEYUfDm/J/ww64j+Gn/Scxdsc6oxTZXv379DB/2ALB48WKEhoZi8eLFqFu3Lvr1Ez/gly8Xpwvs2LEDGRkZsLW1xcCBA0u8XkRS6969Oxo3boyNGzcW+0ecTJBMBgwbJib3N24Ac+cCOTmAtTUwciTQt6/UEZIEwsPDcfDgQXTt2hUNGjSQOhyiCpW38UqpFGcj5861f+mllyCXy3Hy5En88ssvuHv3LmxsbDB48GAAkGSZZisbW8P/FYpHs6cLiSO30yzvj72zq9E2to5ORS6bqbayLvA4llY2httkjyp6CcVcg379+uHvv/9GYmIiAgICEBQUBLNH04JZH6jmYrIvkZMnTxrecG+++abhzeTi4gIvL68yt6699NJLMHu0dIZCocCdG9cAAB6+fqjn3wgAENKnf4lx3blxzdCi2LHvc5DL5VCZmaNDL/FLY1xMNJIT4os7BG5cOgcACOzSHVa2dgCAzs8OAiB+yNx61CKqtrLCa18thFwuR9LDOChVKrw+7weozIpeAiT8gtgK6ubta3Q+9ZsGlOtDfNq0aQCAzZs3IzEx0TDka9iwYVCr1cXtSlQtyGQyDBo0CA4ODli9ejXS09OlDomqWnw8cOQI8OGHwMcfAz//LA7pp1onMTERmzZtQsOGDfHUU09JHQ5RlfLx8TFMwXz99dcBiFMzLS0tAQDyPFOawvbsgE6rhU6rRdgecYqsvbML7Byd0KC5ODc9S6NB2F7xvluXLyAm4iYAwK9ZCwBiz3+uTE3ZV8dp0LyV4f+Dp75q6Dj79M/NGPHqm+g+ZJTR9rIKWzSwoPj4eNy4cQMA8NFHH+HcuXNYs2YNa32YABboq6b69euHGzduQKlUIiAgABYWFjh79iyys7MLbV2rU6eOJC2WTyru3l3DfHltTg7iYqLh3ajwwiElKc/59+7dG35+frh58yZ+/fVXbN0qjk7gEH6qSczMzDBq1CgsW7YMa9euxbhx4ww9HmTioqLECvwXLgAeHoCZGZCUBLi4AMuWAe3bSx0hVZGcnBysW7cOarUagwYN4pd0qpWmTZuG7du3Gxq+836fy5vs37x8Hi91F+fqJ9y/BwAYNOVVAECnZwfinxVLcTv8P3zz+ouGAn16vR6Orm54Zow4XcCtrjeUKhW0OTn4cNIIuHh44bmJLyG4z7OlirV5UAhadeqKc0cO4stXJsHD1w9yhQIPY6KRmZGBD1duMAz9r2yOjo7w8vJCdHQ05syZg1WrVuHu3btQKpXIysqqkhiocrBnXyLt2rUz/CGeP38+srOzAYgta1FRUWVuXZPJZEYfYnUbiL35MRE3DZVCj+/aWmJcdRs0gpmFBQDg6PYt0Ov1yMnOQuijVk8XDy/YOYrzfnJbNPO3Zua2VJ45tA/pKWI16CPbNhvirP+oRTT+/j0snfsuALGKKQAsmfVWsSMHcqcTxEZFIHT3dsPtEVcvGZ1/XrktugAK9HrKZDK8+KJYy2D27NlITU2Fr68vOnXqVGQMRNWRnZ0dRo4ciZiYGPzzzz/FDtUjE/LGG4BCAVy7Jg7lv3JFTPz9/YHXXpM6OqoigiBg27ZtePjwIYYPHw6LR3/HiWqbvn37wvtRcVJvb2906dLFcJ9S/vh74vOvv4sWHTohIzUFNvYOGPLSa+g79gUAgJm5BT76fSP6PD8e9s4uuBd5CxZWVniq/2B8tmaL4XuwjYMjJv3vYzi7eyD5YRzCz59B4sMHZYr3nUXLMezlmXD3ro8H0beRFBcHz/r+GDrtddRr2OhJL0epyWQybNy4Ee3atYNCoYBOp8Off/4JZ2fnKouBKodM4DdCyUyfPh0//PADAMDZ2Rlubm4IDw/H6tWrMWPGDERHR0OlUqFRo0a4e/cusrOzkZ6ejvHjx2PFihWIjIw0FCc5cOAAWnXoiP1RYtGPxAf38UrvEGRpNDBXq+Hs7om4u9HIzhKH6L/y2Xd4evAI7N+0FoveFyuHbvxPnB6wYcl8rP7+KzEuD09oc3KQFCd+eM34aiG6DBCXdvpq+gsI27MDSpUZvBs1QT3/Rnj18/m4FHYMH70wEjqtFtZ29rCxd8S9qFsAgB7Dnse0j7+GIAj46IWRuHDsMBq1bou5K9bh3eHPIuraFbTv0cew5N5LT7dHXEw0hr/yBkZMfwupiQn4vyF9DPP2PXzqQ5uTg/TUFETfj4O9hcrQKPLrr79iwoQJEAQBLi4uiI+Ph4ODA/z9/TFmzBhMnz4dgNjA4unpaWi5nDNnDubOnVsZTzlRpbt48SI2bdqE7t27s9GqNrC3Bw4cAFq3BrRacS6oSgXcuwf4+gJpaQBHeZi8U6dOYdu2bRg0aBBatGghdThEkurTpw927dqFWbNm4aOPPjLcrhcEKB7Nec/9HlxbyAEMaOhWZMcYmS727EtowYIFWLRoEVq1aoW0tDRERESgRYsW8PX1LVfrWt4WSwfXOnh38Qp4NWgInVYHtZU1Xpv3Q6niGjrtdbz86Teo3zQAKfHxyEhNQaNWbfDOouWGRB8ARr32Dhq2bAO5XI6bl87j9nVxmZLmQSH4cOV6tAx5CnqdDnExd+BZvwHGvvU/TJ37JQBg2++/4MKxwzCzsMCrn30HM3MLTP9iPpQqFU7s3Yl9G1cXGpuNgyM+X7sVPYaNhmMdd9yPvo2sTA1adepqdP55yWQyLFu2DA0aNEBKSgpOnDiBqKgow/1OTk4YPny44fdx48aV6joRVUcBAQF46qmnsG/fPly9elXqcKiyyeVAXJz4f6VSTPQB4OJFsVDfoxosZLqio6OxY8cOtGvXjok+1WqffvopevfujV27dsHS0hKv5K5I8khtTnRtzVW1+vxrM/bsmxC9IODv67GojU/ok7ZYfvHFF3jvvffQuXNn/PvvvxUbHFEVEwQBGzZsQHh4OCZOnAh3d3epQ6LKMnkycPo08O23gLe3WJn/9m1g5kygd29g3jxxHj+ZpPT0dCxduhS2traYMGECFAqF1CERSaZr1644fPgw/Pz88N133xlWXMord/RnberZlwHwtbdEqzp2UodCEmCyb2L2Rz5EUlaO1GFUOXtzFZ72Kfu8ok2bNmHVqlWGJfe2bNmC/v1LXrWAqLrLycnBihUrkJaWhsmTJ8PGxqbknajmSUsDxowB9uwB3N0Bc3PgwQOgY0fgp5+AOnWkjpAqiV6vx++//464uDhMnToVtra2Je9EVMtFJmfgTGyy1GFUuUA3O/jYWZa8IZkcDuM3MY5qVSUuzFE9ySCed3lcuHABGzduhJWVFT799FMm+mQyVCoVRo4cCUEQsGbNGuTk1L5GwFrB2hrYvBk4exb4+mvgs8+AQ4fE25jom7T9+/cjKioKQ4cOZaJPVEr25uX7vljTOdTS8yb27JsctlgSUV4xMTH49ddf0ahRIwwZMoTLcZkqjQZISRF7+gHA0xNgRXaTdfXqVaxbtw49e/ZESEiI1OEQ1Rh6QcCW8Fjoa1H2I5cBA/xZnK+2Ys++iWGLJRHl5eHhgUGDBuHy5cs4dOiQ1OFQZbhxA5g+HXj6aaBHD6B/f+Cdd4DISKkjo0rw8OFDbN68GU2bNkVwcLDU4RDVKHKZDF426lozClYGwMtGzUS/FuN6PCbG1lwJuQy1rsXSxpwvZaKiNG3aFN26dUN2drbUoVBFi4oCnn1WLML30ktij/7Nm8A334g9/V9/DTg5SR0lVZDs7GysXbsWtra2GDBgAEfqEJVDfXtL3E7RSB1GlRAA+Dlw5GttxgzJxOS2WN5J0dSKqvxssSQqnc6dOzMxMEXffw/UqwesXm2c1PfqBYwcCRw5Ajz3HKDXi8v0UY0lCAK2bNmClJQUTJkyBebm5lKHRFRtJSUlISEhASqVyuhHqVTCQa2GnbkSyVlaqcOsdHbmSjhYcEWW2ozJvgliiyUR5VemRF8QADYM1Aw3bgCtW4uJvl4v3iYIQMuWgLMzEB39+Daq0UJDQ3H58mUMGzYMzs5lX32GqDbZsGED7t69W+h97u7u6D1iDE7XghpXDRyspA6BJMZk3wQ5qs1qTYulPEuDNb/+AktLS2i1WmRlZSE7Oxs5OTlo2rRpoWusElEhzp4V/23SRCzsptUCSv6JqPacnR8X5ZPLxaReLgcSE6WNiypUVFQU9uzZg5CQEDRt2lTqcIiqvSZNmhSZ7AcHB8PLRo3zD1KgNeF5r0q5ONqXajeO6TNRtaUlL/3OTTx48ACRkZGIjo5GXFwckpOTkZGRAYVCIXV4RDXDu+8CbdoAL74I9O0r3qZUigk/VW+dOgGZmWIPPwDodOK/MTFA167i85qLvfs1UmpqKtavXw9vb290795d6nCIagRvb+9CR7T17dsXAQEBUMhl8DPx78p+DlZQyDlKr7bj0nsmSqcXsO3mfZNvsezt7YQVvy5HbGxsgfunT58OR0dHCSIjqkFu3ABCQoAlS4D27YERI8T12f/66/E2SUmAvb1UEVJxBEFslFEVsyJJ3vn6nKJRo+h0OqxcuRJJSUmYOnUqrK2tpQ6JqNoSBAFRUVE4duwYwsPDoVKpkJOTA0CcytaqVSv079/f0Aig0wvYGxmHjBydSdW5kgGwVCnQw8eFyT6xZ99U1ZYWS3MzFUaPHg1ra+sCLbibNm3CpUuXoM+dx0pEIr0euH1b/H+DBmJyf/06ULcusG4dcPo0sH69eP+pU8DEicbJP1UfOh2QmgrExQF37gDh4cDFi8DJk8Du3cDVq2KiHxYGHDrERL+G2b17N+7evYvhw4cz0Scqgl6vx6VLl7Bs2TKsXLkSycnJGDhwIF566SXDd0MPDw/07dvX6LuiQi5DW3d7k0r0AbGeVTt3eyb6BIBz9k1aY0drRKdoTLbFsrGj+MXH2toao0ePxs8//wzdoyGsPXr0wM2bN7Fx40bs3bsX7du3R2BgICwsLCSMnKiauHAB+P13YOpUoFEjccm2f/8VGwCsrYE5c8Q123ftAn76SRwS/uCB1FFTYbZtA2bOFBtssrMfD9VXKMTnbMoU4IMPgKNHgdhYoEsXaeOlUouOjsaJEyfQt29feHl5SR0OUbWTnZ2NM2fOIDQ0FMnJyahfvz5Gjx4NPz8/Q1LfsmVL3LhxAyNHjoSykDo0Tmoz+DtYITwxvarDrzT+DlZwVLMCP4k4jN/ExWuyceh2vNRhVLiu9ZwKfJBduXIF69evh7u7O6ZMmQKZTIbY2FiEhobi4sWLUCqVaN26NYKCguDg4CBR5ETVwNmzwODBwKJF4hz9S5fE3//4QxzKr9UCGzYAv/4qzt2fORPo0UPqqKkwFy4Av/0mJvsKBWBmJhZYzC2y2KwZ0K4dcOsWkJ4OBARIHTGVgiAIkMlkiIyMLHLuMVFtlZqaihMnTuDUqVPIzs5G8+bNERwcDDc3twLb6vV66HQ6qIqZ6mQqw/k5fJ8Kw2S/Frj4IMXkWiwDXG0Lve/q1atwdnaGi4uL0e2pqak4efIkTp06hczMTDRu3FisxurlxS9RVDt99hmwcCGwb5/Ym9+sGbBsGTBggDh//6efxF7i114DXn1V3CcrC+Da3jUP5+nXWLlJPxEBDx48wPHjx3HhwgUolUq0adMGQUFBsLOze+JjJzzqHKvJSZEMQJdCOsOodmOyXwuwxfKxnJwcnD9/HqGhoYiPj4enpyeCg4PRpEkTyOUsYUG1zJQpwJkzYu/ws88Cb7wB/PMPsGcPYGMDtGolzgk/duzx0nxMHKuf1FRxTv7Dh0Dr1uLUjIwM4O5dwMkJyC1UyueOiGoYQRAQGRmJY8eO4caNG7CxsUFQUBDatGlT4VMz76ZqEBaTVKHHrEpBHvbw5FJ7lA+T/VqCLZbGBEFAeHg4QkNDERERATs7O87rp9rp5EmxgNvNm8COHcB//wG9ewNz54r363Ritf6nnwY+/1zSUKkQaWnAe++JUzKsrQFPT2DTJsDLC/jmGzHRnzGDiX51k7tCQkYGYGkpdTRE1Y5er8fly5dx/Phx3Lt3D3Xq1EFwcDCaN29eqUsrRyZn4ExscqUdv7IEutnBx46fJVQQk/1ahC2WheO8fqr1Tp8G3n5bTAYHDwZeftn4/o4dgZYtgcWLpYmPinbpklh0748/gOBg4MUXxToLf/4J/PgjsGIFEBoqNtpU4hdkKoeoKODbb4FRo4AOHaSOhqhayMrKwtmzZ42K7oWEhKB+/fpVNqWlpiX8TPSpOKzGX4t42qgR6CbUqA+wXIFudpU2NMnNzQ0DBw5E9+7dceLECZw+fRonTpxAkyZN0KFDB9StW7dSHpeo2nBzA9RqcYm9IUMe367RAMuXA0lJj6u4s4e4epHLxZ/evcV/hwwBPvpIvM/XF7h3T/w/n7PqIW+jy/79Yt2MqChxRYxu3VgTg2qt1NRUhIWF4dSpU8jJySm26F5l87GzhEouw4lHHWTVsVc09xO9PYfuUwnYs18LscWyeJzXT7VSSgpgm6fw5YMHwM8/A3//LVZw//xzIF/hS8NQZJJOXBwwZoxYRLF/f+DAAWD8eHEZxdmzxfoLx4+zkaY6yPscjBsnvt/CwsRk39YWeOcdYNAgwNlZ2jiJqlBlFt17UgmabJy8l4T0HJ3UoRRgpVKgnbs9i/FRiZjs11J3UzVssSxBYfP6g4KC0Lp1a87rJ9N27ZpYmX/fPqBrVzHRt7AATp0Sh43XrQu0bQvY2YnLuxWydjFVEUEQV06YMwd4801xeb1PPwVmzRKH9s+aJSaWVH0sWCCuhnH6tJjYy+ViA82OHWIP/4QJYpFFIhOVv+iera0tgoKCqmXdJJ1ewJWHqQhPTIcM0n5nzn18fwcrNHW24fJ6VCpM9msxtliWHuf1U60RGQm8/joQHQ0MGyb2Nt6/D3zwAfDLL4CPjzgM2cEBOHFC3Ic9/NLRaAArK6BOHSA7W2x4cXN7nEC+/rrUEVKu3J79F14AkpOBDRuMG8veegv44QdxpMa0aUCbNtLGS1TBdDodrly5gmPHjiE2NhZ16tRBSEgImjVrVqlF9ypCvCYbpyT+zlzdvhtTzcBkv5Zji2XZpKamGub1Z2Zmcl4/maY33gAaNwamThV/791b7IX8/XexCFxKipiw2NoCGzdKGyuJw8CVSnG+t5mZ+FPNescoj//9D9i5U3xPAWKDjVoNHDki9upnZwNNmgBbtwIqlaShElWErKwsnDlzBqGhoUhJSYGfnx+Cg4OrtOheRdDpBfyXkIabienQ6qvuG7NSLoOfgxUaO1pXy+/GVL0x2ScAbLEsq+zsbJw/fx5hYWGIj4+Hl5cXOnTowHn9ZHreeUecu3/yJFC//uPeybVrga++Anbt4hzj6kirFZPIZcvE+fwyGRPH6uL8eXGFiyFDgJUrH99+6ZI4JeOll8RpMrNni8sqEtVQKSkpCAsLw+nTp5GTk4OAgAAEBwejTp06Uof2RHR6AdGpGtxITEdylrbCO8tyj2dvroSfgxW8bNRM8qncONGSAABOajP08HFhi2UpmZmZoV27dmjbti3Cw8Nx/PhxbNiwgfP6yfRcvw6MGCEm+jk54vBwhQJISBCLw+n14nYsACednBzg7FkxWUxMFOftZ2SI/1+2DDh6VPz9r7/Y4y+VhARxxIUgiMtYrlolDtUPCADmzhWnyixZArRoATRrJi7Fl/veIqph7t+/j+PHj+PixYtQqVSGonu2eYvA1mAKuQzedpbwtrNEgiYbt5IyEJ2qQe5X57Im/3m3l8sALxs1/Bws4WBR/Tu/qPpjsk8GCrkMzZxt0NjRmi2WpSSTydCwYUM0bNjQMK9/7969OHjwIAIDAxEUFAR7e3upwyQqO0EAMjOBrKzHPfe5PcP//isWgRsyBHB1FW+7dQvw82PSL4WvvxaX27O0FOfvq9WPfywsxOfRykpc9o2qTm4ti1WrxCX20tKAkBBg7FhgwACx/sWHH4ojL9zcgObNgT//FPdNShIbB4hqCEEQEBERgWPHjuHmzZuwtbVFjx49EBgYCHMTXlLSUW0GR7UZAt3skJqlRWJWDpIyc5CgyUFKVg6Ka7KTA7A1V8FRrYK9hQoO5irYmCsh599QqkAcxk/FYotl2eXO6z916hSysrI4r59qtiVLxDnGf/4p9jju3An8+CPg7w98/DHQsKHYQ3nkiFiwT831fqtcgwbA228/rrGQl5kZcO8e4ORU9XHVZrmNXv/9J/bWf/SRuJxleDgQGys+V1OmiNtGRorJvrm52CDw8svAmTPA5cuSngJRaeh0Oly+fBnHjx9HbGws3NzcEBwcXCOK7lU2vSAgI0cHrV6AXhB/5DIZ5DIZlHIZLFUKJvZU6ZjsU6noBYEtlmWUO68/NDQUCQkJnNdPNdfMmeKyYPfviwnMxInA0KFisb79+4EvvwT69RMTmNxh4uzhrzoeHmINhc6dHw/9zq3y7u8P/P232GvM56Ty5V5/uVz8/59/AleuiMtXAmLti+XLgdBQoFs3cQh/7tDme/fEgpcrV4qV+r29JTkFotLIysrC6dOnERYWhpSUFDRo0ADBwcHw9fWtUUX3iEwdk30qN7ZYlo4gCLh+/TpCQ0MRGRlpmNdv6kPbyMTcugXcvi32UiqVjxOUkBDA0RFYsUIc7p+RIQ4nB7gkX1X58ENg5MjC12Zfv15MKllEsep99BGwbp1YjO+nnx7fHh0tvl+2bRN78zdufDzy4vZtsSaGp6ckIROVxFSL7hGZKib7RFXo3r17CA0NxaVLl6BUKjmvn2ouvR4YPFhc9u3wYXG4+KFD4vzjZ58FvvlG6ghrn2vXgGPHxF59a2tx2kWLFlJHVTts2SKuTLFokVgbISsLmDVLvC05WUz6g4Mfb5+VJRZPTEkB3n9furiJSik2NhbHjx/HpUuXTLLoHpGpYrJPJIGUlBScPHmS8/qpZtLpgMWLxSH8o0eLvZGRkcDu3WL1/p49xbn9AIeNV7bcofmLF4s9/Dk5YnE3GxugVStxCsaAARxhUZl0OrEAn58f0L8/kJoqXn9ALM63dKl4/SdOFIvzFYajYKgaEgQBt27dwvHjxw1F9zp06MCRiUQ1CJN9IglxXj/VSDduiHP2MzLE5feeew5o2lTsWZbLxfnJeYeNM5GpXHv2iEUSJ0wA3n0X6NQJeOstsSDcypVib3PbtpyzX5lycsTVKuLjxYT/pZeAcePE+/btA375BYiIAPr2Bd54Q1wdgaiayi26d+zYMdy/fx9ubm4ICQlB06ZNa33RPaKahkvvEUnIzMwM7dq1Q9u2bQ3z+jds2MB5/VS9/fcfcOEC0L498N57Yo9lbvXwPn3ERD8iQlz3vUULFhqrbOvWAV26iBX5lUoxoY+PF6u6//EHcPo0k/3KlJvoC4JYbd/TE5g3T2wU++gjoHt3oF49cRWLf/4BLl4Ui/RZW0sdOZGRzMxMnDlzxqjoXu/eveHj48Oie0Q1FJN9ompAJpOhUaNGaNSokWFe/969e3Hw4EHO66fq59lngePHxSrwdeuKPfevvy4OYx41Cpg/X1yKb9s2sTFg9mypIzZtKSlAnTqP12W3shLnhAPibWlp4v85kK9yqFTivy++KI5ymT1bLIz411/itJbvvxdXRfjoI7ERwM2NiT5VK8nJyYaie1qtFi1atEBwcDBcXV2lDo2InhCH8RNVU4XN6w8ODoaXl5fUoRE9lpoqDh3ftg346itxGb7UVGD4cGDQIKBNG+PtOaS/4r3xhjid4pdfxOR+wACxMn+nTsAXX4hJZs+e7NmvDLnXdP9+MdE/exZo0ABITBRHXPz+u/ia//JLcWnEwvYlkkj+ontt27ZFUFAQbHJrThBRjcdkn6iaK2xef3BwMBo3bsx5/SS9nTvFecj16wN2dkBQkFgozs5O7FHeuFEc0t+0KTBmjLgPk5yKtWoV8PffYqNL69bACy+IjS9164rPzZw5bGCpTDduAFevAmFhwCefPH596/XA9u1iwn/kCPDpp2JdBSIJ5RbdO3bsGG7dugU7Ozt06NABrVu35rRBIhPEZJ+ohhAEwTCvPzIyEvb29mjfvj3n9ZO0cgv0DRgAdO0KdOjw+L4ffgA++wwICBDn+U+eLC5HxmS/YiUmismkry/QvLmYYO7ZIz4n3bpJHZ1pEwRxWsuOHUC7duLzoFKJyx8qH82UPHlSnKM/darYGEMkAZ1Oh0uXLuHYsWN48OAB3N3dDUX32HFAZLqY7BPVQLnz+i9dugSlUsl5/SStzExAoXg8dxkQlyN7+mnAx0esCJ87zHnDBqB3b8lCNXn37onX3soKsLdno0pVCA8XVzxYsEDs2X//ffH2vAl/err4nLChi6pYZmYmTp8+jbCwMKSmpsLf3x/BwcEsukdUSzDZJ6rB8s/rb9q0KTp06MB5/SSN7GyxV7l1a7EC/7JlwE8/icXKfH3F4eT374sFyzgapWIlJwNr1ohF4VJTxYS/QQNxXXc2rlQ+nU6sWTFnjliv4vffxaQ+b8JPVIWSk5MRGhqKM2fOsOgeUS3GZJ/IBHBeP1ULt2+Lw/QHDACGDBGLlc2aJS7NN2QIcPSouCxfo0ZSR2paUlOBmTOB334DJk0CmjQBNBpxaHlUlNi48txzLI5YEXQ6cRTLmTPi6/nmTbEeRf/+gLu7WCth2jTxdb5mDdCwodQRUy1z7949HD9+HJcvX4aZmRnatm2L9u3bs+geUS3FZJ/IhOTO6z9+/DiioqJgb2+PoKAgFt6hqjNlCnDlipgIAWKSb2cnzlmmynHgAPD88+IUiY4dje+bMkWsl3D48OP14Kl8chP9a9eALl3EH60WuHhRXFpvwwbAwkK83hMmALduiY0tlpZSR04mThAE3Lx5E8eOHUNERISh6F5gYCDMcpfkJKJaick+kYnKO69fpVKhdevWnNdPVaN5c7FH8/nnxTnMzZoBf/7JnuXKsn+/WPzw1i3x97zzwpcvB5YuBUJDpYvP1LRtC7RvDyxeDNy5I45U+eEHcVRFRoaY3MfFAbGxYnFKztOnSqLT6XDx4kUcP36cRfeIqFBM9olMXEpKCk6cOIHTp09zXj9Vjbg44LXXxB5QCwtxeLmfn9RRma6bN4EZM8TpEgMHPr790iUxIW3bVqwEr9GIPdPs6Su///4Tl5DcsEEsPtmihbjc5LJlYqHKX38VR1e0aCF1pGTCCiu6FxISAm9vbxbdIyIjrBpDZOJsbW3Ro0cPPPXUUzh37hzCwsLwyy+/oG7duujQoQPn9VPFc3EBVqwQK5A7OEgdjenz9BR7l0ePBkaNAurVA+Ljgb17xUrxWi2wcyeQlAS4uQGrVkkdcc1Vp47YSy+TAePGib348+eL98XGAlu3Aq6uTPapUiQlJSEsLAxnzpyBTqczFN1zcXGROjQiqqbYs09Uy+j1eoSHh3NeP0lGEAT2PlWkmBjAy0scPZFb/V2tBpycxMaWzEzA1lbs0ffxAT76SOqIq7fCht1fuCA2XrVpIxbju3BBnJJy4oTY2AKI13XNGuD0afH6E1WQ3KJ7ly5dgrm5OYvuEVGpMdknqsViYmIQGhqKy5cvQ6VSITAwEO3bt+e8fqpUt27dQt26daFisTiqzhYvFnvvzc3FERFLlojL6iUmAiNGiBX5V6wA0tLElSjmzgV27wY6dXpczI+onARBwI0bN3D8+HFERETA3t4eHTp0QOvWrVl0j4hKjck+EXFeP1WZ1NRULFiwAI0aNcKQIUPYw19R8v4pL64gHK936SQkAN26AZGR4rD8kBBg5UogO1scIXHrlpjc79gh1qVo0wYYOVL8YSFKegJarRaXLl0yFN3z8PBASEgImjRpwil3RFRmTPaJyCA7O9swrz8hIYHz+qlSXL16FevWrUOXLl3QtWtXqcMheiw2VuzFB4CsLMDXV7xt7lxg9mzx9ryNKRERYrJvbQ3kDqlm9X0qh8zMTJw6dQphYWFIS0tDw4YNERISgnr16rFRlIjKjck+ERWg1+tx/fp1hIaGcl4/VYrDhw9j//79GDJkCJo3by51OETiMnr16wOffgq8+abYi//yy+Kc/O++A3r2BFavFufj5+QAKpVYANHfX+rIqQZLSkpCaGgozp49y6J7RFThmOwTUbEKm9cfFBQEOzs7qUOjGkwQBPz111+4evUqJkyYAM/cImdUboIgQKfTQaFQsCewvD75BPjsM2DoUGDBAiC3fsmePWLiDwBbtgBNmohLSi5bJg7lt7aWLGSqme7du4djx47h8uXLMDc3R7t27dC+fXtY87VERBWIyT4RlUph8/qDg4OZpFG5abVarFy5EklJSZgyZQpsbW2lDqlG0+v1CAsLQ/369VGnTh2pw6m59u8HxowB3N2BX399vIze9evAW2+Jy+sNGSIm/X/8AQwbxqH7VCq5RfeOHTuGyMhI2NvbIzg4GK1atWLRPSKqFEz2iahMcuf1h4aGIjExkfP66YmkpaXh559/hlqtxsSJE/mF9wkIgoCPP/4Yffv2Rdu2baUOp2a7excYNQq4eBH48Uex+j4gLr+3apW4vN7TT4vV+f+fvfsOj7LKHjj+nUkmvfdGCIQeakhIwipdRRBUELCsDRF11XUtP3Vddy27a1t3dS3rquBaEQQRqSJFECGF3ntLB9J7MuX9/XGZSQIBAiaZlPN5njxkZt553ztJSObce865EuiLSzCZTOzevZvk5GTOnDkjTfeEEC1Ggn0hxBWRun7RVE6dOsXs2bOJjo5m6tSpkoL+K7z22msMGzaMoUOH2nsobYs1YNc0tbWen5+6/8knVb3+M8+oBn2urvWPP/dzIeqorKxky5YtpKWlSdM9IYRdSLAvhPjVpK5f/FoHDx5k7ty5XHXVVYwePdrew2mz/vnPfxIXF8fw4cPtPZS2w2wGBwf4+Wf4z3/Uan5YmKrfHzwYvvkGZs5UK/nvvANRUfYesWjlrE33tm3bhsViYcCAASQlJREQEGDvoQkhOhgJ9oUQTUbq+sWvsWnTJlatWsVNN93EgAED7D2cNumdd96hT58+jBkzxt5DaRssFtDrITMTYmNh4kSVmv9//wclJfCHP6hA/8gRuPFGdezu3bUr/ELUkZ2dzaZNm9i3bx8uLi7Ex8cTHx8vTfeEEHYjwb4Qosk1VNeflJREz549pT5RXJCmaSxevJjdu3dz991306lTJ3sPqc354IMPiIqK4vrrr7f3UNqW665TDfk+/VTV5ffoAd26wYYN8MgjqjGfuzvs3w9XXWXv0YpWRNM0Dh8+THJyMidOnMDX15fExERpuieEaBUk2BdtmkXTqDCaMVk0LJr60Ot06HU6HPU63AwO6KUuzm6krl9cLrPZzOeff05eXh73338/Ptatz0SjzJo1i6CgICZOnGjvobQdR4/CG2+ooL5fPxg2DCIiVCO+P/0JXn1V3b9kCURG2nu0opUwmUzs2rWL5ORk8vLyCA8PZ+jQodKsVgjRqkiwL9oMi6ZRUm2iqNpIUZWRgkojJdVGLBd5jh7wcjbg52rAx8WAj7MBL2dHmQCwA6nrF41VUVHBxx9/jJOTE9OnT5eJocvw2Wef4eHhweTJk+09lLajpkat4CclwbJl8Mor8N13qjb/f/+DVavAzQ1mzbL3SEUrYG26l5qaSnl5OT179mTo0KF06tRJmu4JIVodR3sPQIhLKais4VhRBZmllVjOTk3pgMbMUlmAomojxdVG2/F6HUR4uhLt64avi6TYtZSwsDAmTZrE6NGjbXX9KSkpxMTEkJiYKHX9wsbNzY3bb7+d2bNns3DhQqZNmyYrZY1kMBgwGo32Hkbb4uQE1qaQ1dWqLt/NTd3Oz4fOndXqPoDJBI7y1qlNq6iAEyegT5/ang2NUFhYSEpKCtu3b5eme0KINkNW9kWrZLZoZJRWcrSwnOJqU6OD+8ayns/b2ZFuvu5EeLrioJcZ+ZZUU1PD9u3bSU1Nlbp+0aAjR44wZ84cEhMTufbaa+09nDZh/vz5VFVVceedd9p7KG3T8uVwww1w//3g4gIffQSLFqmaftH2lZfDww/D2rWQnt6op2RlZZGcnFyv6d6QIUNwd3dv5sEKIcSvJ8G+aFXMFo0D+WUcLSrHZGm5H01HvY5oX3d6+XlI0N/CrHX9ycnJpKen4+PjY2tuJOnbIjU1lR9++IEJEyYQGxtr7+G0eosWLaKgoIDp06fbeyht19y5qlY/JgbGj4cHHrisFWDRimkaLF4MM2aoLRVHjlT3nZN+r2kaBQUFLFmyhJMnT+Lr60tSUhIDBw7EYDDYafBCCHH5JNgXrUZ+ZQ1bcoooN5rtNgZ3gwPxoT74uUp6vz1Y6/r37NmDk5OT1PULNE1j2bJlbN++nTvvvJMo2eP8opYtW0ZmZiYPPPCAvYfSJmia1nCddXW1CgJdXKwHnhcQijbEbFaTNTqdKs2YOROKi2H16gtO5FRWVjJv3jwSEhIk40wI0WZJsC/szmzR2JdXyuHC8iZP179c1ut393WnT4CnrPLbSXFxsa2uv6amRur6Oziz2cxXX31Fbm4uM2bMwM/Pz95DarV+/PFHDh06xCOPPGLvobQJBQUF8vPUkSxfDlu2qMmbV1+FPXvUFosXWN2XhntCiLZOpimFXRVU1rD6xBkOF5YD9g30617/cGE5q0+coaCyxq7j6ai8vb255ppreOKJJ7juuuvIyspi1qxZ/O9//2P//v1YLBfbg6EBl3u8aFUcHByYMmUKrq6ufP3111RVVdl7SK2WNOhrvBMnTvDee+9x+PBhew9FNKWG1rCKiuCmm+COO9TnmzapXRjefPOCz5FAXwjRHkiwL+wmq7SS9en5VNgxbf9iKoxm1qfnk1Vaae+hdFhOTk4kJCTwyCOPMHXqVAC++eYb3nvvPVJTU6murm7ciST9ss1zdXXl9ttvp6ysjAULFlz+hE8HIcF+45SUlDB//nyioqKIjo6293BEU7BY1EdDQfqmTbB1K/z0E/zrXzBnjurFMHcunDkjfyOEEO2W/HYTdnGiqILU7CI07L+afyHWsaVmF3GiuMLew+nQ9Ho9vXv35t5772XGjBmEh4ezcuVK3nrrLUpLS7lgNVJmJkyfDgUF9e+XQLFN8vf3Z8qUKRw7doyVK1faezitksFgoKZGMpIuxmw2M3/+fBwdHZk8ebLUYrcXer36yMpStfinTtU+duoUGAxquz0Af3/VpC8srHZ1X/4uCCHaIfkLJ1rciaIKtp0qtvcwLsu23GIJ+FuJ8PBwJk+ezGOPPcaYMWPw9PS8cLrlm29CRoZqxFSXvLlvs7p27cq4ceNIS0tjy5Yt9h5Oq+Pk5ITZbJbMh4tYuXIlOTk5TJ06VbZPa09OnlSp+r16wQsvQO/eauVe09TfgJAQ2Lu39vjevSE2Fr74oraBnxBCtDPym020qKzSyjYX6Fttyy2WlP5WxNvbm7i4uAuv6peVwYIFqkazS5fa+x95RG25VJfFot7siTYhLi6OIUOGsHz5co4dO2bv4bQq1m3BTCaTnUfSOu3cuZPNmzczduxYafjZFmkaXOhn+1//Ur/Ld+yAjRtVwP/3v8NXX6ktFPPyIDm59ng3N6iogNxceOcddZ9Mkgkh2hkJ9kWLKaisIS27yN7D+FXSsoukaV8rc8FV/U8/hZ49ISGh9r79+2HpUtWBGdSbwvR0taLj4KDuswb927bB998317DFr3TdddfRtWtX5s+fT35+vr2H02pYg32p2z9fbm4uS5cuZeDAgQwePNjewxGXy9ox39FR3V6+XKXsA+zbp+ry33gDoqNh/XqYPx+ys1VA3707DBmiavXnzVPP2bFDpfbfdBP8/LO6T1b3hRDtjPxWEy3CbNHYnFNk72E0ic05RZgtrbXTgABUwP7WWzBunNpWyeqjj1TNZt++8Oyz8NvfqjTOq6+GDRvUMdag/9gx+PJLOHq05ccvLkmv13PLLbfg4eHBnDlzqKyUrBuoDfalbr++yspKvvnmGwICAhg3bpx0Wm+LdDowGuHllyEgAJ58UgX0oFbk9+5VK/p9+8K0aTB0qJq0nTlTHfPSSzBoENx9t5oEvuoq6NoVPvkEvvvOfq9LCCGakQT7okXsyyul3Ghutc34GksDyo1m9uWV2nso4mK2bgUfH0hMVCs3oDour1mj3uyZzepN4t//rlZ3Bg+Gxx6DZctqz3HLLeoY6dTdarm4uHDbbbdRWVnJ/PnzMUsphqzsN0DTNL777jsqKyuZOnWq7WskWjlriVbdUq0PP4SFC+G//1WB/cSJ6v7wcDWR+9hjahJg9261yt+5s5q43bRJBfbvvqsyAm69FTZvhldfVX8rhBCinZJgXzS7/MoaDheW23sYTepwYbmk87dmZ86oxnxeXrX3zZqlUjRHj1ar/enpqiNzRAS8/bZ6gxgTo47985/h88/Vm0xrDafUcrZKfn5+TJs2jZMnT7JixYoL93DoICTYP9/PP//M4cOHmTRpEr6+vvYejmgsnU6VXlmzMPLz4ZVX1ETsLbeoIL1rV/WYwQAjRoCrK9x7LwQG1j7nn/+EtDSwbtU6ahQ8/rhq0CeEEO2cBPuiWZktGltyimhvCZM6JJ2/VYuJUW/2Xn8d1q6FP/5RreDExan0zfh4Fdw/+ST873/qOXfcAVFRqrHfrFlqxb+sTE0Q5ObWr+WU5metSufOnRk/fjxbt24lLS3N3sOxKwn26zty5Ajr1q1jxIgRdO/e3d7DEXWlpNR+3lBWzq5d6nf50qXq9uHD4O2tsrNA/U7WNPXh4QF/+AP4+qrSrKefVmn7sbEqlT8uDlxcmv0lCSFEayPBvmhWBwrK2kX6/rms6fwHCsrsPRTRkKgo1Ym/qEi9Udy4UaV5JibWbsP33HMwebKaBLDWfYKq6w8IgAkTwNNTbecUFqbemB4+rI6xNogSrUZsbCxJSUmsXLmSI0eO2Hs4diPBfq3CwkK+/fZbunfvzrBhw+w9HFHXrFmqpj4zU9229kqp22yzUye48UY1aWu9nZUFOTm1q/SgVv4rK1WW1sKFMGkSHD+umu79/e+qA/9VV7XM6xJCiFZGgn3RbMwWjaPtLH3/XEcLy2V1vzXSNJWiuXSpqtucOVOl77u4qFrPtDSV4v/003D99bVvJgE++wyGD69N6X/vPfXv++/DXXeprs4rV7b8axKXNGbMGLp3786CBQs4c+aMvYdjFxLsK0ajkW+++QZXV1duvvlmacjXmlgsMHWq2vf+66/VfaWlavJ18mR1W9PUKv306WqydscONWE7cqTaSs+65aZOp7bUe/NNdbtvX3j+efV7fM0a1YRVCCE6MAn2RbPJLK3E1M4DYZNFI7NUuoC3OjqdSgvVNLUK/9vfqqB9+HDVsXnSJHjxRbX6/9130KWLet7cuVBSAmPGQFAQ1NSohk5Tp6oJg+XLVef+N99UbzDPZbE0nI4qWoRer2fSpEl4e3vz9ddfU1FRYe8htTgnJyegYwf7mqaxfPly8vLymDp1Kq6urvYekgD1+9FiUen3Xl5w//3q92txMbi7w7XXqtT9kydr6/QTElQGwAsvqNsvvwyFharsavZstY3eHXeo3+N1M3rc3Fr+9QkhRCskwb5oNkfa+aq+VUd5nW2Og4N6w1i3yV6nTvDtt2qVfvVqeOcdteL/7rvq8VmzVKr/wIHq9uuvqyZ+f/6zCvJ9feHBB9WKUUFB7bXMZvWGVa+vTUft4I3i7MXZ2ZnbbruN6upq5s2b1+E69Ov1enQ6XYcO9rdt28aOHTu44YYbCAkJsfdwhJVerz6Sk1VWVUyMSuNfvlzdP2qUmnh97TV1vKap37933glLlsDp0zBggFrZ791brd4/9ZT6/Kef6m+zKoQQApBgXzSTgsoaiqs7RhOz4mqTdOZvzXS62uZ61qD/xhvhl19g8WIV4IeEqAB+xw4YN07V/IOaDLjrLvUm0hq8b92qVv2DgtTtI0fUylJSkpoQSE6uva6wCx8fH2699VaysrJYunRph+rQr9PpMBgMHTbYz8rKYsWKFcTFxTFgwAB7D0ec67nn1ARrSQmsWqXue/99lUXVubPaEm/+fJXWr9OpydOAAHXcO++of2Ni4MsvVWZWRobaTcXb2y4vRwghWjsJ9kWzOFZU0e468F+IDvV6RRtgDfqtKf4+PrUr8QUFKs2/f391+6uvVNf9KVPA2bk2eH/vPTVZ4OMDP/ygAv29e+HZZ2HIENXw76ef4JtvWvrViTo6derEhAkT2LFjB8nWCZgOwmAwUFPT8SYgy8vL+eabbwgNDWXs2LH2Hk7HpGkXLmU6eRIWLVJlUP/9L/z73yoNPzlZBf5OTiqV39e3fh+VgwehZ0+17Z51wlanq51wFUIIcUHSUlo0OYum6tg7ylqahupPEBvijV5Wc9sGa4Bf15Qp6sO6CvzEEyqttGfP2mOWLYPsbJg2Tb2hnT1brTp9/rlKNwWYMUOtXA0apGr9hd0MGDCAvLw8Vq1ahb+/Pz3rfi/bsY64sm+xWPj2228xmUxMmTIFh4b+j4umdfw4bNqkJjxB/e60rsaXlalsqW7dapudGo1w4IDa6QRUXf0tt8B116nAf/x4dexTT8FDD6nftcXFauvTL79Uk656WaMSQojLIb81RZMrqTbRzvvynceiQWkHKVtot85djfrqK9XV2d299r6331YTAElJqgwgPR1uuKE20AfVrR/Um1dhd6NGjaJXr14sXLiQU6dO2Xs4LcLJyanDBftr167lxIkT3HLLLXh5edl7OB3Dt9/C0aNQVaVu63Tq83feUavuTz0Fw4aptHyLRaXm9+ql+qWAypzS6eD221U2VFqaaqj6wANqC9TqajUh8PnnMHiw6rQvhBDiskiwL5pcUXXzvMk8nZnB5F5hTO4Vxp7UTZc8/sFRQ5jcK4x5777ZLOM5V2EzvW7RQqwrgdbsjDFj1Oq81Y4daqVq0iRwdVUrVwUFcM01tcdUVKiU/t69ZV/nVkKn03HzzTfj5+fH119/TVlZmb2H1Ow62sr+/v372bhxI6NHj6aLdWcN0fyeeAL+8he1pSnAI4+ocqbt29X2pGlpMHEivPQSpKaq5nt9+6oMKVCBPagmfWazSu03nZ00nzEDvvhCfURHt/xrE0KIdkKCfdHkiqqMzVKvb3ByovuAWLoPiMXNwwOAPambbBMApzMzmuGqjaNDvW7RTmmaSkedNQt+8xt1n7OzWtVyrFMNtXu3qkl9/PHa5wm7c3Jy4rbbbsNsNjNv3jxMpvadhdORgv38/HwWLVpE7969GTp0qL2H07Ho9bB/P/zf/6mGewEBalXfaKzdveS999RE6nffqT4nEyeqJqevvKK20MvPh6wstQ1faiqUl9c/vxBCiF9FavZFkyuoNDZ5vb6xpgbfoGBem7e0ic/cNDTU6xbtlE4HHh4wfXrtfYMGqcD/xRfV3s9pafDWWyrt9N57a593lqZp6KSng914eXlx66238umnn7J48WJuvvnmdvv96CjBfk1NDfPmzcPLy4sbb7yx3X4/WzUnJ9Vkr39/tdL/8cfg51dbv+/urnY4+eknFeT/9rcqoH/qKVUqlZGhsqDmzgUpvxBCiCYn06aiSVk0jeI66eyr53/F5F5h/HZwD9t+13+b+Vsm9wrj83/8FYDcjJO21flDO7baPl80633eePQ+7ojtxn//8vR5afzz3n2TF+6+xXath8YkMLlXGO8++4d6YzIZjfzv1Re5OyGGe4f2Y/bf/4y5zsqesaaaue/8g4ev+w3T+nXm3qH9eP+5xykpzLcdU3jmNG8/9TD3XT2Qaf2iuO+qAbxw9xS2rl9jO6ak2ohFVnLbL02rXamvrlarVq+8Art2qYZTixerrtJPPaVWss75WdDpdBw8eLBDdklvLcLDw7nxxhvZvXs3v/zyi72H02w6QrCvaRqLFy+muLiYqVOn4uzsbO8hdUzR0TBihPr95+4OkyerNP69e2uPmTFDlT39+KNa9X/gAdiyRU0O/PADLF8ugb4QQjQTCfZFk6owmuut6scMUWmVleVlpB/aj6ZpHNqxFYADW9MA2L8lFQAXN3ei+9bui/z1v//B7uRfCAqPxNFgOO9a/iGhRER3t93u0juG7gNiCYnsXO+4pZ9/zLpF83FycaGkIJ/lX8xm7cJ5tsffeHQG8//zFqcz0wnv2h1TTQ1rF87jz3dOprqqEoCPX/4jG5Z+R1V5OZHde+JoMLA3bRNHdm23ncdy9vWLdqruquGSJao79NVXw7Zt8P33ats9g0Glo55zvKZplJaWMm/ePN566y1Wr15NSUlJC78AAdC3b1+GDx/O2rVr2b9/v72H0yw6QrCfmprK3r17mThxIoGBgfYeTsf2xBNw+LCq03/sMThyRHXpt4qOVg32vvkG9uxR9/XsCffdB1J6IYQQzUrS+EWTMp3Thj+0cxf8Q0LJz81h/9Y09HoHykuKcfPw5Oje3dRUV3Fgmwr6e8XG41Cn/jm4UySvfL0YD28fzGYz+TnZ9c49ZsodhER2sa3uP/3uJwRFdDpvTD4BQbz53Y8YnJx4+JqhFJzOZXfKBq6Zegd705LZdnZ1/sVP5xMTn0jh6VP87tokMo8cYsPS7xhzy+3knDgOwAMvvc6wCZMAKDx9ivKy+gHbua9ftDPWAL6kRDWdWrhQdZL+/nvYuBGefBK8vVXn6Tr1pjqdDk9PT37/+9+TlpbGli1bSE5OJiYmhsTERMLCwuz0gjqm4cOHk5eXx3fffYePjw+hoaH2HlKTau/B/smTJ/nxxx9JSkoixrqtm7CfAQMgJAQWLIBPPlGToMuXq+al1oaJjz2mavKlo74QQrQoWdkXTaqhNPaY+CQADmzbzIHtmwG49tY7MRlrOLxrB/vPrvDHDEmq97wRN03Bw9sH4FftmRw/6lrcPb1wcnaxTQYU5eUBcHh37cr8X+6cxOReYcwYNoias1sJHd65DYC4karj+rvPPsbD1w7llQfuYv2Sb/ELCrnk6xft0PTpqjO/lxe8/rpqNPX002qrPrhgYykfHx+uvfZaHn/8ca655hoyMjL4+OOP+fTTTzlw4AAWi6UFX0THpdPpuPHGGwkMDOTrr7+mtLTU3kNqUu052C8tLWXBggV07tyZMWPG2Hs4HUp5eTlZWVnn/57S6dRE5+7dKqB/8km1yr9uXe0xsbHw0EMq+0kIIUSLkZV90aQaDPaHJPHzkoUc3L4ZBwcH3L28uWbanSya9R/SVv9A9vGjAPQdUj+dz8e/aVIz3T1rawEdHM7+yDcwzu4DYs+7zycgCIDbH3+WXrHx7PhlHemHD7JvSwpb169mb1oyf/rwC9vxEux3IN26qf2fjUZVw392h4jGcHZ2JjExkSFDhnDgwAFSUlKYN28efn5+JCQkMHDgQJycnJpx8MJgMHDrrbfy8ccfM3fuXO655x4M7SQQaa/BvtlsZv78+eh0OiZPnoxeurW3iLy8PJKTk9m5cycBAQE88MAD5x80cqTameSjj2D2bFWnH3v+31QhhBAtS4J90aT0DXRDttbt5+Vks2XdanoOiiOkU2f8gkJYPf8rNE07r14fqF8jfQHOrq62z6sqKy57vN36DrR9PmnmIwwZPRYAs8nEruQNhHfpBsCBbWn0iU9i8Ai1kvTLskW89eTv2Lc5pd75Gnr9op0zGK54tUqv19OnTx/69OlDZmYmKSkp/PDDD/z0008MHjyYIUOG4CWNq5qNp6cnt912G//73//4/vvvmTx5crvo6N5eg/1Vq1aRlZXFPffcg8dlTK6Jy6dpGhkZGWzatImDBw/i7u7O8OHDiYuLa/j/iKMjPPggHDigJj/ffbflBy2EEOI8EuyLJtVQsFu3br+itIResfEA9IyNJ/mHJcD59fqNFdKpM44GAyajkZemTyMwLIIb732QpLE3NOr5fROGMvCqEez4ZR2vPzydsC7R6B0cyMvOpKqigpc+W0BQRCe+/OcrHNm9k4DQMNw8PMk8dhiAzj17X/L1C9EYERER3HLLLRQVFUldfwsKDQ3l5ptv5ptvviEgIIARI0bYe0i/WnsM9nfv3k1qairXX389nTqd35tFNA2LxcKBAwdITk4mMzOTgIAAJkyYQP/+/XG81N/ou+5q1CS9EEKIliPBvmhSjvqG/9DHxKtUfoCeA+MA6F0n2D+3Xr+xPH39mP6nv7Lww3fIz82h6MxpCvNOX9Y5nnn/ExZ++C6/LPue05npuLh5EN61O4OuHklkj54A/Ob6iWiaRs7J4+TlZOHp40f8qOu486k/1TvXhV6/7LEuGsta1z98+HC2b99Oamoqu3fvpnPnziQlJdGjRw/5WWpivXv3ZtSoUaxdu5aAgAD6tvEmYgaDAZPJhMViaRep7qdOnWLJkiX079+f+Ph4ew+nXaqpqWHHjh2kpKRQWFhI586due222+jevXvjf9/I7yUhhGh1dJomRcai6Vg0je8P5dIRf6j0wMQeIeh1OioqKjh+/DjHjh3jyJEjaJrG448/LkGauGzWlbaUlBQyMjKkrr+ZaJrGokWL2LdvH/fccw/h4eH2HtIV2717NwsXLuSPf/xjm/8Zqaqq4uOPP8ZgMHDfffe1m74KrUVZWRmbN29m8+bNVFVV0adPH5KSktr0z78QQohasrIvmpRep8Pb2UBRdftKIW0Md4OeOV99RX5+PkVFRYCqybZYLHh5eUmgL66I1PW3DJ1Ox4QJEygsLGTu3LnMmDEDb29vew/rilgDfKPR2KaDfesETHl5OTNnzpRAvwnVbbqn1+uJjY0lISEBX19few9NCCFEE5JgXzQ5P1cDxdXGDrW6rwMcqis4evRovfutWxQFBARgNpt/1RaCQtSt609NTa1X15+UlNTu9otvaY6OjkybNs3Wof/ee+9tk8GyNShu63X7v/zyCwcPHuS2227Dz8/P3sNp8zRNIz09neTkZA4ePIiHh4et6Z5rnWa3Qggh2g9J4xdN7kRxBdtyi+09jBYXG+KNOS+Hb775BqPRyLn/tRwcHAgODiYsLIzw8HDCw8Px9/dvFzW1wj6qq6ttdf1FRUVS199ETp06xSeffELXrl2ZOnVqm/taZmRk8Mknn/DQQw8RFBRk7+FckaNHj/LVV19x9dVXM3LkSHsPp02zWCzs37+f5ORksrKyCAgIYOjQofTr1+/STfeEEEK0aRLsiyZXVGVk7ck8ew+jxY3uHIC3i4Hi4mLmzp3LqVOnbAH/+PHjMZvNZGdnk52dTV6e+vo4OTkRGhpKeHi4bRLA29u7zQUXwr7O7aDt5+dHYmIiAwYMaJMr063BwYMHmTt3LldddRWjR4+293AuS25uLh9++CEzZsxok7XXRUVFfPTRR4SFhXH77bfLhOgVsjbdS05OpqioiKioKIYOHUq3bt3kb4wQQnQQMqUrmpyXsyN6HVg60DSSXgeezuq/k7e3N/fddx9Lly5l586d6HQ6+vfvXy/oqqqqIicnh6ysLLKzs9m7dy+bNm0CwM3NzRb8WycA3N3d7fK6RNvQUF3/ihUrWLt2rdT1X6GePXtyzTXXsGrVKgICAhgwYIC9h9RobTmN32QyMX/+fJydnZk0aZIE+legrKzMtn1nVVUVMTExTJkyRbbvFEKIDkiCfdHk9DodEZ6uZJRUdoi6fR0Q4emKvs5KiaOjIzfeeCORkZEUFhaet7rq4uJCly5d6NKli+2+srIysrOzbRMAaWlpVFZWAmoCoe7qf2hoKM7Ozi3y+kTbcm5d/+bNm0lOTqZv374kJiZKXf9lSEpK4syZMyxZsgRfX18iIyPtPaRGacvB/ooVKzh16hT33Xcfbm5u9h5Om3LmzBmSk5PZtWuXreleYmIiPj4+9h6aEEIIO5E0ftEsCiprWJeeb+9htJiRnf3xdWnadGlN0ygqKqo3AZCdnW17Ax8QEFBvAiA4OFjqL8V5qqur2bZtG6mpqRQXF0td/2Uym8188cUXnDlzhvvvv79NBE6VlZW88cYbTJkyhT59+th7OI22bds2lixZwsSJExk0aJC9h9MmWJvubdq0iUOHDuHh4UFCQgKDBw+WpntCCCEk2BfNZ82JMxRXm+w9jGbn7ezI6KjAFrmWxWIhLy+vXvCfm5uLxWJBr9cTEhJSL/0/ICBA0mAFIHX9v0ZFRQWzZs3CYDAwffr0Vp9VYzKZ+Pvf/85NN93UZsoPsrOz+eSTTxgwYAATJkyw93BaPWvTvU2bNpGdnU1gYCBDhw6lb9++MukrhBDCRoJ90WxOFlewtQN05R8c4k1nb/ulm5pMJk6dOmWbAMjKyjqvAaA1+A8LC8PHx0dWdDu4jIwMUlJS2L9/P87OzsTFxREfHy91/Rdx5swZZs+eTWRkJLfeemurnkTTNI2//vWvjBs3jri4OHsP55IqKir46KOPcHd3595775Vg9SJqamrYvn07KSkpFBUV0aVLF5KSkqTpnhBCiAZJsC+ajdmisezoKUztuFOfo17H+OhgHPSt601WdXV1vQaAWVlZFBeriRc3N7d6q/9hYWF4eHjYecTCHqx1/du2bcNkMkld/yUcOXKEOXPmkJiYyLXXXmvv4VzUq6++yogRI0hKSrL3UC7KYrEwZ84ccnJymDlzJt7e3vYeUqtUVlZGamoqW7Zsobq6mpiYGJKSkqTpnhBCiIuSYF80q715pRzML7P3MJpNT38PYgI87T2MRikvL6+X/p+VlUVFRQWgGgCeOwHQ2lOVRdM5t64/KiqKxMREqetvQGpqKj/88AMTJkwgNjbW3sO5oDfffJMhQ4YwbNgwew/lotauXcsvv/zCb3/7W7p27Wrv4bQ6dZvuOTg4EBsbS0JCQpvoHSGEEML+JFdONKtefh5kllRSYTS3q878OsDN4EAvv7azIu7u7k6PHj3o0aMHoFJ9i4uL663+b9iwgZqaGkA1AKwb/IeEhEh6bTvl7OxMUlISCQkJ7N+/n5SUFObOnSt1/Q0YMmQIZ86cYdmyZfj5+REVFWXvITXIYDDY/i+3VgcPHmTDhg2MHj1aAv06NE3j5MmTJCcn25rujRgxgri4OFxcXOw9PCGEEG2IrOyLZpdfWcP6dtiZf0SkP36u7SsAslgs5Ofnk5WVZZsEOHXqFGazGb1eT3BwcL0JgMDAwFZduyyuXEN1/UOGDMHTs21ksjQns9nMV199RW5uLjNmzMDPz8/eQzrPf/7zH7p06cL1119v76E0qKCggI8++oguXbowdepUySBB/f7dt28fycnJZGdnExQURFJSEv369cPBwcHewxNCCNEGSbAvWsTu0yUcLiy39zCaTHdfd/oFdYxmZtYGgHXT/8+cOQOo1cO6DQDDw8NbpgGgpoEEBy1C6vobVllZyezZs9HpdNx3332tbsX1448/Jjg4mIkTJ9p7KOepqalh9uzZmEwm7r///lb3tWtpDTXdGzp0KNHR0TIJIoRocyyaRoXRjMmiYdHUh16nQ6/T4ajX4WZwQC+/21qMBPuiRZgtGqtPnGnz6fzW9P0xUYGtrilfS7I2AKw7AVBUVASAq6trvfr/8PDw5msAqGnqQ7ILmp3U9Z8vPz+fWbNmER4ezu23396qslw+++wzPD09mTRpkr2HUo+maXz33XccOHCAGTNmEBQUZO8h2U1paSlpaWm2pnt9+/YlKSmpw0+kCSHaDoumUVJtoqjaSFGVkYJKIyXVRiwXeY4e8HI24OdqwMfFgI+zAS9nR5kAaCYS7IsWU3A2nb8t/8DpgOHtMH2/KZSXl9sCf+skQHm5yubw8vKypf5bP65oNc9shoMHoawMYmLA3f3Cx4GaBDhzBkaMgAULoE+fK3txwsa6v3dKSgqZmZn4+/uTkJDQYev6jx8/zpdffklcXFyrSpmfM2cODg4OTJs2zd5DqSctLY0VK1YwefJk+vbta+/h2MWZM2fYtGkTu3fvtjXdS0xMlJ0IhBBtRkFlDceKKsgsrcS66ZYOLus9ft3j9TqI8HQl2tcNX5eO916iOUmwL1pUVmklqdlF9h7GFUsI8yHc09Xew2gTNE2jpKSkXv1/dna2rWmYv7+/bQIgPDy8cQ0AT5yAjz+G776DzEzo1g1efhluuOHCz/npJxg9Go4fh86dm+4Finp1/S4uLgwePLhD1vVv2bKFZcuWMW7cOOLj4+09HADmz59PVVUVd955p72HYpORkcGnn35KfHw8Y8eOtfdwWpS16d6mTZs4fPgwnp6eJCQkMHjw4A5fxiCEaBvMFo2M0kqOFpZTXG267OD+Uqzn83Z2pJuvOxGerh06i7apSLAvWtyJ4gq25RbbexiXLTbEmyhvN3sPo03TNI28vLx6GQC5ubm2BoBBQUEMHDiQhISEhk+Qnw+FhRAaClVV8PzzsGsXzJ4NvXpBRQUsXgw//giDB8M998Dbb8OcObBtG5y7naDZrGr/W1H6dVtUWFhIWlpah67rX7FiBZs3b241W8gtWrSIgoICpk+fbu+hAGqf+I8++ghfX1/uuuuuDtNwztp0b9OmTeTk5BAUFMTQoUPp27dvh/kaCCHaNrNF40B+GUeLyjFZWi5sdNTriPZ1p5efhwT9v4IE+8Iu2lrAL4F+8zGbzbYGgFlZWYSFhREbG3vhN8IHDqgAvUcP9W9YGLz7LkyeDFOnwubN0L+/mhgYP16t7Pv7w9dfq/r+vDwIDGz43JoGFsv5EwAFBWpSITERZBXugqqqqti+fXu9uv6kpCS6d+/e7uv6LRYLX3/9NZmZmdx3330EBATYdTxLly4lKyuLBx54wK7jAPV//IsvviA/P5+ZM2d2iMyP6upqW9O94uJiunbtSlJSkjTdE0K0KfmVNWzJKaLcaLbbGNwNDsSH+kgJ7RWSYF/YTVZpJWlnU/pb4w+h9e3YEEndb3Gapp3/hthsht//HlJTobhYBe2RkbB7N/zwA5w+DY88AvPnwzXXQHk53HILrFwJH34I998POTnQty8895yq99+9G26+GUaOhIutsm3ZorIIZsxQ55TdAC7KWtefnJxMVlaWra5/4MCBGAwGew+v2VRVVTF79mwsFgszZszA1dV+vzd+/PFHDh06xCOPPGK3MVitXLmStLQ07r77biIjI+09nGZVWlpKamoqW7dupaamxtZ0LyQkxN5DE0KIRjNbNPbllXK4sLzJ0/Uvl/X63X3d6RPgKav8l0mCfWFXBZU1bLbzjOGFyExiK/P993DrrfDeeyqYr6yEb7+FN96Ab75RDfgyM2H58trnzJ8P06bBxo2QlKRW50eOVCv7d90FO3fCmjUq9T8qCt55Rz3v9ttVdgDUD+ytn0v6f6N1tLr+goICZs2aRUhICHfccYfdUrV/+uknduzYweOPP26X61vt3buXBQsWcN1115GYmGjXsTSn06dPk5yczK5du3B0dGTw4MEkJCRI0z0hRJsj783bl0t0wxKiefm5OjEmKlBmD8Wlbd0KISEqVd8aKDo4qBR9Jye1st+zp7rfZAJHR5WS7+EB1hrq/fuhtFTV8F93nXp8+HB44gnw9oZhw2D9ejVhsHKl6g2g06keANHR6kPTzs8CaCj4v/de6N0bnn66+b82rVinTp3o1KmTra4/LS2NTZs20a9fPxITE9vdiqefnx/Tpk3j888/Z/ny5dxwww12Sds2GAwYjcYWv25dZ86c4fvvv6dv374X7sPRhmmaxokTJ9i0aRNHjhzB09OTUaNGSdM9IUSbVTfrtjWqMJpZn54vWbeXQYJ9YXcOeh39grwI83Sxe12Qm8wYtl6jRqmV+j/+EW67DZYsgbfegkmTVJf9oiIV2IMK9EGt6EdHQ0CACtI3b1a1/tddpx6vqVEr+AsXqmO7doU771RZAAsXwsMPq4mDxx9X9338sQrq//Qn1fzP2xuCghouAbj5ZnBrZJ+HDlAW4Ovry3XXXcfw4cNtdf07d+5sl3X9nTt35oYbbmDx4sUEBQXZJdC1d7BfXV3NvHnz8PX1ZcKECe3mewuqB8G+fftITk4mJyeH4OBgbrrpJmm6J4Ro004UVbDtVOvup2VdEEzNLiI2RJN+Wo0gwb5oNfzPrvIfKCjjaKF0/BTnGDYMnn0W/vtfWLEC/vlPMBpVIN+li2rU9+OPqq4/MFCl5i9cCBMnqmC8qkrV3tdNJS4pgWPHYMSI2tV/nQ5iY9U2fwCHDqlJhH791GMZGfDqq+p+UGMZPlxNPPToUXvuiRPPfw1mc+016mYBtKNA6FJcXFxISkoiISHBVtf/9ddf4+/vT2JiIgMGDGgXdf2DBg3izJkzrFy5Ej8/P7p3796i1zcYDJhMpob7XzQzTdP4/vvvKSsr4/7778fJqX1MnlZXV7Nt2zZbA8quXbvadl9oT5MZQoiOpy0E+ueyNvqWgP/iJNgXrYqDXkdMgCe9/DzILK3kSDPv5enj7Ei07OXZNuj1cPfd6sNqyRIID1efv/yy6sg/fDj85jcqKM/OhquvVo8XFalO/jNm1D4/Lw+OHIGnnqq9LzsbzpxRmQSg6vzNZujUSd3esQMMBqiuVtd8+mn4wx/gtdfgk0/UMWvWwOuvq54CdWvTG1r1y8+HWbNUA0E/v1/xBWpb9Ho9MTExxMTE2Or6ly9fztq1a9tNXf+YMWPIz89nwYIF3HfffQQFBbXYta0TJkajscWD7U2bNrF//36mTZuGv79/i167OVib7m3ZsgWj0ShN94QQ7UpWaWWbC/SttuUWY9DrJKX/IiTYF62Sg15HZ283Onu7UVBZw7GiCjJLK7Eu9l9u8F/3eL0OIjxdifZ1w9elfaw4dVjjx9d+3q0bLF2qVtpzcuCBB2DtWpXGD3D8uKrrr7uyn5Ojgu3f/Kb2vvR01e1/0CB1e/du8PJSDfwAfv4ZYmLg739Xq/0AQ4fC6tVQUaFS99etU/0B3NxUX4Cff1Yr/8XFqhzgppsgPl5NYJw6pUoT7r9fnasDpPSfq25df2pqarup69fr9UyaNIlPPvmEr7/+mhkzZuDu7t4i17ZXsH/8+HHWrFnDVVddRa9evVrsus2hoaZ7iYmJeHl52XtoQgjRJAoqa1p1jX5jpGUXMTzSQUpwL0CCfdHq+bk64efqRGyIN6XVJgqrjRRVGSmoNFJSbcRykefqAS9nA36uBnxcDPg6G/B0dkTfwYKpDqNTJ5g5s/Z2TY0KtkGtzg8cqCYFQAXVe/aoFfq+fWufk56uVuCt3fgPHVKNAa0r+9u3qzR/a0YBqCA/LExNHLi5QXJy7XZ+334LL72kgvthw2DVKnXdDz5QuwHcdpt67tatqpzAYDg/4Lem/7fzemBfX1/Gjh3LiBEj2LZtG2lpaezcuZMuXbqQmJjYJuv6nZ2due2225g1axbffPMNd955J46Ozf+nt26w31KKi4tZsGABXbp0YeTIkS123aakaRrHjx8nOTmZI0eO4OXlxejRo4mNjZWme0KIdsVs0dicU2TvYTSJzTlFjIkKlCzdBkiwL9oMvU6Ht4sBbxcDnN3NyKJpVBjNmCwaFk196HU69DodjnodbgYHCew7Omtt/FVXwbZttfebzSrFfsSI2vvKytRKvre3SqkvL1cp/YmJqg8AqFr+MWPAx6f2eQcPqkkE6327d6vGgaDKCfz9Vcp/eLjq/L9xowrm4+JUPwCdTm0raDTChx+qCQBNU2UGgYEXDvLN5nY5AeDi4sLQoUNJTExsF3X9Pj4+TJs2jc8++4xly5YxceLEZp+0aOlg32QyMX/+fAwGA5MnT0bfxraltDbd27RpE7m5uQQHB3PzzTcTExMjTfeEEO3SvrzSVrm93uXSgHKjmX15pfQLksyrc0mwL9o0vU6Hh5P8GIsr4OgI06erDyuzGSIjVXAOql7/2LHaZnv796tjunWrnUQoKVHlANdeqyYPTpxQQXp8vHr8+utVPf+0aaq7/6RJauLBymCA555TZQenToG7u8pGeOMN+OEHlUkQFaWOmTq1/op/Ow9CrHX9ffr0ITMzk+TkZFtdf1xcHPHx8W2mrr9Tp05MnDiR7777joCAAH5Tt3SkGVhT91sq2F+5ciW5ubnce++9uDV2F4pWwNp0LyUlhZKSEqKjo7nzzjvp0qVLm8siEUKIxsqvrOFwYbm9h9GkDheWE+7pIun855AoSQghrLy91Qq8VadO8MwzKm0f4JdfVN193UZr+/apwN9a0791q1qtt97u2VM19Xv3Xfj0U5Xi/9JL4OsLmZmQlQW9e6tjg4PVv7/7nWom+PvfQ69eKuj/29/URERSkjrmnntUs8LISHB1VaUA59I09dHGVlnPpdPpzqvrT01NZePGjW2qrr9///7k5eWxevVqAgIC6NmzZ7Ndy7qyX1NT02zXsNqxYwdbtmzhhhtuILxueUsrVlJSQmpqKlu3bsVoNNKvXz+SkpIItv4fFEKIdsps0diSU9Tkza/tTYek8zdEgn0hhLiQiAi1Gm81ebIK3uvW+P/yC5SWqrp+gA0bVIAeGKh2ADCZ1GPPPQfLlqntA4OC4Pnn1aq9iwvU3ZbtzBmVyv/CC6p8ICwM+vRRJQgLF8KQIarcYM4c1XQwJET1BXj+eXjxRTWWI0fUdoQ+Pg03+9M0laGg16uPZ55RWQnPP98MX8SmdW5df2pqapuq6x85ciR5eXl8++233Hfffc0SXFo0DaPOARcff4przORVVDdbeVNOTg7Lli1j4MCBxFonxVqxU6dOkZyczO7duzEYDAwePJiEhARpuieE6DAOFJS1i/T9c1nT+Q8UlBET0Day/lqCTtO09jSpI4QQLSsnB/buVd37/f0hIUHtADBnDixYAJs2qVKBvn1VScCUKTBggNqm749/hJUrYfPm2pT8r7+GO+5Qx588qdL8e/VS5QKOjiro37JFBf033qh2BQgOVhML5eXwpz+pJoOHDqnnvfkmjB598dfQoweMGwdvv93cX60mZ7FY2LdvHykpKWRlZbWJuv6amho+/fRTKioqmDFjBh4eHld8LoumUVJtouhXNC71cTbgdQWNSysrK/noo49wdXXl3nvvbbVfb2vTvU2bNnH06FG8vLxITEwkNjYWZ2dnew9PCCFajNmisezoKUyW9hv+Oep1jI8OltX9s2RlXwghfo3QUPVh9csvKjAHVQZw5Ija2i8wUK20BwWp9HtQ3fiDg+vX3u/cqRr3rV2rsgL27IG0NEhNVVv+gSoFCAyEf/1LreCDCvb/8Ae148CXX6pdBv7zH3jySVUGYM08yMxUEw1eXjB2rBp7dvalJwRaKb1eT9++fYmJiWkzdf1OTk7ceuutfPzxx8ybN4+77777sjv0/5otSS1AUbWR4mrjFW9JqmkaCxcupLq6mrvvvrtVBvpms5m9e/eSnJxMbm4uISEh0nRPCNGhZZZWtutAH8Bk0cgsraSzd9vpH9OcZGVfCCGaW3GxCtbz8lTDPl9fdf+bb8IXX6iV/4kTVeD+5ZcqhX/27Po7BdR1221qQmHJEpWmr9PBRx/Bgw/CK6+oawwYAIWFcPvtKptg+nQ1aXDrrao3gaur6i1w771w552qR4B1W8I2zlrXv337dkwmU6ut68/KyuLTTz+ld+/e3HzzzZcsPzBbNDJKKzlaWE5xtanJ6y2t5/N2dqSbrzsRnq4XXBlZt24d69ev54477qBbK/u5qa6uZuvWraSmplJSUkK3bt1ISkqSpntCiA5vzYkzFFeb7D2MZuft7MjoqEB7D6NVkGBfCCHspaAA3n8f5s5Vq/6rVqnAffJkVUP/f/+nUuxzclQt/oABKq2/Z08VoD//vKq/1+lg/HgVsHfurJoGVlaqLIKjR+Gvf1Ur/BMmqGPnzlVbC374ITz0kDrv+vVqtb8dqaqqstX1l5SU0KVLF5KSkujWrVurCfr27t3LggULGDlyJMOGDWvwGLNF40B+GUeLylt0RcZRryPa151efh71gv7Dhw8zZ86ci47ZHqTpnhBCXFhBZQ3r0vPtPYwWMyLSXzrzI8G+EEK0PocOwdNPw48/qkmAvn3VKv8zz6gsgU6dYNEiuOaa2mC/Tx+1Nd+LL0JNjQryd+xQGQWPPKJuP/OMWvkfN05d59Qpdd7YWJVh0Ma79l+I2Wxm//79JCcnk52d3erq+tevX8+6deuYMmUKffr0qfdYfmUNW3KK7NpMyd3gQHyoD36uThQWFvLRRx8RGRnJrbfe2iomTXJzc0lOTmbPnj3SdE8IIS5gS04RGSWV7aoD/4XogE5ersSF+th7KHYnNftCCNHa9OihgnlQq/RZWeo+BwfYvVut2kdHq8etwdbNN8O8eSpdPzJSbefXu7dK+QdYvFh1/rcGk2azSuevrFSTCe000AdwcHCw1fVnZGSQkpJSr65/yJAhv6pJ3q81bNgw8vLy+O677/D19SU0NBSzRWNfXimHC8uxdzhdYTSzLj2faG9XkhfPx9XVtVFlB81J0zSOHTtGcnKyrenemDFjpOmeEEI0wKKpOvaOEOiDKknLLK0kNsS7yXafaatkZV8IIdoSTVMTAL161W/sd+yYqr/v2VMF+OHhqhmfiwsMHap6ALzwgrrP6vBh1fRv2TKVJXDepbRWsXLbHOrW9ZvNZvr27WvXun6j0chnn31GSUkJU+6ezr7imta3NZKmUVNeSlyIN93C7fN1MpvN7Nmzh+TkZE6dOkVISAhDhw6lT58+0nRPCCEuoKjKyNqTefYeRosb3TkAbxf7Z/DZkwT7QgjRXqSmqvr8TZvAzQ0SE9U2fjffDCkpcPXV8P33Ko3/zBl47TVVt79vn8oGqEPTNE6ePMnq1asJCwsjLCyM8PBwAgIC2tUEQGuq6y8tLWXO0h8IHPQbdDpdK12B0dChY0iYD+Geri121XO/T926dWPo0KFERUW1q59HIYT4tUaMGMH69esZPnw469atA+BEcQXbcovtO7Am8pc7J7N3czIjbprKo6+9fdFjY0O8iergXfkljV8IIdqLhARYulR9npenGgCGh6vbgwbB738P992nmvl5eMA778CwYeDv3+DpnJyc8Pf359ixY2zevNl2X93gPywsDG9v7zYbcLm4uDB06FASEhJsdf1z5swhICCAxMRE+vfv32J1/flmBwJjrwKatst+01KTEKnZRcSGaM3+Jqq4uNjWdM9kMtG/f3+SkpIICgpq1usKIUR7UlRlbPIdXOwlolsPamqqCYnsfNHjdKjXjXfLjKu1kpV9IYToKEpKVO3+unVw443w3/+q7v7W/gAXUVVVRU5ODllZWWRnZ5OVlUVJSQkAbm5utsDf+q+7u3vzvpZmommara5///79uLq6tkhd/4miCradanurLs21anJu0724uDgSEhLw9PRs8msJIUR70tDK/toTeRRVG5vlesaaGgxOrbPrvY+zgVFRAfYehl1JsC+EEB1ZYSH4+l7RU8vKymzBv3UCoLKyEgAfH596GQChoaFtrnFaQUEBqamp7NixA7PZTL9+/UhMTGzyrdyySitJzS5q0nO2pIQmSum3Nt3btGkTx44dw9vbm8TERAYNGtTmfnaEEKIlFBYW8sADD7B06VICAgJ47rnnmDt3br1gv7KqinuefI6fly0iLzsTN08v4kaM4c7/ex4vX5XZN+/dN/nm/X8RGBbB3U//hTlvv8aZ7Cy69unLAy+9QeeevQF499k/sG7RN8TEJxE7fBTLvviEwtO5LNifBcD6xd+y7PNZZBw5iF7vQK/YeH775HN06d0XUH1Xvn77dTauWEzh6VM4u7oSHBHJ0HETuem+3wGwbtF8lnz6IbnpJwHwDwkluu8AHnvjXaDhNP7SokLmvvMGm9f+SFHeGTy8fRgwdBi/ffxZ7hsRh16n48UXX+Sll16ic+fO/OMf/+DPf/4zGRkZDB48mI8//piePXu22PetJUmwL4QQoklomkZRUVG91f+cnByMRrWaEBgYWG8CIDg4GEfH1l9N1px1/QWVNaxPz2/TqZU6YPiv2M/Y2nRv06ZNnD59mtDQUFvTPX073iVCCCF+rcmTJ7Nw4UIAevbsSebZJrzl5eW2YP+668fx4w8r0Ds40KlbT85kZVBRVkpEtx68sWAFzi6utmDf0WBAp9MTHNmZ3JPHMRmN+AWH8t4PG3B2dbMF+44GJyxmE2FdoinOz+PTlL0smvU+X7z5dwDCorpSVVFBwelcXNzceH3+CiKiu7Ps81l88spfbGOprqokLzuLngMH8/IX33LiwF6euvlaNE0jpHMXnJycOZ2VQVVFOd8eyAbOD/Zrqqt45pZxpB8+gIOjI6FRXTmdkU5NdRV+QSFs2baNLuGhtmDf0dERnU5HdHQ0Bw8eRNM0hg4dysaNG+3zTWxmrf9dlhBCiDZBp9Ph6+uLr68vffuqWXyLxUJeXh5ZWVm2SYDdu3djsVjQ6/WEhITUS/8PCAhodQFec9X1my0am3OKmn7AdrA5p4gxUYE46Bs/+VFVVcXWrVtJTU2ltLSU7t27M3bsWGm6J4QQjXD06FFboD9lyhSuuuoqwsLCuM265S6wfv16fvxhBQAvfjqfmPhECk+f4nfXJpF55BAbln7HmFtutx1vMhp5/uM5DLp6BNs3rONv999Owakc1n2/gOtuvavOcTX86aMviR02CrPZTHVlBd+8/y8Apj36FFMffgKzycQfb53A0T07+fbDd3jsjXfJOXkcgFGTpvHQX98EoLK8nKxjhwHIOXkCTdMIi+rKv5f/jF6vx2w2c2Db5gt+HX5Zuoj0wwcAePLtD0kYcz3H9u7imSnjKDidy3//8z6v//1vtWM3mVi8eDETJkzgiSee4K233mLTpk1UVlbi6tpyjWdbigT7Qgghmo1erycoKIigoCAGDRoEqD+0ubm5tvT/EydOsGXLFkA1AAwNDbVNAISHh7eaBoAODg707duXmJgYW13/0qVLWbt2LXFxccTHx19WXf++vNLWt73eFdCAcqOZfXml9AvyuuTx0nRPCCF+vb1799o+HzBgAIWFhRQWFhIUFER2djZms5m0tDTbMX+5c9J55zi8c1u9YN/D24dBV48AYNDVI/Dw9qGsuIj0Q/vrPS+sSzSxw0YB6m/j8SOHqD5bxjfv3TeZ9+6b9Y4/tHMbAINHXMMPcz5l9fw5bFu/ltCornQfMIhrptwBQK/YeDy8fcg+cYx7EmMIi+pKVK8Yrp5w/titjuzZCYCzqysJY64HoGtMf8K6RJN59DDbt26td7y3tzcTJkwAoE+fPrb7T58+TefOF2/61xZJsC+EEKJFOTo6EhERQUREhO2+6upqW/CfnZ3Nvn37SE5OBlQDwHN3AGjOZnmXotPpiIyMJDIy0lbXn5yczMaNGxtd159fWcPhwvIWGnHLOFxYTrinywXT+XNyckhOTmbv3r04OTkxZMgQhgwZIk33RMegadDQpKXFonqnuLhAG21sKlqW2WympqaGiooK230mk8n2ubVCOzMzk9TUVNv93QfEnncun4Arm2T18Q+84GMR0d1x9aj/e93TR/UGGnT1CP6xcCWbfljKyQP7OL5/D3vTNrHuu294b+UmfAODeHvJT6xfvICje3eRfugAq775kjUL5vD3rxfTo4HXcCnnlsn5+PjYPq9bStheK9sl2BdCCGF3zs7OdOnShS5dutjuKy8vr1f/v2XLFn7++WdAzczXDf7DwsLs0sTNz8+P66+/npEjR7J161bS0tLYsWMHXbt2JTExscG6frNFY0tOUbvZBslKx/np/JqmcfToUTZt2sTx48fx9vbmmmuukaZ7om0qLITcXIiIgMZMUuXkwMyZcM01autTsxkcHNRj1uA/NRWmT4eHHlLHiDbPbDZjNBoxGo3U1NRc9PNz7zOZTBd8zPq5xWIBID8/33bN1atXM2bMGPLy8jh16hSgfv/WnRifNPMRhoweq8ZoMrEreQPhXbrVG3tZcRE7N65nwG+Gs3PjesqKiwCI7NG73nHn/l3r1K0HTi4u1FRVMfCqkdzz7Au2Y47t201NVRUAJw7uw8vPnzsefxaAwjOnmXH1QIryzpB9/Ci+gUGUFBVw04yHbef+/bhhZB07woGtaQ0G+936DmAlUF1ZSerqFbY0/uzjRwEYFDu4Ed+19kuCfTuwaBoVRjMmi4ZFUx96nQ69ToejXoebwQF9K0hZFUIIe3J3d6dHjx706NEDUG9ciouL69X///zzz9TU1AAQEBBQL/gPCQlpsQaALi4u/OY3vyExMfGSdf0HCsraRfr+uazp/AcKyujl68bu3btJTk62Nd2bPHmyNN0TLWvTJqiogDFjVKD98cdq95Fp0y680t4Qa5D+9dfw1lvwwQfqnBYL6PXqX+uqoF5fe15vb3j4YbCmBlsD/brc3MDfv/b5otlZLJZGB98NfX6p46zB+KUYDAbbh5OTU73PXVxc8PT0bPCxup8fPHiQH3/8kV9++YUDBw5QXFyMXq/HYrHg4eHB22+/TWZ2DmtW/cjrD08nrEs0egcH8rIzqaqo4KXPFhAU0al2TE7OvPbwvQR36kzOCVVf7xsYzIgbb7noa3F2dWPKQ4/z1VuvsvSzj9i0YjFefn7k5eRQVlzI1IefoFdsPJtWLGHhh+/gHxKKl68/eTlZZ5/vSkhkZ47s2cnL02/Fy88fv6BgKsrKOJ2ZDkBkj14NXvuqG25iyacfkX74AP/8wwO2Bn0WiwW/oBBmPvS7Rn0/2isJ9puZRdMoqTZRVG2kqMpIQaWRkmojF/s1oAe8nA34uRrwcTHg42zAy9lRJgCEEB2aTqfDx8cHHx8fYmJigNoGgNbV/3MbAAYHB9er/2/uBoDn1vUnJyfXq+uPjYvjaDtL3z/XoTMl/PjlJ5QUF9G9e3euv/56Onfu3Cr6LogO5h//gMzM2mD/s88gOLg22AcVqDcUhNdl/dkNCIDAOunLdQP8hri5wdixtcc29H9ApwODAUpLG/+62jlrMN7Y4PtyAnGj0YjZ3LjJVkdHxwsG23WD8XMfu1hwXvf4pvid+PXXXzNz5kyWLFlCVVUVI0eO5OTJkxw8eJCAgAB8fHyYu+BbfvfHv/DLsu85nZmOi5sH4V27M+jqkUT2qL/dnE9AIPc9/1dbV/0eAwbzwEuv4ezqdsmxTHrgUfyCQ1jx1f9IP3yAirIS/EPCGHr9BBKuHQdAn7gEju0bycmD+0k/fBBXd3f6JV7FlIefwN3Lm+BOnfnNuBs5umcn2SeOodc7ENWrD2Nvv5eBV41o8LpOzi68/MW3tq33ck4cw93Lm8Rrx3H7488SEtyx+8HI1nvNpKCyhmNFFWSWVmI5+xW+3JTNusfrdRDh6Uq0rxu+Lle2vZEQQnQEJpOJU6dO1ZsAOHPmDKBWUs5tAOjj49Osgai1rn/79u14d+5OaNxVzXat1kKXfYyr+vYgMPDCdZ1CNBtrYP2HP8CuXbB2rQr2b79dPfbNN2A0qiD7Yqwr+tbzLV4ML78ML70E48erY0pLYdEi2LoVnJ3hppsgKUk9VlICL7wAHh7w17+q+zIz4emn1Rh69VLn2b4d4uLglVea6QvStDRNu6JA/EJB+bnHXG4wfqmgujHBd0Oft6UJyoMHD7JhwwaGDRtG9+7d643doml8fyj3ojGIdeu9wLAI/rs27SJHti16YGKPkA69YCor+03IbNHIKK3kaGE5xdWm84L7y51VqXu8RYOMkkrSSyrxdnakm687EZ6ul7XNkRBCdASOjo62QD4+Ph5QDQBzcnJswf+BAwdISUkBwNXVtV76f3h4eJM2AKxb17/2ZB5VTXbm1suriwT6ooUYjaqWvrRUfR4UBH5+6jE3NxVwgwrWXVxUzT2oQP/4cXjsMbjqKhWAr1+vgvM9e9S5xoyBZ56BIUPUc1xdVeB/tv6Y0lJ4/XUVuMfFQV4e/PCDes7tt6vjDh4EazlRaSm8+iqkpUFysppI+PvfYfVqSEhosi+JNRi/krrxxqS1120GdzEODg4XDKSdnJxwc3O7ZFB+sSBeSoJq9ezZk549ezb4mF6nw9vZQFG1sYVHZX9ezoYOHeiDBPtNwmzROJBfxtGickyW2hC9qVMmrOcrrjaxNbeYnadLiPZ1p5efhwT9QghxEc7OzkRFRREVFWW7r7y8vN7q/5YtW2zdjb28vOpNAISFheHi4vKrxlCh6aniEunC7URxtYmCypoLduYXokkUF8N//qNq8UtL1cr68OEqYO/RQwX7lZUqVV+nUyvsxcXquSdPwj33qLT+++5T9xmNKu3+v/8Fk0mtxt93nwrGg4PVZIGmqXMC/PQTfPihCvinT1dj+MMf1PNuvll11/f3h4ICdfyePbBhAzz7LJydiOSFFyAlpXZcdWiaxrFjx8jIyLisdHWjsXFBnTUYv1BQ7erq+qtWxiUYbz38XA0UVxvbVVPYS9GhXndHJ8H+r5RfWcOWnCK7NFsyWTQO5peRWVJJfKiPvKkSQojL4O7uTvfu3enevTtQ2wCw7gTAhg0bbA0A/f39bRMA4eHhl90A8FhRRbvrwH8hOtTrlb9LollVV0N0tEqv79sXjhxRDfEeewxWrFDBdmWlCtydnFSw7uiomvbdfjuEh8P//qeO0zQYMUKt5ls9/bQ61/ffq6761mDfmma+dasK5qdPV/d5eqrj1qyBjRth9Oj69fhlZWr1f9Cg2mv4+anbFwj2T548yY4dOxpc8fby8vpVK+MOl+pVINoNHxfDRf/2THv0KaY9+lSLjaclaKjX3dFJsH+FzBaNfXmlHC4sx95r6hVGM+vS8+nu606fAE9Z5RdCiCtQtwFgnz59APVmOy8vzxb8Z2dns3fvXsxmM3q9nqCgoHoTAIGBgQ2uZlk0jczSyg4R6IN6k5VZWklsiHeHT6EUzSgoCKZOVan6R4+qtPjRo+Hf/4byctV5v7JSBeKaphrsbd8O998PXbvCu++qQN/aVb+qStXkL1oE+flqUsDJSW2hByqNH+DsBCClpbX3GY3q+u7uqgt/Xp7KJnBzU+cB9bnRWDtZACobwWJRExfn0Ov1jBo1ilGjRjXP1090GD7OHTPo9e2gr7suCfavQEFlDZvrrObb+82b9fqHC8vJLquSVX4hhGgiOp2OwMBAAgMDGThwIKD2UD516pRtAiA9PZ2tW7cC9RsAWicAfH19Kak2YbH3H4sWZtGgtNqEt6ysdDiapl3WXuMXS1GPiopi2LBhF7oQLF8Of/ubCsiNRhVYe3pCVhZ4eakg2lpj7uWlgv/du6FLF/DxUY85Oqr7X3gBvvtOba/Xpw8UFamVfeuqu4uLCuCtNfthYXD6tPrc2bn2mOxsNbEAKsC3BvKBgSoTIDm5tg9ASYmagLj66qb8FghRj9rViw71d0ivA09nCXXlK3CZskorScsusvcwLqjCaGZ9ej5DwnwI93S193CEEKLdcXBwsAXzVjU1NRdtANg1NhF9p+72GrLdFFYbJdhvpazBeHPtNd7YzZ4ulm7u5uaGq+tF3sscPw533gl33aVq5Tt3VoH0iBEq8PfwUKvwRqMK0h0cVBD+0UfwwANwxx3w1VfqXMXFsGUL3HYb3Hijuu/YMTh0qH6DPkfH2uB92DCVCfCf/8Dvfqfuf/dddczIkeranp61kw2dOqnygRdfVD0FQkPh/fdVwF9UdJnfQSEaT6/TEeHpSkZJx8gw06F2MZPMMgn2L8uJogq2nTq/pqo1sf4HTs0uIjZEI8r70vtiCiGE+HWcnJzo3LkznTt3tt23f/9+WznAX/8zi5hO3dvdm6y/3DmZvZuTGXHTVB597e16j+mAoiojeNtlaG1eU62MX+hzi8XSqHFcSTf1xjZxc3Bw+HXbmxUUqDr43/8eoqLUivuqVWp1vapKpdSDCvZBrbLrdJCYqJrw/e53qpHed9+pVX8/P1i5UtXdFxaqRnsmU23NvbOzyhywBuaDBqm6/n/9C9atU+M5fRrefrt2yz6jEdLT1fGurvDEE6pE4NZb1TjvvFM17Nu9+8q/DkI0QlcfN9JLKu09jBahAdG+EgOBBPuN1hYC/XNty1XjlYBfCCF+vREjRrB+/XoA+vfvz86dO22P5efnExERQdXZ9N5nnnmGxx57jISz22kFdIpCA/akbuKFu28B4IPVqQRFdGrZF9HEIrr1oKammpDIzuc9pgEFle13qyeLxdKsK+OXE4xfKKh2cXFpVBO3C33u6OjYuvcaj4pSK+cvvKCa5O3ZA8uWqQmAsjIVXFdU1HbP1+ngzBn1eVISfPmlel5cnCoHeOUVdbtPH5VyP3OmSru3NrJzc1Nb5EVHq9sGAzz/PHTrprIC+vRRq/3WGntHR9Uw8Pbba8fs4aHKBP797xb5Eglh5efqhLezI8XVjds6sS3zdnbE10VKmkGC/UbJKq1sc4G+1bbcYgx6naT0CyFEE9q1axc///yzrZZ41qxZtkDfKjQ0lJSUFCyaxveHcq9oVd9YU4PBqfW+YZn5wqsXfbyk2ohF0+ySSmkNxi93ZbympgaTyXTJ48zmxu3C4+joeMGVcRcXFzw9Pa94ZbzVB+PNLSAAFixQq+u33QZDh6q0/BkzVHM+f3+1dZ6Hhzr+N7+BDz5QK+46HcTEwLffqmZ6fn6q4d+aNepYV1d1TF1ubjB79vnjuPVW9dGQ4GD1UZdsSSfspJuvO1tz22ZMczm6+brbewithk5rbFFVB1VQWcP69Pw2nXqpA4ZH+kvTPiGE+BWsK/sGgwGj0cgtt9zC/PnzMZvNdO3alZycHNv+1s888wwPPvggXbp0AeClzxawN20T37z/r/PPezYF/sFRQziTncnE6Q9SVlRIyqoVdOndl5c/X8AX//w7W35aRcGpXKorK/Dy9WfA0GH89snn8A2qDSSWf/kJ3330HuWlxQwZPZZu/Qbyv1dfAFQmwa6UDXzw/FM4u7oya8MO3Dw8Afj0tZdY8umHhHWJ5t0VG3j32T+wbtE3xMQnkTT2Br6f/QGlRYXExCfx0N/exDcwCDg/jf90ZgYPjVHZDA+/8hYpK5exL20jwcHBPP/889xn3c8cyMzM5Pnnn2flypXk5+cTGhrKlClTeOCBBxoVqF8qcL+cYLyxAXZjjjv3+A4djAshWhWzRWPZ0VOY2nGnPke9jvHRwbI72Vmysn8RZovG5pwiew+jSWzOKWJMVKD84AshxK80cOBA8vPzWbRoEZmZmWzevJn09HRuu+02vv766ws+zz8klIjo7mQePQxAl94xODo5n5cCv/yLT9A76AmJ7IKTiwsAOzb8RMGpXAJCwjCbTWQfP8q67+eTeewwr89fDsDmtT8y+2/PA+Dl68f+ralsXruy3rmvHn8Tn73+MhWlJfyy7HuunfZbAFJXqXOMvGlqveMP7tjC4V3b8Q8Jo6qinK3rV/PZ6y/xhzffv+TX6cMXnsYvKATQceLECe6//34OHz6Mn58fxcXFvPfee5SUlODk5ISfnx+ZmZn885//ZM2aNdx000228zg4OFxwxdvJyQl3d/crXhmXYFwI0ZE46HVE+7pzML/M3kNpNtG+7hLv1CHB/kXsyyu1ba/XlmlAudHMvrxS+gV52Xs4QgjRpun1eh5++GGefPJJPvjgA5KTkwF49NFHLxrsj5lyByGRXWw1+0+/+0mDNftuHh78Y+FKAkLDbavTv3/9XTp174n+bPrv6vlf8cGf/48ju3eQm36CkMgovp/9HwCCIiL516LVOLm48NK909i7Odl2bmdXN0bcNIXlX8xm7cK5XDvttxzds4vTWRno9XqGTZxUbywWs5nX5y8nqlcMbzx6H6mrVrA75ZdGfZ3iR13Hk29/yMmflvDk7x5E0zSqq6sZOnQon332GSUlJfj7+7NkyRKCg4P56aefmDFjBjt37uTTTz+lV69eGAwG22sWQgjx6/Xy8yCzpJIKo7lNZy6fSwe4GRzo5edh76G0KvIX9ALyK2s4XFhu72E0qcOF5RRU1th7GEII0eZNnz4dd3d33n33XX766ScGDx5MUlJSvWMam0Z+rsRrxxMQGg6oVW2A4wf28swt13NHbDcm9wrjgz//n+34gtOnAMg4cgiA2GEjcfXwwMHRkcRrx513/utuuwuAwzu3kXHkECk/LgMgJmGo7bpWkT16EdUrBoCI6B4AFOWdadTruHrCzeh0Om6/47e2+3x8fLjqqqvIzs4GVGPDoUOHEh0dzYwZMwC1R/uePXtwdnaWQF8IIZqYg15HXKhPuwr0QS1uxof6yKr+OWRlvwFmi8aWnCJ00K7+I+iQdH4hzlNaCjfcoPZprlNPLNo3TdMwm80XrQE/93ZhYSEAhYWFrFmzhsTERNacbeYVExPDu+++azv/xo0bz2vY11je/gH1bu/fmsp7zz6Gpml4+vgSEd2DqopyWzmA5TInFSK6dqdvwm/Yk7qRtQvnsmXtj4DqHXAud8/affOsEw+NZX2uk8Fgu+/cNkGenp627QnrcnOTXWSEEKK5+Ls60d3XvV0tbHb3dZf+ZA2QYL8BBwrK2kX6/rms6fwHCsqICfC093CEaD6aBtZtq/T68zsqWyxgNqttkywWyM6GnJyWH6e4IE3TGhWAN3S7scc1tj+ttba7vFy9KTIajZSVlXHNNdewZs0avL29mTRpUr0AtWvXrlx77bX8+5zttZxda3dGqaqsaPB659aQH9653TbWtxavxTcomIUfvctX/6rfCb9T957s35LKzo0bqKqowODsTMqqFQ1e47rb7mJP6kZ+nPs5VRUVuLi5k3jN+VkATaGhTvzx8fEsX74cR0dH5s6dS1RUFAClpaV899133Hzzzc0yFiGEEEqfAE+yy6rafDq/NX2/j8Q2DZJg/xxmi8bRdjTL1ZCjheX08vOQ1X3R8jStdsujcwMAs7l2OyKzWT1+mSuJNpd6rl5fey0PD7VFk3UfZtEoFoul0Z3RryQgN5katw+wXq+/aLd0Dw+PRnVVv1DzNgcHB1vwvXTpUo4ePUpQUBB33303APfffz+Ojo54edXvhxIaGtrginVIp844GgyYjEZemj6NwLAIbrz3QZLG3nDB19i5Z2/b549PHIWXnz/F+fnnHXfj9IfYvyWVnJPH+N01iRicnCgtKmzwnENGj8U3MJjCM6oEIPHa8bg002q6YwN/ax5++GFmzZpFVlYWPXv2pHfv3pSWlpKRkYHRaOSuu+5qlrEIIYRQHPQ64kN9WJ9+/t+TtkbS9y9Mgv1zZJZWtuvtKABMFo3M0ko6e0uapGhhDQX5VnWDc8dL/Goym8EaDJaVgYsLuJ/dU9VohM2bYccOqKqChAS1t7KVxQKffab2WjYY4JFHwNsbSkrU49bJiDbMmqJ+uavilxOQW6yZE5dg3dbsQsG0m5tbowPwhm5fbmp5U/Pz82vUcdafKE9fP6b/6a8s/PAd8nNzKDpzmsK80xd97oDfDOfOp/7Ess9nU15aTHjXbkx79Cn+9fiD9Y6LH3Ut9z3/NxZ++C4VZSXEDEmic4/efP3vNwBsnf0BHA0GRk+5jQX/eRuAETfd0rgXfJn0qBWXcwUGBpKSksJf/vIXfvjhB/bu3UtgYCBXX301EyZMaJaxCCGEqM/P1YkhYT6kZhfZeyhXbEiYj6TvX4ROa2weYwex5sQZiqsbt6LUlnk7OzI6KtDewxDtldmsgubSUjhzRq2e19TAoUMqqPbxgfh4FWQDFBfDxx9Dly4qAP/b3yAwEB5/HMaMUedzcIDkZPjDH1Qwf8010KMHbNwIjz0Gd9+trvnpp/D+++DsrM5VVQW//a0K6gE++QRefhkmT4a+fWHNGpgzR533X/9qkWC/bor6laapN3WKemP2F7+SgFy2NVPWnsijqNrYrNcwGY0UnMq1dfg3m8288sCd7PhlHb6BwXz887Z6349fli3irSd/R2BYBB+sSW2W75WPs4FRUQGXPlAIIYTdnCiuYFtusb2HcdliQ7yJksXLi5KV/ToKKms6RKAPUFxtoqCyRmbCRNPbswcefBCGDoXUVEhPh5tuUgH9xo1qFd5ohOuug+eeU0F9UREsXAiHD6smeffdBz/+CE89BW+9BSNHwpEj8Mwz4OcHJ06oiYPnn1fnd3ZW1161CmbPhqefhqlnm4395z8wd65a3e/VC776Sn3+z3+qx7t2VdcqKLjgSzIajeTm5v7quvErSVG/WDB9pSnq1tt1U9RF8/JzNVBcbWzWusjqygoevm4o0X0H4BMQSPqhA5zKOAnArY/9n+17vW9LKj/M+R87N24AYOK9DzTTz4GGl0F+voQQorWzBsxtKeCXQL9xJNiv41hRRbvrwH8hOtTrlWBfNDkPDxXwV1bCP/6hAvUtW1RA/8kn6piff1aB/OzZ8OyzagU+IEBNCNx7L/TsCcOGwfTpsGiROse6daqJ3pw5EBmpPoqLYcYMONs4jU2bICtLne/991XK/r59sHs3rF+vxlZYCHfeWTve+Hg1MZGXd8GXVFpayifWsddxoRR16+1zU9QvtXLe2lLURdPxcTE0+98Wg7MzscNGcWTPTo7v242TiysxQ4Yy4Z77iR91ne243PQTbFy+GHcvb8b9djpj77i3WcajabBpzY+klOQTGRlJp06diIyMxM/PTyaZhBCilYnydsOg15F2NqW/NcZD1r8cQ8J8CPd0veixQpFg/yyLpurYW+MPdnPQUP0JYkO8G+yULMQVc3JSq/fTpsGoUaq2Pj5epfEnJ6u0/qIilZq/bZt6jqOjOq5PHxXoA3TurAL6o0fV7bw8dVyvXrXXCguDbt1qg32TCU6ehDfeUKn47u4qwJ8yRQX0ZWUqC6BuTwC9XpUVnDhxwZfk7e3NQw89JCnq4or5OBsufdCv5OTswh8/+OySx42aNI1Rk6Y1+3h0Oh1DYwdw6uRxMjIy2L59O6C21asb/IeGhsrElhBCtALhnq4Mj3Rgc05Rq9yZzM3gQHyo1OhfDgn2zyqpNtHO+/Kdx6JBabUJb5fmfxMqWo9LdVFvbIq6j48P48ePP/8Cjo4QFAShobW3MzNVHf7PP6uJAEdHlZYfEFB7jKenqq8HtSSo14Ora+2WeO7uUF2tJgmsXF3VJEJ1de19PXuqSYWG7NtXe22rmhp1DeOF66kdHBwICgq6xFdWiAvzcnZEr6ND/Z3R6yA2pjf6vmpXgqqqKjIzM0lPTycjI4OffvoJk8mEo6MjYWFhtgmATp064eoqKzZCCGEPfq5OjIkKZF9eKYcLy+2e9Wy9fndfd/oEeErX/cvULoP9ESNGsH79eoYPH866desa9ZzmbpzU3PakbuKFu1U35Q9Wp9oaNF3M2oXzmPzc4wCNbuYlmteVdlG33jaZTJc8zmxu3Ext3RT1htLPXep09q7HYDi/m/7cuSr9fvVqGDxYNdt7+OHaoNwa2Bee3SZMp1P3ubvXrtp37apKA3bsgBEj1H2nTsHBg7Wd+YcNg1mz4L33ahvylZerIN/bW2UOjBwJ774LkyapBn1z5qha/6uvbtTXRYgrodfpiPB0JaOkY2SQ6YAIT9d6mWMuLi5069aNbt26AaqBYG5uLhkZGaSnp7Njxw5++eUXQHXrt678R0ZG4uPjI5k0QgjRQhz0OvoFeRHm6cIWO6/yy2r+r9Mug/0rUVRlbLaZqysJxC+Xm4cH3QfEAmBwatx/Bm8/f/rFxtXbFunFF1/kpZdeonPnzpy4SFpzR9UUXdQvdVxjJ14uVvPt4uKCp6fnFdWJOzk54ejoiN66D/3lMpzNFLGu0ldWqjr6qCgYMkTdt2ULrFihMgBABf+enrUr9NaVfU9PtfIOMGgQJCXB73+vOu4XFanmfd7eUFGhjklKgkcfhX//W9XpOzursgFHR1X/36MHzJypmvuNGaMmE4YMUZ38ly69stcrRCN19XEjvaTS3sNoERoQ7XvxxkkODg6Eh4cTHh5OYmIimqZRVFREenq6bfV/29lSHw8PD9uqf2RkJCEhIZL6L4QQzcz/7Cr/gYIyjhaWt+j25I56HdG+7vTy85DV/F+hQwf7NTU1OJ0NjAsqm7dLcnPrGtOf1+ZdXrAyeMQYRl93fb1tkayBZllZGQcPHqSntX66jWiqFPWLrZw3hrWL+oWC6bpd1BsThJ/7mKOjY+td5XJwUMG6NXB3dYXhw9Xe9o8/rurwDxxQzfMOH1bH6HQqYD92rPY8Op1asc/IULfDwlRw/+ijKqjv0QPuuksF8tY93z094U9/Uiv2ixapbf4iI9XxcXHqmIgI1aF/1y411i5dVIf/f/yj9rpCNLHS0lJ2bN6M2SccB3cvew+n2Xk7O+LrcnmrMDqdDl9fX3x9fRkwYAAAlZWVZGRk2D7Wrl2LyWTCYDAQHh5uC/4jIiIunG0khBDiijnodcQEeNLLz4PM0kqOFJZTXG1q8kVS6/l8nB2J9nUnwtNVgvwmoNPaeP52YWEhDzzwAEuXLiUgIIDnnnuOuXPnnpfGbw2MXn/9dVJSUvjxxx+55ZZbePHFF+nSpQsAL322gL4JQwF4cNQQzmRnMvXhJ5j26FOAWqGf/bfnyTl5nOi+/Zk081FeefAuAB5+5a0GGx7Ne/dNvnn/X+fdP+KmqTz62tuYzWaWffYxa779mtz0kzg5O9Ot/0Cm/O4J+sQlAPDGo/eRumoF4V278c9FqzA4OfOP399Pyo/LCOsSzZsLV3J4144Gswd2blzPd7Pe5+junRhraggMj+CWh/7A8ImTWbtwHu/XSeMfOnQoyQ3UOs+ePZuXX36ZkydP8qc//Ym//e1vABQUFBAcHIzJZOLrr7/m1ltvvej3qrlT1GtqarBYg75LcHBwuORqt6Oj42VtZ1b38w694mQ0wlVXqY731lR6kwk+/1x14zcYVMO82FgVkL/2mqrD37IFsrPh5ptrz3X6NJSWQnR0w9c6fFhto/fOO3DrrWqSQYJ10Yrk5OSQkpLCnj17cHR0ZMDwa6jyD7f3sJrd4BBvOjfDlkhms5mcnBzbyn96ejoVZzN7goOD663+e3t7t95JUSGEaMMKKms4VlRBZmmlrRfN5Qb/dY/X61TpV7Sv22VPFIuLa/Mr+zNmzGDhwoWA6vD71FNPXfT4P//5z7i4uNClSxfbqn5jFJ45zasP3UVVRQVOLi6UFhXyrycevOTz/ENCiYjuTuZRtYLZpXcMjk7OhER2BuDDF55mzYKvAQjp3IWyoiJ2bdrA3rRkXvhkHjFDknjw5Tc4uGMrWceO8M37b9GldwwpPy7D0WDgD/94H2fXht9QbfphCf96/EE0TcPJxYXQzl3Iy8ni6J6dDJ84ud6x3377LUajES8vL0pKSnBwcKBr1654eHgAMGnSJN566y1mzZrFhAkTMJvNLF68GJPJhLu7Ow4ODixYsOCC+4pfSYr6hYLri6WoN+a2wWC48hR1cWkGA6Sm1r/PmkY/fXr9+xMT1b8ODpCQcP65goJqU/1Bpd+npqrJhBMn1ESBvz/ccIN63PrGXtPUar81+Lf2AKjL+rMowYBoYhaLhYMHD5KamsrJkyfx9vZmzJgxDBo0CIOTM8uOnmrRVMiW5qhX/Qmag4ODAxEREURERABqErmgoMAW/J84cYItW7YA4OnpWa/rf3BwsPzuF0KIJuDn6oSfqxOxId6UVpsorDZSVGWkoNJISbWRiy296QEvZwN+rgZ8XAz4OhvwdHaU3cGaSZsO9o8ePWoL9J955hlee+01Dh48SN++fS/4nK5du7Jp0yZ8fX0xm81kWFOEL+GHOZ9SVVGBXq/n1XlLierZh6///QYLPnj7os8bM+UOQiK72Fbdn373E9uqe276CdZ+OxeA8XfNYPpzL1NeWsKTN47hTHYmc9/5B3/9ciFevv48/Pd/8feZv+X72f/BzcMTgKkPP0l03/4XvPYXb/4dTdMIiYzib18twjcwCGNNDTknj5937J49e7jhhhv46aefWL9+PR4eHtxxxx0AZGRk4ODggF6v59SpU7z33nvExMSwePFiAAYOHEhJSYktkPbw8DhvVfxyAvJWnaIurlzdAFyvV0G22VzbzE/Tah8793nWnwezGf75T5XK7+ioGvItX66216tLp1MTCBcjP2OiiVVXV7N9+3bS0tIoLCykU6dOTJkyhV69etULMqN93TmYX2bHkTavaF/3Fku91Ol0+Pv74+/vz6BBgwCoqKiwrfpnZGSwatUqzGYzTk5ORERE2Fb/IyIicHZ2bpFxCiFEe6TX6fB2MaidvbzVfRZNo8JoxmTRsGjqQ6/TodfpcNTrcDM4SGDfgtp0sL93717b55Mnq5Xqnj170r9/f1tTn3Pdfffd+Pr6AlxWqnXGkYMAhHXtRlRPtY3Q0LETLhnsX8zRvbtsK91X36BSl909vYgdPpqVX3/G0b07bcfGDhvFdbfdzcqvP6O0qJCeg+K4eeYjFzx3cUE+pzPTARg5aRq+gWp11ODkRGT38+vwdTrdeavuXbt25ZprrrEF4SdOnGDBggVUV1fz8MMP8+KLLwLw2muvcdVVV13x10F0EA0F4HW79ltX4Bt6nlXv3rB166UDeSFaUFFREampqWzfvh2j0UhMTAyTJ08mPLzhdP1efh5kllRSYTS36V4x59IsFnSmGjq5eNp1HG5ubvTs2dPWc8ZkMpGdnW0L/tPS0li/fj06nc6W+m/t+u/l1f77KQghRHPS63R4OLXpELNd6XDfieDg4Hq3664gWyy120pUlJW22Jga60x2pu3zwjOnqa6owPXcFc0r9MQTT7B582Y2bNhgu89gMBASEmK7/eijj7JgwQIWL17MZ599RnV1NdHR0RLoi5Ylgb5oBTRNIyMjg5SUFA4cOICzszNxcXEMGTLkkgGjg15HXKgP69PzW2i0LUOn05GR8hMfLD/D6NGjiY2NbRVp846OjrZgHtT3Li8vz9b07+jRo2zevBkAb29vW+p/p06dCAoKahWvQQghhLgSbTrY79Onj+3z7777jvj4eA4dOsSuXbsu+Jxz08OD6tQDZ584Rv+kq9m56WfKS4rrHdepe09SV60g+/hRMo8eJiK6O5t+WNKocTq71tYuVlVW2D6PjulvW1HfsPQ7uvcfRHlpCdvWrzn7+ADbsT98/Rnb1q/B1d0Db/8ActNP8Mkrf+bhV95q8Jrefv4ERURyOjOdn777hmum3IG3fwAmo5Gck8fp1K1HveM9PDwYOXIkKSkprFmzBrPZfN4b1mHDhtGnTx/27dvHs88+C8Cdd97ZqK+BEEK0B2azmX379pGSkkJ2djb+/v6MGzeO/v37X1YfGH9XJ7r7unO4sLwZR9uyuvt5cN3t01i9ejXLli1jx44djB8/ntDQUHsPrR6dTkdgYCCBgYHExqota8vKyuql/u/duxeLxYKzs7Mt9T8yMpLw8PDL+j4LIYQQ9tTmu/HffPPNLFq0CIBevXqRkZGByWSiurq6wW78//vf/7jnnnvqnWNIYhKbU1NwcnGhx4DBHN61DWN1NRaLxdaNv/DMaR65bihVFRW4uLnhHxJGXk4W1ZVqz+QLdeMHKC0sYMawQZiMRnwCgwgMi+DGex8kaewN/Of5J89r0FdWXIiDoyN/mT2XvglDyT5+lKcmXUt1ZSUPvPg6nXv25vk7bsJisfD0e7NJGHM9e1I3ndeNv26DPmdXV4I7RZGXk8XIm6cy/bmXz+vGD7B48WJuvPFGALp3746fnx9z5syha9euALz33ns8+uijtq/p0aNHbbsZCCFEe1VZWcnWrVtJS0ujtLSUrl27kpiYSLdu3a64x4jZorH6xJk2n86vA9wMDoyJCrTV6qenp7Ns2TLOnDlDXFwco0aNalNb4xmNRrKysupt+1dVVYVOpyM0NNQW/Hfq1AlPT/uWLQghhBAX0qZX9kFtC+fg4MCyZcsoLi7m5ZdfZvHixaxfv77R5/hw1mzuuHc6R/fsJD83h/v/8irz3n2zXtq8b2AQf/zgc2b97U/knDiOu6c3U373OG8/9TAAzhd5E+Pp68f0P/2VhR++Q35uDkVnTlOYdxqAB156g/Au3Vi7cC656ScxODnRf+jVtq33zCYT/376UaorK+mXdBXX3qpW0ifc+wDfz/6A//7laXoOjGvwukPHTsDd04vvPn6fo3t2knPiGIFh4UT3HdDg8QA33HAD999/PwsXLuTw2T3QrdsaAdx11108++yzlJeXc9VVV0mgL4Ro1/Ly8khNTWXnzp1YLBb69+9PQkLCeSVhV8JBryO+naTzx4f61GvKFxkZycyZM0lNTWXdunXs27eP6667jr59+7aJBqwGg4GoqCiioqIANSF+5swZ28q/dbcFAB8fn3pd/wMDA9vEaxRCCNH+tfmV/aZg0TS+P5R7yZWV7BPHCIvqaru94L//5uu3Xwfg38vXE9G1ezOOsnnogYk9Qi6rK2bv3r05cOAAs2fPZvq5W6kJIUQbp2kax48fJyUlhcOHD+Pu7k58fDxxcXG4u7s3+fWySitJzS5q8vO2lIQwH8IvstVeSUkJK1euZN++fXTp0oVx48YREBDQgiNsHqWlpfVS/3NyctA0DRcXF1vNf2RkJGFhYRgMBnsPVwghRAckwf5Za0/kUVRtvOgxT940BpPRSGjnLhScPsXRPapb/rCJk3nsjXdbYphNzsfZwKioxr3pevzxx9m8eTMbN24kLCyMY8eOybZFQoh2w2QysXv3blJSUjh9+jTBwcEkJibSt29fHB2bNxHuRHEF23KLL31gKxMb4k2Ut1ujjj1y5AjLly+nuLiYoUOHMmzYsHYVBNfU1JCVlWUL/jMyMqipqUGv1xMaGlpv9b85Jo2EEEKIc0mwf9aOU8UcL6q46Or+l/98hU0/LKHw9CnQQVhUV4bfOIXxd96HQzO/EWwOOqCLjxsDg70bdXxUVBSZmZn07duXDz/8kISEhOYdoBBCtICysjI2b97Mli1bqKiooEePHiQmJhIVFdWi6dhtLeC/nEDfymg0snHjRn755Rc8PT25/vrr6dGjx6Wf2AZZLBZOnz5db/W/uFh9f/38/OoF//7+/pL6L4QQoslJsH9WW3uT1VSu5M2aEEK0B7m5uaSmprJ79270ej0DBw4kISEBf39/u43p5x17OePsg16vb5VN+6zh6JBLpO5fSn5+PitWrODo0aP07NmTsWPH4uPj0yRjbM2Ki4vrBf+nTp1C0zRcXV3rNf0LCwtr9mwSIYQQ7Z8E+2cVVRlZezLP3sNocaM7B+Dt0n7SKIUQ4mI0TePQoUOkpqZy/PhxvLy8GDJkCLGxsbi6Xnnw2hQyMjL49NNPGZh0FU5dYyg3mu06noa4GxyID/XBz/XXbz+naRr79u1j5cqVVFVVMWzYMJKSknBwcGiCkbYN1dXVZGZm2iYAMjMzMRqNODg4EBYWVm8CwM1NJuaFEEJcHgn2z7JoGosP52LpQF8NvQ4mdr+85nxCCNEW1dTUsGPHDlJTUykoKCA8PJzExER69+7dKoLL0tJSPvroI/z8/LjrrrtAp2dfXimHC8vRgV1X+TWLBZ1eR3dfD/oEeNbrut8UqqurWbduHampqQQEBDBu3DhbF/yOxmKxcOrUKdvKf3p6OqWlpQAEBATUa/zn5+cnqf9CCCEuSoL9OrbkFJFRUtkqUyebmg7o5OVKXKiPvYcihBDNpri4mLS0NLZt20Z1dTV9+vQhMTGRiIgIew/NxmQy8dlnn1FcXMzMmTPx8PCwPZZfWcOWnCK7rvKbK8sp3J3G9NumNmtqeW5uLsuWLSMzM5P+/ftzzTXX1PtadESaplFcXFwv+D99Wm3d6+7uXi/4Dw0NbRUTV0IIIVoPCfbrKKisYV072O+4sUZ29sfX5denYgohRGuTmZlJSkoK+/btw8nJidjYWBISEvD2blxD0pa0ZMkSdu7cyb333kt4ePh5j5stGgcKyjhaWI6pBdPPHPU6on3d8TWVM/vjjxk2bBjDhw9v1mtqmsb27dtZvXo1mqYxatQoBg8ejF6vb9brtiVVVVVkZmbaJgAyMzMxmUw4OjoSHh5umwDo1KmT3UtThBBC2JcE++dYc+IMxdUmew+j2Xk7OzI6KtDewxBCiCZjsVjYv38/KSkpZGZm4ufnR0JCAgMHDsTJqXVObG7dupWlS5cyceJEBg0adNFjzRaNzNJKjhSWU1xtavL0fuv5fJwdifZ1J8LT1Zayv3r1alJSUnjwwQcJCGjcdq2/RkVFBatXr2b79u2EhYUxfvx4wsLCmv26bZHZbCY3N7fe6n95eTkAgYGBtpX/yMhIfHx8Wib1PzkZ8vJg7FhoR9srCiFEWyPB/jlOFlewtQN05R8c4k1n6cIvhGgHqqqq2LZtG2lpaRQXFxMVFUViYiLdu3dv1SvC1oZ8gwcPZty4cZf13ILKGo4VVZBZWmnrNXO5wX/d4/U6iPB0JdrXrcGML6PRyAcffICXlxd33313i9WKZ2RksGzZMk6dOkVcXByjR4/GxcWlRa7dVmmaRmFhYb2u/2fOnAHAw8PD1vCvU6dOhISENE/q/5w5sH07PPcc+Po2/fmFEEI0igT75zBbNJYdPdWiqZItzVGvY3x0cJM3WRJCiJZUUFBASkoKO3bswGw2069fPxITEwkJCbH30C7p3IZ8VxpwWTSN0moThdVGiqqMFFQaKak2YrnIc/SAl7MBP1cDPi4GfJ0NeDo7XrJZ67Fjx/jiiy8alYXQlCwWC6mpqaxbtw6DwcC1115Lv379pDndZaisrKwX/GdlZWE2mzEYDLbU/8jISCIiIpp+MsViAev3Sr5nQgjRoiTYb8DevFIO5pfZexjNpqe/BzEBnvYehhBCXDZN0zh58iQpKSkcPHgQNzc34uLiiI+PbzPN3C7WkK8pWDSNRctWUF5ZyfgbJmDRNPQ6HXqdDke9DjeDwxXvwrJo0SIOHjzIww8/3OJf75KSElauXMm+ffuIiopi3LhxBAZKOdqVMJlM5OTkkJGRYZsEqKioACA4OLjeln/e3t6XN7FSVARffAG33QYtUPIhhBDiwiTYb4DZorH6xBkqjOZ21ZlfB7gZHBgTFSir+kKINsVkMrFnzx5SU1PJzc0lMEkaX98AAJ2WSURBVDCQxMRE+vXrh6GN1QRfqiFfU5gzZw56vZ5bb721Sc9bUVHBe++9R3R0NJMnT27SczfWkSNHWLFiBUVFRSQlJTF8+PA29zPQ2miaRkFBAenp6bbV//x81bDYy8urXtf/4ODgi5fHrFoFDzwAK1bA6tWQmqpuFxXBgAHQ0E4YFgu04pIbIYRoq5pvD502zEGvIy7Uh/XtrDO/BsSH+kigL4RoM8rLy9myZQtbtmyhrKyMbt268dvf/pauXbu2yTTuLVu2sG3bNiZOnNhsgT6ovet9fHya/Lxubm5cd911LFq0iAEDBtCtW7cmv8aldOvWjYceeoiNGzeyYcMG9uzZw/XXX0/Pnj1bfCzthU6nw9/fH39/f1uJRnl5uW3lPyMjg1WrVmE2m3FycuKOO+6gU6dODf8fTE5WQX3XrrBjB3z5pQrms7Nh3Tr461/hT3+C48ehogJiYs4P9DVNPUe2EhRCiF9Fgv0L8Hd1oruvO4cLy+09lCbT3dcdP9fW2ZFaCCHqOn36NCkpKezatQudTseAAQNISEho02nb6enprFixgvj4+Gavea+ursbZ2blZzt2/f3927tzJsmXLeOihh+yy04GjoyPDhw+nX79+LF++nLlz59KzZ0/Gjh3bLJMcHZG7uzu9evWiV69egMquyc7OJj09neDg4AtPtv30EwwcqLrwb9oECQnw+9/DkCHw9tvwzjtQXAxVVbBwoQrs582Dq66qPYdOVz/QtyahtsEJPiGEsCfJmbqIPgGeuBscaOt/WnSAu8GBPlKnL4RoxTRN4/Dhw3zxxRd88MEHHDlyhOHDh/P4449zww03tOlAv7S0lPnz5xMREcF1113X7NdrzmBfp9Nxww03UFZWxrp165rlGo3l5+fHHXfcwZQpU8jOzub9999nw4YNmM1mu46rPXJ0dCQyMpKrrrrqwj9bZWVQWAj9+0NWFuTnw8yZKtAHuPlmOHFCPfbQQ3DggHrstdegulods2oVXH017NsHv/yiMgJ0uvMDfYuldhJACCFEg2Rl/yIc9Dri20k6v6TvCyFaK6PRyM6dO0lNTSUvL4+wsDAmTZpEnz59mmdbsBZmMpn45ptv0Ov1TJkypUVeU3MG+6CC7GHDhvHTTz/Rr18/QkNDm+1al6LT6ejTpw/R0dGsX7+en376iV27djFu3Di6dOlit3F1SEePqpT8QYNUOr+PD/TpU/v47t3g5qZW+nv3VveNGwfPPgvOzmAyqXNs3KjS/TMyYOtWmDABPv8c6u4UcKEaf02TDAAhhDhLVvYvwc/ViSFhPvYexq8yJMxH0veFEK1OSUkJa9as4a233mL58uUEBgZy7733MmPGDPr169cuAn2AFStWkJOTw9SpU1ukg72mac0e7AMMHTqUwMBAlixZgsVysc3+WoazszPXXnstDzzwAK6urnz++ecsXLiQsrL2u7tOq5OcDMHB0KOHqs/v0gXCwmof/+EH6NsXoqNr7ztxAjp1Up9XVMCWLeDvDyNHqpX9VasgLQ0++kgdYzTCiy/CI4+oiYHkZJVRYGUN9DUNJMNDCNHBycp+I4R7uhIborEtt9jeQ7lssSHehHu62nsYQghhk52dTUpKCnv37sXR0ZHY2FiGDBmCr6+vvYfW5KwN+W688cZmbchXl8lkwmKxNHuw7+DgwIQJE5g9ezZpaWkkJiY26/UaKzg4mHvvvZcdO3awatUqDh06xKhRo4iLi7t4F3nx682dq7bbc3NTq/NjxtTffm/dOhg1CjzrlBX+/DPEx6vPi4tVsH/rrSr9X9NULf+YMbBokcoIOHUK9uyBH39UwfzChSqD4OBBVQqwcydERUFQ0PkN/sxmafonhOhQJNhvpChvN4A2FfDHhnjbxi2EEPZksVg4ePAgKSkppKen4+PjwzXXXMOgQYOaPSi1l7oN+QYOHNhi160+W/vsUjfluZlEREQQHx/P2rVr6d27N97e3s1+zcbQ6XQMGjSInj17smbNGlasWMGOHTsYP358i026dEj/+Y9anbd+dOkCrnUWHA4dUp34rf/nKypg1y61NR+o+vwjR+Af/1C3q6rU8ysr1QQCQF4ebNsGiYlwzz3wr39BTQ0cPqzKAbZtg9xclT3wj3/A9dfXXr+hQF/T1IdMBAkh2iEJ9i9DlLcbBr2OtOwiQG1l19pYq9SGhPnIir4Qwu6qq6vZvn07qampFBUVERkZydSpU+nZs2e7XmW1NuTr1KlTizTkq6uqqgqgxSZRRo8ezYEDB1i2bBm33XZbq9oS0c3NjQkTJjBo0CCWLl3KrFmziIuLY9SoUbi6yt/IJle3Pv/gQRWsW+3cqWry6/ZR2L9frcZbG/gdPqwmALp3V7etP8O7doH1/9GRI+q8L7ygOv2Dun3PPSponz0b4uLgD39Qjf9iYiAyEp57DkpL4d1364/5Qs3/GrpfCCHaGAn2L1O4pyvDIx3YnFNEubH11YK5GRyID5UafSGEfRUWFpKamsr27dsxmUzExMQwZcoUwurW77ZTdRvy3XLLLS3ee8C6st9Swb6zszPjxo1j3rx57Nu3j5iYmBa57uWIiIhg5syZpKWl8dNPP7F//36uueYa+vfv36omJ9o8a3M867/W7BJNgwEDoKCgdoUeYMMGdVxkpFq9P3BA3f/BB/D662q1fds21Zn/zTfVYwcPqpr+utkya9eqiYJ162onHF54AQYPVjX9kZGqRODYMTWZYB1DdjYsXgzDh9c2DIT6q/zS8E8I0YZJsH8F/FydGBMVyL68Ug4XlqPDvqv81ut393WnT4CndN0XQtiFpmlkZGSQkpLCgQMHcHFxYciQIcTHx+Pl5WXv4bUITdNYvnw5OTk53HvvvS3SkO9cLR3sA7b92H/44Qeio6NbpITgcun1ehITE4mJiWHlypUsWrSI7du3M27cOIKCguw9vPbBGhSfGxxbb/v41L//979XafYuLpCTo+r1hw9XK/V//rMKuj/7DMaOVSv7BQWqFKBzZ3B3V+cwm1WGQEhI/cyCzp1VJoHRqG7HxUFKCpSU1Ab7778PX32lJgN691bHr1+vtgZMTFSNButOXgghRBsjwf4VctDr6BfkRZinC1vsvMovq/lCCHsym83s3buX1NRUsrOzCQgIYNy4cQwYMACDwWDv4bWorVu3sn379hZtyHcuewT7ANdffz3vv/8+q1ev5oYbbmjRa18OT09PbrnlFgYNGsTy5cv58MMPSUpKYtiwYTg5yd/RFqXXQ8+e6vPTp9UKvjX1/rHH1Gr8H/4At92mjjl+HE6eVBMCoAJ9vV4919r0z2gEg0Gt4js6gnWicdAg2Lu39nZWFrz9Nvz3v7UlAmPHqvr/0lLIzFQB/yefQGBgS3w1hBCiyUmw/yv5n13lP1BQxtHCckyWllvjd9TriPZ1p5efh6zmCyFaXEVFBVu3bmXz5s2UlpYSHR3N7bffTrdu3TpkarS9GvKdy17BvpeXF6NHj2bFihX079+fyMjIFr3+5YqOjuahhx5i48aNbNiwgT179jB27Fh69uzZIX9+7e7wYSgsVFvuhYaqlPxzlZaqbvwDBqjb1u76gYEqMyAjo3Ybv3nzwNe3Nj2/okJtA5iRoTr1//WvauX+zjvVYy+9pFbvly8HDw91nSlT4I03ahsGCiFEGyPBfhNw0OuICfCkl58HmaWVHCksp7ja1OTp/dbz+Tg7Eu3rToSnqwT5QogWl5eXR0pKCjt37kTTNPr3709iYmKHToUuKSnhm2++sUtDvnNVV1fj6OjY4r0CAOLi4ti9ezdLlizhgQcewNGxdb/NcHR0ZPjw4fTr148VK1Ywb948evTowdixY9vlVpCtlsWiAn0fHxXoG40q8D7352fECNWszzoZY83EuOceWL0annkGHnpIbdP36aeqO7+12Z+np9oG8NgxVS6wcaOq6we14r9iheri/+qrqh/AhAlq54AHHlDBvqTyCyHaIJ2maa2xqXybV1BZw7GiCjJLK7Eu9l9u8F/3eL0OIjxdifZ1w9dF0gyFEC1L0zSOHTtGSkoKR44cwd3dnfj4eOLi4nC31s52UCaTiU8//ZTS0lJmzpxp96/H+vXr2bx5M0899ZRdrn/q1Ck++ugjhg0bxnBrunUboGkaBw4c4IcffqCiooJhw4aRlJTU6ics2hXrSv2FAuuLBdzr16ugfMsWte3e736nVuadnGrP27s33HIL/PADjB+vgn2dDj7+WNXvjxqltvZLSYEzZ1QZQbduqkmgHfpvCCHEryV/wZqJn6sTfq5OxIZ4U1ptorDaSFGVkYJKIyXVRiwXea4e8HI24OdqwMfFgK+zAU9nR/QyoyyEaGFGo5Hdu3eTkpLCmTNnCAkJ4aabbiImJkaCIGob8uXm5jJ9+nS7B/qgVvbt2SAvODiYoUOHsmHDBmJiYggICLDbWC6HTqejd+/eREdHs379etatW8fOnTsZN24cXbt2tffwOgZrNsqF3u9c7H3Q8OG1tfxlZfWDc+t5DQb4+99h2DB45JHa8wUEqMZ9//d/tZkFp07B5s1q+79ztgnVNE1KPYQQbYKs7NuBRdOoMJoxWTQsmvrQ63TodToc9TrcDA4S2Ash7KqsrIzNmzezZcsWKioq6NmzJ4mJiXTu3Fne5NaxefNmli9fzo033mjXOv26lixZQm5uLvfff7/dxmA0Gvnggw/w8vLi7rvvbpM/M6dPn2bZsmWkp6fTt29frr32WjytTeBE62M2q5X/C01Cms0wZw588QU88YRqxmdVUABdu8KTT8Jzz9VODlxESkoKAJGRkYSEhKA/Z0JACCFaAwn2hRBC2OTm5pKSksKePXvQ6/UMGjSIhIQE/Pz87D20Vic9PZ3PPvuMuLg4rr/+ensPx2bBggVUVFRw11132XUcx44d44svvmDChAnExsbadSxXStM0du7cyapVqzCbzYwcOZL4+HgJ7Nqj775Taf1Dh8Lo0SoL4OBB1QegAfPmzePw4cOYzWYMBgMRERF06tTJ9tHSDTKFEKIhEuwLIUQHp2kahw4dIiUlhRMnTuDt7c2QIUOIjY1tlfultwYlJSV89NFHBAQEcOedd9qlGd6FfPXVVzg6OjJt2jR7D4VFixZx8OBBHn74YTzacM1zZWUla9asYevWrYSEhHDDDTfYbWtF8SuYTColv6HJGpNJNen74gvYuVM1C7zlFpXab7E0+ByTyUROTg7p6elkZGSQkZFBRUUFoMpZOnXqRGRkJJGRkXh7ezfzixNCiPNJsC+EEB1UTU0NO3bsIDU1lYKCAiIiIkhMTKR3796ycnkRra0h37k++eQT/Pz8uOmmm+w9FCoqKnjvvfeIjo5m8uTJ9h7Or5aZmcmyZcvIzc1l8ODBjB49GldXV3sPSzSH6mpVu+/h0ehO/JqmkZ+fT0ZGhm0CID8/H1BbU1qD/06dOhEcHCy/Z4UQzU6CfSGE6GCKi4tJTU1l27Zt1NTU0KdPHxITE4mIiLD30Fo9TdNYsmQJu3btYvr06YSFhdl7SOf54IMPiIqKajWlBTt37mTRokXcfvvtdLdug9aGWSwWNm/ezE8//YSDgwPXXHMNAwYMaJN9CcQ5rHX/Dg5Nts1eeXm5bdU/PT2d7OxsLBYLTk5OttT/yMhIIiIicHKS3ZY6GunjJZqbBPtCCNFBZGZmkpKSwr59+3B2diY2NpYhQ4ZIeullsDbku+mmmxgwYIC9h9Ogt99+m/79+zNq1Ch7DwVQEyRffPEFBQUF/O53v2s3AU1paSk//vgje/bsITIykvHjxxMUFGTvYYlWzmg0kp2dbZsAyMjIoLKyEp1OR0hISL3Vfy8vL3sPVzQhi6ZRUm2i6Ffs0OXjbMBLdugSl0GCfSGEaMcsFgv79u0jJSWFrKws/Pz8SEhIYODAge0m6GoprbUh37lee+01rr76an7zm9/Yeyg2BQUFfPDBB8THx3PttdfaezhN6tixYyxfvpzCwkISExMZPny4/N8SjaZpGnl5eba0//T0dAoLCwHw9va2Bf6RkZEEBgZK6n8bVFBZw7GiCjJLK7Gcjbp0wOUEYHWP1+sgwtOVaF83fF3kd424OAn2hRCiHaqqqmLr1q2kpaVRUlJCly5dSEhIoEePHpJufAVac0O+ujRN4+WXX2b8+PHExcXZezj1/PLLL6xdu5b777+f0NBQew+nSZlMJjZt2sSGDRtwc3Nj7Nix9OrVS/6viStSVlZWr+4/JycHi8WCs7Ozrdt/ZGQk4eHhGAwGew9XNMBs0cgoreRoYTnF1abLDu4vxXo+b2dHuvm6E+HpioNeft+I80mwL4QQ7Uh+fj6pqans2LEDi8VCv379SEhIICQkxN5Da7Nae0O+umpqanj11VeZPHkyffv2tfdw6jGbzXz00Uc4ODgwY8aMdrlCWVhYyIoVKzh8+DDdu3fn+uuvx9fX197DEm2c0WgkKyurXtf/6upq9Ho9ISEh9Vb/2/KuF+2B2aJxIL+Mo0XlmCwtF2I56nVE+7rTy89Dgn5RjwT7QgjRGpnNqklUI2iaxokTJ0hJSeHQoUO4ubkRHx9PXFycvPH7lTRNY/HixezevbvVNuSrq6SkhLfeeqvVNsPLzMxk9uzZXHfddSQmJtp7OM1C0zQOHjzIihUrqKio4Oqrr2bo0KE4Ojrae2iindA0jdOnT9db/S8qKgLA19fXFvx36tSJwMBAyTBpIfmVNWzJKaLcaLbbGNwNDsSH+uDnKun9QpG/PEII0ZpY93O2BvqFhXCRlUFN06ioqOCLL74gMDCQiRMn0q9fPwksmsiWLVvYsWMHN910U6sP9AGqq6sBcHZ2tvNIGhYREUF8fDxr166lV69e+Pj42HtITU6n09GrVy+6du3K+vXrWb9+Pbt27WLcuHF07drV3sMT7YBOpyM4OJjg4GBbuU5JSUm94H/Xrl1omoaLi0u9pn/h4eHy96GJmS0a+/JKOVxYjr2nVSqMZtal59Pd150+AZ6yyi9kZV8IIVqlf/0LvvwS/PwgIQF+/3sIDr7g4adOnSIoKEhWcJrQyZMn+fzzz1t9Q766rCvnDz74IMEX+Xmxp+rqat5//31CQkK47bbb2v3P7OnTp1m+fDknT56kb9++XHvttXh6etp7WKKdq6mpITMzs17X/5qaGvR6PWFhYfUmAFpzaVJrV1BZw2Y7r+ZfiKzyC5BgXwghWp+ZM+GXX+DJJ1U6/7x5YDDAwoXg5mbv0XUIbaUh37mOHj3Kl19+yWOPPdaqV80PHDjAvHnzuOWWW4iJibH3cJqdpmns2rWLH3/8EZPJxKhRo4iPj2+XfQtE62SxWDh9+nS9rv8lJSUA+Pv712v85+/v3+4n4ZpCVmkladlFQNM232sq1u/gkDAfwj1d7ToWYT+SxyOEEPa2d69K3e/dG1atgnXr4McfISpKPX7wILz1FmzaBGPG2HOkHYLJZGLevHk4ODgwZcqUNhPoQ20av4uLi51HcnG9evWiV69erFixgq5du+Lq2r7fiOp0OgYMGECPHj1Ys2YNP/zwAzt27GD8+PFERETYe3iiA7A28wsJCWHIkCEAFBcX12v6t3PnTjRNw83NrV7wHxoaKqn/5zhRVMG2U8X2HsZFWScgUrOL+P/27js8yjLr4/h3Jpn0DqEGCCUQepGqKEVApCiIig3boqJg3fVd3eKqu+uqW+y96+pasdClSFNC771DCDWNlMlkkpn3j9sJvSd5kpnf57q4SCbPzJwndc5zzn3uTnW8JMeqWBCI9JMrIlJZSkrg+BdM+/aZSn7nzvDSS+ByQf36Zs3+XXfBl1+aiwAffwy9elkTdwDxer1MmjSJAwcOcMcdd1S79lZfsl8d9nm/8soree2115gxYwZDhw61OpxKER4ezpAhQ+jYsSOTJk3ivffeo1OnTvTr18/vL3hI1RMbG0vbtm1p27YtYH5/pKenl10AmDNnDm63m6CgIOrXr192AaBBgwZEBHCXWXVI9I+3bJ+JVwl/4FGyLyJSWYKDT5yyn5AATie0b2/e37MHtm6FZs1gyBD47jvo08d8rKjItPNLhaluA/mOV1RUhMPhqBbt4TExMfTr14/JkyfTrl07GjVqZHVIlaZ+/fqMHj2aJUuWMGvWLDZs2EC/fv3o0KGD2qfFMqGhoTRt2pSmTZsCpvV/3759xwz9+/nnnwGoWbNmWeW/YcOGxMfHB8T37p48Z7VL9H2W7cvFYbeppT/AaM2+iEhFOLqK7/WCzQZbtkC7dmbw3uDB4JuY3ru3qd6/8QYsWWIq+t27m/d98vPh4Yfh1lvh0kuPPKaUG99Avi5dujBw4ECrwzkvs2fPZtmyZTzyyCNWh3JWvF4v77//PkVFRdxzzz0B2Sqcn5/Pjz/+yOrVq2nYsCGDBg2qssMVJbB5vV5ycnKOmfp/4MABACIjI4/Z8q9u3brVagnU2chyFjNnV2aVXJ9/tmxAr4Y1NLQvgCjZFxGpSNu2mbZ8X2J/772wYgXceKOZsF9UZAbxZWfDZ5+ZYx5+GCZMgDFj4IoroLDQTOfftg3+8Q+t268AvoF8iYmJ3HLLLdX2Req0adPYsmULY8eOtTqUs7Z//37efvttLrvsMnoF8FKV7du3M2nSJLKysujevTu9e/euFssxJLAVFRUdk/zv2bOHkpISgoODy1r/fRcBqvoskdMp9XiZseMghe7Sap/sRziC6JecqG35AoSSfRGRC+XxmP/t9iMV988/hz//GdxuaNwYBg2CRx+F3Fx4+23zsalTTVX/llsgLAzeesu0+GdmmmPefReiomDXLtMJ8Ne/mseSclVSUsIHH3xAfn4+d999d7Vbp3+0H374gQMHDjB69GirQzknM2fOZMGCBYwZM4aaNWtaHY5lSktL+eWXX5g7dy4RERFcccUVtGzZMiDao8U/lJaWsnfv3rKhf7t27aKgoACAWrVqHZP8x8XFVZvv7dUHDrM5u8DqMMpNSnwkbWvFWB2GVAIl+yIi58vjMQm+T1GRSdqnTzdD9x54wLTjjx9vKvMffmgq+sHBMGqUqdQ/8QTs3AmvvAKrVx/bnu90mi6A9u2PbLmn9v1y5fV6+eGHH1izZg133HFHtVynf7SvvvqKoqIiRo0aZXUo58TtdvPmm28SHR3NbbfdVm0SgIqSnZ3N1KlT2bRpE82aNePKK68kISHB6rBEzpnX6yU7O/uYLf8OHToEQFRUVFni37BhQ+rUqVMl541k/tq+7296q50/ICjZFxG5UHl5cPvtsGoVbN4M110HBQVmuJ6vDfeuu8zH33sP2rSBvXvNdnrvvAM33WQ+9sMPEB9/8ucoLTVJfhV8IVSdLVq0iClTpjBs2DDa+4YkVmP//e9/CQkJ4frrr7c6lHO2bds2PvnkE4YOHUqnTp2sDqdK2LBhA1OnTiU/P59LL72USy65JCDnGoh/KSwsPGbq/549eygtLcXhcJCUlFSW/CclJRHqWwJnEX9p3z+e2vkDh/5iiIicDd910aMrjlu3wquvQoMGJkl/5RVz+4ED0LatSfSLi83/f/yjuW3nTpPs160Lzz8Pu3ebQXzdu5uE/lSq6Rryqmznzp1MmzaNbt26+UWiD2brrOjoaKvDOC9NmjShffv2TJ8+nebNmxMVFWV1SJZLTU2lSZMmzJ07l7lz57Jq1SoGDRpUNi1dpDqKiIigefPmNG/eHDBLqfbu3VuW/C9evJi5c+dis9moVavWMdX/2NjYSo11Q1Y+Be7T/G2uprxAgbuUDVn5tK5ZPf9myNlRsi8icibHb5fns2iRqd47nfDNN3DJJSa579EDpkwxx4SEmPsnJ5tBfatXm/X3vosA//oXXH65uS2A1ypXttzcXL766isaNmxI//79rQ6n3LhcLssrYRdiwIABbN68mWnTpjFixAirw6kSQkJC6NevH+3bt2fSpEn897//pXXr1lxxxRXV9sKOyNGCg4PLpviDaf3PzMwsa/vftm0bixcvBsyWnUcn/7Vq1aqw1v9Sj5etfrRO/2S2ZheQmhCl6r4fU7IvInIyR1fyg4JMtf6TT6BpU+jaFerVg8suM9vgTZliEn0wCXy3bvD112aLvVtuMfffsMGs6a9V68hxYC4A+IapaT1+pSgpKeHLL78kODiYa6+9ttpO3j+ZoqKiap3sR0REMGDAAL777jvatWtHSkqK1SFVGYmJidx2222sXr2aH3/8kVdffZU+ffrQtWvXKrnOWeR82Ww2atasSc2aNenYsSMABQUFx0z9X7duHR6Ph5CQEJKSksouACQlJZ3VLhbZ2dkUFRVRt27dUx6TnuekxONPzfsnKvF4Sc9z0ig2wupQpIIo2RcRORlf0n3ggEnUBw6ElBQzTT8y0myN16SJ2Rpvxgzz/tCh5j6XXWYq9ePGQXo69Opl2v1r14arrz758ynRrxRer5dJkyZx4MAB7rzzzmo9ef9kXC5Xtd7eCqBdu3asWrWKSZMmcd9992n7uaPYbDbatWtH8+bNmTlzJtOmTWPFihUMHjy4rCoq4o8iIyNJTU0lNTUVMEM9MzIyyi4ApKWlMXv2bGw2G3Xq1Dlm6n9MzIlT5ydOnMj27du54oor6Nq160mHgm7x86q+z5bsAiX7fkwD+kREPB6TbB9d4fV44OOP4Z57YMQIM0V/6FCT+N96KyQmmsp9fj7ce6+Zlv/ll8c+7oMPwtKlZm1/x47w739Dy5ZK7C3kG8g3fPhw2rVrZ3U45crr9fL000/7xYC7rKws3njjDbp06cKAAQOsDqfKysjIYOLEiezdu5eOHTvSr18/IiL0ol0Cj9fr5dChQ8dM/c/OzgYgLi7umOS/Zs2aPPfcc7jdbgA6derEoEGDjunyynIWM9sPJ/Cfiibz+y9V9kVEfC2wXi+UlIDDYW5r2BCaN4dly8zwPa8XUlPhpZdgyBCYMweGDYN+/eDNN81E/XbtjqzHf+klyMoyFxGOHiqkRN8SRw/k87dEH0xVH6jWbfw+CQkJ9OrVi1mzZtG2bdvTttoGsnr16jF69GiWLl3KzJkz2bBhA/3796dDhw4Bv32hBBabzUZiYiKJiYlcdNFFAOTn55cl/7t372bt2rV4PB4cDkdZog+wbNkyDh48yA033FB2sWxbTiE28KsJ/Kdiw5yvkn3/pEVeIhJ4SkqOfT8nB8aONVP1f/Mb05IPJnHv0cNU72vUMEl6aam5rX59+Oknc9zFF5vp+i++aN53OI48dkKCSfRLS08/bV8qVG5uLl9++SUNGzb020qxPyX7AD169KBWrVpMmDABj8djdThVlt1up0uXLowbN46UlBR++OEHPvjgA/bv3291aCKWioqKolWrVlxxxRWMHj2axx57jNtuu43GjRufcOzu3bt56aWXSE9Px+M169gDIdEHc0EjPc+JR83efknJvoj4L6/XtNHDkVZ9AN8+1QcOmP9//BEOHoS//hUyM02bfk6OmY5/zTVw6BBMnXrkccBcCNi40bzdtq0Z2udwgNt98sp9UJC2z7OIbyCfw+Hg2muv9dthZv6W7AcFBTFkyBD27t3LwoULrQ6nyouKimL48OHcdtttOJ1O3nrrLaZNm1b2fSES6BwOB8nJyYSEhBzT+eJ7u7i4mA0bNnDYVYKfz+U7gccLea6SMx8o1Y7a+EXEf916q5l+36oVhIcfuX3KFHjoIdNq37692Trv6aehdWsYPhw6dYK//x3++U+z1r5vX/jzn83ttWrB3r2mtf/ee83jhYfDk08e+xxSJfj7QL6j+VuyD5CUlETXrl356aefaNmyJXFxcVaHVOUlJyczZswYFixYwJw5c1i7di0DBw6kZcuWau0XAfbt24fX68Vut1O/fn2Sk5Np1KgRSUlJhIaGsiO3sOzYJ0aNYO3iBbTu0oOnP/mGEan1ABj7zAv0vWbkWT/nmL5dOZiRzvVjH2Hk/b8r93MqD9kuN7FhjjMfKNWKkn0R8V9vvAFRUUfef+89U12fOhXuustU+J991myj59vjPi4OHnjAJPv/939mgv5NN5nju3c3b3/6qXncgQOPPLYv0fd4jswAEMstXryYFStWMHz4cL9f9+1L9qv7NP7j9e3blw0bNjB58mRuvPFGJaxnISgoiJ49e9KmTRumTp3KV199RdOmTRk0aBAJCQlWhydiqeHDh1NSUkK9evUIDj4xFcopcp9yvX5KezP8NDahRsUGeRprFv7CX267FoA3ZiykVtKF78Rhw5w3sWc8VKoZvSIVEf8VFWWq8J99Zt7/8EO4806TwP/ud6a6/+9/m3b83buP3O/WW007/hdfmPe7djXb6TVsCH36wB/+AKtXm634jqdEv8rwDeTr3r27Xw7kO15RURHgX5V9MOdz5ZVXsnnzZtatW2d1ONVKXFwcN9xwAzfccAOHDh3i9ddfZ/bs2ZQcP7fkZDQnQfxUvXr1aNiw4UkTfYAsp/uU6/Wf/WIiz34xkYt696u4AC3gxZy3+B+9KhUR/5aWBn/8o1m7/89/mtb9+vWPfPzmm01V/ttvwbe2NSHBXBR48UXT4t+4sanir15thvPddZc5TgP3qqyjB/L179/f6nAqha+y74/70qemptKyZUumTJmC0+m0Opxqp0WLFowdO5YePXowb948Pv/8c06783JR0ZELl0r6JUBkZ2dz3fXXc2XLBtzTpzPTPv/4hGNGpNZjRGo9Zo03xYDMfRn87e5buLv3RdzYvgk3tm/CQ0P7MPGjd076M1ZSUsIH//gLt3VrzajOLXj7qcdxFx+Zq+EudvH5y/9k7BWXMLJtI+64uC2v/eFhDmebbQC/eOVfZVV9gHv7dWNEaj1eeewhADweDxM/fpeHhvbhhnaNubVrS/714N3sT99Vdh9nQQFvPfkYd/e+iJFtk7mjRxv+cONVfPf5pxrS54eU7IuIfxs82EzK//Zb04bfrh1s3myG7vncfz988smx1f2774Z9+2DLFjN4r29fqFMHnn/efNzt1sC9KsrtdgfEQL7juVwuQkND/bbNfeDAgZSUlDBjxgyrQ6mWHA4Hl19+OWPGjKF///6n3uHA6YTLL4e5c837drsZbqqkX/zc6NGj+fqrryguKiIkLJyPn3+arWtXnvY+h7OzWD53FgD1mzYjPCqK3Zs38sE//sLUzz484fjJn7zLnO+/JiI6msL8PKb97yP+++9/lH38+ftH89XrL3AgfRf1m6RQUlzMrPFf8OdRI3AVOalRpy5JTY90FTZu2ZqU9p2o07ARAO/+9Y988MwT7N68kTqNkrHb7SyYNpE/3HgVuZnmdc/nL/+THz//mMNZWTRIaU5YZBSbVy1n9cJfKHSriOFvAuMVkIgErpAQuPFGmDcP9uyBMWPMi9g1a44c8/vfw/79Zss9X3traqqZyN+2rXm/aVPTyv/OO+Z9h4bYVEVHD+QbOXKkXw/kO54v2fdXMTExXH755SxbtoydO3daHU61lZiYSO3atQk61cXKN94wA0hfe80MIf3+e7PDSIBcNJPAtHXrVsaPHw/AsLvG8sqUeTz/9VTcxcWnvV+tpIa8MWMhb89eyr/G/8i781bQqnN3AH6e/P0Jx8cn1uGNGQt5Y0YaPQcPA2DqZx9SkHeYtYsWsGzOTACe/PAr/vP9DF6ePJeQsDDSt2xi3sRv6Xfdzdz1xJGLA//3yvs8+8VErrvvYfan7+LHX7sR7n/2JV6c8BNvzFxEjTp1yTl4gMn/fR+AvTu3AXDtfQ/xr/E/8saMNN7/eRVDb7+LkkDbhiAA6De3iPi/m2+G3Fz46isYNcok9LNnmwoWQFgYXHWVadM/ujU/OPhI8h8VBY89Zo6RKmvRokWsXLmSoUOH+v1AvuP5e7IP0LlzZ5KSkpg4ceLZrTuXc7Ntm0n2u3SBAQPMXJIRI+Dtt489TkuYxM+sXbu27O0eAwYDUL9JMxo1b3na+wUFBfPde69zT98uXN+mIde1SmLdkjQAsg7sP+H4i3r3I/zXwcE9B18NQIm7mL07trF59fKy454YdQ0jUusx+rKOFP86j2XzymWnjWXrmpVlSwdeeexBRqTW45aLUsjctxeATSvNVsSd+wwA4POXnueevl14+jc3MuW/7xNbI1Ft/H5I0/hFxK94PB5sNtuxrcwJCdC7N0yfbtrzb70Vxo+HK6+Ebt3MMZ9+aroAjnf0AJ9GjSo0drkwRUVFzJs3L2AG8h0vEJJ9m83G0KFDeeutt5g/fz69e/e2OiT/4fXCb39rtiN99llo1szcvmYNTJ4Mv/kNrFpltiMNCjLH+37P5uZCrMZ4S+D54B9PMOMrMwS4bqMmRMXFsX/XDg5nZ+G5gItivqn/R4urWeus79+4ZWuCQ479e5BYLwmAASNvoX6TZiyZNY2dmzawbe0qVv48h1+mTeTqFadftiDVj5J9EfEL+fn5LFmyhM2bNzN69OgTD3jgAbj2WvjmG5Pwf/aZebHq40v0tXVetRUSEsJ9993nd1vPna1ASPYBatWqxSWXXML8+fNp06YNNX3bZsqF+e47yMiABx88kugDrFtn2voff9wMOk1Ph88/N0k/mO6nceNM4v/xiQPNRKqDVq1alb29cPoUmrXtQMb2rezctP6099u0wlTb21/Siyfe+x/FriIeHzmEw9lZJz1+2ZwZ3PDAo4RHRvLLlAkABDtCqJvchKLCwrLjrrl7HF0vN9v7lpaUsGrBPOo3Nj+Xob6tfoEi55H7NGndDpvNhtfrpffwkQy51bwW8nq9rF+6iIjoaAA2r1pOw2bNad2l+6/nsJTHbxjK7s0bycnKomZEYHXF+Tsl+yJSre3fv5+0tDRWr16N3W6nQ4cOFBcXn5j0NGliKvwrVphW/o0bT/6ASvSrLbvdTnh4uN8OqDsTl8tF+FEvAv3ZpZdeytq1a5kwYQK33357wH7Ny83hw2b4aM+eMHTokds/+AC2b4c//QlGj4boaLjpJnjpJXjvPVPhDw6Gl18225we7ejKv0gV16xZM4YNG8Z3333H+LdfYeGMKWTuy8BuD6KUUy8ZatSiJbs2b2Dlz3O4f2BP8nNz8Jxm3XvWgX3c168b4VHR7N9tZo9cceOtREbH0KbbxXTo2ZsV82fz3Ng7qde4KfagIA5lpFNUWMhTH31NraQG1GnQiGCHgxK3m6fuHElivSSuvmMMPQYOod91NzP9y//ywTNPMOnjdwmLiORQRjqF+XmMfeYFklu0YvIn7/HzlB+oUbsuUbFx7Nu1A4CE2nWpUaNGuX5exXpK9kWk2vF6vWzevJm0tDS2b99OTEwMffr0oVOnTqdPdr755thW09JSTdT3M4Gc9LlcLmIDpJXa4XAwZMgQPv74Y5YvX06nTie2vMo5ePddKC6GYcNMQg+Ql2cuAFx3nUn069Uzt190EXz0kfn9efAg/PyzWdcfH28eY/9+aNBAib5UO++99x5em50pkydTmJfHyPsfZcmsH1m7eMEp73P7Y09S5Cxk9YL5OAsKuPo397J7y2Zmf/flSY8fNGo0xUVOZn/3FeGRUVw6ZDi3/PYPZR///WvvM/6tV5g/6XsOpO8iLCKK+k1S6HhpHxo2bwFAdHwCd/7xr4x/62Uy9+0l5+ABsg8dAODuJ58lqWkKM7/5nL07tuEICSGxfgPa9biUNl0vBqBTr8vJOrCf9K2b2LV5A5ExsXTu0p0bH/o9jiAVPPyNzXvajVZFRKqO4uJiVq5cycKFC8nMzKR+/fp0796dli1bnnqy9MmoVV/80KuvvkpKSgpXXHGF1aFUmu+//54NGzYwduxYon4deiXnadkyOPqiyUMPmZ1LXngBevU6cnu7dnDxxfDmm/DII/Dii6YzICICdu402/b97ndw331H7qMqv1QTHq+X7zftIxCTIztwVfM62PWz6ldU2ReRKi83N5dFixaxbNkyXC4XLVu25Oqrr6ZBgwbn94BK9KsfXaA5I5fLFXDzCvr378+mTZuYNm0aI0aMsDqc6sn3s3V0oj9vnqn2//WvR4aYArz6qmnrf/ttWLzYtPK/+qrZreT3vzfdU07nkUTf5YLQUHOfJk0q97xEzoPdZiM21EGOy211KJUuJtShRN8PKdkXkSprz549pKWlsXbtWkJCQujUqRNdu3YlLi7O6tCkMvmWW7hcZhr4smVw2WVQty7oe6FMoAzoO1pERARXXHEF3377Le3atSMlJcXqkKqfk11ECw+HW26B/v3N1qQABQUmoX/kEbMzyX33mUF+vsS+SROzdV90NHz5JVx/vUn0wRzTqpWZ8n+yXU9EqpCEcAe5LndAVfdtmPMW/6NkX0SqFI/Hw/r161m4cCG7d+8mPj6eK664gg4dOgRcIiOYqqNvicY115hJ4DabSThGjYK//MUk/QHO4/HgdrsD8mekbdu2rFy5kkmTJnHfffcRomTywnXubP4d7a67oHlzs3XprFnw/fewcKH52ObNMGkSXHKJmcx/zz2wfr35+QSYOhU2bFCiL9VCXJgjoBJ9AC/mvMX/KNkXkSqhqKiIZcuWsWjRInJzc2nUqBEjR46kefPm2NW+Hbh8X/uHHjKJ/uTJUL8+pKSYdcJ16lgaXlXhcrkAAjLZt9lsDBkyhNdff52ffvopoGYWVJjjl82sWWO22/voI3P7U0+Z5L9LFygshClTYPZsmDPHbMnXr58Z1rdrF4wfb35+U1OtOhuRcxIXGphJb3yAnre/U7IvIpbKyspi4cKFrFixgpKSEtq2bUu3bt2oq2qtgBnslZVlWvf/8heT6D/8sKnuv/CC+X/mTLPeOD7e6mgtE8jJPkB8fDy9evVi1qxZtGvXTr8/LtTxF1jbtIEFCyA5GZ54wkzhf+kl87HVq+H11+G220yiX1wMvu27rrrKrNcfMMC08ft4POZnV+uDpQqKCQ3GboPT7KDnd+w2iA5VWuiP9FUVkUrn9XrZuXMnaWlpbNy4kYiICLp160aXLl2I9m37JIHNV1m02cx2iXl50LQp/PgjfPihqSTWrm1uf/ttMy383nsDNnkI9GQfoEePHqxZs4YJEyYwevRodQSVF98kfd+gvrg4M4E/LMzM0fj8czOU7+WXjxwP8MUXZsbGU09BixZHHq+4+Eg7v7Y/lSrIbrORFB3O7sPOgGjntwFJ0eEazuenlOyLSKUpLS1lzZo1pKWlsW/fPhITExk6dCht27bF4VD7mBzFbjcJRGYmJCWZduE774R16+Djj6F7d3Pc+vWwaFFAJ/pwJNkPtGn8RwsKCmLo0KG8++67LFy4kB49elgdkn84/ufqueeOvB0cDBMnwt13m+MKC80WfC4X/O1v0LcvDBxoEvqZM820/rVr4Yor4A9/OJLoa7cNqWKaxEWw67DT6jAqhRdoGh9hdRhSQZTsi0iFKywsZMmSJSxevJj8/HyaNWvGLbfcQpMmTbAFcIImR/FVD3/5xbzw79kTOnSA0aPh0UdNor9tGzRoYNr1XS7TVjx6tBnc17u31WdgqaKiIiCwK/sA9evXp2/fvjRs2NDqUPzT8Ul5YSG0a2cG9t1xB9SrZ27/05/Mz/Ttt5sOnM8/Nz/DPXpA166mOyc721wQCA1Voi9VTkJ4CLGhweS6SqwOpcLFhgYTH6bhmf7K5vV6A6FDRUQscPDgQdLS0li1ahUA7du3p1u3biQmJlocmVRJhw/DTTeZ/4OCYP9+U8n3+f57kyTMnm0+npRkLgh8+KH5eABXB1evXs348eN5/PHHA34avdfrxev1qo2/shQUwIgRkJtrqvebNsHVV8OYMeZC3bJl8MADppX/o4/MfdLT4a9/hZ9/hhtvhD/+8cjj+S78iVhsZ24hS/flWh1GhbuoTiyNYlXZ91eq7ItIufJ6vWzdupW0tDS2bt1KVFQUl112GRdddBEREfpjIqcRE2MSgHvugSVLzATvo119tUnuc3LMNl5dukDjxuZjAb721+VyYbPZtBwGM53/rDqG3G6TjD79tPnek3NXWgqRkWZrvZ07TQv/mDFmt4yhQ4+0+R86BBMmHLlPzZqwfDns2WOOPfrn12YzF+4gYC/eSdWQFB3OygOHKfHjSX3BdjOfQPyXkn0RKRdut5tVq1aRlpbGoUOHqFu3LsOHD6d169YEBXASJueobVuTwNevb9bi33WXWdvbuLGp+DVqZP61b3/kPl5vQCf6YJL90NBQLYs5G16vmQcREQHR0fDTT+ZCkpy7oCCTqNvt5ucSzM9sVJSZ4A/w7bdw3XWQmGgusDgcZkjf9u1w881w+eXmcdLT4euvoX9/aN3a3DeAu3XEekF2G03jI9mYmW91KBWmaXwkQXb93fBnSvZF5ILk5eWxaNEili5ditPpJDU1lSFDhtCwYUMlHnJ2jm7bDQ6Gd94xidi//gWTJ5sK/6OPmnX8GzaYdb6vvHJkqz19n5Ul+3IGe/aYteMpKfDqq2Y7x2C9FLogx19o+81vjrxdUGC24XO7zfu+zpM//tF83kePPrJN308/weLF8Pe/w/Dh8OabSvTFcqkJUaQfdlLoLvWryfw2IMIRRGpClNWhSAXTXzgROS8ZGRksXLiQNWvWEBwcTMeOHenWrRvxAbzXuZyHoyt3+/cfSdxjYuCxx8y6/P/9zyT73brBpElw6aVHEn0BlOyfUUmJuYj09tvQsKHZqhFMwqk938vX0RfvIiNN5f7tt826/pAQs07/xRfNv1atjtxv1Cjzb9kyuP9+ePBBc8EvONhcUCguNr8jGjSw4qwkQAXZbXSuG8ecXZlWh1KuvECXunGq6gcAJfsictY8Hg8bN24kLS2NXbt2ERcXR79+/ejYsWNAb/klF8CX6P/1rzBtmqm8du4M119vWn9vucUkZ+PHm232rrzyyH7eavEto2T/NFavhkceMYMfhw+HsWNN8jhmDLzwAoRrvWq58iX6q1aZi3Z//rPZQvPWW82We6+/DoMHm2GcDgfMm2e25HO7zXKKAQPMVprPPGN23QgNNRcQli0ztz/8sHkskUpSIzyElPhINmcXWB1KuUmJjyQhPLCHuQYKJfsickYul4vly5ezaNEisrOzadCgAddddx2pqamaeC3nz5esv/GGSbrefBPCwkxr9UMPwYoVpqX3ssugY0ezDtiXSAT4QL7juVwuXXA7XlGRmfcwZw6kpsJTT8HFF8Onn5q39+yB224z28FJ+XK7TRK/cuWRKv4//gFvvWXmJDzwgBnSN2WKSd6jo83P+O23mw6eK6+EhATIyDDdAL//PUyfbhL/W24xz6HfAVKJWtWMJiO/qNq38/va91vVjLY6FKkkSvZF5JRycnJYuHAhy5cvx+1207p1a0aMGEH9+vWtDk38gd0OW7aYROC990zV9bvvzG3XXw8ff2zadp95BmrVOva+epF/DJfLRWRkpNVhVC1btpiE8447zA4PO3bAoEEmAa1b1/x7911TNb74YtPqr/X75cPhgIED4f33zaC+m24ynTkTJpgunksuMcelpUFhoZnFUVoKf/qT6bgYM8ZU/1NTzXE1aphj4uPN5P9Bg/Q7QCpVkN1GFz9p51f7fmDRXzUROYbX62X37t2kpaWxYcMGQkND6dy5M127diVG21PJhVq1Ctq1O/L+gQPm/X79YO1a8yL/rbdg5EjTzvvBB2Ybvp9+grg4ras+haKiIs3LOJrXa5LMSZPMhaJnnzVDHdu1g//858gE+A8+MGvJ9+5Vol/emjaFpUvhtdfM1yEx0Vy4+93vjhwTE2MS+NxciI01X6tLLoG5c80gTjBD+5YvhyFDzAWEq682S3nuucd83G7Xkh6pFAnhIXStF8fCjByrQzlvXevFqX0/wOgvm4gAUFpayrp160hLSyMjI4MaNWowaNAg2rVrR0iI/jBIOfj7382e2wsWHLnt4otNhTU6Gj76yGy7dc01JhG7+GKzXn/kSA3kOwO18R/Hd1GoVi3TEr5qFYwbB1dddWRbNzBzIV57DWbPht69rYjU/40daxLzoy+m+JLzG26AL7+ETp1Me/68eebfmDFme828PLMjx/r15sJMjx5w7bVm68Sjk3u73Vzg8XqV9EuFqh8dTqc6Xpbty7U6lHPWqU4s9aM1oyTQKNkXCXBOp5OlS5eyaNEi8vLyaNKkCTfddBPNmjXT1nlSvv74R7NWF0zS36uXSfIbNza3HToEu3ebdftgErQrrjDVPDh2yrccQwP6TsKXUP71r2Z9/uWXm7kPR3vjDbNUpE4da2IMFMd3TfiS8/r1YeFCs+PG/v1mjX7Dhqb7AsxFmEmTYOhQk+h7PEeW9Hz4IWzbBjt3mtkLffvq94NUiuTYCIBqlfB3qhNbFrcEFiX7IgHq0KFDpKWlsXLlSrxeL+3ataNbt27Url3b6tDEn0VHw/btpsI6eLAZyuebAdGnj2nXHTjQrPldtsxM4Qcl+megZP8kfBXezp3Nv6OtXw9PPmnWjD///JG14VJ5bLYjQ/ZuvNEk8nv3QosW5uf/4EFT1bfbzVp+MG9nZJiLAePHm5b+yEgz72PUKDP/Q8sxpBIkx0bgsNtY9GtLf1Uc2uf7i9m1Xpwq+gFMvxFFAojX62X79u2kpaWxefNmIiMj6dmzJ507d9ZwL6kcBw6Yyt2iRebFeb9+pn2/a1eT/O/fbyp9YWFm3W5QkAannUFpaSklJSVK9s/Wv/9tBsfVrm0S/htuOPbjurBUeXxD9nzt9889d+Rj4eEwaxaMHm3W83s85nfBZ5+Z3xndu5tdPMD8LnnwQdi8GVq2rPzzkIBUPzqcXg2DWLw3hwJ3qdXhnCDCEUSXulqjH+j06kkkAJSUlLBq1SoWLlzIgQMHqF27NldffTVt2rQhWEmUVLQffjAt1JGRZmja11+b7fTmzzf7ZffrB6++at7+7W9NouVL8D0eJfpn4HK5AJTsn8nevaYdvLTUdI/cdpsZ2LdqlWkF37HDDIFLSjKVZQ19qzw224mf75ISqFfPXBjMyTEDOrOz4YsvTKKfl2fmfTz7rPlaFhWZrfyU7EslSggPoV9yIusO5bE5uwAb1lb5fc+fEh9Jq5rRmrov2Lxeb1XsPBGRcpCfn8/ixYtZsmQJhYWFNG/enO7du5OcnKz1+FI51q0z2261aAFr1pgX4l9/faR91+uFxx+Hf/3LTOn+85/NRQFVV89adnY2L7/8MrfeeiuNffMP5OQeewyaNTNDICMjzXC+b74xbf1BQaba36uXuV2sd+iQuUATE2Pa9jMyzIDFLVtMh9Crr5rBn3Xrwr59ZrvOfv2sjloCVKazmCUWV/kjVc2X46hcIuKH9u3bR1paGmvWrMFut9OhQwe6detGjRo1rA5NAk2rViaZf/BBU4n74x/N7Ue35z/7rJm8ffPNpnr32GNK9M+BKvtnwXdx6amnwPd5eucdM6Cvf3947z1o3tzs4X777dCzp1lHXlpqqs36fqx8paVQs6bZvWPnTvP1Cwsz1f5588zvi3HjzIWbp582w/ri4qyOWgJYjV+r/Buy8tmaXUCJp/LqqcF2G03jI0lNiFI1X46hyr5UGx6vl0J3KSUeLx6v+We32bDbbATbbUQ4grAH8Asyr9fLpk2bSEtLY8eOHcTExNC1a1c6depEeLgGs4gFfNX5TZvgrrtMJTUvz7RK//a3JtE/ej3+hg2mAyCAf47Px44dO/joo48YN26cLuidrZ074aKL4N57zbT+o73wglnTv2LFkTXlYg3fRZqj3X23mf3xzjuQmHjk9owMcyFApAoo9XhJz3OyJbuAXFdJubf3+x4vLjSYpvGRJEWHK8mXk1JlX6okj9fLYVcJOS43OUVuspxuDrvceE5zHzsQE+ogIdxBXJiDuFAHMaHBfn8BoLi4mBUrVrBw4UKysrKoX78+I0aMoGXLlgTphapY5ej1t02bwk8/wdatR6Zop6ebKn+dOmaf7U2b4A9/OPnaXTktVfbPQ36+qQJfc415/+ik8tJLzcdzcqBGDXOBavp0U+33bfsmleNkf8Oeesp0XbRtC2PGQIMGcP31SvSlSgmy22gUG0Gj2AiynMVsyykkPc+Jr9h/rsn/0cfbbZAUHU7T+Ajiw9SuL6enZF+qlAv5hegBclxucl3ugPiFmJuby6JFi1i2bBkul4tWrVoxfPhwkpKSrA5NAp2vWl9UZLbSKyiALl0gJcVUUV97zUzZvuUWM7jvT38ybdS+BF+J/jlRsn8eSkrM92VYmHk/KOjIRaaWLaFxY5Por1gB338PH3wAw4aZrd3EOh6PWZ8/ezZ89RV8+qm5aON0mm09j+P1evF4PLrwLZZKCA8hITyETnViyXOVkH0Bhaz4UAfRAVDIkvKjNn6xXKnHy+48J1sruNUpNjSYZn7Q6pSenk5aWhrr1q0jJCSETp060a1bN2JjY60OTeRY/fodGXwWFgZvvw29e5uPffyxmZy9Ywdce61p69dQvvOyePFipk6dyp/+9CcN3jwXV19tvufeesskkEd//2VlmT3eP//cdKSMGGE6TyIirI1ZTmztdzrNNn3H8Xq9zJ8/n9WrVzNo0CCSk5MrL0aRs6QlqlLRVNkXy5R6vGzIzGdrzrFDTMr76pPv8XJdJSzdl8vKA4er3RATj8fD+vXrSUtLIz09nYSEBAYOHEiHDh0ICfGvjgWpxo5Olv79b8jMhGnTzFrazz6Dvn3hn/80if2tt5op26GhRxIoJfvnxeVyERoaqkT/bPkq+J98Yr4nv/rK7BhRs6b5Hpw/30zonzHDtIi/9x5cfLG578nWkEvl8n3+fV/HU8yksdlspKSksGnTJj766CPatWtH//79iYqKqsRgRU7PbrMRFaJ0TCqOKvtiCW1PcnaKiopYunQpixYt4vDhwyQnJ9O9e3dSUlKwq9VZqhpfsr5o0ZGK/i23mI8dPGgGav3lL2aK9ocfnvy+cs5mzJjB2rVrefDBB60OpfrwJe07dpgLTnXrmqF9P/wA335rvl9vv91cmIIjiaXmSVQ7Xq+X5cuXM2PGDLxeL3379uWiiy7S31ARCQi6lCSVqtTjZd2hPDZnF2D1y/pCdymzd2WSEh9Jq5rRVarKn5WVRVpaGitWrKC0tJS2bdvSvXt36tSpY3VoIqdms5lq/siRJnF66ilzu9drpmY/+KCZtn/77Wby/oIFRxJ8JfrnzVfZl3Pgqw4nJ4PbbZL8H36An3+Gjh3hzTfNVnxgBkiuWgV/+5sS/WrIZrPRqVMnUlNTmTFjBpMnT2bFihUMHjyYehrqJyJ+TpV9qTRZzmIWW1zNP5WqUOX3er3s2LGDtLQ0Nm3aREREBJ07d6ZLly5qO5Tqo7DQ7FX+6qtmuNmkSdCjx5GPl5QcSfJ79rQsTH+yb98+CgsLadKkidWhVE+5uWa+hNsNjz5qOk8Adu0yy1F+/hliY+Hdd83gPqnWdu/ezaRJk9i/fz9dunShb9++hPkGNYqI+Bkl+1Ip9uQ5WZSRA5T/mvzy4Kspdq0XR/3oyt2TvqSkhDVr1rBw4UL27dtHYmIi3bt3p23btjgcjkqNReScnayt2euFdevMlP1Zs8w6/bvvtia+AOD1evF6vWpLPh++79+ZM6F9e7NuH8wykw8+MO3+/fubLfratrU0VCk/Ho+HhQsXMnv2bBwOBwMGDKBt27aaeyEifkfJvlS4HTmFLNufa3UYZ61TnViSYyt+4nJBQQFLlixh8eLFFBQU0KxZM7p3706TJk30gkOqh6PX2f/4IyxZAg4HtGtnKqUHDsArr8Drr8Ntt8FLL1kbr8jxjp8V4XKZXSM+/dS08V97LQwaZLaSFL9z+PBhpk2bxrp160hOTmbQoEEkJiZaHZaISLlRsi8Vqrol+j4VmfAfOHCAtLQ0Vq1ahc1mo3379nTr1k0vMKT68VVFX3sNnn0WunSBnBzYuBEeewzuv98MOvvhB/P2yJGmWipSVR04AJdcYv797W+QlHTsx2fNgjp1oFUrDevzI1u2bGHKlCnk5OTQo0cPevXqpc46EfELSvalwuzJc7Lw19b96qhbObb0e71etmzZQlpaGtu2bSM6OpouXbpw0UUXEaF9m6U6W7MGLrvMbE82fLj5/3e/g59+gg4dTBu012vapNu2BQ3Ekqps+nSz5OSnn8zwPp9Dh0zF/4svoFMnXbTyQyUlJcyfP5/58+cTFRXFlVdeSYsWLawOS0TkgijZlwqR5Sxmzq7MKrk+/2zZgF4Na1zQ0D63283KlStZuHAhhw4dom7dunTv3p3WrVsTpL2apTrztT9/8AF8/LFJjhYuhCuugJdfhltvhe3bzXCz664z25uBqqFStZWUmJ0j/vlPs21kWJjZiu+jj2D/ftO9ct11cOmlVkcqFSQrK4vJkyezdetWWrRowcCBA4mLi7M6LBGR86JkX8pdqcfLjB0HKXSXVvtkP8IRRL/kxFNuy7dmzRpq1KhB3bp1j7n98OHDLF68mKVLl1JUVERqairdu3enQYMGWo8v1Ztvf3Kf77+Ht96CyZPNpPJrrzWJEsB335lK/4svQtOmVkQrcvZKSsza/IkTYcIEM42/oMBsJ9m0KVx//bEXrnyOX/cv1Z7X62X9+vVMnToVp9NJr1696NGjhy7Si0i1o2Rfyt3qA4fZnF1gdRjlJiU+kra1Yk64fc2aNXzzzTckJiZy7733YrPZyMjIIC0tjbVr1xIcHEzHjh3p1q0b8fHxFkQuUk6OT/DBJPkXX2zW5HfvDiEh0Lev2ZPcd59Bg6B+fXj//cqP2R95POb/4xNLJZrl7+uv4aGHICEBhg2DO+4wF7OKikyrv9NpBlGmpprjlfD7JZfLxZw5c0hLS6NGjRoMGjSIxtp+UUSqESX7Uq4yf23f9ze9j2vnz8jI4P3336e0tBSAXr16sX37dnbt2kVcXBzdunWjY8eOhB5fARKproqKzNC9F1+EV1+FF14wbfs1a5oK/sMPQ0qKGda3ahVMmQIzZsC2baZtX+37Uh34kvbcXHjgAZPoDx9uPvbOO2YQZUYG1K5tvqcffdQMn3S5Tqz4i9/Yv38/kyZNYvfu3bRr147+/fsTFRVldVgiImekZF/Kjb+07x/v+Hb+vLw83nrrLQoLCzn6x6dhw4Z0796dFi1aaL9r8T8zZ8KNN5okZ8MGmDsXevQwCU9hIUybBk8/DXv2QFycGcb3r3+Z9mdfe7Scv5Ur4e9/N5/P6GizrrxuXQgPN+/HxkJ8PEREQGSkqswXwndhqrDQfD4B/u//zPfzvfeahP/AATOP4q67zPC+6GhYuxbmzYMxY6yNXyqE1+tlxYoVTJ8+HY/HQ9++fencubP+3otIlaZkX8rN2kN5bMzMtzqMCtOiRhTNY8N45513OHjw4AkfHzduHDVq1LAgMpFKMmECXH21SWwmTDBT+I+3fLlp3Q8Lg5iYky8BkHP388+m0hwVBcXFpmPi4EHzeQ4LM5Xl4mLz+R41ygyUk/IxbZq50OXbccLH44F77oEHH4RJk0zHS4MGZomLtlL1W4WFhcycOZNly5ZRt25dBg8eTP369a0OS0TkpJTsS7ko9XiZtHU/JR7//XYKtts49PNUdu/cedKPd+nShUGDBlVyVCKVwNfavGAB/Pe/JqH87DP4wx9Ma79PaampcvpanFXxKj/FxWZQXGio6ax45x1Teb7xRtNJsWeP2RmhoMDshtCli9UR+48XXzQXT2bNMp/roiLTUbF3L3TubLoqPB4YORIGDza36Xvf7+3evZtJkyaxf/9+OnfuTN++fQkPL5/tekVEyov6KqVcpOc5/TrRByjxeKnfsh3e0lIiIyNxu924XC5cLhfFxcVq5RP/5WsJ79HD/DtwAJKSzNT9tWvhk0/Mx2+8EXr2NBVo/TyUr5AQ07YPsGSJSeo//PBImzlAv37wyCOmu0LJfvkpLjb/fINWw8PNgL5HHjEXt/r0gWuuMQMqfVu0LV0KF11kWchS8Ro0aMDdd9/NokWL+Omnn1i/fj39+/enXbt22nVHRKoMVfalXMzccZBcV4nVYVS42NBgLk9We6YECF91fsUK2LIFdu+GAQPMVPKQEPjiC3jqKZN4du0K8+ebvciV6FcMtxscDrNOPDMTxo8/8Zjhw6F5c3juucqPz98cPWG/QQOzPCIlxXwdnnnG/Azccw8MHAitWx+535o10KEDpKdDnTqWhC6VKy8vj2nTprF27VoaNWrE4MGDSdRSDhGpAvSKTC5YlrM4IBJ9gFxXCVnOYqvDEKl4paUmaZ83z2yh9/TTJoEcONC8vWsX3HyzSfhvuMEkNUuXmvuUBMbvg0rnm31w8cWwbh28/rpZt5+ZaVrLJ00yLf7Nm1sbp7+w2Y58Ly9YYLoo7r7brNG/7DLz+b/nniOJ/l//anaoaNPGXCCLOXHLVvFP0dHRXHvttdxyyy3k5eXx5ptvMmPGDIqL9XpBRKylyr5csCV7c9h92OlXE/hPxQY0iAmnc904q0MRqXj5+dCqFdx3H4webbbZe/55s26/Z0945ZUjCahvEJ/W6le8ggIzL2HiRLPPe926pp18+nSzlOK550DDQsvf739vtpMcOxYuvxwaNTK3L18Od95pdkx4801zQUACVklJCT///DPz5s0jKiqKgQMH0qJFC7X2i4gllOzLBfF4vfyweR9+vlz/GHYbXJVSB7v+cIu/mzPHJPmTJ5v2ZZ/x4001/3//gxEjrIsv0E2daibFp6ebKf0332zWjetiS/nyXcAqLj6yFj8kxHxs3DhT4b/ySvjjH037vm+OwtHLACTgZGVlMWXKFLZs2ULz5s0ZOHAg8b65DyIilUTJvlyQnCI3s3YesjqMSnd5o5rEhjmsDkOkYq1ZYyqYEyaYNflOpxlOBtC7t2llfvppS0MMaIWFZss9JRCVb+JE08IP8MQTMGyY2YUCzHyLmBioVUsJf4Dzer1s2LCBqVOnUlhYyGWXXUaPHj0IDtZ8bBGpHLr8Lxckx+U+5v0nRo1gRGo9nhhlqn0jUusxIrUes8Z/UeGxHEjfXfZ8axb+UqHPlX3ceYv4heOv/bZsCe3amYFwvu3GfEJCzG1S+UpLzZ7ud95ppu7PmWNunzoV5s7VzISK9tRTcNVVZpbFlCnm6+DbbvKNN8zMhBdeMMcq0Q9oNpuNli1bMnbsWLp27crs2bN588032b59u9WhiUiA0KVFuSA5RW5scMr1+intOwEQm+A/60dtmPMm1upIRMpRSQkEB5vBb199Bbm5kJwMf/+7qd43aWLWIzscZru9efNMYgOqXla2t982sxNGjYJvvjHJP8C+fWaewuefm/kKUr583+d33WWG8PXte6Sr4pdf4P77zWA+h8Mk/7/8YoYp+n62JGCFhITQv39/2rdvz6RJk/j4449p27Yt/fv3Jzo62urwRMSP6a+PXJAsp/u0g/me/WJiuT2Xu7gYh2+d5Ek+Vlm8mPMW8Rter0lGsrLgkkugfXtTtZ8920wY/+tfoXNnuOUWs494rVpmCn/TpkcG80nlefZZ+M9/4Npr4d13wZcs9OoFjz+uxLKi2GzmZ6VevSOzKvLy4E9/gtdeM5X+V181y13Wr4drroHNm83XRxfEBKhVqxa33347K1euZPr06WzatIk+ffrQpUsX7Jq1ISIVQK8I5LxlZmXx53vvZMns6cTEJ3DNPQ+ccMyI1HoAjH3mBfpeM5LMfRm88cT/sWvTevKyswGo3bAR/a69icG3ji6bVjumb1cOZqRz1Z1jyM/JJm36FBq3bMPTH39d9pijfvdHNq1cxsqf59B9wBBGjvtt2fNmHdjHc+PuZOXPc4hNqMmIex+k37U3Hfn4/n3876XnWD5vNnk5WSTUrkvfa0Zyzd33E/TrC+W5E8Yz6eN32b97J4X5eYRFRNKsbQdufPD/aNGuIx6vV0P6pPo7enr+q6+ahOXTT81e4ps3w4svwqOPmnX799xjEpmoqCPrkZXoV76sLNO+D+brERlp3g4NNR/zDYiT8nf07/xZs8xa/Ro14IMPzNBKx6+zXPr2NR0Y//qXafvX3wr5lc1mo0OHDrRo0YKZM2cydepUVqxYwZAhQ6hfv77V4YmIn9FlRDlvd/5mNL9MnUBxUREhYeF8/PzTbF278rT3OZydxfK5swCo37QZ4VFR7N68kQ/+8RemfvbhCcdP/uR95k/+npp16xMSFnbMx/730j9ZvWA+teo3JNhx7LC8N/78O3asX0tQUDAH9uzmrSf+j/RtmwHIy87i8RuGMGv8FxQVFlC/SQqZ+zL4/OV/8uYTj5Y9xpbVK9i1aQPRcfE0aNac4qIiVv48h6fuGEnmwQMUukvP59MmUrX4Ev1vvzUtyB07mvcdDrNm/8knzQWADz80W7w1aWISfVACY4WSEvN1mTDBvG+3Q5065u3Jk6Fx4yOT4qViRUebZH/ePLOkwuEwF88AMjLM8MTkZCsjlCosPDycIUOG8Jvf/AaAd999l4kTJ+J0Oi2OTET8iSr7cl62bt3KD999C8Cwu8Yy6rd/ZM+2LTx8Vd/T3q9WUkPemLGQWkkNAPB4PPzl1mtZtySNnyd/z5U333HM8RFRUfxz/DRq1q1PaemxyXXtBg155n8/EBUbR2lpKZl7M8o+dlGvfvz2xbfYuWk9v726Hx6Ph7WLFpDUJIUpn37Aob0ZxNVM5D8/zCI2oQaLZk7lubF38tO3X3LNPQ9Qt1FjBt50Ozc//Bih4aZKtnfndsZdcQnOgnyWzpnBiM6tLvjzKFIl5OebVv31600y+bvfmdttNtOy3L49fPIJ5OSYNn6xTnAw/Pa38M9/mmn8eXmQlgbbtsE//mHa+KXieb2mu+Ljj4+8b7OZiy+bNpmhfVlZ0K2btXFKlZeUlMRdd93F4sWLmTVrFuvXry9b32/TBVURuUBK9uW8rF27tuztHgMGA1C/STMaNW/JtnWrT3m/oKBgvnvvdZbOmUH2gf2UHjU1OuvA/hOO7z5gMDXr1v/1vse2C/cedh1RsXEn/dilQ4djs9lo0LR52W25hw4CsHn1CgByDh3kzovbHnM/r9fL5lXLqduoMQWHc3nn6cfZtnY1BYdzOXqXyuwD+/Fo10rxF1FR8PPP8Mgj8MMPZiuxe+4BX0tpWJhJMrWmtGoYORL27zcDE1NSzPrx2FgzIG7cOKujCwxHJ2FHr8d/+mn429+ge3eYP99M5hc5A7vdTrdu3WjVqhU//vgj33//PcuXL2fw4MHU8nVSiYicByX7Uqk++McTzPjqMwDqNmpCVFwc+3ft4HB2Fp7SE9viY2uceqJ0XI3EU34sMtqMyg86alCV97jkPDwyiqRmJ74QCw0Lx1lQwF9H30TB4VxCQsNo3LINQQ4Hm1cuA8BTWqpkX/xLeDi8/rpJTj76yFSL+/c3a8Lffhuee87sHX70Gn+xzgMPmH/r1pn28aZN9XWxis1mhlmOHQt795oOi4ceMvMsVq82F8u8XmjQwPycaailnEJ0dDQjRoygY8eOTJ48mbfeeovu3bvTq1cvQrQ8R0TOg5J9OS+tWh1pYV84fQrN2nYgY/tWdm5af9r7bVphkuX2l/Tiiff+R7GriMdHDuFwdtZJjz9tC9t5trc1a9OeZXNmEhQczCP/fqNsSYEzP5+FM6bQrf+VbF2zioLDuQDc9/d/c+mQ4WxasZTHbxha9jgazid+x2aDhx82bft33WX2b7/pJjN8rH9/bSFWFeTlwcqVpuuicWNo1QqWLDFb8F188ZFuDKlcr75qlrx89ZX5muzZYzpkli+H3btN90yPHvDZZ0r05YyaNGnCmDFj+OWXX5g3bx5r1qxh4MCBpKamqrVfRM6JXrXJeWnWrBmDh17FpAk/MP7tV1g4YwqZ+zKw24MopeSU92vUoiW7Nm9g5c9zuH9gT/Jzc/B4KrdCPvDmO5jx9f/I2r+X+6+8lKSmzXAWFJC5L4MSt5vew66jdoOGhEVEUFRYyOt/+i3j336Vw1mHjnkcJfviD7xeL16v99htn/r2NYn+LbeY9fz79plqpBJ96/haxZcvh7/8xVSPGzc2Sf6tt5qtEtu3N+83bmx1tIHDV6X/9FMoLjZD+1auhPvuM7sj3HQTXHSR2d3i9tvNlomPPKKt+OSMgoODueyyy2jbti1Tpkzhyy+/JCUlhSuvvJL4+HirwxORakI9f3LeXn/7HboPGExIaBiFeXmMvP9RmrfvdNr73P7Yk3S5/ArCIiJxFhRw9W/upXOf/pUUsRGbUINnv5hA32tGEh0Xz+4tmyguKqLlRd244/GnAIiKjeO3L75NUrPmeD1eHA4Hj7/x0TGPE2zXCzWp/tauXYvL5TphmQtJSTBpktnW7a23TJUyN9eaIMUkhwAbN5qlFd27m4nvX30Ft91mKv4NG5r93qXy+Kr0oaEm0QfTCWOzwZ/+ZOYo9OkDAwbAs8+aHS+Ki83HfZP7RU4jPj6eG2+8kZEjR7J//35ef/115s6dS0nJqQsrIiI+Nu8Jr/BEzo7H6+X7TfsIxG8gO3BV8zqq7ku1tnXrVj799FMuv/xyLrnkkpMf5PGYgWPLlpmqsVqQreGrID/3HPz4I8ycaf49/zw8+ij062eWYOzbB//7n9XRBq4DB0y7/gMPwIMPHvuxv//dDO3r399U90XOUXFxMXPmzCEtLY34+HgGDRpEkyZNrA5LRKow9WTKebPbbMSGOshxua0OpdLFhDqU6Eu1lp2dzddff03Tpk3p0aPHqQ+0201Vv6BAib6VfL9vkpLMlm7//S9MnGiG8/XsaT62bx9ocrc1Zswwg/hatTI/K0dP4Xc6YeFCs15//Xo4eNDsdhERoVZ+OSchISFl2/JNnjyZTz75hDZt2jBgwACifZ0lIiJHURu/XJCEcAeB9lLFhjlvkeqquLiYL774gvDwcK655ppj1+ufSmRkxQcmp+b7Gg0bBkOHwjPPmMFv995rksy1a01S2aGDlVEGpvx8M0dhzRpISIDhw03L/k8/wYIFZjeLBx6A7GzTdbFkifl5UqIv56lWrVrcdtttDBs2jG3btvHqq6+ycOFCPFoaIiLHURu/XJAduYUs2xd463g71YklOTbC6jBEzpnX6+Wbb75h06ZNjB49Wns4VzeHDsG2bWbtfosW0KyZmfS+aBFs2gRXXKGJ/FZ49lmzVn/FCrO93tNPm+345swx3RcjRpitLWPNtrDawlLKi9PpZObMmSxdupQ6deowePBgkpKSrA5LRKoIJftyQXKK3MzaeejMB/qZyxvVJDZM1X2pfn7++WdmzJjBddddd8wWmlLF+dbsP/aYWaufnGxuczhM0li7NrhcMG4ctG5tdbSBqXNn83VITjaV+2+/NUP7/vlPuPxyc4ySfKkge/bsYdKkSezdu5dOnTrRr18/wsPDrQ5LRCymZF8uiMfr5YfN+6jk3fMsZbfBVSkazifVj28g3yWXXMLlvuRDqpdvvoHFi6GkxOyOUFAAW7fCunVmDfjEidCli9VRBqbt2+G992DqVKhRA7p1MxV+H223JxXM4/GwZMkSZs2aRVBQEP369aNDhw7Y9H0nErCU7MsFW7I3h92HnQExld8GNIgJp3PdOKtDETkn2dnZvP322yQlJXHjjTee3Tp9qT7+/ndzAeCRR45sASfWKCoy2+vFxJj3fV0ZIpUkPz+fH3/8kdWrV9OwYUMGDRpE7dq1rQ5LRCygZF8uWJazmNm7Mq0Oo9L0aVSD+LAQq8MQOWvFxcW89957uN1u7rrrLrV2+qPiYjMBfsoUaNnS6mgETlnJ93q9qrRKpdi+fTuTJ08mMzOT7t2707t3b0JC9PpFJJBo6z25YAnhIcSGBpPrKrE6lAoXGxqsRF+qFa/Xyw8//EB2djajR49Wol/dbd9u1nyHhJj1+sHBpmq8bBnk5amqX5WcJKH3eDwUFRUREaEBr1LxGjduzJgxY/jll1+YO3cua9eu5YorrqBly5a64CQSIFTZl3KxM7eQpQEwlf+iOrE00hR+qUY0kM/P9O9vhrxFRZmp75GR4HbDtGlmCNwHH0BoqNVRyins3buX999/n5tvvpnk5GSrw5EAkp2dzdSpU9m0aRPNmjXjyiuvJCEhweqwRKSCKdmXclHq8TJp635K/HhSX7DdxuCmtQmy62q4VA8ayOeHZs2CnBzIyjryz+Mxrfs332wq/lJleb1ePvjgAwoLCxkzZgzBwWqwlMq1YcMGpk6dSn5+PpdeeimXXHKJvg9F/JiSfSk3aw/lsTEz3+owKkyLGlG0rqkWWakesrKyeOeddzSQT6SKOXjwIG+++SY9e/akT58+VocjAai4uJi5c+eyYMEC4uLiGDRoEE2bNrU6LBGpAHr1J+UmNSGKSEcQ/lb3tgGRjiBSE6KsDkXkrBQXF/PFF18QERHBiBEjlOiLVCGJiYn07NmT+fPnc/DgQavDkQAUEhJCv379GDNmDDExMfz3v//l66+/Ji8vz+rQRKScqbIv5SrTWcwcP5zM37thDRLC1R4rVZ/X6+Wbb75h8+bN/OY3v6FWrVpWhyQixykpKeHNN98kIiKCO+64Q8PSxDJer5fVq1fz448/4na76dOnD127dtVFYhE/oZ9kKVc1wkNIiY+0OoxylRIfqURfqo2ff/6ZtWvXMmzYMCX6fsy3neKOHTusDkXOQ3BwMEOGDGH37t0sW7bM6nAkgNlsNtq1a8e4ceNo164d06ZN4+2332b37t1WhyYi5UDJvpS7VjWj/aKd39e+30rr9KWa2LJlCzNnzuTSSy+lpfZa92tFRUWkp6fjdrutDkXOU3JyMh06dGD69OlqnxbLhYWFMXjwYO666y7sdjvvv/8+P/zwA4WFhVaHJiIXQMm+lLsgu40udeOsDqNcdKkbp+n7Ui1kZWXxzTffkJKSQu/eva0ORyqYy+UCIFTb7FVrAwYMICgoiKlTp1odiggA9erVY/To0QwaNIh169bx6quvsnz5crTqV6R6UrIvFSIhPISu9eKsDuOCdK0Xp/Z9qRaOHsh3zTXXaK1lAFCy7x/Cw8MZOHAg69atY9OmTVaHIwKA3W6nS5cujBs3jpSUFH744Qc++OAD9u/fb3Vo58Xj9ZJfXEJOkZssZzGHCl1kOYvJKXKTX1yCRxcyxI9pY02pMPWjw+lUx8uyfblWh3LOOtWJpX50uNVhiJyR1+vlhx9+ICcnh9GjRxMWFmZ1SFIJfMm+vt7VX5s2bVi1ahWTJk0iOTmZkBBdZJaqISoqiuHDh9OxY0cmTZrEW2+9Rbdu3ejdu3eVvdDo8Xo57Cohx+X+Nbl3c9jlxnOa+9iBmFAHCeEO4sIcxIU6iAkNxq7BmeIHlOxLhUqOjQCoVgl/pzqxZXGLVHW+gXzXX389iYmJVocjlUSVff9hs9kYNGgQr7/+OrNmzWLgwIFWhyRyjOTkZMaMGcOCBQuYM2cOa9euZeDAgbRs2bLK7CSR5SxmW04h6XlOPL8W6m3A2dTsPUCOy02uy112vN0GSdHhNI2PID5MF+Ck+lKyLxUuOTYCh93Goowc4Ox+8VY235+qrvXiVNGXakMD+QJXUVERgKrAfiI+Pp4+ffowY8YM2rVrR7169awOSeQYQUFB9OzZkzZt2jB16lS++uormjZtyqBBg0hISLAkplKPl915TrZmF5DrKjkhuT/X15tHH+/xwu7DTnYddhIbGkyz+EiSosM1x0mqHS3slEpRPzqcXg1rEOEIsjqUk4pwBNGrYQ0l+lJtaCBfYHO5XISEhGg+gx/p3r07tWvXZsKECXg8p2s6FrFOXFwcN9xwAzfccAOHDh3i9ddfZ/bs2ZSUlFRaDKUeL2sP5jFp636W7csl12Weu7yLSb7Hy3WVsHRfLpO27mftoTxKPVWxbCVycnqVIJUmITyEfsmJpMRHAli+NZ/v+VPiI+mXnKhhfFJtaCCfuFwutfD7GbvdztChQ9m/fz9paWlWhyNyWi1atGDs2LH06NGDefPm8frrr7Nly5YKf95MZzEzdhxkY1Y+JZWcdJd4vGzMzGfGjoNkOYsr9blFzpdeIUqlCrLbaFsrpkpU+SMcQfRuWIO2tWLUliXVhtfr5fvvvycnJ4cbbrhBA9oClJJ9/1SvXj26du3KTz/9RHZ2ttXhiJyWw+Hg8ssvZ8yYMcTGxvLpp5/y1Vdfcfjw4XJ/rlKPl9UHDjNnVyaF7tJyf/xzUeguZfauTFYfOKwqv1R5SvbFEjV+rfK3qBFFcCUn2sF2Gy1qRKmaL9XSzz//zLp16xg2bJgG8gUwJfv+q2/fvkRGRjJ58mTtbS7VQmJiIrfeeivXXHMNO3fu5LXXXmPBggXlthwl69dq/ubsAsD62U++59+cXaAqv1R5SvbFMkF2G61rRjO4aW0uqhNLbKiZF1neqb/v8eJCg7moTiyDm9amdc1oVfOl2tFAPvFRsu+/QkJCGDRoEFu2bGHNmjVWhyNyVmw2G23btmXcuHG0b9+e6dOn8/bbb7Nr164Letw9ec4qUc0/lUJ3KXN2ZbInz2l1KCInpWRfLBdkt9EoNoLLkxPp3bAGDWLCOToPP9eU/Ojj7TZoEBNOn0Y16JucSKPYCCX5Ui0dPZCvT58+VocjFnO5XFrC4ceaN29Oq1atmDp1Kk6nkgipPsLCwhg0aBCjR48mKCiIDz74gO+//57CwsKyY5YtW8aXX355xsr/jpxCFmbk4MX6av6p+GJbmJHDjtzCMx0uUulsXvWISRXk8XrJc5WQ7XKTU+Qmy+nmsMvN6f4s2IGYUAcJ4Q7iwhzEhzqIDg3GXkX2gBU5X8XFxbz33nuUlJRw1113KckT3nvvPWrWrMnVV19tdShSQfLy8njttddo2bKlvs5SLXk8HpYtW8bMmTOx2Wz069ePxo0b89prr1FaWsqVV15J165dT3rfHTmFLNufW8kRX7hOdWJJjo2wOgyRMsFWByByMnabjdgwB7FhDog1t3m8XgrdpZR4vHi85p/dZsNusxFstxHhCFJiL37n6IF8o0ePVqIvABQVFamN389FR0fTv39/Jk6cSPv27UlOTrY6JJFzYrfb6dy5M6mpqcyYMYMJEyYQFhZWVtGfMWMGqampxMTEHHO/PXnOapnoAyzbl4vDbtNWzlJlqI1fqg27zUZUSDBxYQ4SwkOoGRFKQngIcWEOokJUwRf/5BvIN3z4cA3kkzJq4w8MnTp1omHDhkycOLFS9zEXKU9RUVEMGzaMvn37UlRUVDZ4sqSkhClTphxzbJazmEUZORZEWX4WZeRoaJ9UGUr2RUSqKN9Avssuu4zU1FSrw5EqRAP6AoPNZmPIkCFkZ2czb948q8MROW9ut5slS5ZgO6ow4/V62bBhAxs2bADM9nqL9+ZYFGH5Wrw3R9vySZWgZF9EpAryDeRr3rw5vXv3tjocqUI8Hg/FxcVK9gNEYmIiPXv2ZP78+Rw8eNDqcETOy7Zt2zh8+DBerxebzYbdfiQF+frrr3G73aw7lEeBu7TKDuM7W16gwF3KukN5VociojX7IiJVTXFxMZ9//jkREREMHz78mEqISHGxaQ9Vsh84Lr30UtauXcuECRO444479DtBqp3mzZtz2223kZ+fT0FBAQUFBRQWFrJ//37y8vLILHSxObvA6jDL1ebsAupHh5EQHmJ1KBLAlOyLiFQhvoF8ubm5GsgnJ+VyuQAl+4EkODiYIUOG8NFHH7F06VI6d+5sdUgi58Rms51yyGSpx8uMHQexUXW32DsfNkw7f7/kRG37LJZRG7+ISBUyf/58DeST01KyH5iSk5Pp2LEjM2bMIC9P7cHiPzZk5ftF+/7xfO38G7LyrQ5FApiSfRGRKmLz5s3MmjVLA/nktHzJvro+Ak///v0JDg5m6tSpVociUi5KPV62+ln7/vG2ZhdoWJ9YRsm+iEgVkJWVxfjx4zWQT86oqKgIUGU/EIWHhzNw4EDWrVvHxo0brQ5H5IKl5zkp8fNEuMTjJT3PaXUYEqCU7IuIWMzlcvH5558TGRmpgXxyRmrjD2ytW7emWbNmTJ48uWxYo0h1tcXPq/o+gXKeUvUo2RcRsdDRA/lGjhyp1mw5I1+yHxKiCc+ByGazMWjQIJxOJ7NmzbI6HJHzluUsJtdVYnUYlSLXVUKWUxfnpPIp2RcRsdD8+fNZv369BvLJWXO5XISGhqoDJIDFx8fTu3dvFi1axJ49e6wOR+S8bMspJFB+i9kw5ytS2ZTsi4hYRAP55Hz4kn0JbN27d6d27dpMmDCB0tJSq8MROScer1nH7t+r9Y/wYuYTeLyBcsZSVSjZFxGxgAbyyflSsi8AdrudoUOHcuDAAdLS0qwOR+ScHHaV4Odz+U7g8UJegCxbkKpDyb6ISCXTQD65EEr2xadevXp069aN2bNnk52dbXU4ImWSk5Ox2Ww8+eSTJ/14jstd4THMGv8FI1LrMSK1XoU/19nKroTzFjmakn0RkUp09EC+G264QQP55Jy5XC5930iZPn36EBkZyaRJk/CqRViqiZwid8Cs1/exYc5bpDIp2RcRqURHD+SrWbOm1eFINVRUVKTKvpQJCQlh0KBBbN26lTVr1lgdjshZyXK6z3u9fmlpabWcU+HFnLdIZVKyLyJSSTSQT8qDy+XStntyjObNm9O6dWumTp2K0+m0OhyRMsXFxTzyyCPUqFGDWrVq8eCDD1LsdpPrcvPJv//Og0N6M6pLKte3acjoSzvyyu8fJPvA/rL7f/HKvxiRWo8xfbsy+7uvuK9/D25o24jMvRns2baFf9x7G3dc3JaRbZO5q9dF/O2um9m8avkJcWxYtpj/u/ZKbuzQhN9dM4BNK5ae9Dl+mTqB+6+8lJs6NuVPtwxnz7YtxzzOsrmz+PMt13BzpxRubN+EP908jNVpPx9zzA/vv8n9V17KjR2aMKpzCx65uh8fPf80AIddbiZOmkSPHj2Ii4sjIiKCZs2aMXLkSC3FkQqhZF9EpBJkZmbyzTffaCCfXDC18cvJDBw4kNLSUn788UerQxEp8+KLL/LRRx8RHh7OwYMHefnll3nr3ffwAivm/UTW/n3UrFOPOg2TyTl0gNnff8WzY+844XGyD+7n1ccfIigoiNgaZpvaF353H0t+mo6ntJQGKc3xejwsn/cTu7dsOuH+T//mBpwF+ZSWlLB93Rr+88i9lJYcOywv68A+Xnp0HDabjeKiItYvWchrf3yk7OM/T/6eZ+4ZxbolaUTHxROXWIv1Sxfx9G9uKEv4F8+axkfPP03G9q3USmpIfK3a7N25jQVTJ5rzyMpkxDXXkJaWRmxsLCkpKWRmZvLll1+Sm5tbXp92kTLBVgcgIuLvXC4XX3zxBVFRURrIJxdMA/rkZKKioujfvz8TJ06kXbt2NG7c2OqQRKhTpw7Lly8nNDSUpk2bkpGRwU+zZnFL36t54LlXaJDSArvd1B5nfPUpb/z5UbasXsG+XTuo0zC57HFK3G7ufvJZrrjhVrxeL16vl707tgPw+BsfktqpKwD703dhO8k0gFse+QODRv2GSR+/y/vPPMHBjHT27tpOUpOUsmNKS0p47PUP6dJ3AB/840kmfvQ2G5cvwVXkJDQsnP/++xm8Xi99R9zAfX/7NwD/fGA0C6dP4YtX/knb7peUxdTu4kv5y/tfAOAudrF1zSoADmXsobi4mOjoaDZs2EB4eDher5clS5aQmJhYzp99EVX2RUQqlAbySXlTsi+n0qlTJxo2bMjEiRMpKdEWX2K9q666itjYWMLCwsouQB08cACA7RvW8vtrr+TmTs0YkVqPN/78aNn9so5q5QcICQuj//W3AGCz2bDb7XTu0x+Av9x2HQ8Muozn7x/N8nk/EV+r1glx9Lr6WgCSmjUvuy330KFjjomIjqFL3wEANGh25CJAbmYmuVmZHNizG4BZ33zOtS3rc23L+iycPgWgbOlAh569CXaEsOqXedzRow1/vOlqPv7n3wgNDzePm9Kc5MaNycvLo1atWnTq1Inbb7+dvXv3EhkZefafWJGzpMq+iEgFmjdvHuvXr+eGG27QQD65YB6PB7fbrWRfTspmszFkyBDefPNN5s2bR58+fawOSQJcXFxc2dvBwSbt8Hg9rF+6kFcfexCv10t0XDxJTZtTVFhA+tbN5pjjBvDFJNQo6wDweeC5l+nSdwBrFy1g99ZNLJ87i4XTJ7N78wbueuIfxxwbGRMLQFDQkdTn+N0rIqNjyt62H3Ucxx1Xu0EjYhJqnHCu7uJiGjZP5cWJPzFv4rdsX7+GHRvWsWHZe8z8+jNemjSHxHpJzJi/gMnffMnChQtZt24dn3zyCR9//DFffvkl11133Uk/jyLnS8m+iEgF2bRpEz/99BO9evWiRYsWVocjfsDlcgEo2ZdTSkxM5NJLL2XevHm0bt2aWiepcopYyYaNzSuXlyXbL/wwi/hatRn/9it8+p9/nPI+x1u3ZCHd+l9Jz8HDAMruv27xwnKPOTahBon1kjiYkU6TVm15+N+vE/TrxYuM7Vs5mJGOIySEjB3bsNvtXD/WrPV3Fxdz58VtKczPY8vqlUTGxLJl7z7GjRvH/fffD5h5G9OmTWPu3LlK9qXcKdkXEakAmZmZjB8/nhYtWtCrVy+rwxE/4Uv2tRxETqdnz56sWbOGiRMncscdd2hOiFQ5jVq0LHv74av6EpNQg9zMzHN6jJd//wD5udnUrFOP0PDwssF8Rz92ebr54cd48dFxLJg2kbWLF1Cjdh2yDx4g59BBeg+7nvaX9GLd4gW88edHiU+sTVxiIrmHDlGYn4c9KIgGzZqTm3mIUVf0Ij4+nqSkJIqLi9m4cSMA7dq1q5C4JbBpzb6ISDnTQD6pKKrsy9kIDg5myJAh7N69m6VLl575DiKVyGaD9pf0YtTv/khCrToUu4qo36QZdz958qr+qfS9ZiQNmrXgcHY2u7dsJq5mIv2vv4XRf/57hcR96dBr+MObH9O6Sw+Ki4rYs30rYZFR9L76OvpddyMAjVu2pVv/Kwl2OEjfspkiZyHN21/E7158m6SmKUTHxXPzrbdSu3Zttm/fzu7du0lNTeWZZ55h9OjRFRK3BDab9/gFKyIifsbj9VLoLqXE48XjNf/sNht2m41gu40IRxD2C0jIDx48yI8//kj//v1JTEzkyy+/ZNu2bdx1111apy/laufOnXz44YeMHTtW31tyRj/88APr1q1j7NixREdHWx2OCGD+Jn+/aR+BmIDYgaua17mg1xwi50Jt/CLiVzxeL4ddJeS43OQUuclyujnscuM5zX3sQEyog4RwB3FhDuJCHcSEBp/1H+N169axZcsWduzYQWpqKhs2bNBAPqkQquzLuejfvz+bNm1i6tSpWgssVYbdZiM21EGOy211KJUuJtShRF8qlZJ9EfELWc5ituUUkp7nxPNrucAGZ1U58AA5Lje5LnfZ8XYbJEWH0zQ+gviwkNPePz09HYCSkhLWrFlDgwYNSElJOe19RM6Hkn05F+Hh4QwcOJBvvvmGjRs3alCoVBkJ4Y5j/uYGAhvmvEUqk9bsi0i1VerxsiO3kJk7DjJ7Vya7Dx9J9OHsEv2jHX28xwu7Dzv5aWcmM3ccZGduIaWeEx/R6/WWJfs+u3fv5rPPPqO4uPgcIxA5PZfLhc1mw+HQC0Y5O61bt6ZZs2ZMnjy57GKRiNXiwhwBleiDeY0RF6bf3VK5lOyLSLVT6vGy9mAek7buZ9m+XHJdJcC5J/dn4nu8XFcJS/flMmnrftYeyjsm6c/JyaGoqOiY+9lsNrZu3cq+ffvKOSIJdC6Xi9DQUA19lLNms9kYPHgwTqeTn376yepwRACICw3MpDc+QM9brKM2fhGpVjKdxSzZm0OBu7TSn7vE42VjZj7ph510qRtHQnjIMVV9m82G1+ulVatWXHLJJdStW7fSYxT/VlRUpBZ+OWdxcXH07t2b6dOn07ZtW+rXr291SBLgzFwcOEnDnN+y2yA6VKmXVC59x4lItVDq8bLuUB6bswuwuqZZ6C5l9q5MUuIjWb5iJQB2u52LLrqIHj16EB8fb3GE4q98lX2Rc9W9e3dWr17NhAkTuOuuuwgKCrI6JAlgdpuNpOhwdh92BkQ7vw0zB0jD+aSyKdkXkSovy1nM4qOq+Va/MPA9/+bsAmIvuow2NRK5svelREREWBqX+L/i4mLCwsKsDkOqIbvdztChQ3n33XdJS0vjkksusTokCXBN4iLYddhpdRiVwgs0jddrBKl8WrMvIlXanjwnc3ZlUmhB2/7Z8AQ5sDdtR3aprtZLxVMbv1yIevXq0a1bN2bPnk12drbV4UiASwgPITZA2tpjQ4PPuLOPSEVQsi8iVdaOnEIWZuTgxfpq/qn4YluYkcOO3EKrwxE/pzZ+uVB9+vQhMjKSSZMm4fVW1d+sEiiaxUdaHUKlCJTzlKpHyb6IVEk7cgpZtj/X6jDOybJ9uUr4pUIp2ZcLFRISwuDBg9m6dStr1qyxOhwJcEnR4QTb/bszLthu5hOIWEHJvohUOXvynNUu0fdZti+XPXmBsQZRKp+SfSkPKSkptG7dmqlTp1JYqAuUYp0gu42mfl71bhofSZCfX9CQqkvJvohUKVnOYhZl5FgdxgVZlJFDlrPY6jDEDynZl/IycOBAPB4P06dPtzoUCXCpCVFEOoIs32mnvNmASEcQqQlRVociAUzJvohUGaUeL4v35lgdRrlYvDeH0kDaQFgqhZJ9KS9RUVH069ePFStWsH37dqvDkQAWZLfRuW5clZ3Nc768QJe6carqi6WU7ItIlbHuUB4F7tJq/wffCxS4S1l3KM/qUMSPlJaWUlJSomRfyk2nTp1o2LAhEydOpKSkxOpwJIDVCA8hxc/a+VPiI0kI1wR+sZaSfRGpEjKdxWzOLrA6jHK1ObtA7fxSblwuFwBhYWEWRyL+wmazMWTIEHJzc5k7d67V4UiAa1Uz2i/a+X3t+61qRlsdioiSfRGxXqnHy5K9OdX+D/zxbKidX8pPUVERgCr7Uq4SExPp2bMnP//8MwcOHLA6HAlgQXYbXerGWR1GuVD7vlQVSvZFxHIbsvL9on3/eL52/g1Z+VaHIn7AV9lXsi/lrWfPnsTHxzNx4kS8Xn/7TSzVSUJ4CF3rxVkdxgXpWi9O7ftSZSjZFxFLlXq8bPWz9v3jbc0uUHVfLpiSfakowcHBDB06lN27d7N06VIAvF4vhw8ftjgyCUT1o8PpVCfW6jDOS6c6sdSPDrc6DJEySvZFxFLpeU5K/DwRLvF4Sc9zWh2GVHNK9qUiNWrUiI4dOzJjxgx2797NJ598wgsvvEBmZqbVoUkASo6NqHYJf6c6sSTHRlgdhsgxlOyLiKW2+HlV3ydQzlMqjgb0SUXr27cvHo+HDz74gB07dgCQlZVlbVASsJJjI+hWLw4bVNmZPr7YutWLU6IvVVKw1QGISODKchaT6wqM7Z5yXSVkOYu1jk/Om8vlwm63ExQUZHUo4ocyMjL47rvvcLvdx9yel3d+W4h6vF4K3aWUeLx4vOaf3WbDbrMRbLcR4QjCbquqKZxUFfWjw+nVMIjFe3MocJdaHc4JIhxBdKmrNfpSdSnZFxHLbMspxAZ+N5jvZGyY89ULAjlfRUVFhIaGYlOCJBVgypQpHDx48Jjb7Hb7WSX7Hq+Xw64SclxucorcZDndHHa58ZzmPnYgJtRBQriDuDAHcaEOYkKDdQFATpAQHkK/5ETWHcpjc3aB5a8bfM+fEh9Jq5rRmrovVZqSfRGxhMdr1rEHQqIP5oVBep6TTnVi9WJWzovL5VILv1SYESNGMGXKFDZt2oTNZsPr9eLxeMjPP/VuIlnOYrblFJKe58Q3euVsEzEPkONyk+tylx1vt0FSdDhN4yOID9OFUTkiyG6jba0Y6kWHscTiKr+q+VKdKNkXEUscdpXg53P5TuDxQp6rhNgwh9WhSDXkcrk0nE8qTFxcHDfeeCObN29m0qRJ5ObmAnDgwIFjjiv1eNmd52RrdgG5rpITkvtz/bV+9PEeL+w+7GTXYSexocE0i48kKTpclVMpU+PXKv+GrHy2ZhdU6oDfYLuNpvGRpCZE6XtSqg0l+yJiiRyX+8wH+aFsl1vJvpwXJftSGVJSUhg3bhzz5s1j7ty5Za39pR4vGzLz2ZpzbIJV3qmW7/FyXSUs3ZfLygOHlWDJMYLsNlrXjCY1IYr0PCdbTnHh6UL5Hi8uNJimuvAk1ZSm8YuIJXKK3MdM131i1AhGpNbjiVEjKuT5vnjlX4xIrceI1HoV8vhnw4Y57+M9+eST2Gw2kpOTKz0mqT6U7EtlCQ4Opk+fPtxzzz1cd911ZDqLmbHjIBuz8it9q9QSj5eNmfnM2HGQLGdxpT63VG1BdhuNYiO4PDmR3g1r0CAmnKNz8XNNy48+3m6DBjHh9GlUg77JiTSKjVCiL9WSKvsifiI5OZmdO3ee9pi//OUvPPnkk5UT0BlkOd3Vdr3+moW/8Jfbrj3mtrCISGrWq8+lg4cx5La7CYs4cQseL+a8j5eUlES3bt2oW7fuOcfSu3dv5syZw2233caHH354zveX6sPlchETE2N1GBJAEmvVZt2hPJbvyrR867NCdymzd2VqKJqcVEJ4CAnhIXSqE0ueq4TsCxgWGR/qIFrDIsVPKNkX8RMdO3akTp06AKSnp7Nnzx4AOnToUFYNTEpKOq/HLi01g3DKa8svj9dLrp+08ddu0IiYhBocythD+pZN/O+l59m8ajmPv/HRSY8/7HKXbUHlM3r0aEaPHl1ZIUs1pcq+VKYsZ/Ex251ZfXHW9/ybswvIyC/SgDQ5KbvNRmyYwyyXizW3aRtICWRq4xfxE99++y1paWmkpaUdkzgeffs111zD2LFjadCgAQ6Hg9q1a3PLLbewa9eusuOPbin/+OOPadq0KSEhIezevZuNGzdy1VVXUatWLUJDQ0lKSuLKK69k0aJFgLnIMGjQIBo0aEB4eDjh4eG0adOGF198Ea/3yEvFPQcO8c+H7uHGDk24p09npn3+8UnPyV3s4vOX/8nYKy5hZNtG3HFxW177w8Mczs487efC6/Xy2YvPcVu31ozqksq7f/0jJe6TX1yY88M3/N+1V3Jjhybc3CmFv46+ie3r15z15/3aex/i2S8m8tbsJaS07wTAkp+mk5+bA0BeTjbvPP04d/e+iOvbNOT2S9px0803n/Jz7pOcnIzNZuP3v/8948aNo0aNGtSqVYsHH3yQkpISAGw2G3PmzAHgo48+wmazYbPZ2LFjBwAbNmzguuuuIzExkZCQEFq2bMkbb7xxTPyTJ0+mR48exMXFERERQbNmzRg5ciTZ2dln/TmQyqFkXyrLnjwnc3ZlUlgF9zUHU+WfsyuTPXlOq0ORasBusxEVEkxcmIOE8BBqRoSSEB5CXJiDqBBV8MW/KdkXCRBFRUX06tWL119/nX379tG8eXMOHz7Mp59+So8ePU7YXzkjI4Pbb7+d4OBgateuDcCNN97IhAkTKCkpoXXr1ng8HqZOncq6desAOHToEFOmTAGgZcuWxMTEsHbtWh5++GFef/31sscee8/dLJg6geKiIkLCwvn4+afZunblCTE/f/9ovnr9BQ6k76J+kxRKiouZNf4L/jxqBK6iU7/Im/Lf9/nmzZfIz80mPDKSX6ZOYPJ/3zvhuO/efY2X/+9+tq5ZSc069YiIimbF/Nn86eZhpG/dfO6f5OMUu4p4YtQIpn72ETmHDlI3uQnO/Hy++N//Tvo5P5kXXniB//3vf4SHh3Pw4EFefvllPvjgAwC6detGdHQ0ADVr1qRbt25069aN0NBQNm/eTPfu3fn666/xeDy0aNGCjRs3ct999/H0008DcPDgQYYPH05aWhqxsbGkpKSQmZnJl19+WTaJW6qOoqIiJftS4XbkFLIwIwcv1lfzT8UX28KMHHbkFlodjohIlaVkXyRA/O9//2PNGlOx/uqrr1i7di0///wzdrudjIwMXn311WOOd7vdvP7662zcuJE9e/bQsGFDNm82CfCECRNYtmwZGRkZbNu2jd69ewPQuHFjtm/fzu7du1m2bBl79+7lsssuA+Dzzz8HYOvWrUz4/jsAht01llemzOP5r6fiLj528NLaRQtYNmcmAE9++BX/+X4GL0+eS0hYGOlbNjFv4renPNfv3jMXFlpe1JU3ZizkjRlpJNQ+dj28y1nIl6/9B4CR9/+OV6bO581Zi2japj1FhYV889bLZ/V5/fqNF3ls5BDu6d2ZzSuXAdC5T3+iYuOYP/E7dm3eAMBvX3yLlybO5u+ffXfKz/nJJCUlsW3bNrZs2UK9ema44MyZ5vOSlpZGp06mm2Dw4MFlHRx169blmWeeITc3lzZt2rB7925Wr17NCy+8AMCzzz5LXl4eu3btori4mOjoaDZs2MDKlSvJyspi0aJFJCYmntX5S+Xwer2q7EuF25FTyLL91etC37J9uUr4RUROQcm+SIBYvHgxABEREQwbNgyATp060aJFCwCWLFlyzPHh4eHcfffdgGkXt9vtDB06FIA+ffrQsmVLRowYwdSpU8sGywUHB/P888/TqFEjHA4HQUFBzJ07FzCdAgBr164te44eAwYDUL9JMxo1b3nM829evbzs7SdGXcOI1HqMvqwjxUVF5uO/JtbHK8zPI3PfXgA69x1AUHAwoeERXNSr3zHH7d6yCZfTdAf4JvVf36YhW9eYDoNNp3j84+3fvZPNK5fhLMgjqVlzbnjgUR7+t2mV3/LrY4WGh9Ot35UANGndjmbNmwMnfs5P5qqrriI2NpawsDAaN25snnP//jPez7e0Ys2aNURGRmKz2XjooYcAcDqdrFq1itatW9OkSRPy8vKoVasWnTp14vbbb2fv3r1ERkae1flL5SgtLcXj8RAWFmZ1KOKn9uQ5q12i77NsX65a+kVETkID+kTkpBITE7Hbj70e+PHHH3PVVVcxe/Zs1q1bx+TJkxk/fjxr1qzhtdde46GHHuLdd98FzF7NCQkJbN26lUOHDpUN+TsfvrXwR4urWeu8H+94SU1TCI+KPua26Lj4s7rv2GdeoO81I8stluPFxcWVvR0cbH5lHz3/4Exq1qxJ06ZNT7g9KCiIsLAwli5dyieffMLChQtZt24dn3zyCR9//DFffvkl11133QXHL+Wj6NeLXKrsS0XIchazKCPH6jAuyKKMHHo1DNLQPhGRoyjZFwkQXbp04Y033qCwsJDvvvuOYcOGsWzZMjZu3AhA586djznedpKBNfPmzWP48OHccMMNgGkHf/zxx8uq92lpaQAMGDCAadOmUVRURPfu3Tl06FDZY7Rq1ars7YXTp9CsbQcytm9l56b1xzxXszYdyt6+5u5xdL18IAClJSWsWjCP+o2bnfQ8I6KiqVGnLpn79rLkp+kMve1uStzFLJs785jjGjRrTkhYGMVFRXTo2YfbH/tL2TlvW7e6rIPgQjRr055pgMvpZOGMKXTrdyXb1q5iy6ZNwImf8/MR8esWfwUFBcfc3qVLF9atW0dsbCyTJ08mISEBMHMVZs6cSffu3Tl8+DDr169n3Lhx3H///QAMHDiQadOmMXfuXCX7VYjL5QKU7Ev5K/V4Wbw3x+owysXivTn0S07UtnwiIr9Ssi8SIG688Ub+85//sGbNGq677jqaN2/Otm3b8Hg81KtXj3Hjxp3xMUaNGkVWVhYNGjQgIiKirCW/Xbt2Zf+vWbOGH3/8kRYtWpCVlYXHc+zuts2aNWPIVVcz8YfvGf/2KyycMYXMfRnY7UGUUlJ2XJtuF9OhZ29WzJ/Nc2PvpF7jptiDgjiUkU5RYSFPffQ1tZIanDTOq+68lw+eeYL1SxZyb79ulJaUUHD48DHHhIZHcN29D/PpC/9g4kdv88uUH4hJSODQ3r3k52Zz/dhHSO3U5Zw+x8frOWQYEz58m12bN/Dvh+6hbnITDuzedU6f8zNJTU1lypQpjB8/nk6dOlGrVi2mTp3K448/zrfffsvWrVtp0KABzZs3Jysriz179pCUlMTIkSM5cOAAF198MfHx8SQlJVFcXFx28cf3NZWqQcm+VJR1h/LKtterzrxAgbuUdYfyaFsrxupwRESqBK3ZFwkQYWFhzJkzh/vuu486deqwadMmoqOjufnmm1mwYMFZDWS74447aN26NYcOHWLdunXUqVOHu+++u2zQ3H/+8x+uvvpqoqKiyMvL49FHHy1b53+0D95/j+4DBhMSGkZhXh4j73+U5idp1f/9a+9z3X0PU7dREw6k7yLn4EHqN0nh2nsfomHzFqeMc9AtdzL8rnFExcZRmJfHRb37MfjW35xw3DX33M/9z75Es7YdyD+cw75dO4itUYMBN9xKtwGDzvj5OJOQ0DCe/uQbBt50G3E1E9m7YxthkZHcdA6f8zP53e9+R79+/YiIiGD58uVlcwBatGjBggULuO6668ouzHg8HgYOHMhf//pXAGrUqMHtt99O7dq1ywYrpqam8swzzxyzfaNYT8m+VIRMZzGbswvOfGA1sjm7gCxn8ZkPFBEJADbvuSz+FBEpJ7N2HCLH5bY6jEoXF+qgb3JNq8OQambDhg188cUXPProo2VLN0QuRKnHy4wdByl0l1bZLfbOhw2IcASpnV9EBFX2RcQiCeEOAu1lmA1z3iLnylfZDwnR8DEpHxuy8inws0QfjrTzb8jKtzoUERHLKdkXEUvEhTn87kXmmXgx5y1yroqKiggKCirbkUHkQpR6vGz1s/b9423NLqDUE2h/ZUREjqVkX0QsERcamElvfICet1wYl8tFWFiY1WGIn0jPc1Li54lwicdLep7T6jBERCylZF9ELBETGkygLae02yA6VJVZOXcul0vD+aTcbPHzqr5PoJyniMipKNkXEUvYbTaSosMDZt2+DUiKDsduC5QzlvKkZF/KS5azmFxXyZkP9AO5rhJN5heRgKYSk4hYpklcBLsOB0abpRdoGq8p6nL2Dhw4wOzZs3E4HKSnp1NaWsr8+fMJCwujTZs2auuX87ItpxAbBMTMFBvmfBPCNdhSRAKTkn0RsUxCeAixocEBUWWKDQ0mPkwvOOXsHT58mPXr12Oz2fDtkjtr1iy8Xi8hISG0a9fO4giluvF4zTr2QEj0wVzQSM9z0qlOrLqqRCQgqY1fRCzVLD7S6hAqRaCcp5SfJk2aEBsbW5boA3i9XmJiYmjVqpWFkUl1ddhVgp/P5TuBxwt5AXBBWUTkZJTsi4ilkqLDCfbzSX3BdjOfQORc2O12unfvfsLtV1xxhbbgk/OS43JbHYIlsgP0vEVElOyLiKWC7Daa+nnVu2l8JEF+fkFDKkaHDh2OSewbNGhAy5YtLYxIqrOcIvd5DUV9YtQIRqTW44lRI8o9plOZNf4LRqTWY0RqvQt6HBvmvEVEApGSfRGxXGpCFJGOIL+bzG8DIh1BpCZEWR2KVFNhYWF07Nix7P0rr7wSm9Yey3nKcrqr3Hp934WEVx57qEIe34s5bxGRQKRkX0QsF2S30bluXJV7EXqhvECXunGq6ssF6datG2Cq+nXr1rU4GqmuPF4vuQHazn7Y5cbj9be/MCIiZ6ZFfyJSJdQIDyElPpLN2QVWh1JuUuIjteWTnDOP10uhu5QSjxeP14s3PIr+V19Dk+Rk8otLiHAEabK4nLNCd+lZXVDNz83hzb/8nqWzpxMTn8A19zxwwjHuYhffvPky8yZ9x6GMdCKiY+jcux+jHv0TMfE1ANi+fg0fPfc0u7duIj8nh6DgIJKaNmfwraPpdZVZDnB0i/7s775k9ndfAvDGjIXHPN+GZYt5/5kn2L1lI/WbNOPuJ/5B8w4XnfW5e349/6gQvewVkcCi33oiUmW0qhlNRn7RWb8orapsQIQjiFY1o60ORao4j9fLYVcJOS43OUVuspxuU4U8/sDwmuzbnw/kYwdiQh0khDuIC3MQF+ogJjRYFwDktErOcgz/63/6HQunTwYgJCycj59/+oRjnr9/NMvmzMQeFESDZi04uGc3s8Z/waZVy3n+6ymEhoVzYM9u1i76hRp16tEgpTkH96Szdc1KXv6/+4mKieWi3v1Iad+J9C2bcBbkExOfQO2GyQA4Qo69SPr0b26gRp16lJaUsH3dGv7zyL289uMvBJ3DoMqzPX8REX+iZF9Eqowgu40udeOYsyvT6lAumNr35XSynMVsyykkPc9ZthWaDc7qIpcHM1U913Vk/bXdZna2aBofQXyYuknkRGfTxr5v146yRH/YXWMZ9ds/smfbFh6+qm/ZMWsXLWDZnJkAPPnhV7Tu0p3sA/u5b0AP0rdsYt7Eb+l37U00b38R78xdTlzNRACKXUU8fNXl7Nu5nfmTv+ei3v149ouJPDFqBGsXL6BTr37c/+yLJ43rlkf+wKBRv2HSx+/y/jNPcDAjnb27tpPUJKVcz19ExN8o2ReRKiUhPISu9eJYmJFjdSjnrWu9OLXvywlKPV525znZml1ArqvkhOT+XFORo4/3eGH3YSe7DjuJDQ2mWXwkSdHhuuAkZc4m2d29ZWPZ2z0GDAagfpNmNGrekm3rVgOwefXysmOeGHXNCY+xeeUy+l17EzabjY+ee4rVaT+Tm3UIT2lp2THZB/afU+y9rr4WgKRmzctuyz10SMm+iMgZKNkXkSqnfnQ4nep4WbYv1+pQzlmnOrHUjw63OgypQko9XjZk5rM1p+CYVuLyTj18j5frKmHpvlxWHjhM0/hIUhOilPRLhSzzSGnf6YTb4mrWAuCl/xvHql/mYbPZSGrWnLCIyLKW/aMT/7MRGRMLQFDQkZet3nNM3rXMRUQCkZJ9EamSkmMjAKpVwt+pTmxZ3CIAmc5iluzNocB9bslNeSjxeNmYmU/6YSdd6qrbJNCdTbKb1PRI5Xzh9Ck0a9uBjO1b2blpfdntzdp0KHv7mrvH0fXygQCUlpSwasE86jduBsCmFcsA6HfdzYx5+nnycrJ5eGhfnAX5xzxnSLi5OOpyFp7fiZ0lJfsiEoiU7ItIlZUcG4HDbmPRry39VbEJ0/fysWu9OFX0pUypx8u6Q3lszi7A6hSj0F3K7F2ZpMRH0qpmtKr8ASr4LL7udRs1pmu/gSyaMZXxb7/CwhlTyNyXgd0eRCklALTpdjEdevZmxfzZPDf2Tuo1boo9KIhDGekUFRby1EdfUyupAY1atGTj8iXM/Poz1i9bRPaB/dhOknDXb9yM5XNnsXD6ZH53zQBiE2ry53c/s+T8RUT8jd3qAERETqd+dDi9GtYgwhFkdSgnFeEIolfDGkr0pUyWs5gZOw6WbSNp9UUq3/Nvzi5gxo6DZDmLLY1HrBHhCDqrC0/3/e3fdB8wmJDQMArz8hh5/6M0P65d//evvc919z1M3UZNOJC+i5yDB6nfJIVr732Ihs1bADDuHy/SptslOEJDKXY6uePxp2jUvOUJz3f1nWNod/GlhISFs33dGrauWVkep3sMO1TZvyEiIhXJ5j3XRU8iIhY4vlJq5S8u3/OrUirH25PnVCeKVFmzdhwix+W2OoxKFxfqoG9yTavDEBGpdKrsi0i1EGS30bZWTJWo8kc4gujdsAZta8Uo0ZcyO3IKWZiRg5eqmegDZbEtzMhhR27FrpGWqich3GH5spLKZsOct4hIINKafRGpVmqEh9AvOZENWflszT52unlFC7bbNN1cTmpHTiHL9lefYZJwZPilhkoGjrgwR5W9EFVRvJjzFhEJREr2RaTaCbLbaF0zmtSEKNLznGw5xb7lF8r3eHGhwTTVvuVyCnvynNUu0fdZti8Xh92mlv4AERcamElvfICet4iIkn0RqbaC7DYaxUbQKDaCLGcx23IKSc9z4iv2n2vyf/TxdhskRYfTND6C+DBtWSYnl+UsLlujX10tysihV8Mgbc0XAGJCg7HboBIboixnt0F0qF7uikhg0oA+EfErHq+XPFcJ2S43OUVuspxuDrvceE5zHzsQE+ogIdxBXJiD+FAH0aHB2pdZTqvU42XGjoMUukurdWu0DTOHol9yojpXAsCSvTnsPuys1t+zZ8sGNIgJp3PdOKtDERGxhC51iohfsdtsxIY5iA1zQKy5zeP1UugupcTjxeM1/+w2G3abjWC7jQhHkBJ7OWfrDuVR4C61OowL5gUK3KWsO5RH21oxVocjFaxJXAS7DjutDqNSeIGm8ZpJISKBS8m+iPg9u81GVIh+3Un5yXQWszm7wOowytXm7ALqR4epnd/PJYSHEBsaTK6rxOpQKlxsaLCWYYlIQNPWeyIiIueg1ONlyd4cv9vCzAYs3ptDaSAt6A5QzeIjrQ6hUgTKeYqInIqSfRERkXOwISufgmq+Tv9kfO38G7LyrQ5FKlhSdDjBfj6fIdhuI0m7TIhIgFOyLyIicpZKPV62+ln7/vG2Zheouu/nguw2mvp51btpfKQGTopIwFOyLyIicpbS85yU+HkiXOLxkp4XGAPcAllqQhSRjiC/XI4S6QgiNSHK6lBERCynZF9EROQsbfHzqr5PoJxnIAuy2+hcN84vl6N0qRunqr6ICEr2RUREzkqWszggJpgD5LpKyHIWWx2GVLAa4SGk+Fk7f0p8pHaUEBH5lZJ9ERGRs7Atp9DvWp5PxYY5X/F/rWpG+0U7v699v1XNaKtDERGpMpTsi4iInIHHa9ax+1vL86l4MfMJPN5AOePAFWS30aVunNVhlAu174uIHEvJvoiIyBkcdpXg53P5TuDxQl6ALFsIdAnhIXStF2d1GBeka704te+LiBxHyb6IiMgZ5LjcVodgiewAPe9AVD86nE51Yq0O47x0qhNL/ehwq8MQEalylOyLiIicQU6R2/I1zV+88i9GpNZjTN+ulfJ8Nsx5S+BIjo2odgl/pzqxJMdGWB2GiEiVFGx1ACIiIlVdltNt+Xr9GnXqktK+E/GJtSrl+byY85bAkhwbgcNuY1FGDoDl3/cn47vw1rVenCr6IiKnYfN6NX1HRETkVDxeL99v2lclk56KZgeual4Hu83qvgapbFnOYhbvzaHAXWp1KCeIdATRpa7W6IuInIkq+yIiIqdR6C69oER/TN+uHMxIZ9hdYykqKGD+pO/wlJZy6dBruOPxJ3GEhPLJv//Okp+mk7V/Hy5nITHxNWh/8WXc8ts/EF+rNmDa+L987T8k1kvizVmLjn3s0fdRVFjI/EnfYw+y03PwMG7//V8ICr6wP/OeX88/KkQvFwJNQngI/ZITWXcoj83ZBdiwtsrve/6U+Eha1YzW1H0RkbOgv94iIiKnUVJOY/gnffQuYRERRETHcCB9F9P+9xGOkFDuePxJVsz7iaz9+6hZpx6lpSVkbN/K7O+/In3bZp77avIZH3viR+8QFhFFSFgYWfv3MvmT92iYkkr/62++4LjL6/yl+gmy22hbK4Z60WEssbjKH6FqvojIOdOAPhERkdMor73ma9atzxszFvLGjDR6Dh4GwNTPPqQg7zAPPPcKHy1cxwsTZvHy5LmMefp5ALasXsG+XTvO+NgJtevy+owFvPbjzyTUqgPA6rR55RJ3eZ2/VF81fq3yt6gRRXAlV9SD7TZa1IiiX3KiEn0RkXOkyr6IiMhplFeye1HvfoRHRQHQc/DVzJ/0HSXuYvbu2Eb6ti28+vhDZOzYSlFh4TH3yzqwnzoNk0/72F36DiAyOgaAWkkNyDqwj5xDh8olbiX7AqbK37pmNKkJUaTnOdmSXUCuq6Tc2/t9jxcXGkzT+EiSosPVsi8icp6U7IuIiJxGRQ+nK3a5ePWxB/F6vUTHxZPUtDlFhQWkb90MgKf0zK3TvkQfICjo1z/t5ZSkazifHC3IbqNRbASNYiPIchazLaeQ9DwnvtUe55r8H3283QZJ0eE0jY8gPkxVfBGRC6VkX0RE5DTKK9ldNmcGNzzwKOGRkfwyZQIAwY4Q1qTNx7cxzgs/zCK+Vm3Gv/0Kn/7nH+XyvBdKyb6cSkJ4CAnhIXSqE0ueq4Rsl5ucIjdZTjeHXW48p7mvHYgJdZAQ7iAuzEF8qIPo0GB9v4mIlCMl+yIiIqdRXmuUsw7s475+3QiPimb/7p0AXHHjrbTo2LnsmIev6ktMQg1yMzPL5TnLQ2Wv0Zbqx26zERvmIDbMAbHmNo/XS6G7lBKPF4/X/LPbbNhtNoLtNiIcQUrsRUQqmAb0iYiInEaEI4jySEkGjRrNZVeNoOBwLuGRUQwYOYpbfvsH2l/Si1G/+yMJtepQ7CqifpNm3P1kFanqY85f5FzZbTaiQoKJC3OQEB5CzYhQEsJDiAtzEBWiCr6ISGWweb2avCMiInI6s3YcIsflPq/7junblYMZ6Vw/9hFG3v+7co6sYsWFOuibXNPqMEREROQ8qLIvIiJyBgnhjnKp7lcnNsx5i4iISPWkZF9EROQM4sIc5bq9WHXgxZy3iIiIVE8a0CciInIGcaHnn/S+OWtROUZSueIv4LxFRETEWqrsi4iInEFMaDCBNpTeboPoUNUEREREqisl+yIiImdgt9lIig4PmHX7NiApOlwT00VERKoxJfsiIiJnoUlcRMCs2/cCTeMjrA5DRERELoCSfRERkbOQEB5CbIC0tceGBhMfFmJ1GCIiInIBlOyLiIicpWbxkVaHUCkC5TxFRET8mZJ9ERGRs5QUHU6wn0/qC7ab+QQiIiJSvSnZFxEROUtBdhtN/bzq3TQ+kiA/v6AhIiISCJTsi4iInIPUhCgiHUF+N5nfBkQ6gkhNiLI6FBERESkHSvZFRETOQZDdRue6cX43md8LdKkbp6q+iIiIn1CyLyIico5qhIeQ4mft/CnxkSSEawK/iIiIv1CyLyIich5a1Yz2i3Z+X/t+q5rRVociIiIi5UjJvoiIyHkIstvoUjfO6jDKhdr3RURE/I+SfRERkfOUEB5C13pxVodxQbrWi1P7voiIiB9Ssi8iInIB6keH06lOrNVhnJdOdWKpHx1udRgiIiJSAZTsi4iIXKDk2Ihql/B3qhNLcmyE1WGIiIhIBbF5vV5/2z1IRETEEnvynCzKyAGoklvz+Vbld60Xp4q+iIiIn1OyLyIiUo6ynMUs3ptDgbvU6lBOEOkIoktdrdEXEREJBEr2RUREylmpx8u6Q3lszi7AhrVVft/zp8RH0qpmtKbui4iIBAgl+yIiIhUk01nMEour/Krmi4iIBCYl+yIiIhWo1ONlQ1Y+W7MLKPFU3p/cYLuNpvGRpCZEqZovIiISgJTsi4iIVIJSj5f0PCdbsgvIdZWUe3u/7/HiQoNpGh9JUnS4knwREZEApmRfRESkkmU5i9mWU0h6nhNfsf9ck/+jj7fbICk6nKbxEcSHqV1fRERElOyLiIhYxuP1kucqIdvlJqfITZbTzWGXG89p7mMHYkIdJIQ7iAtzEB/qIDo0GLtNVXwRERE5Qsm+iIhIFeLxeil0l1Li8eLxmn92mw27zUaw3UaEI0iJvYiIiJyRkn0RERERERERP2O3OgARERERERERKV9K9kVERERERET8jJJ9ERERERERET+jZF9ERERERETEzyjZFxEREREREfEzSvZFRERERERE/IySfRERERERERE/o2RfRERERERExM8o2RcRERERERHxM0r2RURERERERPyMkn0RERERERERP6NkX0RERERERMTPKNkXERERERER8TNK9kVERERERET8jJJ9ERERERERET+jZF9ERERERETEzyjZFxEREREREfEzSvZFRERERERE/IySfRERERERERE/o2RfRERERERExM8o2RcRERERERHxM0r2RURERERERPyMkn0RERERERERP6NkX0RERERERMTPKNkXERERERER8TNK9kVERERERET8jJJ9ERERERERET+jZF9ERERERETEzyjZFxEREREREfEzSvZFRERERERE/IySfRERERERERE/o2RfRERERERExM8o2RcRERERERHxM0r2RURERERERPyMkn0RERERERERP6NkX0RERERERMTPKNkXERERERER8TP/D4azqMEngtNcAAAAAElFTkSuQmCC\n"},"metadata":{}}]}]}